[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "vicuna-7b_response": "Acrokeratosis paraneoplastica is a condition characterized by the development of thick, rough, and often discolored patches of skin on the fingers, toes, and sometimes the soles of the feet. These patches are caused by the body's immune system reacting to a cancerous or precancerous growth in the body.\nOne possible name synonym for Acrokeratosis paraneoplastica is \"hand-foot syndrome.\" This name is sometimes used to describe the condition when it is limited to the hands and feet, and does not involve other parts of the body.\nAnother possible name synonym for Acrokeratosis paraneoplastica is \"pachyonychia hystrix.\" This name refers to the thick, rough texture of the skin patches that are characteristic of the condition.\nIt's important to note that while these names may be used to describe similar conditions, they may not always be used interchangeably with Acrokeratosis paraneoplastica. It's always best to consult with a medical professional for a proper diagnosis and treatment plan.",
    "vicuna-7b_fact_raw": "1. Acrokeratosis paraneoplastica is characterized by thick, rough, and discolored patches of skin.\n2. The condition often affects the fingers, toes, and sometimes the soles of the feet.\n3. Acrokeratosis paraneoplastica is caused by the body's immune system reacting to a cancerous or precancerous growth.\n4. \"Hand-foot syndrome\" is a possible name synonym for Acrokeratosis paraneoplastica when it is limited to the hands and feet.\n5. \"Pachyonychia hystrix\" is another possible name synonym for Acrokeratosis paraneoplastica, referring to the thick, rough texture of the skin patches.",
    "vicuna-7b_fact": [
      "Acrokeratosis paraneoplastica is characterized by thick, rough, and discolored patches of skin.",
      "The condition often affects the fingers, toes, and sometimes the soles of the feet.",
      "Acrokeratosis paraneoplastica is caused by the body's immune system reacting to a cancerous or precancerous growth.",
      "\"Hand-foot syndrome\" is a possible name synonym for Acrokeratosis paraneoplastica when it is limited to the hands and feet.",
      "\"Pachyonychia hystrix\" is another possible name synonym for Acrokeratosis paraneoplastica, referring to the thick, rough texture of the skin patches."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: \"Hand-foot syndrome\" is not a synonym for Acrokeratosis paraneoplastica. Hand-foot syndrome, also known as palmar-plantar erythrodysesthesia, is a side effect of some types of chemotherapy.\n5. FALSE [correction]: \"Pachyonychia hystrix\" is not a recognized synonym for Acrokeratosis paraneoplastica. Pachyonychia congenita is a different genetic disorder affecting the skin and nails, and the term \"hystrix\" refers to a porcupine-like appearance, which is not specifically associated with Acrokeratosis paraneoplastica.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "vicuna-7b_response": "Weaver syndrome and Sotos syndrome are two distinct genetic disorders that have some similarities but also have distinct characteristics.\nWeaver syndrome, also known as Weaver-Wintle syndrome, is a rare genetic disorder that is characterized by a combination of physical and developmental abnormalities. The main features of Weaver syndrome include:\n* Short stature\n* Broad chest and wide-set shoulders\n* Wide nasal bridge\n* Low-set and posteriorly rotated ears\n* Abnormalities of the hands and feet, such as webbing between the fingers and toes\n* Delayed bone maturation\n* Intellectual disability\n* Speech and language delays\n* Behavioral and emotional problems\nSotos syndrome, also known as cytomegalic inclusion disease, is a genetic disorder that is characterized by a combination of physical and developmental abnormalities. The main features of Sotos syndrome include:\n* Large head size (macrocephaly)\n* Abnormal facial features, such as a flat face, full cheeks, and a wide forehead\n* Delayed bone maturation\n* Intellectual disability\n* Speech and language delays\n* Behavioral and emotional problems\n* Macrocephaly\n* Abnormalities of the hands and feet\n* Delayed bone maturation\nWhile both Weaver syndrome and Sotos syndrome have some similarities in terms of physical and developmental abnormalities, they are distinct disorders with different genetic causes and underlying mechanisms. Weaver syndrome is caused by mutations in the PHF8 gene, while Sotos syndrome is caused by mutations in the SOX18 gene.\nIn summary, while Weaver syndrome and Sotos syndrome share some similarities in terms of physical and developmental abnormalities, they are distinct disorders with different genetic causes and underlying mechanisms.",
    "vicuna-7b_fact_raw": "1. Weaver syndrome is characterized by a combination of physical and developmental abnormalities including short stature, broad chest, wide nasal bridge, and intellectual disability.\n2. Sotos syndrome is characterized by a combination of physical and developmental abnormalities including large head size (macrocephaly), abnormal facial features, and intellectual disability.\n3. Weaver syndrome is caused by mutations in the EZH2 gene (not PHF8 as stated in the answer, which is incorrect).\n4. Sotos syndrome is caused by mutations in the NSD1 gene (not SOX18 as stated in the answer, which is incorrect).\n5. Both Weaver syndrome and Sotos syndrome involve delayed bone maturation, speech and language delays, and behavioral and emotional problems.",
    "vicuna-7b_fact": [
      "Weaver syndrome is characterized by a combination of physical and developmental abnormalities including short stature, broad chest, wide nasal bridge, and intellectual disability.",
      "Sotos syndrome is characterized by a combination of physical and developmental abnormalities including large head size (macrocephaly), abnormal facial features, and intellectual disability.",
      "Weaver syndrome is caused by mutations in the EZH2 gene (not PHF8 as stated in the answer, which is incorrect).",
      "Sotos syndrome is caused by mutations in the NSD1 gene (not SOX18 as stated in the answer, which is incorrect).",
      "Both Weaver syndrome and Sotos syndrome involve delayed bone maturation, speech and language delays, and behavioral and emotional problems."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Weaver syndrome is characterized by rapid growth beginning in the prenatal period and continuing through the childhood years, broad chest, wide nasal bridge, and intellectual disability, but not typically short stature.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "vicuna-7b_response": "The JASPAR database is a repository of protein-protein interaction data that is widely used in bioinformatics research. Here is a list of the releases of the JASPAR database:\n1. JASPAR 2019: This is the latest release of the JASPAR database, which was released in 2019. It includes 83 datasets of protein-protein interactions, covering a wide range of organisms and functional categories.\n2. JASPAR 2016: This release of the JASPAR database was released in 2016 and includes 74 datasets of protein-protein interactions.\n3. JASPAR 2014: This release of the JASPAR database was released in 2014 and includes 66 datasets of protein-protein interactions.\n4. JASPAR 2012: This release of the JASPAR database was released in 2012 and includes 59 datasets of protein-protein interactions.\n5. JASPAR 2010: This release of the JASPAR database was released in 2010 and includes 52 datasets of protein-protein interactions.\nIt's worth noting that the JASPAR database is updated regularly, and new releases are made available periodically. Researchers can access the latest version of the JASPAR database through the official website of the JASPAR consortium (<https://jaspar.genereg.net/>).",
    "vicuna-7b_fact_raw": "1. The JASPAR database had a release in 2019 known as JASPAR 2019.\n2. JASPAR 2016 is a release of the JASPAR database that includes 74 datasets of protein-protein interactions.\n3. The JASPAR 2014 release includes 66 datasets of protein-protein interactions.\n4. JASPAR 2012 was released with 59 datasets of protein-protein interactions.\n5. The JASPAR 2010 release contains 52 datasets of protein-protein interactions.",
    "vicuna-7b_fact": [
      "The JASPAR database had a release in 2019 known as JASPAR 2019.",
      "JASPAR 2016 is a release of the JASPAR database that includes 74 datasets of protein-protein interactions.",
      "The JASPAR 2014 release includes 66 datasets of protein-protein interactions.",
      "JASPAR 2012 was released with 59 datasets of protein-protein interactions.",
      "The JASPAR 2010 release contains 52 datasets of protein-protein interactions."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: JASPAR 2016 is a release of the JASPAR database that includes new and updated profiles for transcription factor binding sites, not datasets of protein-protein interactions.\n3. FALSE [correction]: JASPAR 2014 is a release of the JASPAR database that includes new and updated profiles for transcription factor binding sites, not datasets of protein-protein interactions.\n4. FALSE [correction]: JASPAR 2012 is a release of the JASPAR database that includes new and updated profiles for transcription factor binding sites, not datasets of protein-protein interactions.\n5. FALSE [correction]: JASPAR 2010 is a release of the JASPAR database that includes new and updated profiles for transcription factor binding sites, not datasets of protein-protein interactions.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "vicuna-7b_response": "The viral KP4 protein is a viral protein that plays a critical role in the replication of certain viruses. The KP4 protein is found in the Kobuvirus family of viruses, which includes the Kobuvirus genus of baculoviruses.\nThe KP4 protein is a small, non-structural protein that is produced during the replication of the virus. It is thought to play a role in the regulation of viral RNA synthesis and the translation of viral RNA into proteins.\nIn addition to its role in viral replication, the KP4 protein has also been shown to play a role in the immune response to viral infection. It has been shown to inhibit the activity of the interferon signaling pathway, which is a key component of the host's antiviral response.\nOverall, the function of the KP4 protein is to help the virus replicate and evade the host's immune response.",
    "vicuna-7b_fact_raw": "1. The KP4 protein plays a critical role in the replication of certain viruses.\n2. The KP4 protein is found in the Kobuvirus family of viruses.\n3. The KP4 protein is involved in the regulation of viral RNA synthesis.\n4. The KP4 protein plays a role in the translation of viral RNA into proteins.\n5. The KP4 protein has been shown to inhibit the activity of the interferon signaling pathway.",
    "vicuna-7b_fact": [
      "The KP4 protein plays a critical role in the replication of certain viruses.",
      "The KP4 protein is found in the Kobuvirus family of viruses.",
      "The KP4 protein is involved in the regulation of viral RNA synthesis.",
      "The KP4 protein plays a role in the translation of viral RNA into proteins.",
      "The KP4 protein has been shown to inhibit the activity of the interferon signaling pathway."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific scientific context or a passage providing detailed information about the KP4 protein, it is not possible to determine the accuracy of these statements. The KP4 protein is not a widely recognized term in virology that can be addressed without specific context.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "vicuna-7b_response": "DITPA (3,5-diiodo-L-thyronine) is a thyroid hormone analog that has been used in experimental and clinical studies. It is structurally similar to L-thyronine, the natural form of thyroid hormone, but with an iodine atom replaced by a hydrogen atom and an additional iodine atom attached to the carbon atom that is two positions away from the iodine atom in L-thyronine.\nDITPA has been studied for its potential to treat a variety of thyroid-related conditions, including hyperthyroidism, hypothyroidism, and thyroid cancer. It has been shown to have a similar effect on the body as L-thyronine, but with a longer half-life and a more consistent release of hormones into the bloodstream.\nIn clinical studies, DITPA has been administered to patients through oral or intravenous routes. The safety and efficacy of DITPA have been evaluated in several clinical trials, and the results have been promising. However, more research is needed to fully understand the potential benefits and risks of DITPA as a treatment for thyroid-related conditions.\nOverall, DITPA is a thyroid hormone analog that has been studied in experimental and clinical settings. It has shown promise as a potential treatment for thyroid-related conditions, but more research is needed to fully understand its safety and efficacy.",
    "vicuna-7b_fact_raw": "1. DITPA (3,5-diiodo-L-thyronine) is a thyroid hormone analog used in experimental and clinical studies.\n2. DITPA is structurally similar to L-thyronine, with modifications including an iodine atom replaced by a hydrogen atom and an additional iodine atom attached to the carbon atom two positions away from the iodine atom in L-thyronine.\n3. DITPA has been studied for its potential to treat thyroid-related conditions such as hyperthyroidism, hypothyroidism, and thyroid cancer.\n4. DITPA has a longer half-life and a more consistent release of hormones into the bloodstream compared to L-thyronine.\n5. The safety and efficacy of DITPA have been evaluated in several clinical trials.",
    "vicuna-7b_fact": [
      "DITPA (3,5-diiodo-L-thyronine) is a thyroid hormone analog used in experimental and clinical studies.",
      "DITPA is structurally similar to L-thyronine, with modifications including an iodine atom replaced by a hydrogen atom and an additional iodine atom attached to the carbon atom two positions away from the iodine atom in L-thyronine.",
      "DITPA has been studied for its potential to treat thyroid-related conditions such as hyperthyroidism, hypothyroidism, and thyroid cancer.",
      "DITPA has a longer half-life and a more consistent release of hormones into the bloodstream compared to L-thyronine.",
      "The safety and efficacy of DITPA have been evaluated in several clinical trials."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: DITPA is structurally similar to L-thyronine, but instead of having modifications such as an iodine atom replaced by a hydrogen atom, it actually has two iodine atoms added to the thyronine structure.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "vicuna-7b_response": "COUGER is a tool that stands for \"COmputer-based UGer Reasoning\". It is a software application that is used to analyze and evaluate the reasoning skills of individuals. COUGER is commonly used in the field of psychology and education to assess cognitive abilities such as problem-solving, critical thinking, and decision-making.\nThe COUGER tool typically consists of a series of tasks that are designed to test specific cognitive skills. For example, one task might involve a person being presented with a series of shapes and being asked to identify the shape that is different from the others. Another task might involve a person being presented with a series of statements and being asked to determine which statement is the most logical conclusion based on the other statements.\nThe results of the COUGER tool are typically used to help diagnose cognitive disorders, such as attention deficit hyperactivity disorder (ADHD), and to help identify areas where an individual may need additional support or training.\nIt's important to note that COUGER is just one of many tools that can be used to assess cognitive abilities, and that the results of any one tool should be interpreted in the context of the individual's overall cognitive profile.",
    "vicuna-7b_fact_raw": "1. COUGER stands for \"COmputer-based UGer Reasoning\".\n2. COUGER is a software application used to analyze and evaluate reasoning skills.\n3. The tool is commonly used in psychology and education to assess cognitive abilities.\n4. COUGER consists of tasks designed to test specific cognitive skills such as problem-solving and critical thinking.\n5. The results of the COUGER tool can be used to help diagnose cognitive disorders like ADHD.",
    "vicuna-7b_fact": [
      "COUGER stands for \"COmputer-based UGer Reasoning\".",
      "COUGER is a software application used to analyze and evaluate reasoning skills.",
      "The tool is commonly used in psychology and education to assess cognitive abilities.",
      "COUGER consists of tasks designed to test specific cognitive skills such as problem-solving and critical thinking.",
      "The results of the COUGER tool can be used to help diagnose cognitive disorders like ADHD."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: There is no widely recognized acronym or tool known as COUGER for \"COmputer-based UGer Reasoning\". It's possible that COUGER could be a fictional or less-known tool, but without specific context, this statement cannot be verified.\n2. UNKNOWN: Since the existence of COUGER as \"COmputer-based UGer Reasoning\" is not established, the purpose of such a tool cannot be confirmed.\n3. UNKNOWN: The common use of COUGER in psychology and education cannot be confirmed without establishing the existence and recognition of the tool.\n4. UNKNOWN: Without confirmation of what COUGER is, we cannot determine the nature of the tasks it consists of.\n5. UNKNOWN: The use of COUGER results to diagnose cognitive disorders like ADHD cannot be confirmed without more information about the tool and its validation in the field.",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "vicuna-7b_response": "Yes, there are drugs available for the treatment of Tick-borne Encephalitis (TBE). TBE is a viral infection that is spread through the bite of infected ticks. The most common symptoms of TBE include fever, headache, muscle and joint pain, and a skin rash.\nThe treatment for TBE typically involves supportive care, such as rest and fluids, to help manage symptoms. Antiviral medications, such as ribavirin and oseltamivir, may also be used to help reduce the severity of the illness and shorten the duration of symptoms.\nIt is important to note that the most effective way to prevent TBE is to avoid being bitten by infected ticks. This can be done by using tick repellents, wearing protective clothing, and conducting regular tick checks after spending time outdoors in tick-endemic areas.\nIn addition, vaccination is also an effective way to prevent TBE. There are two types of TBE vaccines available: inactivated vaccine and live attenuated vaccine. The inactivated vaccine is given as a single dose, while the live attenuated vaccine is given in two doses.\nIt is recommended that individuals who live in or travel to areas where TBE is common consult with their healthcare provider to determine the most appropriate preventive measures and treatment options for TBE.",
    "vicuna-7b_fact_raw": "1. Tick-borne Encephalitis (TBE) is a viral infection spread through the bite of infected ticks.\n2. Common symptoms of TBE include fever, headache, muscle and joint pain, and a skin rash.\n3. Supportive care such as rest and fluids is a typical treatment approach for TBE.\n4. Antiviral medications like ribavirin and oseltamivir may be used in the treatment of TBE.\n5. Vaccination against TBE is possible with two types of vaccines: inactivated and live attenuated.",
    "vicuna-7b_fact": [
      "Tick-borne Encephalitis (TBE) is a viral infection spread through the bite of infected ticks.",
      "Common symptoms of TBE include fever, headache, muscle and joint pain, and a skin rash.",
      "Supportive care such as rest and fluids is a typical treatment approach for TBE.",
      "Antiviral medications like ribavirin and oseltamivir may be used in the treatment of TBE.",
      "Vaccination against TBE is possible with two types of vaccines: inactivated and live attenuated."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Common symptoms of TBE include fever, headache, muscle and joint pain, but a skin rash is not typically associated with TBE. Instead, meningitis, encephalitis, or meningoencephalitis are more serious symptoms that can occur.\n3. TRUE\n4. FALSE [correction]: There are currently no specific antiviral medications proven to be effective for the treatment of TBE. Treatment is mainly supportive and symptomatic.\n5. FALSE [correction]: Vaccination against TBE is possible, but only inactivated vaccines are available. There are no live attenuated vaccines for TBE.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "vicuna-7b_response": "There are several genome browser databases that allow users to annotate DNA shape information. Some of the most popular ones include:\n1. UCSC Genome Browser: This is a free, online genome browser that provides access to a wide range of genomic data, including DNA shape information. Users can view and annotate DNA shape data using a variety of tools and resources provided by the UCSC Genome Browser.\n2. Ensembl Genome Browser: Ensembl is another popular genome browser that provides access to a wide range of genomic data, including DNA shape information. Users can view and annotate DNA shape data using the Ensembl Genome Browser, and can also use the browser to perform a variety of genetic analyses.\n3. Genome Analysis Toolkit (GATK): GATK is a suite of tools for genetic analysis that includes a genome browser called the Variant Analysis Tool (VAT). The VAT allows users to view and annotate DNA shape information, as well as other types of genomic data.\n4. Integrative Genomics Viewer (IGV): IGV is a genome browser that is specifically designed for working with large genomic datasets. It includes a variety of tools for viewing and analyzing DNA shape information, as well as other types of genomic data.\nOverall, there are many genome browser databases available that allow users to annotate DNA shape information. The choice of which one to use will depend on the specific needs and goals of the user.",
    "vicuna-7b_fact_raw": "1. The UCSC Genome Browser is an online genome browser that provides access to genomic data, including DNA shape information.\n2. The Ensembl Genome Browser allows users to access genomic data and annotate DNA shape information.\n3. The Genome Analysis Toolkit (GATK) includes a genome browser called the Variant Analysis Tool (VAT) for viewing and annotating DNA shape information.\n4. The Integrative Genomics Viewer (IGV) is designed for working with large genomic datasets and includes tools for analyzing DNA shape information.",
    "vicuna-7b_fact": [
      "The UCSC Genome Browser is an online genome browser that provides access to genomic data, including DNA shape information.",
      "The Ensembl Genome Browser allows users to access genomic data and annotate DNA shape information.",
      "The Genome Analysis Toolkit (GATK) includes a genome browser called the Variant Analysis Tool (VAT) for viewing and annotating DNA shape information.",
      "The Integrative Genomics Viewer (IGV) is designed for working with large genomic datasets and includes tools for analyzing DNA shape information."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Ensembl Genome Browser allows users to access genomic data, but it does not specifically annotate DNA shape information; it is primarily used for viewing and annotating genomic sequences and variations.\n3. FALSE [correction]: The Genome Analysis Toolkit (GATK) is a software package for analyzing high-throughput sequencing data, but it does not include a genome browser called the Variant Analysis Tool (VAT); GATK is focused on variant discovery and genotyping.\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "vicuna-7b_response": "Mutations in the EZH2 gene have been associated with several syndromes, including:\n1. Wolf-Hirschhorn syndrome: This is a genetic disorder that is caused by a deletion on chromosome 4, which includes the EZH2 gene. It is characterized by growth retardation, intellectual disability, and distinctive facial features.\n2. Dandy-Walker syndrome: This is a congenital brain malformation that is characterized by a cyst in the cerebellum and a large ventricle in the brain. Mutations in the EZH2 gene have been found to be associated with this condition.\n3. Microcephaly: Microcephaly is a condition characterized by a small head size and intellectual disability. Mutations in the EZH2 gene have been found to be associated with this condition.\n4. Renal cell carcinoma: EZH2 has been found to be overexpressed in some cases of renal cell carcinoma, a type of kidney cancer.\n5. Prostate cancer: EZH2 has been found to be overexpressed in some cases of prostate cancer.\nIt's important to note that these are just a few examples of the syndromes associated with mutations in the EZH2 gene, and that the specific symptoms and severity of the condition can vary depending on the specific mutation and the individual affected.",
    "vicuna-7b_fact_raw": "1. Wolf-Hirschhorn syndrome is associated with a deletion on chromosome 4 that includes the EZH2 gene.\n2. Mutations in the EZH2 gene have been found to be associated with Dandy-Walker syndrome.\n3. Mutations in the EZH2 gene have been found to be associated with Microcephaly.\n4. EZH2 is overexpressed in some cases of renal cell carcinoma.\n5. EZH2 is overexpressed in some cases of prostate cancer.",
    "vicuna-7b_fact": [
      "Wolf-Hirschhorn syndrome is associated with a deletion on chromosome 4 that includes the EZH2 gene.",
      "Mutations in the EZH2 gene have been found to be associated with Dandy-Walker syndrome.",
      "Mutations in the EZH2 gene have been found to be associated with Microcephaly.",
      "EZH2 is overexpressed in some cases of renal cell carcinoma.",
      "EZH2 is overexpressed in some cases of prostate cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE: Wolf-Hirschhorn syndrome is indeed associated with a deletion on the short arm of chromosome 4, which can include the EZH2 gene.\n2. FALSE [correction]: Mutations in the EZH2 gene have not been commonly associated with Dandy-Walker syndrome. Dandy-Walker syndrome is typically related to defects in the cerebellum and fourth ventricle of the brain, and the genes more commonly associated with it are not EZH2.\n3. UNKNOWN: While microcephaly is a condition that can be caused by a variety of genetic and environmental factors, without specific evidence linking EZH2 gene mutations to microcephaly, it is difficult to confirm this statement as true or false.\n4. TRUE: EZH2 is known to be overexpressed in various cancers, including some cases of renal cell carcinoma.\n5. TRUE: EZH2 is also known to be overexpressed in some cases of prostate cancer, where it is associated with the progression of the disease.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "vicuna-7b_response": "Certainly! Here is a list of human proteins that are known to undergo a dimer-to-tetramer transition:\n1. Cytochrome c\n2. Cytochrome b\n3. Cytochrome c oxidase\n4. Hemoglobin\n5. Myoglobin\n6. Thioredoxin\n7. Glutaredoxin\n8. Peroxiredoxin\n9. Thioredoxin reductase\n10. DnaK\n11. DnaJ\n12. GrpE\n13. Hsp70\n14. Hsp90\n15. Hsp100\n16. Hsp110\n17. Hsp70-like protein\n18. Hsp60\n19. Hsp40\n20. Hsp27\nIt's worth noting that this is not an exhaustive list, and there may be other human proteins that undergo a dimer-to-tetramer transition. Additionally, the dimer-to-tetramer transition is a common phenomenon in many proteins, not just those found in humans.",
    "vicuna-7b_fact_raw": "1. Cytochrome c is known to undergo a dimer-to-tetramer transition.\n2. Hemoglobin is known to undergo a dimer-to-tetramer transition.\n3. Myoglobin is known to undergo a dimer-to-tetramer transition.\n4. Thioredoxin is known to undergo a dimer-to-tetramer transition.\n5. Glutaredoxin is known to undergo a dimer-to-tetramer transition.",
    "vicuna-7b_fact": [
      "Cytochrome c is known to undergo a dimer-to-tetramer transition.",
      "Hemoglobin is known to undergo a dimer-to-tetramer transition.",
      "Myoglobin is known to undergo a dimer-to-tetramer transition.",
      "Thioredoxin is known to undergo a dimer-to-tetramer transition.",
      "Glutaredoxin is known to undergo a dimer-to-tetramer transition."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Hemoglobin is known to undergo a tetramer-to-dimer transition under certain conditions, but it primarily exists as a tetramer.\n3. FALSE [correction]: Myoglobin functions as a monomer and does not undergo a dimer-to-tetramer transition.\n4. UNKNOWN\n5. UNKNOWN\n\nThe responses to statements 1, 4, and 5 are marked as UNKNOWN because the behavior of cytochrome c, thioredoxin, and glutaredoxin regarding dimer-to-tetramer transitions is not commonly described, and without specific context or additional information, it is not possible to determine the veracity of these statements.",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "vicuna-7b_response": "Phospholamban (PLN) is an important protein that plays a role in regulating the contraction of muscles in the heart. PLN has been found to interact with a number of other proteins, including anti-apoptotic proteins. One such protein that has been found to interact with PLN and is also an anti-apoptotic protein is Bcl-2.\nBcl-2 is a well-known anti-apoptotic protein that plays a critical role in preventing cell death. It has been shown to interact with PLN and to play a role in regulating the contraction of muscles in the heart. In fact, PLN has been shown to interact with a number of anti-apoptotic proteins, including Bcl-2, Bcl-xL, and Mcl-1, which are all important for maintaining the survival of heart muscle cells.\nOverall, the interaction between PLN and anti-apoptotic proteins like Bcl-2 is an important area of research, as it may provide new insights into the mechanisms that regulate heart muscle cell survival and function.",
    "vicuna-7b_fact_raw": "1. Phospholamban (PLN) plays a role in regulating the contraction of muscles in the heart.\n2. PLN has been found to interact with anti-apoptotic proteins.\n3. Bcl-2 is an anti-apoptotic protein that interacts with PLN.\n4. Bcl-2 plays a role in preventing cell death.\n5. The interaction between PLN and Bcl-2 is involved in regulating the contraction of muscles in the heart.",
    "vicuna-7b_fact": [
      "Phospholamban (PLN) plays a role in regulating the contraction of muscles in the heart.",
      "PLN has been found to interact with anti-apoptotic proteins.",
      "Bcl-2 is an anti-apoptotic protein that interacts with PLN.",
      "Bcl-2 plays a role in preventing cell death.",
      "The interaction between PLN and Bcl-2 is involved in regulating the contraction of muscles in the heart."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is no widely recognized interaction between phospholamban (PLN) and Bcl-2 specifically in the context of regulating heart muscle contraction. Bcl-2 is known for its role in apoptosis, not for interacting with PLN.\n4. TRUE\n5. FALSE [correction]: Since Bcl-2 is not known to interact with PLN, the statement that their interaction is involved in regulating the contraction of muscles in the heart is incorrect.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "vicuna-7b_response": "Yes, there is evidence to suggest that vitamin D supplementation may help to reduce the incidence of falls in older people. Several clinical trials have investigated the effects of vitamin D supplementation on falls in older adults, with some studies finding that vitamin D supplementation may reduce the risk of falls.\nFor example, a meta-analysis of 25 randomized controlled trials found that vitamin D supplementation was associated with a significant reduction in the risk of falls in older adults. The study, published in the Journal of Clinical Endocrinology and Metabolism, found that vitamin D supplementation was associated with a 19% reduction in the risk of falls.\nAnother study, published in the Journal of Bone and Mineral Research, found that vitamin D supplementation may also improve balance and reduce the risk of falls in older adults. The study found that vitamin D supplementation improved balance and reduced the risk of falls in older adults with vitamin D deficiency.\nIt is important to note that while vitamin D supplementation may have some benefits in reducing the risk of falls in older people, it is not a guarantee of preventing falls. Other factors, such as age, gender, and underlying health conditions, can also play a role in falls. It is always best to consult with a healthcare professional before starting any new supplement regimen.",
    "vicuna-7b_fact_raw": "1. Clinical trials have investigated the effects of vitamin D supplementation on falls in older adults.\n2. A meta-analysis of 25 randomized controlled trials found that vitamin D supplementation was associated with a 19% reduction in the risk of falls in older adults.\n3. The meta-analysis mentioned was published in the Journal of Clinical Endocrinology and Metabolism.\n4. Another study published in the Journal of Bone and Mineral Research found that vitamin D supplementation improved balance in older adults with vitamin D deficiency.\n5. The same study indicated that vitamin D supplementation reduced the risk of falls in older adults with vitamin D deficiency.",
    "vicuna-7b_fact": [
      "Clinical trials have investigated the effects of vitamin D supplementation on falls in older adults.",
      "A meta-analysis of 25 randomized controlled trials found that vitamin D supplementation was associated with a 19% reduction in the risk of falls in older adults.",
      "The meta-analysis mentioned was published in the Journal of Clinical Endocrinology and Metabolism.",
      "Another study published in the Journal of Bone and Mineral Research found that vitamin D supplementation improved balance in older adults with vitamin D deficiency.",
      "The same study indicated that vitamin D supplementation reduced the risk of falls in older adults with vitamin D deficiency."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN (without a specific reference to the meta-analysis, the exact percentage reduction cannot be verified)\n3. UNKNOWN (without a specific reference, the publication details of the meta-analysis cannot be verified)\n4. UNKNOWN (without a specific reference to the study, the findings cannot be verified)\n5. UNKNOWN (without a specific reference to the study, the findings cannot be verified)",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "vicuna-7b_response": "Yes, there is an association between JARID2 and miR-155 in Th17 cells.\nJARID2, which stands for JmjC domain-containing protein that regulates inflammatory disease, has been shown to play a role in the regulation of Th17 cells. JARID2 has been shown to negatively regulate the transcription of the miR-155 gene, which is a microRNA that has been shown to be involved in the regulation of Th17 cell differentiation and function.\nIn addition, miR-155 has been shown to negatively regulate the expression of JARID2 in Th17 cells. This suggests that the JARID2-miR-155 axis may play a role in the regulation of Th17 cell differentiation and function.\nOverall, the association between JARID2 and miR-155 in Th17 cells suggests that these two molecules may play important roles in the regulation of Th17 cell differentiation and function. Further research is needed to fully understand the role of JARID2 and miR-155 in Th17 cells and their potential as therapeutic targets for inflammatory diseases.",
    "vicuna-7b_fact_raw": "1. JARID2 stands for JmjC domain-containing protein that regulates inflammatory disease.\n2. JARID2 plays a role in the regulation of Th17 cells.\n3. JARID2 negatively regulates the transcription of the miR-155 gene.\n4. miR-155 is involved in the regulation of Th17 cell differentiation and function.\n5. miR-155 negatively regulates the expression of JARID2 in Th17 cells.",
    "vicuna-7b_fact": [
      "JARID2 stands for JmjC domain-containing protein that regulates inflammatory disease.",
      "JARID2 plays a role in the regulation of Th17 cells.",
      "JARID2 negatively regulates the transcription of the miR-155 gene.",
      "miR-155 is involved in the regulation of Th17 cell differentiation and function.",
      "miR-155 negatively regulates the expression of JARID2 in Th17 cells."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: JARID2 stands for Jumonji, AT-rich interactive domain 2. It is a gene that encodes a protein involved in the regulation of gene expression, not specifically \"inflammatory disease\" although it may be involved in pathways that affect inflammation.\n2. TRUE: JARID2 has been shown to play a role in the regulation of Th17 cells, which are a subset of T cells involved in immune responses and autoimmune diseases.\n3. UNKNOWN: Without specific scientific literature or context, it is difficult to confirm or deny whether JARID2 negatively regulates the transcription of the miR-155 gene.\n4. TRUE: miR-155 is known to be involved in the regulation of immune cells, including Th17 cell differentiation and function.\n5. UNKNOWN: The relationship between miR-155 and JARID2 in terms of regulatory mechanisms in Th17 cells is specific and would require referencing current scientific research to confirm.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "vicuna-7b_response": "The human HOXD cluster contains 13 genes.",
    "vicuna-7b_fact_raw": "1. The human HOXD cluster contains 13 genes.",
    "vicuna-7b_fact": [
      "The human HOXD cluster contains 13 genes."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The human HOXD cluster contains 9 genes.",
    "vicuna-7b_judge": [
      "false"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "vicuna-7b_response": "Casein Kinase 1 (CK1) is a serine/threonine protein kinase that plays a role in various cellular processes, including cell division, mitosis, and the regulation of gene expression. Phosphorylation of specific residues on substrate proteins by CK1 is an important mechanism for its regulation and function. Here are some of the phosphorylation consensus motifs for CK1:\n1. S/T-X-X-X-R: This motif is found in many substrates of CK1 and is recognized by the CK1 catalytic subunit. The X's represent any amino acid, and R represents the phosphorylated serine or threonine residue.\n2. S/T-X-X-X-X-R: This motif is similar to the first one, but includes an additional phosphate group.\n3. S/T-X-X-X-X-X-R: This motif is also found in many substrates of CK1 and is recognized by the CK1 regulatory subunit. The X's represent any amino acid, and R represents the phosphorylated serine or threonine residue.\n4. S/T-X-X-X-X-X-X-R: This motif is similar to the third one, but includes an additional phosphate group.\nIt's important to note that these are not the only consensus motifs recognized by CK1, and different substrates may have different motifs recognized by the kinase. Additionally, the specific residues that are phosphorylated by CK1 can vary depending on the substrate and the cellular context in which CK1 is acting.",
    "vicuna-7b_fact_raw": "1. Casein Kinase 1 (CK1) is a serine/threonine protein kinase.\n2. CK1 plays a role in cell division, mitosis, and the regulation of gene expression.\n3. The phosphorylation consensus motif S/T-X-X-X-R is recognized by the CK1 catalytic subunit.\n4. The phosphorylation consensus motif S/T-X-X-X-X-X-R is recognized by the CK1 regulatory subunit.\n5. The specific residues phosphorylated by CK1 can vary depending on the substrate and cellular context.",
    "vicuna-7b_fact": [
      "Casein Kinase 1 (CK1) is a serine/threonine protein kinase.",
      "CK1 plays a role in cell division, mitosis, and the regulation of gene expression.",
      "The phosphorylation consensus motif S/T-X-X-X-R is recognized by the CK1 catalytic subunit.",
      "The phosphorylation consensus motif S/T-X-X-X-X-X-R is recognized by the CK1 regulatory subunit.",
      "The specific residues phosphorylated by CK1 can vary depending on the substrate and cellular context."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The phosphorylation consensus motif S/T-X-X-S/T-P is recognized by the CK1 catalytic subunit.\n4. FALSE [correction]: CK1 does not have a separate regulatory subunit; it recognizes the consensus motif mentioned in the correction for statement 3.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "vicuna-7b_response": "The ASPH gene, also known as the GATase gene, encodes for the aspartate beta-hydroxylase enzyme. This enzyme is involved in the metabolism of l-aspartate, a non-essential amino acid, and is responsible for the first step in the metabolism of aspartate in the urea cycle.\nThere are two main isoforms of the ASPH enzyme, which are produced by alternative splicing of the ASPH gene:\n1. Aspartate beta-hydroxylase (E1) isoform: This isoform is responsible for the first step in the metabolism of aspartate, which is the conversion of l-aspartate to aspartate.\n2. Aspartate beta-hydroxylase (E2) isoform: This isoform is responsible for the conversion of aspartate to N-acetylaspartate.\nBoth of these isoforms are expressed in the liver, kidney, and brain, and are involved in the metabolism of l-aspartate. The E1 isoform is responsible for the majority of the aspartate metabolism in the body, while the E2 isoform is responsible for the conversion of aspartate to N-acetylaspartate, which is then further metabolized in the urea cycle.\nIt is important to note that there are other genes that are involved in the metabolism of aspartate, such as the GAD genes (glutamate decarboxylase) and the GLA genes (glutamate-oxaloacetate transaminase), which are also involved in the urea cycle.",
    "vicuna-7b_fact_raw": "1. The ASPH gene encodes for the aspartate beta-hydroxylase enzyme.\n2. The aspartate beta-hydroxylase enzyme is involved in the metabolism of l-aspartate.\n3. There are two main isoforms of the ASPH enzyme: Aspartate beta-hydroxylase (E1) isoform and Aspartate beta-hydroxylase (E2) isoform.\n4. The E1 isoform of the ASPH enzyme is responsible for the conversion of l-aspartate to aspartate.\n5. The E2 isoform of the ASPH enzyme is responsible for the conversion of aspartate to N-acetylaspartate.",
    "vicuna-7b_fact": [
      "The ASPH gene encodes for the aspartate beta-hydroxylase enzyme.",
      "The aspartate beta-hydroxylase enzyme is involved in the metabolism of l-aspartate.",
      "There are two main isoforms of the ASPH enzyme: Aspartate beta-hydroxylase (E1) isoform and Aspartate beta-hydroxylase (E2) isoform.",
      "The E1 isoform of the ASPH enzyme is responsible for the conversion of l-aspartate to aspartate.",
      "The E2 isoform of the ASPH enzyme is responsible for the conversion of aspartate to N-acetylaspartate."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The aspartate beta-hydroxylase enzyme is involved in the post-translational hydroxylation of aspartyl residues in certain proteins, not in the metabolism of l-aspartate.\n3. UNKNOWN\n4. FALSE [correction]: The E1 isoform of the ASPH enzyme does not convert l-aspartate to aspartate; it hydroxylates aspartyl residues in proteins.\n5. FALSE [correction]: The E2 isoform of the ASPH enzyme is not responsible for the conversion of aspartate to N-acetylaspartate; this is a function of the enzyme aspartate N-acetyltransferase.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "vicuna-7b_response": "Empagliflozin was approved by the US Food and Drug Administration (FDA) in 2014 for the treatment of type 2 diabetes. It is marketed under the brand name Jardiance and is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Empagliflozin works by helping the kidneys remove sugar from the body, which can help lower blood sugar levels in people with type 2 diabetes.",
    "vicuna-7b_fact_raw": "1. Empagliflozin was approved by the US Food and Drug Administration (FDA) in 2014.\n2. Empagliflozin is used for the treatment of type 2 diabetes.\n3. It is marketed under the brand name Jardiance.\n4. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.\n5. Empagliflozin helps the kidneys remove sugar from the body to lower blood sugar levels in people with type 2 diabetes.",
    "vicuna-7b_fact": [
      "Empagliflozin was approved by the US Food and Drug Administration (FDA) in 2014.",
      "Empagliflozin is used for the treatment of type 2 diabetes.",
      "It is marketed under the brand name Jardiance.",
      "Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.",
      "Empagliflozin helps the kidneys remove sugar from the body to lower blood sugar levels in people with type 2 diabetes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "vicuna-7b_response": "Loss of the protein Lon1 in the plant Arabidopsis can result in various negative effects on plant growth and development. Lon1 is a member of the Lon family of proteases, which are enzymes that break down other proteins. In Arabidopsis, Lon1 has been shown to play a role in the degradation of certain proteins involved in stress responses, such as those involved in the heat shock response.\nWhen Lon1 is lost in Arabidopsis, the degradation of these proteins is impaired, leading to an accumulation of these proteins in the cell. This can result in the inhibition of stress responses, leading to increased sensitivity to environmental stressors such as heat, drought, and salt. Additionally, the accumulation of these proteins can also lead to the inhibition of other cellular processes, such as protein synthesis and metabolism, which can further impair plant growth and development.\nOverall, the loss of Lon1 in Arabidopsis can have a significant impact on plant growth and development, making it more susceptible to environmental stressors and impairing its overall health.",
    "vicuna-7b_fact_raw": "1. Lon1 is a member of the Lon family of proteases in Arabidopsis.\n2. Lon1 is involved in the degradation of proteins related to stress responses in Arabidopsis.\n3. The loss of Lon1 in Arabidopsis leads to an accumulation of proteins involved in stress responses.\n4. Plants lacking Lon1 exhibit increased sensitivity to environmental stressors such as heat, drought, and salt.\n5. The accumulation of proteins due to the loss of Lon1 can inhibit cellular processes like protein synthesis and metabolism in Arabidopsis.",
    "vicuna-7b_fact": [
      "Lon1 is a member of the Lon family of proteases in Arabidopsis.",
      "Lon1 is involved in the degradation of proteins related to stress responses in Arabidopsis.",
      "The loss of Lon1 in Arabidopsis leads to an accumulation of proteins involved in stress responses.",
      "Plants lacking Lon1 exhibit increased sensitivity to environmental stressors such as heat, drought, and salt.",
      "The accumulation of proteins due to the loss of Lon1 can inhibit cellular processes like protein synthesis and metabolism in Arabidopsis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided are consistent with the general functions of Lon proteases in cellular mechanisms, including those in plants like Arabidopsis. Lon proteases are known to be involved in the degradation of misfolded, damaged, or unneeded proteins. The loss of such proteases can lead to the accumulation of proteins, which can affect the plant's response to stress and potentially inhibit normal cellular processes. However, without specific experimental evidence or literature references, the exact effects in Arabidopsis for statements 4 and 5 cannot be confirmed, but they are plausible based on the known functions of Lon proteases.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "vicuna-7b_response": "Yes, a linker histone does exist in the yeast genome.\nLinker histones are a type of histone that plays a crucial role in the regulation of chromatin structure and gene expression. In the yeast genome, there are several types of linker histones, including H1, H5, and H7.\nH1 is the most abundant linker histone in eukaryotic cells, including yeast. It is responsible for maintaining the structure of chromatin and facilitating the interaction between DNA and other proteins. In yeast, H1 is encoded by the HOP1 gene and is essential for cell viability.\nH5 and H7 are less abundant linker histones in yeast, but they also play important roles in chromatin structure and gene expression. H5 is involved in the regulation of transcription and is required for proper development in yeast. H7 is involved in the regulation of DNA replication and is required for the proper segregation of chromosomes during cell division.\nOverall, linker histones are important components of the chromatin structure in yeast and play a crucial role in regulating gene expression.",
    "vicuna-7b_fact_raw": "1. Linker histones exist in the yeast genome.\n2. H1 is the most abundant linker histone in eukaryotic cells, including yeast.\n3. In yeast, the H1 linker histone is encoded by the HOP1 gene.\n4. H5 linker histone is involved in the regulation of transcription in yeast.\n5. H7 linker histone is involved in the regulation of DNA replication in yeast and is required for proper chromosome segregation during cell division.",
    "vicuna-7b_fact": [
      "Linker histones exist in the yeast genome.",
      "H1 is the most abundant linker histone in eukaryotic cells, including yeast.",
      "In yeast, the H1 linker histone is encoded by the HOP1 gene.",
      "H5 linker histone is involved in the regulation of transcription in yeast.",
      "H7 linker histone is involved in the regulation of DNA replication in yeast and is required for proper chromosome segregation during cell division."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Yeast, specifically Saccharomyces cerevisiae, does not have linker histones. Linker histones are common in other eukaryotes but are absent in the yeast genome.\n2. TRUE: H1 is indeed the most abundant linker histone in eukaryotic cells that possess linker histones.\n3. FALSE [correction]: The HOP1 gene in yeast encodes a protein that is involved in meiotic chromosome pairing and recombination, not a linker histone.\n4. FALSE [correction]: Since yeast does not have H1 or other linker histones, H5, which is a variant of H1 in other eukaryotes, is not involved in the regulation of transcription in yeast.\n5. FALSE [correction]: As yeast does not have linker histones, including H7, it cannot be involved in the regulation of DNA replication in yeast or required for proper chromosome segregation during cell division.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "vicuna-7b_response": "Yes, there is evidence that tomato juice may help lower cholesterol levels.\nResearch has shown that consuming tomato juice or tomato products, such as tomato sauce or ketchup, may help lower cholesterol levels due to the high levels of lycopene in them. Lycopene is an antioxidant that has been shown to help reduce inflammation in the body, which can contribute to lower cholesterol levels.\nAdditionally, tomato juice contains other nutrients that may also help lower cholesterol levels, such as potassium and vitamin C.\nIt's important to note that while tomato juice may be beneficial in helping to lower cholesterol levels, it should not be used as a sole treatment for high cholesterol. It's always best to consult with a healthcare professional before making any changes to your diet or taking any supplements.\nIn conclusion, there is evidence that tomato juice may help lower cholesterol levels due to its high levels of lycopene and other nutrients. However, it should not be used as a sole treatment and it's always best to consult with a healthcare professional.",
    "vicuna-7b_fact_raw": "1. Consuming tomato juice or tomato products may help lower cholesterol levels.\n2. Lycopene, found in high levels in tomatoes, is an antioxidant that can help reduce inflammation in the body.\n3. Lowering inflammation in the body can contribute to lower cholesterol levels.\n4. Tomato juice contains nutrients like potassium and vitamin C that may also help lower cholesterol levels.\n5. It is recommended to consult with a healthcare professional before using tomato juice as a treatment for high cholesterol.",
    "vicuna-7b_fact": [
      "Consuming tomato juice or tomato products may help lower cholesterol levels.",
      "Lycopene, found in high levels in tomatoes, is an antioxidant that can help reduce inflammation in the body.",
      "Lowering inflammation in the body can contribute to lower cholesterol levels.",
      "Tomato juice contains nutrients like potassium and vitamin C that may also help lower cholesterol levels.",
      "It is recommended to consult with a healthcare professional before using tomato juice as a treatment for high cholesterol."
    ],
    "vicuna-7b_judge_raw": "1. TRUE: Consuming tomato juice or tomato products has been associated with beneficial effects on cholesterol levels due to the presence of compounds like lycopene and dietary fiber.\n2. TRUE: Lycopene is an antioxidant found in tomatoes and is known to help reduce inflammation in the body.\n3. TRUE: Lowering inflammation in the body is generally considered to contribute to improved overall health, including potentially lower cholesterol levels.\n4. TRUE: Tomato juice does contain nutrients like potassium and vitamin C, which have been associated with heart health and could contribute to lower cholesterol levels.\n5. TRUE: It is always recommended to consult with a healthcare professional before starting any new treatment for a health condition, including using tomato juice as a treatment for high cholesterol.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "vicuna-7b_response": "Hsp70 and Hsp110 are two types of heat shock proteins (HSPs) that play important roles in regulating mRNA stability.\nHsp70 is a highly conserved protein that functions as a chaperone, helping to fold and stabilize proteins. It also plays a role in regulating the stability of mRNAs by binding to unstable RNA molecules and preventing their degradation by RNA-degrading enzymes. In addition, Hsp70 can also help to stabilize mRNAs by promoting the formation of RNA-protein complexes.\nHsp110 is another type of HSP that is involved in the regulation of mRNA stability. It has been shown to bind to unstable RNA molecules and promote their degradation by RNA-degrading enzymes. Hsp110 can also interact with RNA-binding proteins and help to regulate the stability of specific mRNAs.\nOverall, Hsp70 and Hsp110 play important roles in regulating mRNA stability by binding to unstable RNA molecules and promoting their degradation or stabilization, respectively. These proteins are important for maintaining the proper balance of gene expression and ensuring that cells respond appropriately to stress conditions.",
    "vicuna-7b_fact_raw": "1. Hsp70 functions as a chaperone that helps to fold and stabilize proteins.\n2. Hsp70 regulates the stability of mRNAs by binding to unstable RNA molecules and preventing their degradation.\n3. Hsp70 promotes the formation of RNA-protein complexes to stabilize mRNAs.\n4. Hsp110 binds to unstable RNA molecules and promotes their degradation by RNA-degrading enzymes.\n5. Hsp110 interacts with RNA-binding proteins to help regulate the stability of specific mRNAs.",
    "vicuna-7b_fact": [
      "Hsp70 functions as a chaperone that helps to fold and stabilize proteins.",
      "Hsp70 regulates the stability of mRNAs by binding to unstable RNA molecules and preventing their degradation.",
      "Hsp70 promotes the formation of RNA-protein complexes to stabilize mRNAs.",
      "Hsp110 binds to unstable RNA molecules and promotes their degradation by RNA-degrading enzymes.",
      "Hsp110 interacts with RNA-binding proteins to help regulate the stability of specific mRNAs."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hsp70 does not regulate the stability of mRNAs by binding to them; it is primarily involved in protein folding. Proteins like AU-rich element (ARE) binding proteins are more typically associated with the regulation of mRNA stability.\n3. FALSE [correction]: Hsp70 is not known to promote the formation of RNA-protein complexes to stabilize mRNAs. Its primary function is in protein folding and stabilization, not RNA stabilization.\n4. FALSE [correction]: Hsp110 is a molecular chaperone like Hsp70 and does not bind to unstable RNA molecules to promote their degradation. It assists in protein folding and prevents protein aggregation.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "vicuna-7b_response": "Skeletal muscle contains several types of deiodinases, including type 1 (D1), type 2 (D2), and type 3 (D3) deiodinases.\nType 1 deiodinase (D1) is also known as the thyroid hormone deiodinase, and it is responsible for converting T4 to T3 in the periphery. D1 is primarily expressed in the thyroid gland, but it is also found in skeletal muscle, heart, and other tissues. In skeletal muscle, D1 plays a crucial role in regulating muscle metabolism and energy expenditure.\nType 2 deiodinase (D2) is also known as the peripheral deiodinase, and it is responsible for converting T4 to T3 in the periphery. D2 is primarily expressed in the liver, but it is also found in skeletal muscle, adipose tissue, and other tissues. In skeletal muscle, D2 plays a role in regulating glucose metabolism and insulin sensitivity.\nType 3 deiodinase (D3) is also known as the gut-derived deiodinase, and it is responsible for converting T4 to T3 in the gut. D3 is primarily expressed in the gut, but it is also found in other tissues such as the liver and skeletal muscle. In skeletal muscle, D3 plays a role in regulating muscle growth and development.\nIn summary, skeletal muscle contains D1, D2, and D3 deiodinases, which play important roles in regulating muscle metabolism, glucose metabolism, and muscle growth and development.",
    "vicuna-7b_fact_raw": "1. Skeletal muscle contains type 1 (D1), type 2 (D2), and type 3 (D3) deiodinases.\n2. Type 1 deiodinase (D1) is responsible for converting T4 to T3 in the periphery and is found in skeletal muscle among other tissues.\n3. Type 2 deiodinase (D2) is responsible for converting T4 to T3 in the periphery and is found in skeletal muscle among other tissues.\n4. Type 3 deiodinase (D3) is responsible for converting T4 to T3 in the gut and is found in skeletal muscle among other tissues.\n5. In skeletal muscle, D1 plays a role in regulating muscle metabolism and energy expenditure, D2 in regulating glucose metabolism and insulin sensitivity, and D3 in regulating muscle growth and development.",
    "vicuna-7b_fact": [
      "Skeletal muscle contains type 1 (D1), type 2 (D2), and type 3 (D3) deiodinases.",
      "Type 1 deiodinase (D1) is responsible for converting T4 to T3 in the periphery and is found in skeletal muscle among other tissues.",
      "Type 2 deiodinase (D2) is responsible for converting T4 to T3 in the periphery and is found in skeletal muscle among other tissues.",
      "Type 3 deiodinase (D3) is responsible for converting T4 to T3 in the gut and is found in skeletal muscle among other tissues.",
      "In skeletal muscle, D1 plays a role in regulating muscle metabolism and energy expenditure, D2 in regulating glucose metabolism and insulin sensitivity, and D3 in regulating muscle growth and development."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Skeletal muscle contains type 2 (D2) deiodinase, but not type 1 (D1) or type 3 (D3) deiodinases.\n2. FALSE [correction]: Type 1 deiodinase (D1) is responsible for converting T4 to T3 in the periphery, but it is not found in skeletal muscle; it is primarily found in the liver and kidneys.\n3. TRUE\n4. FALSE [correction]: Type 3 deiodinase (D3) is responsible for inactivating thyroid hormones by converting T4 to reverse T3 (rT3) and T3 to T2, and it is not primarily associated with the gut nor is it found in skeletal muscle.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "vicuna-7b_response": "Caspases are a family of enzymes that play a crucial role in the process of programmed cell death, also known as apoptosis. There are several inflammatory caspases that have been identified, including:\n1. Caspase-1: also known as interleukin-1-converting enzyme (ICE), is activated in response to bacterial infections and plays a role in the inflammatory response.\n2. Caspase-4: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n3. Caspase-5: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n4. Caspase-6: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n5. Caspase-7: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n6. Caspase-8: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n7. Caspase-9: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\n8. Caspase-11: is activated in response to viral infections and has been shown to play a role in the regulation of the immune response.\nIt's important to note that this list is not exhaustive and there are other caspases that have been identified as inflammatory caspases. Additionally, the role of caspases in inflammation is complex and not fully understood, and further research is needed to fully understand the function of these proteins in the immune response.",
    "vicuna-7b_fact_raw": "1. Caspase-1 is also known as interleukin-1-converting enzyme (ICE).\n2. Caspase-1 is activated in response to bacterial infections and plays a role in the inflammatory response.\n3. Caspase-4, Caspase-5, Caspase-6, Caspase-7, Caspase-8, Caspase-9, and Caspase-11 are activated in response to viral infections.\n4. Caspases play a crucial role in the process of programmed cell death, known as apoptosis.\n5. The role of caspases in inflammation is complex and not fully understood, indicating that further research is needed.",
    "vicuna-7b_fact": [
      "Caspase-1 is also known as interleukin-1-converting enzyme (ICE).",
      "Caspase-1 is activated in response to bacterial infections and plays a role in the inflammatory response.",
      "Caspase-4, Caspase-5, Caspase-6, Caspase-7, Caspase-8, Caspase-9, and Caspase-11 are activated in response to viral infections.",
      "Caspases play a crucial role in the process of programmed cell death, known as apoptosis.",
      "The role of caspases in inflammation is complex and not fully understood, indicating that further research is needed."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Caspase-4 and Caspase-5 (human) or Caspase-11 (mouse) are known to be activated in response to bacterial infections, not viral infections. Caspase-6, Caspase-7, Caspase-8, and Caspase-9 are mainly associated with the apoptotic pathway, although their roles can be context-dependent.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "vicuna-7b_response": "Yes, there is a link between the aurora B kinase and the polycomb protein ring1B.\nThe aurora B kinase is a serine/threonine kinase that plays a crucial role in the regulation of the mitotic process, including the formation of chromosomes during cell division. It is involved in the phosphorylation of several proteins, including histone H3, which is necessary for the proper assembly of the mitotic spindle and the maintenance of chromosome stability.\nThe polycomb protein ring1B is a member of the polycomb group (PcG) of proteins, which are involved in the regulation of gene expression during development. Ring1B is a histone-modifying protein that is involved in the repression of gene expression by modifying histone H2A and H3. It is also involved in the regulation of the mitotic process, and has been shown to interact with aurora B kinase.\nRecent studies have shown that aurora B kinase and ring1B interact and that this interaction is important for the proper regulation of the mitotic process. The interaction between these two proteins may be important for the proper assembly of the mitotic spindle and the maintenance of chromosome stability during cell division.\nIn summary, there is a link between the aurora B kinase and the polycomb protein ring1B, and this interaction is important for the proper regulation of the mitotic process.",
    "vicuna-7b_fact_raw": "1. Aurora B kinase is a serine/threonine kinase that plays a crucial role in the regulation of the mitotic process.\n2. Aurora B kinase is involved in the phosphorylation of several proteins, including histone H3.\n3. The polycomb protein ring1B is a member of the polycomb group of proteins and is involved in the regulation of gene expression during development.\n4. Ring1B is a histone-modifying protein that modifies histone H2A and H3 and is involved in the repression of gene expression.\n5. Recent studies have shown that aurora B kinase and ring1B interact, which is important for the proper regulation of the mitotic process.",
    "vicuna-7b_fact": [
      "Aurora B kinase is a serine/threonine kinase that plays a crucial role in the regulation of the mitotic process.",
      "Aurora B kinase is involved in the phosphorylation of several proteins, including histone H3.",
      "The polycomb protein ring1B is a member of the polycomb group of proteins and is involved in the regulation of gene expression during development.",
      "Ring1B is a histone-modifying protein that modifies histone H2A and H3 and is involved in the repression of gene expression.",
      "Recent studies have shown that aurora B kinase and ring1B interact, which is important for the proper regulation of the mitotic process."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Ring1B is a histone-modifying protein that primarily ubiquitinates histone H2A and is involved in the repression of gene expression. It is not known to modify histone H3.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "vicuna-7b_response": "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are the \"splice consensus sequences\" which are composed of specific nucleotides that are recognized by the spliceosome, the complex of proteins that catalyzes the splicing of RNA.\nThe splice consensus sequences at the donor site are:\n* 5'GT-AG-3' (guanine and thymine followed by adenine and guanine)\n* 5'AGT-3' (adenine, guanine, and thymine followed by adenine and guanine)\n* 5'GGT-3' (guanine, thymine, and cytosine followed by adenine and guanine)\n* 5'GGT-AG-3' (guanine, thymine, and cytosine followed by adenine and guanine)\nThe splice consensus sequences at the acceptor site are:\n* 3'CTG-5' (cytosine, thymine, and guanine followed by adenine and cytosine)\n* 3'CGG-5' (cytosine, guanine, and thymine followed by adenine and cytosine)\n* 3'CGG-CTG-5' (cytosine, guanine, and thymine followed by adenine and cytosine, followed by guanine and thymine)\n* 3'CGG-CGG-5' (cytosine, guanine, and thymine followed by adenine and cytosine, followed by guanine and thymine)\nIt's important to note that these are the most frequent motifs, but not all of them are present in all the species, and some species have additional motifs that are recognized by the spliceosome.\nIt's also important to note that the splice consensus sequences are not absolute and can be modified by various factors such as the presence of introns, the length of the intron, the presence of other elements in the vicinity of the splice site, and the presence of certain proteins that bind to the R",
    "vicuna-7b_fact_raw": "1. The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are known as \"splice consensus sequences.\"\n2. The donor splice site consensus sequences include 5'GT-AG-3', 5'AGT-3', 5'GGT-3', and 5'GGT-AG-3'.\n3. The acceptor splice site consensus sequences include 3'CTG-5', 3'CGG-5', 3'CGG-CTG-5', and 3'CGG-CGG-5'.\n4. These splice consensus sequences are recognized by the spliceosome, which catalyzes the splicing of RNA.\n5. The presence of these motifs can be influenced by factors such as the presence of introns, the length of the intron, and the presence of certain proteins that bind to the RNA.",
    "vicuna-7b_fact": [
      "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are known as \"splice consensus sequences.\"",
      "The donor splice site consensus sequences include 5'GT-AG-3', 5'AGT-3', 5'GGT-3', and 5'GGT-AG-3'.",
      "The acceptor splice site consensus sequences include 3'CTG-5', 3'CGG-5', 3'CGG-CTG-5', and 3'CGG-CGG-5'.",
      "These splice consensus sequences are recognized by the spliceosome, which catalyzes the splicing of RNA.",
      "The presence of these motifs can be influenced by factors such as the presence of introns, the length of the intron, and the presence of certain proteins that bind to the RNA."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The donor splice site consensus sequence is 5'GT-AG-3'. The other sequences listed are not standard consensus sequences for donor sites.\n3. FALSE [correction]: The acceptor splice site consensus sequence is 3'AG-5'. The other sequences listed are not standard consensus sequences for acceptor sites.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "vicuna-7b_response": "The event that results in the acetylation of S6K1 is the interaction between S6K1 and p300/CBP coactivators.\nS6K1 is a serine/threonine kinase that plays a crucial role in regulating cell growth and metabolism. It is activated by the phosphorylation of its T-loop by AKT, which is activated by PI3K signaling. However, S6K1 activity can also be regulated by post-translational modifications, such as acetylation.\nThe interaction between S6K1 and p300/CBP coactivators is a key event in the regulation of S6K1 activity. p300/CBP are transcriptional coactivators that play a role in the regulation of gene expression. They interact with S6K1 and acetylate its lysine residues, leading to the inhibition of its kinase activity and the repression of its target genes.\nIn summary, the acetylation of S6K1 is regulated by the interaction between S6K1 and p300/CBP coactivators, which leads to the inhibition of its kinase activity and the repression of its target genes.",
    "vicuna-7b_fact_raw": "1. The acetylation of S6K1 is a result of its interaction with p300/CBP coactivators.\n2. S6K1 is a serine/threonine kinase involved in regulating cell growth and metabolism.\n3. S6K1 is activated by the phosphorylation of its T-loop by AKT.\n4. AKT activation is a result of PI3K signaling.\n5. p300/CBP are transcriptional coactivators that acetylate lysine residues on S6K1.",
    "vicuna-7b_fact": [
      "The acetylation of S6K1 is a result of its interaction with p300/CBP coactivators.",
      "S6K1 is a serine/threonine kinase involved in regulating cell growth and metabolism.",
      "S6K1 is activated by the phosphorylation of its T-loop by AKT.",
      "AKT activation is a result of PI3K signaling.",
      "p300/CBP are transcriptional coactivators that acetylate lysine residues on S6K1."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: S6K1 is activated by the phosphorylation of its T-loop by mTORC1 (mechanistic target of rapamycin complex 1), not AKT. AKT can lead to the activation of mTORC1, which then phosphorylates S6K1.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "vicuna-7b_response": "Episodic ataxia type 6 (EA6) is a rare genetic disorder that is caused by a mutation in the CACNA1A gene. This gene provides instructions for making a protein called the alpha-1A subunit of the voltage-gated calcium channel, which is responsible for regulating the flow of calcium ions into cells.\nThe mutation in the CACNA1A gene that causes EA6 results in a loss of function of the alpha-1A subunit, which leads to an imbalance of calcium ions in the cells of the nervous system. This imbalance can cause a variety of symptoms, including episodic ataxia, which is characterized by sudden, recurrent episodes of poor coordination and balance.\nOther symptoms of EA6 can include vertigo, dizziness, nausea, and difficulty speaking. The severity of the symptoms can vary widely among individuals, and some people with EA6 may experience only a few episodes of ataxia throughout their lives, while others may have frequent and severe episodes.\nEpisodic ataxia type 6 is inherited in an autosomal dominant pattern, which means that a person with the disorder has a 50% chance of passing the mutated gene on to each of their children. However, not everyone with the mutated gene will develop the disorder, and the age of onset and the severity of the symptoms can vary widely among affected individuals.",
    "vicuna-7b_fact_raw": "1. Episodic ataxia type 6 (EA6) is caused by a mutation in the CACNA1A gene.\n2. The CACNA1A gene is responsible for making the alpha-1A subunit of the voltage-gated calcium channel.\n3. A mutation in the CACNA1A gene leads to a loss of function of the alpha-1A subunit.\n4. The loss of function of the alpha-1A subunit causes an imbalance of calcium ions in the cells of the nervous system.\n5. Episodic ataxia type 6 is inherited in an autosomal dominant pattern.",
    "vicuna-7b_fact": [
      "Episodic ataxia type 6 (EA6) is caused by a mutation in the CACNA1A gene.",
      "The CACNA1A gene is responsible for making the alpha-1A subunit of the voltage-gated calcium channel.",
      "A mutation in the CACNA1A gene leads to a loss of function of the alpha-1A subunit.",
      "The loss of function of the alpha-1A subunit causes an imbalance of calcium ions in the cells of the nervous system.",
      "Episodic ataxia type 6 is inherited in an autosomal dominant pattern."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nEpisodic ataxia type 6 (EA6) is indeed associated with mutations in the CACNA1A gene, which encodes the alpha-1A subunit of the P/Q type voltage-gated calcium channel. Mutations in this gene can lead to a loss of function of the alpha-1A subunit, which in turn can cause an imbalance of calcium ions in the cells of the nervous system. EA6 is inherited in an autosomal dominant pattern, meaning that only one copy of the mutated gene is necessary to cause the disorder.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "vicuna-7b_response": "Chromomethylases are enzymes that add a methyl group to a DNA base, resulting in the formation of a methylated base. These enzymes are commonly found in bacteria and plants, but they are not present in animal genomes.\nIn animals, the methylation of DNA bases is primarily carried out by DNA methyltransferases (DNMTs). DNMTs add a methyl group to cytosine residues in the DNA, resulting in the formation of 5-methylcytosine. This process is important for regulating gene expression and maintaining the stability of the genome.\nWhile chromomethylases are not present in animal genomes, they have been found in some viruses, such as bacteriophages and retroviruses. These viruses use chromomethylases to add methyl groups to the DNA of their host cells, allowing them to establish long-term infections and evade the host's immune system.\nIn summary, chromomethylases are not present in animal genomes, but they have been found in some viruses. In animals, the methylation of DNA bases is primarily carried out by DNA methyltransferases (DNMTs).",
    "vicuna-7b_fact_raw": "1. Chromomethylases are enzymes that add a methyl group to a DNA base.\n2. Chromomethylases are commonly found in bacteria and plants.\n3. Chromomethylases are not present in animal genomes.\n4. In animals, DNA methyltransferases (DNMTs) add a methyl group to cytosine residues in the DNA.\n5. Some viruses, such as bacteriophages and retroviruses, have been found to contain chromomethylases.",
    "vicuna-7b_fact": [
      "Chromomethylases are enzymes that add a methyl group to a DNA base.",
      "Chromomethylases are commonly found in bacteria and plants.",
      "Chromomethylases are not present in animal genomes.",
      "In animals, DNA methyltransferases (DNMTs) add a methyl group to cytosine residues in the DNA.",
      "Some viruses, such as bacteriophages and retroviruses, have been found to contain chromomethylases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Chromomethylases have been identified in some animals, such as the nematode worm Caenorhabditis elegans.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "vicuna-7b_response": "There are several packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis. Here are some of the most popular ones:\n1. ChIPS: This package provides tools for ChIP-seq data analysis, including the identification of TFBSs.\n2. DRIMMER: This package is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n3. MEME: This package is used for the discovery of motifs in DNA sequences, including TFBSs.\n4. PITA: This package is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n5. TESS: This package is used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n6. TRANSFAC: This package provides a database of TFBSs and can be used for the identification of TFBSs from ChIP-seq or ChIP-chip data.\n7. MotifSampler: This package is used for the discovery of motifs in DNA sequences, including TFBSs.\nThese are just a few examples of the many packages available for TFBS analysis in R/Bioconductor. The choice of package will depend on the specific needs of the analysis and the type of data available.",
    "vicuna-7b_fact_raw": "1. ChIPS is a package in R/Bioconductor for ChIP-seq data analysis, including the identification of transcription factor binding sites.\n2. DRIMMER is a package in R/Bioconductor used for identifying transcription factor binding sites from ChIP-seq or ChIP-chip data.\n3. MEME is a package in R/Bioconductor used for discovering motifs in DNA sequences, including transcription factor binding sites.\n4. TRANSFAC is a package in R/Bioconductor that provides a database of transcription factor binding sites.\n5. MotifSampler is a package in R/Bioconductor used for the discovery of motifs in DNA sequences, including transcription factor binding sites.",
    "vicuna-7b_fact": [
      "ChIPS is a package in R/Bioconductor for ChIP-seq data analysis, including the identification of transcription factor binding sites.",
      "DRIMMER is a package in R/Bioconductor used for identifying transcription factor binding sites from ChIP-seq or ChIP-chip data.",
      "MEME is a package in R/Bioconductor used for discovering motifs in DNA sequences, including transcription factor binding sites.",
      "TRANSFAC is a package in R/Bioconductor that provides a database of transcription factor binding sites.",
      "MotifSampler is a package in R/Bioconductor used for the discovery of motifs in DNA sequences, including transcription factor binding sites."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: ChIPseeker is a package in R/Bioconductor for ChIP-seq data analysis, including the identification of transcription factor binding sites, not ChIPS.\n2. UNKNOWN: DRIMMER is not a well-known package in R/Bioconductor, and without additional context, it's unclear whether this statement is true or false.\n3. FALSE [correction]: MEME is a standalone software package for motif discovery in sequences, not specifically a package in R/Bioconductor. However, there is an R/Bioconductor package called 'meme' that provides an interface to the MEME suite.\n4. FALSE [correction]: TRANSFAC is not a package in R/Bioconductor. It is a database of transcription factor binding sites, but it is not provided as a package through R/Bioconductor. There are R/Bioconductor packages that interface with TRANSFAC data, such as 'TFBSTools'.\n5. FALSE [correction]: MotifSampler is not a package in R/Bioconductor. It is a standalone software tool for motif discovery. However, there is an R/Bioconductor package called 'Biostrings' that includes functions for motif discovery among other sequence analysis utilities.",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "vicuna-7b_response": "Certainly! Here is a list of clinical trials for the prevention of sarcopenia:\n1. Sarcopenia Prevention with Resistance Training (SPRT) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of resistance training in preventing sarcopenia in older adults.\n2. Sarcopenia Prevention with Resistance Exercise (SPRE) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of resistance exercise in preventing sarcopenia in older adults.\n3. Sarcopenia Prevention with Progressive Resistance Exercise (SPREE) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of progressive resistance exercise in preventing sarcopenia in older adults.\n4. Sarcopenia Prevention with Progressive Resistance Training (SPRT) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of progressive resistance training in preventing sarcopenia in older adults.\n5. Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance exercise and nutrition intervention in preventing sarcopenia in older adults.\n6. Sarcopenia Prevention with Progressive Resistance Training and Nutrition Intervention (SPRTNI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance training and nutrition intervention in preventing sarcopenia in older adults.\n7. Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of progressive resistance exercise and nutrition intervention in preventing sarcopenia in older adults.\n8. Sarcopenia Prevention with Progressive Resistance Training and Nutrition Intervention (SPRTNI) Trial: This trial is a randomized controlled trial that aims to determine the effectiveness of a combination of",
    "vicuna-7b_fact_raw": "1. The Sarcopenia Prevention with Resistance Training (SPRT) Trial is a randomized controlled trial.\n2. The SPRT Trial aims to determine the effectiveness of resistance training in preventing sarcopenia in older adults.\n3. The Sarcopenia Prevention with Resistance Exercise (SPRE) Trial is a randomized controlled trial.\n4. The Sarcopenia Prevention with Progressive Resistance Exercise (SPREE) Trial is a randomized controlled trial.\n5. The Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial is a randomized controlled trial.",
    "vicuna-7b_fact": [
      "The Sarcopenia Prevention with Resistance Training (SPRT) Trial is a randomized controlled trial.",
      "The SPRT Trial aims to determine the effectiveness of resistance training in preventing sarcopenia in older adults.",
      "The Sarcopenia Prevention with Resistance Exercise (SPRE) Trial is a randomized controlled trial.",
      "The Sarcopenia Prevention with Progressive Resistance Exercise (SPREE) Trial is a randomized controlled trial.",
      "The Sarcopenia Prevention with Progressive Resistance Exercise and Nutrition Intervention (SPRENI) Trial is a randomized controlled trial."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific context or additional information about the SPRT, SPRE, SPREE, and SPRENI Trials, it is not possible to determine the veracity of these statements. These could be hypothetical trials or actual trials that are not widely recognized or documented in publicly available sources as of my knowledge cutoff date.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "vicuna-7b_response": "There are several databases that focus on molecular recognition features in membrane proteins. Here are a few examples:\n1. The Membrane Protein Data Bank (MPDB) is a database that contains structural data for membrane proteins. It includes information on molecular recognition features such as ligand binding sites, ion channels, and transporters.\n2. The Membrane Protein Structure Prediction (MPSP) database is a database that contains information on the structure prediction of membrane proteins. It includes information on the methods used to predict the structure of membrane proteins, as well as information on the molecular recognition features that were predicted.\n3. The Membrane Protein Classification (MPC) database is a database that contains information on the classification of membrane proteins. It includes information on the molecular recognition features of membrane proteins, such as their function and the types of molecules they interact with.\n4. The Membrane Protein Structure Annotation (MPSA) database is a database that contains information on the annotation of membrane protein structures. It includes information on the molecular recognition features of membrane proteins, such as their function and the types of molecules they interact with.\nThese are just a few examples of databases that focus on molecular recognition features in membrane proteins. There are many other databases that may also be relevant, depending on the specific research question or interest.",
    "vicuna-7b_fact_raw": "1. The Membrane Protein Data Bank (MPDB) is a database that contains structural data for membrane proteins.\n2. The Membrane Protein Structure Prediction (MPSP) database contains information on the structure prediction of membrane proteins.\n3. The Membrane Protein Classification (MPC) database includes information on the classification of membrane proteins.\n4. The Membrane Protein Structure Annotation (MPSA) database contains information on the annotation of membrane protein structures.",
    "vicuna-7b_fact": [
      "The Membrane Protein Data Bank (MPDB) is a database that contains structural data for membrane proteins.",
      "The Membrane Protein Structure Prediction (MPSP) database contains information on the structure prediction of membrane proteins.",
      "The Membrane Protein Classification (MPC) database includes information on the classification of membrane proteins.",
      "The Membrane Protein Structure Annotation (MPSA) database contains information on the annotation of membrane protein structures."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nThe first statement is true as there are databases dedicated to storing structural data for membrane proteins, and the Membrane Protein Data Bank (MPDB) could be one such database. However, without specific context or additional information about the existence and content of the databases mentioned in statements 2, 3, and 4, it is not possible to verify the accuracy of these statements. Therefore, the veracity of the statements regarding the Membrane Protein Structure Prediction (MPSP) database, the Membrane Protein Classification (MPC) database, and the Membrane Protein Structure Annotation (MPSA) database remains unknown.",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "vicuna-7b_response": "Yes, rivaroxaban is metabolized in the kidneys. It is a medication that is primarily metabolized by the liver, but a small portion of the drug is also metabolized by the kidneys. The kidneys play an important role in the elimination of rivaroxaban from the body.\nRivaroxaban is a direct factor Xa inhibitor that is used to prevent blood clots from forming in the body. It is commonly used to prevent blood clots from forming in people who have atrial fibrillation, a type of irregular heartbeat that increases the risk of blood clots.\nThe medication is taken orally and is typically taken once daily. It is important to note that the kidneys play a role in the elimination of rivaroxaban from the body, so kidney function should be considered when prescribing the medication.\nIn summary, rivaroxaban is metabolized in the kidneys, and the kidneys play an important role in the elimination of the drug from the body.",
    "vicuna-7b_fact_raw": "1. Rivaroxaban is metabolized by the kidneys.\n2. The liver is the primary organ responsible for the metabolism of rivaroxaban.\n3. Rivaroxaban is a direct factor Xa inhibitor.\n4. Rivaroxaban is used to prevent blood clots in people with atrial fibrillation.\n5. Rivaroxaban is taken orally and typically once daily.",
    "vicuna-7b_fact": [
      "Rivaroxaban is metabolized by the kidneys.",
      "The liver is the primary organ responsible for the metabolism of rivaroxaban.",
      "Rivaroxaban is a direct factor Xa inhibitor.",
      "Rivaroxaban is used to prevent blood clots in people with atrial fibrillation.",
      "Rivaroxaban is taken orally and typically once daily."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Rivaroxaban is primarily metabolized by the liver, not the kidneys.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "vicuna-7b_response": "TRalpha2 is a transcription factor that plays a crucial role in the regulation of gene expression in various tissues, including the heart. TRalpha2 is a member of the thyroid hormone receptor (TR) family, which is a group of nuclear receptors that regulate the expression of genes involved in metabolism, development, and other processes.\nIn the heart, TRalpha2 has been shown to play a role in the regulation of gene expression related to cardiac function and development. Studies have shown that TRalpha2 is expressed in the heart and regulates the expression of genes involved in cardiac growth and development, as well as the regulation of contractility and electrical activity of the heart.\nSome of the genes that have been shown to be regulated by TRalpha2 in the heart include:\n* Myh7: Myosin heavy chain 7 (Myh7) is a gene that encodes for a protein that is involved in the development and function of skeletal muscle, including the heart. TRalpha2 has been shown to regulate the expression of Myh7 in the heart.\n* Nkx2.5: Nkx2.5 is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Nkx2.5 in the heart.\n* Tbx20: Tbx20 is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Tbx20 in the heart.\n* Gata4: Gata4 is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Gata4 in the heart.\n* Mef2c: Mef2c is a gene that encodes for a transcription factor that is involved in the development of the heart and other tissues. TRalpha2 has been shown to regulate the expression of Mef2c in the heart.\nThese are just a few examples of the genes that have been shown to be regulated by TRalpha2 in the heart. TRalpha2 plays a crucial role",
    "vicuna-7b_fact_raw": "1. TRalpha2 is a transcription factor that regulates gene expression in various tissues, including the heart.\n2. TRalpha2 is a member of the thyroid hormone receptor (TR) family.\n3. TRalpha2 regulates the expression of the Myh7 gene in the heart.\n4. TRalpha2 regulates the expression of the Nkx2.5 gene in the heart.\n5. TRalpha2 regulates the expression of the Tbx20 gene in the heart.",
    "vicuna-7b_fact": [
      "TRalpha2 is a transcription factor that regulates gene expression in various tissues, including the heart.",
      "TRalpha2 is a member of the thyroid hormone receptor (TR) family.",
      "TRalpha2 regulates the expression of the Myh7 gene in the heart.",
      "TRalpha2 regulates the expression of the Nkx2.5 gene in the heart.",
      "TRalpha2 regulates the expression of the Tbx20 gene in the heart."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nExplanation:\n1. TRalpha2 is indeed a transcription factor that regulates gene expression in various tissues, including the heart.\n2. TRalpha2 is a member of the thyroid hormone receptor family, which is consistent with the naming convention (TR).\n3. TRalpha2 has been shown to regulate the expression of the Myh7 gene in the heart, which is associated with cardiac muscle contraction.\n4. The regulation of the Nkx2.5 gene by TRalpha2 is not as well-established in the literature, and without specific context, it's difficult to confirm its accuracy.\n5. Similarly, the regulation of the Tbx20 gene by TRalpha2 is not clearly established without additional context or specific studies to reference.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "vicuna-7b_response": "There are several biomedical question answering systems available, including:\n1. BioASQ: A system for answering biomedical questions using a machine learning approach.\n2. Biocreative: A system for generating biomedical text from unstructured data, including questions and answers.\n3. Biomedical Question Answering Challenge (Bio-QA): A competition aimed at developing and evaluating biomedical question answering systems.\n4. Clinical Question Answering (CRAQ): A system for answering clinical questions using a knowledge base and natural language processing.\n5. MedQA: A system for answering clinical questions using a machine learning approach.\n6. PubMedQA: A system for answering biomedical questions using the PubMed database.\n7. Question Answering Challenge (QAC): A competition aimed at developing and evaluating question answering systems in general.\nThese are just a few examples, and there may be other biomedical question answering systems available as well.",
    "vicuna-7b_fact_raw": "1. BioASQ is a system that uses a machine learning approach to answer biomedical questions.\n2. Biocreative is a system that generates biomedical text from unstructured data.\n3. The Biomedical Question Answering Challenge (Bio-QA) is a competition for developing and evaluating biomedical question answering systems.\n4. Clinical Question Answering (CRAQ) is a system that answers clinical questions using a knowledge base and natural language processing.\n5. PubMedQA is a system that answers biomedical questions using the PubMed database.",
    "vicuna-7b_fact": [
      "BioASQ is a system that uses a machine learning approach to answer biomedical questions.",
      "Biocreative is a system that generates biomedical text from unstructured data.",
      "The Biomedical Question Answering Challenge (Bio-QA) is a competition for developing and evaluating biomedical question answering systems.",
      "Clinical Question Answering (CRAQ) is a system that answers clinical questions using a knowledge base and natural language processing.",
      "PubMedQA is a system that answers biomedical questions using the PubMed database."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: BioCreative is a challenge evaluation that focuses on the evaluation of text mining and information extraction systems applied to the biomedical domain.\n3. TRUE\n4. FALSE [correction]: There is no widely recognized system specifically named \"Clinical Question Answering (CRAQ)\" that is known for answering clinical questions using a knowledge base and natural language processing. However, there are various systems designed to answer clinical questions, and they may use knowledge bases and NLP.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "vicuna-7b_response": "The transcription factor that activates the betalain pathway is known as the Beta-carotene-15,15'-oxygenase (BCO) transcription factor. BCO is a transcription factor that is responsible for activating the genes involved in the betalain pathway, which is responsible for the synthesis of betalains in plants.\nThe betalain pathway is a complex pathway that involves several enzymes and genes. The BCO transcription factor is responsible for activating the genes involved in the pathway, which are located on the long arm of chromosome 4 in the genome of Solanum tuberosum, the species that is commonly used as a source of potatoes.\nThe BCO transcription factor is a member of the basic helix-loop-helix (bHLH) transcription factor family, which is a family of transcription factors that play important roles in the regulation of gene expression in plants. The BCO transcription factor is a key regulator of the betalain pathway, and its activity is required for the synthesis of betalains in plants.\nIn summary, the BCO transcription factor is the transcription factor that activates the betalain pathway in plants. The BCO transcription factor is a key regulator of the betalain pathway, and its activity is required for the synthesis of betalains in plants.",
    "vicuna-7b_fact_raw": "1. The Beta-carotene-15,15'-oxygenase (BCO) transcription factor activates the betalain pathway.\n2. The BCO transcription factor is responsible for activating genes involved in the synthesis of betalains in plants.\n3. Genes involved in the betalain pathway are located on the long arm of chromosome 4 in the genome of Solanum tuberosum.\n4. The BCO transcription factor is a member of the basic helix-loop-helix (bHLH) transcription factor family.\n5. The activity of the BCO transcription factor is required for the synthesis of betalains in plants.",
    "vicuna-7b_fact": [
      "The Beta-carotene-15,15'-oxygenase (BCO) transcription factor activates the betalain pathway.",
      "The BCO transcription factor is responsible for activating genes involved in the synthesis of betalains in plants.",
      "Genes involved in the betalain pathway are located on the long arm of chromosome 4 in the genome of Solanum tuberosum.",
      "The BCO transcription factor is a member of the basic helix-loop-helix (bHLH) transcription factor family.",
      "The activity of the BCO transcription factor is required for the synthesis of betalains in plants."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Beta-carotene-15,15'-oxygenase (BCO) is an enzyme, not a transcription factor, and it is involved in the cleavage of beta-carotene to form retinal, not in activating the betalain pathway.\n2. FALSE [correction]: The BCO enzyme is not responsible for activating genes involved in the synthesis of betalains. Betalains are synthesized by a different set of enzymes and the transcription factors involved in their synthesis are not BCO.\n3. UNKNOWN: Without specific information on the genomic location of the genes involved in the betalain pathway in Solanum tuberosum (potato), it is not possible to confirm or deny the location of these genes on chromosome 4.\n4. FALSE [correction]: Since BCO is an enzyme and not a transcription factor, it is not a member of the basic helix-loop-helix (bHLH) transcription factor family.\n5. FALSE [correction]: The activity of the BCO enzyme is not required for the synthesis of betalains in plants. Betalains are synthesized through a different pathway that does not involve the BCO enzyme.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "vicuna-7b_response": "There are several technologies that are commonly used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses. Some of the preferred technologies include:\n1. Ion exchange chromatography: This technique involves the use of an ion exchange resin to separate charged molecules, including phosphorylated peptides.\n2. TiO2 beads: These beads are coated with a layer of titanium dioxide, which can selectively bind to phosphorylated peptides.\n3. Phosphopeptide enrichment columns: These columns contain a resin that is specifically designed to bind to phosphorylated peptides, allowing for their enrichment from a larger sample.\n4. Phospho-specific antibodies: Antibodies that are specific to phosphorylated peptides can be used to capture and enrich them from a sample.\n5. Phospho-specific affinity beads: These beads are coated with a ligand that specifically binds to phosphorylated peptides, allowing for their enrichment from a sample.\nIt is important to note that the choice of technology will depend on the specific requirements of the experiment, such as the size of the sample, the sensitivity of detection, and the specificity of the enrichment.",
    "vicuna-7b_fact_raw": "1. Ion exchange chromatography is used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses.\n2. TiO2 beads are used to selectively bind to phosphorylated peptides for their enrichment.\n3. Phosphopeptide enrichment columns are designed to bind to phosphorylated peptides for their enrichment.\n4. Phospho-specific antibodies can be used to capture and enrich phosphorylated peptides from a sample.\n5. Phospho-specific affinity beads are used to bind to phosphorylated peptides for their enrichment.",
    "vicuna-7b_fact": [
      "Ion exchange chromatography is used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses.",
      "TiO2 beads are used to selectively bind to phosphorylated peptides for their enrichment.",
      "Phosphopeptide enrichment columns are designed to bind to phosphorylated peptides for their enrichment.",
      "Phospho-specific antibodies can be used to capture and enrich phosphorylated peptides from a sample.",
      "Phospho-specific affinity beads are used to bind to phosphorylated peptides for their enrichment."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nIon exchange chromatography, TiO2 beads, phosphopeptide enrichment columns, phospho-specific antibodies, and phospho-specific affinity beads are all methods used to enrich or capture phosphorylated peptides in the context of phosphoproteomic analyses. Each of these techniques takes advantage of the unique chemical properties of phosphorylated residues to selectively isolate them from a complex mixture.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "vicuna-7b_response": "The Palmini classification is a system used to rate the severity of various medical conditions. It is not a specific disorder, but rather a way of categorizing and comparing the severity of different conditions. The Palmini classification is typically used in the field of neurology to assess the severity of conditions such as stroke, traumatic brain injury, and other neurological disorders.\nThe Palmini classification is based on the degree of motor and sensory impairment, as well as the presence of other symptoms such as language and cognitive impairment. The classification is divided into five levels, ranging from level 1 (mild impairment) to level 5 (severe impairment).\nIt is important to note that the Palmini classification is not a diagnostic tool and should not be used to diagnose a specific condition. If you have concerns about a medical condition, it is important to speak with a qualified healthcare professional.",
    "vicuna-7b_fact_raw": "1. The Palmini classification is used to rate the severity of various medical conditions.\n2. It is commonly used in the field of neurology.\n3. The Palmini classification assesses conditions such as stroke and traumatic brain injury.\n4. This classification system is based on the degree of motor and sensory impairment, as well as language and cognitive impairment.\n5. The Palmini classification is divided into five levels, with level 1 indicating mild impairment and level 5 indicating severe impairment.",
    "vicuna-7b_fact": [
      "The Palmini classification is used to rate the severity of various medical conditions.",
      "It is commonly used in the field of neurology.",
      "The Palmini classification assesses conditions such as stroke and traumatic brain injury.",
      "This classification system is based on the degree of motor and sensory impairment, as well as language and cognitive impairment.",
      "The Palmini classification is divided into five levels, with level 1 indicating mild impairment and level 5 indicating severe impairment."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Palmini classification is not used to rate the severity of various medical conditions in general; it is specifically used for classifying types of malformations of cortical development related to epilepsy.\n2. TRUE\n3. FALSE [correction]: The Palmini classification is not used to assess conditions such as stroke and traumatic brain injury; it is used in the context of epilepsy.\n4. FALSE [correction]: The Palmini classification is not based on the degree of motor and sensory impairment, language, or cognitive impairment; it is based on the anatomical description of cortical malformations.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "vicuna-7b_response": "Subacute thyroiditis is an inflammatory condition of the thyroid gland that can be caused by a variety of factors, including viruses.\nViruses such as the human immunodeficiency virus (HIV), cytomegalovirus (CMV), and herpes simplex virus (HSV) have been implicated in the development of subacute thyroiditis. These viruses can cause direct damage to the thyroid gland or trigger an immune response that leads to inflammation.\nThe symptoms of subacute thyroiditis can be similar to those of other thyroid disorders, such as hyperthyroidism (too much thyroid hormone) and hypothyroidism (too little thyroid hormone). Therefore, it can be difficult to definitively diagnose subacute thyroiditis without further testing.\nTreatment for subacute thyroiditis typically involves medications to reduce inflammation and symptoms, as well as hormone replacement therapy if the thyroid gland is damaged. In some cases, surgery may be necessary to remove part or all of the thyroid gland.\nIt is important to note that while viruses can play a role in the development of subacute thyroiditis, other factors such as autoimmune disorders, infections, and medications can also cause this condition. Therefore, a thorough evaluation by a healthcare professional is necessary to determine the underlying cause of subacute thyroiditis and develop an appropriate treatment plan.",
    "vicuna-7b_fact_raw": "1. Subacute thyroiditis is an inflammatory condition of the thyroid gland that can be caused by viruses.\n2. Viruses such as the human immunodeficiency virus (HIV), cytomegalovirus (CMV), and herpes simplex virus (HSV) have been implicated in the development of subacute thyroiditis.\n3. Symptoms of subacute thyroiditis can be similar to those of other thyroid disorders, such as hyperthyroidism and hypothyroidism.\n4. Treatment for subacute thyroiditis typically involves medications to reduce inflammation and symptoms.\n5. Hormone replacement therapy may be used in the treatment of subacute thyroiditis if the thyroid gland is damaged.",
    "vicuna-7b_fact": [
      "Subacute thyroiditis is an inflammatory condition of the thyroid gland that can be caused by viruses.",
      "Viruses such as the human immunodeficiency virus (HIV), cytomegalovirus (CMV), and herpes simplex virus (HSV) have been implicated in the development of subacute thyroiditis.",
      "Symptoms of subacute thyroiditis can be similar to those of other thyroid disorders, such as hyperthyroidism and hypothyroidism.",
      "Treatment for subacute thyroiditis typically involves medications to reduce inflammation and symptoms.",
      "Hormone replacement therapy may be used in the treatment of subacute thyroiditis if the thyroid gland is damaged."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: While viruses are implicated in subacute thyroiditis, the specific viruses typically associated with it are the mumps virus, influenza virus, and other respiratory viruses. HIV, CMV, and HSV are not commonly associated with subacute thyroiditis.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "vicuna-7b_response": "STAT3 (signal transducer and activator of transcription 3) is a transcription factor that plays a role in various cellular processes, including cell growth, differentiation, and survival. It has been shown to be involved in the regulation of autophagy, a process of cellular self-digestion that is important for maintaining cellular homeostasis.\nEIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2) is a kinase that plays a role in the regulation of cellular metabolism and autophagy. It has been shown to be involved in the suppression of autophagy in response to various stimuli, such as nutrient availability and stress.\nThere is evidence to suggest that STAT3 may be involved in the EIF2AK2-dependent suppression of autophagy. For example, studies have shown that STAT3 can interact with and phosphorylate EIF2AK2, which may play a role in the regulation of autophagy. Additionally, STAT3 has been shown to be involved in the regulation of the expression of genes that are involved in the suppression of autophagy, such as the inhibitor of apoptosis protein (IAP) family member 2 (XIAP).\nOverall, while the exact role of STAT3 in the EIF2AK2-dependent suppression of autophagy is not fully understood, there is evidence to suggest that it may play a role in this process. Further research is needed to fully elucidate the relationship between STAT3 and EIF2AK2 in the regulation of autophagy.",
    "vicuna-7b_fact_raw": "1. STAT3 is a transcription factor involved in cell growth, differentiation, and survival.\n2. STAT3 plays a role in the regulation of autophagy.\n3. EIF2AK2 is a kinase involved in the regulation of cellular metabolism and autophagy.\n4. EIF2AK2 has been shown to suppress autophagy in response to various stimuli.\n5. There is evidence suggesting that STAT3 may interact with and phosphorylate EIF2AK2, which could affect the regulation of autophagy.",
    "vicuna-7b_fact": [
      "STAT3 is a transcription factor involved in cell growth, differentiation, and survival.",
      "STAT3 plays a role in the regulation of autophagy.",
      "EIF2AK2 is a kinase involved in the regulation of cellular metabolism and autophagy.",
      "EIF2AK2 has been shown to suppress autophagy in response to various stimuli.",
      "There is evidence suggesting that STAT3 may interact with and phosphorylate EIF2AK2, which could affect the regulation of autophagy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: EIF2AK2, also known as PKR, is a kinase that has been shown to promote autophagy in response to various stimuli, not suppress it.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "vicuna-7b_response": "Theatre is a software tool for genomic analysis that provides a comprehensive solution for analyzing and interpreting genomic data. It is designed to help researchers and clinicians to identify genetic variants that are associated with disease, and to understand the functional impact of these variants on gene expression and protein function.\nTheatre provides a user-friendly interface that allows users to easily navigate and analyze large-scale genomic data sets. It includes a range of tools for data visualization, variant annotation, and functional analysis, which can be used to identify and prioritize genetic variants for further study.\nOne of the key features of Theatre is its ability to integrate data from a variety of sources, including whole-genome sequencing, RNA sequencing, and ChIP-seq data. This allows users to analyze data from multiple angles and to gain a more comprehensive understanding of the genetic and functional changes that occur in disease.\nIn addition, Theatre includes a range of tools for functional analysis, such as gene set enrichment analysis and pathway analysis, which can be used to identify genes and pathways that are associated with disease. This information can be used to develop new diagnostic tools and therapeutic strategies.\nOverall, Theatre is a powerful tool for genomic analysis that provides a comprehensive solution for analyzing and interpreting large-scale genomic data sets. It is widely used by researchers and clinicians in the fields of genomics, genetics, and personalized medicine.",
    "vicuna-7b_fact_raw": "1. Theatre is a software tool used for analyzing and interpreting genomic data.\n2. The software is designed to help identify genetic variants associated with disease and understand their impact on gene expression and protein function.\n3. Theatre offers a user-friendly interface for navigating and analyzing large-scale genomic data sets.\n4. It integrates data from various sources, including whole-genome sequencing, RNA sequencing, and ChIP-seq data.\n5. Theatre includes tools for functional analysis, such as gene set enrichment analysis and pathway analysis.",
    "vicuna-7b_fact": [
      "Theatre is a software tool used for analyzing and interpreting genomic data.",
      "The software is designed to help identify genetic variants associated with disease and understand their impact on gene expression and protein function.",
      "Theatre offers a user-friendly interface for navigating and analyzing large-scale genomic data sets.",
      "It integrates data from various sources, including whole-genome sequencing, RNA sequencing, and ChIP-seq data.",
      "Theatre includes tools for functional analysis, such as gene set enrichment analysis and pathway analysis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Theatre is not a known software tool for analyzing and interpreting genomic data. The statement may be referring to a hypothetical or incorrectly named software. Commonly used tools for genomic data analysis include software like Genome Analysis Toolkit (GATK), PLINK, and others.\n2. UNKNOWN: Since \"Theatre\" is not a recognized software tool for genomic data analysis, the specific features and design goals cannot be confirmed.\n3. UNKNOWN: Without confirmation of the existence of \"Theatre\" as genomic data analysis software, the claim about its user interface cannot be verified.\n4. UNKNOWN: The integration capabilities of \"Theatre\" cannot be confirmed as it is not identified as existing genomic data analysis software.\n5. UNKNOWN: The availability of functional analysis tools such as gene set enrichment analysis and pathway analysis within \"Theatre\" cannot be confirmed without recognizing the software.",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "vicuna-7b_response": "The Smith-Waterman algorithm is a widely used algorithm for the alignment of two sequences. The execution time (complexity) of the Smith-Waterman algorithm depends on several factors, including the length of the sequences being aligned, the gap penalty and extension penalty used, and the algorithm's parameters.\nIn general, the execution time of the Smith-Waterman algorithm is O(n^2), where n is the length of the sequences being aligned. This is because the algorithm performs a sliding window search, where it compares each position in one sequence with every position in the other sequence.\nHowever, the actual execution time can be much faster than O(n^2) in practice, depending on the specific implementation and the parameters used. For example, if the gap penalty is set to zero and the extension penalty is set to a large value, the algorithm can be very fast, as it will not allow for any gaps or extensions in the alignment.\nIn summary, the execution time of the Smith-Waterman algorithm for the alignment of two sequences is O(n^2), but it can be much faster in practice, depending on the specific implementation and parameters used.",
    "vicuna-7b_fact_raw": "1. The Smith-Waterman algorithm is used for the alignment of two sequences.\n2. The execution time (complexity) of the Smith-Waterman algorithm is generally O(n^2).\n3. The complexity depends on the length of the sequences being aligned.\n4. The execution time can vary based on the gap penalty and extension penalty used.\n5. The actual execution time can be faster than O(n^2) in practice with specific implementations and parameters.",
    "vicuna-7b_fact": [
      "The Smith-Waterman algorithm is used for the alignment of two sequences.",
      "The execution time (complexity) of the Smith-Waterman algorithm is generally O(n^2).",
      "The complexity depends on the length of the sequences being aligned.",
      "The execution time can vary based on the gap penalty and extension penalty used.",
      "The actual execution time can be faster than O(n^2) in practice with specific implementations and parameters."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe Smith-Waterman algorithm is indeed used for the alignment of two sequences, typically in bioinformatics for protein and nucleotide sequences. The execution time or complexity of the Smith-Waterman algorithm is generally O(n^2), where n is the length of the sequences being aligned, making the third statement true as well. The execution time can vary based on the scoring scheme, which includes gap penalties and extension penalties, so the fourth statement is also true. Finally, the actual execution time can be faster than O(n^2) in practice with specific implementations, such as using heuristics or optimized hardware, and parameters, which makes the fifth statement true.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "vicuna-7b_response": "FLVCR1 is a member of the SLC22A1 family.",
    "vicuna-7b_fact_raw": "NO FACTS",
    "vicuna-7b_fact": [],
    "vicuna-7b_judge": []
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "vicuna-7b_response": "GATA-1 is a transcription factor that plays a crucial role in the regulation of gene expression in various cell types. It has been shown to interact with a wide range of proteins, including other transcription factors, chromatin-modifying enzymes, and signaling molecules.\nOne approach to identifying GATA-1 interacting partners is through the use of biotinylation tagging. This method involves introducing a biotinylated version of GATA-1 into cells, which allows for the capture of proteins that interact with GATA-1.\nSeveral studies have used biotinylation tagging to identify GATA-1 interacting partners. Here are some examples:\n1. A study published in the journal Molecular Cell in 2007 used biotinylation tagging to identify GATA-1 interacting partners in hematopoietic cells. The study found that GATA-1 interacted with a number of proteins involved in the regulation of gene expression, including other transcription factors, chromatin-modifying enzymes, and signaling molecules.\n2. A study published in the journal Blood in 2011 used biotinylation tagging to identify GATA-1 interacting partners in erythroid cells. The study found that GATA-1 interacted with a number of proteins involved in erythroid differentiation, including erythropoietin, transferrin receptor, and glycophorin A.\n3. A study published in the journal Cell Death and Differentiation in 2013 used biotinylation tagging to identify GATA-1 interacting partners in pancreatic ductal adenocarcinoma cells. The study found that GATA-1 interacted with a number of proteins involved in the regulation of cell proliferation and survival, including cyclin D1, survivin, and c-Myc.\nOverall, these studies have identified a number of GATA-1 interacting partners using the biotinylation tagging approach. These interactions are likely to play important roles in the regulation of gene expression and cellular processes in various cell types.",
    "vicuna-7b_fact_raw": "1. A study published in Molecular Cell in 2007 identified GATA-1 interacting partners in hematopoietic cells using biotinylation tagging.\n2. The 2007 study found that GATA-1 interacted with proteins involved in the regulation of gene expression, including transcription factors and chromatin-modifying enzymes.\n3. A study published in Blood in 2011 used biotinylation tagging to identify GATA-1 interacting partners in erythroid cells.\n4. The 2011 study reported interactions between GATA-1 and proteins involved in erythroid differentiation, such as erythropoietin, transferrin receptor, and glycophorin A.\n5. A study published in Cell Death and Differentiation in 2013 identified GATA-1 interacting partners in pancreatic ductal adenocarcinoma cells through biotinylation tagging, including proteins like cyclin D1, survivin, and c-Myc.",
    "vicuna-7b_fact": [
      "A study published in Molecular Cell in 2007 identified GATA-1 interacting partners in hematopoietic cells using biotinylation tagging.",
      "The 2007 study found that GATA-1 interacted with proteins involved in the regulation of gene expression, including transcription factors and chromatin-modifying enzymes.",
      "A study published in Blood in 2011 used biotinylation tagging to identify GATA-1 interacting partners in erythroid cells.",
      "The 2011 study reported interactions between GATA-1 and proteins involved in erythroid differentiation, such as erythropoietin, transferrin receptor, and glycophorin A.",
      "A study published in Cell Death and Differentiation in 2013 identified GATA-1 interacting partners in pancreatic ductal adenocarcinoma cells through biotinylation tagging, including proteins like cyclin D1, survivin, and c-Myc."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: Erythropoietin, transferrin receptor, and glycophorin A are not proteins that directly interact with GATA-1. They are involved in erythroid differentiation, but GATA-1 typically interacts with transcription factors and chromatin-modifying enzymes, not with these proteins directly.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "vicuna-7b_response": "TAF10 is a transcriptional co-activator that interacts with various transcription factors, including GATA1. The interaction between TAF10 and GATA1 can affect gene expression and play a role in the regulation of cellular processes.\nThe specific outcome of TAF10 interacting with GATA1 depends on the context in which they interact. In some cases, the interaction may enhance the transcriptional activity of GATA1, leading to increased expression of target genes. In other cases, the interaction may inhibit the transcriptional activity of GATA1, leading to decreased expression of target genes.\nThe exact outcome of TAF10 and GATA1 interaction will depend on the specific genes they are regulating, the cellular context, and other factors. However, it is clear that the interaction between TAF10 and GATA1 can have a significant impact on gene expression and cellular processes.",
    "vicuna-7b_fact_raw": "1. TAF10 is a transcriptional co-activator that interacts with various transcription factors, including GATA1.\n2. The interaction between TAF10 and GATA1 can affect gene expression.\n3. The interaction between TAF10 and GATA1 can play a role in the regulation of cellular processes.\n4. The interaction may enhance the transcriptional activity of GATA1, leading to increased expression of target genes.\n5. The interaction may also inhibit the transcriptional activity of GATA1, leading to decreased expression of target genes.",
    "vicuna-7b_fact": [
      "TAF10 is a transcriptional co-activator that interacts with various transcription factors, including GATA1.",
      "The interaction between TAF10 and GATA1 can affect gene expression.",
      "The interaction between TAF10 and GATA1 can play a role in the regulation of cellular processes.",
      "The interaction may enhance the transcriptional activity of GATA1, leading to increased expression of target genes.",
      "The interaction may also inhibit the transcriptional activity of GATA1, leading to decreased expression of target genes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided are consistent with the general understanding of how transcriptional co-activators like TAF10 can interact with transcription factors such as GATA1 to modulate gene expression. These interactions can indeed lead to changes in the regulation of cellular processes, and they can either enhance or inhibit the transcriptional activity of the transcription factor, thereby affecting the expression levels of target genes. Without specific contradictory information from the provided context, these statements are considered true based on general biological principles.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "vicuna-7b_response": "Yes, there are several decision support systems for chronic pain management. These systems are designed to help healthcare providers make informed decisions about the treatment of chronic pain.\nOne example of a decision support system for chronic pain management is the Clinical Decision Support (CDS) system. CDS systems are computerized tools that provide healthcare providers with patient-specific information and recommendations to support clinical decision-making. CDS systems for chronic pain management can provide recommendations on medication dosages, treatment options, and follow-up care.\nAnother example is the Pain Management Decision Support System (PMDSS). PMDSS is a web-based tool that provides healthcare providers with patient-specific information and recommendations for the management of chronic pain. The system uses a patient-specific algorithm to generate recommendations based on the patient's medical history, medications, and other relevant factors.\nIn addition, some electronic health record (EHR) systems have built-in decision support systems for chronic pain management. These systems can provide healthcare providers with patient information and recommendations based on the patient's medical history and other relevant factors.\nOverall, decision support systems for chronic pain management can help healthcare providers make informed decisions about the treatment of chronic pain, and can improve the quality of care for patients with chronic pain.",
    "vicuna-7b_fact_raw": "1. Clinical Decision Support (CDS) systems are computerized tools that provide healthcare providers with patient-specific information and recommendations to support clinical decision-making.\n2. CDS systems for chronic pain management can provide recommendations on medication dosages, treatment options, and follow-up care.\n3. The Pain Management Decision Support System (PMDSS) is a web-based tool that provides healthcare providers with patient-specific information and recommendations for the management of chronic pain.\n4. PMDSS uses a patient-specific algorithm to generate recommendations based on the patient's medical history, medications, and other relevant factors.\n5. Some electronic health record (EHR) systems have built-in decision support systems for chronic pain management.",
    "vicuna-7b_fact": [
      "Clinical Decision Support (CDS) systems are computerized tools that provide healthcare providers with patient-specific information and recommendations to support clinical decision-making.",
      "CDS systems for chronic pain management can provide recommendations on medication dosages, treatment options, and follow-up care.",
      "The Pain Management Decision Support System (PMDSS) is a web-based tool that provides healthcare providers with patient-specific information and recommendations for the management of chronic pain.",
      "PMDSS uses a patient-specific algorithm to generate recommendations based on the patient's medical history, medications, and other relevant factors.",
      "Some electronic health record (EHR) systems have built-in decision support systems for chronic pain management."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "vicuna-7b_response": "Angiogenin is a protein that is primarily localized in the endoplasmic reticulum (ER) and the Golgi apparatus. It is also found in the nucleus of certain cells, such as those in the liver and kidney. Angiogenin is a glycoprotein that is involved in the regulation of cell growth and differentiation, and it has been implicated in the development of cancer. It is also a potent inducer of angiogenesis, the process by which new blood vessels are formed.",
    "vicuna-7b_fact_raw": "1. Angiogenin is primarily localized in the endoplasmic reticulum (ER) and the Golgi apparatus.\n2. Angiogenin is found in the nucleus of certain cells, including those in the liver and kidney.\n3. Angiogenin is a glycoprotein involved in the regulation of cell growth and differentiation.\n4. Angiogenin has been implicated in the development of cancer.\n5. Angiogenin is a potent inducer of angiogenesis, the process by which new blood vessels are formed.",
    "vicuna-7b_fact": [
      "Angiogenin is primarily localized in the endoplasmic reticulum (ER) and the Golgi apparatus.",
      "Angiogenin is found in the nucleus of certain cells, including those in the liver and kidney.",
      "Angiogenin is a glycoprotein involved in the regulation of cell growth and differentiation.",
      "Angiogenin has been implicated in the development of cancer.",
      "Angiogenin is a potent inducer of angiogenesis, the process by which new blood vessels are formed."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Angiogenin is primarily localized in the nucleus and cytoplasmic compartments, not in the endoplasmic reticulum (ER) and the Golgi apparatus.\n2. TRUE\n3. FALSE [correction]: Angiogenin is not a glycoprotein; it is a ribonuclease enzyme involved in the regulation of cell growth and differentiation, particularly in its role in angiogenesis.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "vicuna-7b_response": "Ranolazine is a medication that is used to treat angina, a condition characterized by chest pain due to reduced blood flow to the heart muscle. It works by blocking the late sodium current in heart cells, which helps to reduce the amount of energy required by the heart to contract and pump blood.\nOne of the ways in which ranolazine affects kinase signaling activation in the heart is by blocking the activity of the voltage-gated sodium channel. This channel is responsible for allowing sodium ions to flow into heart cells, which can lead to the activation of several signaling pathways, including the protein kinase C (PKC) pathway. By blocking the activity of this channel, ranolazine can prevent the activation of PKC and other downstream signaling pathways, which can help to reduce the energy requirements of the heart and improve blood flow.\nAnother way in which ranolazine affects kinase signaling activation in the heart is by blocking the activity of the late sodium current. This current is activated in response to increased intracellular calcium levels, and it can lead to the activation of several signaling pathways, including the protein kinase C (PKC) pathway. By blocking the activity of this current, ranolazine can prevent the activation of PKC and other downstream signaling pathways, which can help to reduce the energy requirements of the heart and improve blood flow.\nOverall, ranolazine can have a beneficial effect on kinase signaling activation in the heart by blocking the activity of the voltage-gated sodium channel and the late sodium current, which can help to reduce the energy requirements of the heart and improve blood flow.",
    "vicuna-7b_fact_raw": "1. Ranolazine is used to treat angina, which is characterized by chest pain due to reduced blood flow to the heart muscle.\n2. Ranolazine works by blocking the late sodium current in heart cells.\n3. Blocking the late sodium current helps to reduce the energy required by the heart to contract and pump blood.\n4. Ranolazine affects kinase signaling activation in the heart by blocking the activity of the voltage-gated sodium channel.\n5. Blocking the voltage-gated sodium channel and the late sodium current can prevent the activation of protein kinase C (PKC) and other downstream signaling pathways.",
    "vicuna-7b_fact": [
      "Ranolazine is used to treat angina, which is characterized by chest pain due to reduced blood flow to the heart muscle.",
      "Ranolazine works by blocking the late sodium current in heart cells.",
      "Blocking the late sodium current helps to reduce the energy required by the heart to contract and pump blood.",
      "Ranolazine affects kinase signaling activation in the heart by blocking the activity of the voltage-gated sodium channel.",
      "Blocking the voltage-gated sodium channel and the late sodium current can prevent the activation of protein kinase C (PKC) and other downstream signaling pathways."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Ranolazine does not directly affect kinase signaling activation by blocking the activity of the voltage-gated sodium channel. It primarily works by blocking the late sodium current in heart cells, which can indirectly affect the heart's metabolism and reduce oxygen demand, but its effect on kinase signaling pathways is not a primary action.\n5. FALSE [correction]: While blocking the late sodium current can have various effects on the heart's function, the statement that ranolazine prevents the activation of protein kinase C (PKC) and other downstream signaling pathways by blocking the voltage-gated sodium channel is not accurate. Ranolazine's primary mechanism is to inhibit the late sodium current, which may indirectly affect various cellular processes, but it is not specifically targeted at inhibiting PKC or other kinase signaling pathways.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "vicuna-7b_response": "VSR endonuclease is a type of restriction endonuclease that is involved in the regulation of genetic recombination in bacteria. The regulation of VSR endonuclease is not independent of the growth phase of bacteria.\nIn general, the expression of restriction endonucleases, including VSR endonuclease, is regulated by the growth phase of bacteria. The expression of these enzymes is typically higher during the exponential phase of growth and lower during the stationary phase.\nThe regulation of VSR endonuclease expression is also influenced by the availability of certain nutrients and the presence of certain signaling molecules. For example, the expression of VSR endonuclease can be induced by the presence of certain amino acids, such as glutamine, and can be repressed by the presence of certain inhibitors, such as antibiotics.\nIn summary, the regulation of VSR endonuclease expression is not independent of the growth phase of bacteria, but rather is influenced by a variety of factors, including the availability of nutrients and the presence of signaling molecules.",
    "vicuna-7b_fact_raw": "1. VSR endonuclease is involved in the regulation of genetic recombination in bacteria.\n2. The regulation of VSR endonuclease is not independent of the growth phase of bacteria.\n3. The expression of restriction endonucleases, including VSR endonuclease, is typically higher during the exponential phase of bacterial growth.\n4. The expression of VSR endonuclease is lower during the stationary phase of bacterial growth.\n5. The expression of VSR endonuclease can be influenced by the availability of certain nutrients and the presence of signaling molecules.",
    "vicuna-7b_fact": [
      "VSR endonuclease is involved in the regulation of genetic recombination in bacteria.",
      "The regulation of VSR endonuclease is not independent of the growth phase of bacteria.",
      "The expression of restriction endonucleases, including VSR endonuclease, is typically higher during the exponential phase of bacterial growth.",
      "The expression of VSR endonuclease is lower during the stationary phase of bacterial growth.",
      "The expression of VSR endonuclease can be influenced by the availability of certain nutrients and the presence of signaling molecules."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nThe statements about the specific expression levels of VSR endonuclease during different growth phases of bacteria (statements 3 and 4) would require specific scientific evidence to confirm, and without that evidence provided, their truth cannot be determined.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "vicuna-7b_response": "There are several computational tools available for the prediction of beta-barrel transmembrane proteins. Here are some of the most commonly used methods:\n1. TMHMM: TMHMM is a widely used software tool for the prediction of transmembrane helices in proteins. It uses a hidden Markov model to identify beta-barrel structures in proteins. TMHMM can be used to predict the location and length of transmembrane helices, as well as the orientation of beta-strands within the barrel.\n2. PONDR-VLXT: PONDR-VLXT is a software tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins. It uses a probabilistic model to identify beta-barrel structures in proteins and can also predict the location and orientation of beta-strands within the barrel.\n3. BetaBarrel: BetaBarrel is a software tool that uses a combination of sequence and structural information to predict beta-barrel transmembrane proteins. It uses a hidden Markov model to identify beta-barrel structures in proteins and can also predict the location and orientation of beta-strands within the barrel.\n4. SOPMA: SOPMA is a software tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins. It uses a probabilistic model to identify beta-barrel structures in proteins and can also predict the location and orientation of beta-strands within the barrel.\n5. PredictProtein: PredictProtein is a web-based tool that uses a combination of sequence and structural information to predict transmembrane helices in proteins. It uses a hidden Markov model to identify beta-barrel structures in proteins and can also predict the location and orientation of beta-strands within the barrel.\nThese are some of the most commonly used computational tools for the prediction of beta-barrel transmembrane proteins. The choice of tool depends on the specific requirements of the user and the available resources.",
    "vicuna-7b_fact_raw": "1. TMHMM is a software tool that predicts transmembrane helices in proteins using a hidden Markov model.\n2. PONDR-VLXT is a software tool that predicts transmembrane helices in proteins using a combination of sequence and structural information.\n3. BetaBarrel is a software tool that predicts beta-barrel transmembrane proteins using a hidden Markov model.\n4. SOPMA is a software tool that predicts transmembrane helices in proteins using a combination of sequence and structural information.\n5. PredictProtein is a web-based tool that predicts transmembrane helices in proteins using a hidden Markov model.",
    "vicuna-7b_fact": [
      "TMHMM is a software tool that predicts transmembrane helices in proteins using a hidden Markov model.",
      "PONDR-VLXT is a software tool that predicts transmembrane helices in proteins using a combination of sequence and structural information.",
      "BetaBarrel is a software tool that predicts beta-barrel transmembrane proteins using a hidden Markov model.",
      "SOPMA is a software tool that predicts transmembrane helices in proteins using a combination of sequence and structural information.",
      "PredictProtein is a web-based tool that predicts transmembrane helices in proteins using a hidden Markov model."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: PONDR-VLXT is a software tool that predicts protein disorder using a combination of sequence and structural information, not specifically transmembrane helices.\n3. TRUE\n4. FALSE [correction]: SOPMA is a software tool that predicts the secondary structure of proteins, not specifically transmembrane helices.\n5. FALSE [correction]: PredictProtein is a web-based tool that offers a broad range of protein structure and function predictions, not limited to transmembrane helices and not exclusively using a hidden Markov model.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "vicuna-7b_response": "Galassi classification is used for the classification of skeletal disorders. It is a system of classification that was developed by the Italian radiologist, Galassi, in the 1970s. The Galassi classification system is based on the location and the type of bone lesion. It is widely used in radiology to describe and classify bone tumors and other bone disorders. The Galassi classification system is divided into three main categories: benign, malignant, and uncertain. Benign tumors are non-cancerous and do not spread to other parts of the body. Malignant tumors are cancerous and can spread to other parts of the body. Uncertain tumors are not clearly benign or malignant and require further evaluation.",
    "vicuna-7b_fact_raw": "1. The Galassi classification is used for the classification of skeletal disorders.\n2. The Galassi classification system was developed by an Italian radiologist named Galassi in the 1970s.\n3. The system classifies bone lesions based on their location and type.\n4. The Galassi classification system is used in radiology to describe and classify bone tumors and other bone disorders.\n5. The Galassi classification system divides bone tumors into three main categories: benign, malignant, and uncertain.",
    "vicuna-7b_fact": [
      "The Galassi classification is used for the classification of skeletal disorders.",
      "The Galassi classification system was developed by an Italian radiologist named Galassi in the 1970s.",
      "The system classifies bone lesions based on their location and type.",
      "The Galassi classification system is used in radiology to describe and classify bone tumors and other bone disorders.",
      "The Galassi classification system divides bone tumors into three main categories: benign, malignant, and uncertain."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Galassi classification is used for the classification of middle ear effusions as seen on temporal bone CT scans, not for skeletal disorders.\n2. TRUE\n3. FALSE [correction]: The system classifies middle ear effusions based on their appearance on CT scans, not bone lesions based on their location and type.\n4. FALSE [correction]: The Galassi classification system is used in otolaryngology and radiology to describe and classify the extent of middle ear effusions, not bone tumors and other bone disorders.\n5. FALSE [correction]: The Galassi classification system does not divide bone tumors into categories; it categorizes the extent of middle ear effusions into three types based on the level of involvement of the tympanic cavity and mastoid air cells.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "vicuna-7b_response": "Shapiro syndrome is a rare genetic disorder characterized by a variety of symptoms, including:\n1. Elevated levels of uric acid in the blood (hyperuricemia)\n2. Gout: recurrent attacks of joint pain, swelling, and redness (inflammation) caused by the buildup of uric acid crystals in the joints.\n3. High blood pressure (hypertension)\n4. Kidney stones: small, hard deposits that form in the kidneys and can cause pain and other complications.\n5. Low blood counts: a decrease in the number of red blood cells, white blood cells, and platelets.\n6. Eye problems: such as cataracts, glaucoma, and other vision problems.\n7. Skin problems: such as psoriasis, eczema, and other skin rashes.\n8. Heart problems: such as high blood pressure, abnormal heart rhythms, and heart failure.\n9. Kidney problems: such as kidney stones, chronic kidney disease, and kidney failure.\n10. Joint pain and stiffness.\nIt's important to note that not all individuals with Shapiro syndrome will experience all of these symptoms, and the severity of symptoms can vary from person to person. Additionally, there are different types of Shapiro syndrome, and the symptoms can vary depending on the type.",
    "vicuna-7b_fact_raw": "1. Shapiro syndrome is characterized by elevated levels of uric acid in the blood (hyperuricemia).\n2. Individuals with Shapiro syndrome may experience gout, which includes recurrent attacks of joint pain, swelling, and redness.\n3. High blood pressure (hypertension) is a symptom associated with Shapiro syndrome.\n4. People with Shapiro syndrome can develop kidney stones.\n5. Shapiro syndrome can lead to low blood counts, affecting red blood cells, white blood cells, and platelets.",
    "vicuna-7b_fact": [
      "Shapiro syndrome is characterized by elevated levels of uric acid in the blood (hyperuricemia).",
      "Individuals with Shapiro syndrome may experience gout, which includes recurrent attacks of joint pain, swelling, and redness.",
      "High blood pressure (hypertension) is a symptom associated with Shapiro syndrome.",
      "People with Shapiro syndrome can develop kidney stones.",
      "Shapiro syndrome can lead to low blood counts, affecting red blood cells, white blood cells, and platelets."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Shapiro syndrome is characterized by the presence of recurrent episodes of spontaneous hypothermia, hyperhidrosis, and agenesis of the corpus callosum, not by elevated levels of uric acid in the blood.\n2. FALSE [correction]: While gout is associated with hyperuricemia, it is not a characteristic of Shapiro syndrome, which does not typically involve elevated uric acid levels.\n3. UNKNOWN: There is no direct association between Shapiro syndrome and high blood pressure (hypertension) commonly established in medical literature, but since the statement is not specific, it's difficult to confirm or deny without additional context.\n4. UNKNOWN: Shapiro syndrome is not typically associated with kidney stones; however, without specific context, it's difficult to confirm or deny this statement.\n5. FALSE [correction]: Shapiro syndrome does not typically lead to low blood counts affecting red blood cells, white blood cells, and platelets. This condition is more commonly associated with hypothermia and other neurological symptoms.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "vicuna-7b_response": "BRAG1 is a protein that is involved in the regulation of cell division. Mutations in the BRAG1 gene have been linked to the development of a rare genetic disorder called Bragg syndrome. Bragg syndrome is characterized by the development of multiple tumors, particularly in the brain, spinal cord, and other parts of the nervous system. The tumors that develop in Bragg syndrome are called brainstem gliomas and they are typically aggressive and difficult to treat.\nIt's important to note that Bragg syndrome is a very rare disorder and it's not very common for people to have mutations in the BRAG1 gene. However, it's important to be aware of the potential link between BRAG1 mutations and Bragg syndrome, as it can help in the diagnosis and treatment of the disorder.\nIt's also important to note that there are other genetic disorders that are linked to the development of brain tumors, such as neurofibromatosis type 2 (NF2) and tuberous sclerosis complex (TSC). These disorders are characterized by the development of benign or malignant tumors in the brain and other parts of the nervous system.\nIf you have any questions or concerns about Bragg syndrome or any other genetic disorders, it's best to speak with a healthcare professional who can provide you with more information and guidance.",
    "vicuna-7b_fact_raw": "1. Mutations in the BRAG1 gene have been linked to the development of Bragg syndrome.\n2. Bragg syndrome is characterized by the development of multiple tumors, particularly in the brain, spinal cord, and other parts of the nervous system.\n3. The tumors that develop in Bragg syndrome are called brainstem gliomas.\n4. Brainstem gliomas associated with Bragg syndrome are typically aggressive and difficult to treat.\n5. Bragg syndrome is a very rare genetic disorder.",
    "vicuna-7b_fact": [
      "Mutations in the BRAG1 gene have been linked to the development of Bragg syndrome.",
      "Bragg syndrome is characterized by the development of multiple tumors, particularly in the brain, spinal cord, and other parts of the nervous system.",
      "The tumors that develop in Bragg syndrome are called brainstem gliomas.",
      "Brainstem gliomas associated with Bragg syndrome are typically aggressive and difficult to treat.",
      "Bragg syndrome is a very rare genetic disorder."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: There is no known BRAG1 gene or Bragg syndrome associated with it. It's possible that this is a fictional or incorrectly named condition.\n2. UNKNOWN: Since Bragg syndrome is not recognized as a medical condition, the characteristics of such a syndrome cannot be confirmed.\n3. UNKNOWN: Without a recognized medical condition known as Bragg syndrome, it is not possible to confirm the type of tumors associated with it.\n4. UNKNOWN: The aggressiveness and treatment difficulty of brainstem gliomas associated with Bragg syndrome cannot be determined as Bragg syndrome is not a recognized medical condition.\n5. UNKNOWN: Since Bragg syndrome is not a recognized medical condition, its rarity cannot be assessed.",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "vicuna-7b_response": "The main inhibitor of protein phosphatase 1 (PP1) is okadaic acid.",
    "vicuna-7b_fact_raw": "NO FACTS",
    "vicuna-7b_fact": [],
    "vicuna-7b_judge": []
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "vicuna-7b_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a process by which bacteria, such as Bacillus subtilis, undergo mutations in response to environmental stress. This process is a form of genetic adaptation that allows bacteria to survive in harsh conditions.\nThere are several mechanisms that underlie adaptive mutagenesis in Bacillus subtilis:\n1. Mutation accumulation: As bacteria undergo stress, such as starvation or exposure to antibiotics, they experience DNA damage. This damage can lead to mutations in the bacterial genome. Over time, the accumulation of mutations can lead to the evolution of new traits that allow the bacteria to survive in their environment.\n2. DNA repair mechanisms: Bacteria have several mechanisms to repair DNA damage, such as base excision repair, nucleotide excision repair, and mismatch repair. However, these mechanisms are not perfect, and some DNA damage can go unrepaired, leading to mutations.\n3. Transposable elements: Transposable elements are DNA sequences that can move around the genome, sometimes disrupting the normal functioning of genes. In Bacillus subtilis, transposable elements have been shown to play a role in adaptive mutagenesis. They can cause mutations by inserting themselves into the genome or by disrupting the normal functioning of genes.\n4. CRISPR-Cas system: The CRISPR-Cas system is a defense mechanism that allows bacteria to protect themselves against viruses and other foreign DNA. However, it can also be used as a mechanism for adaptive mutagenesis. The Cas proteins can cut DNA, leading to mutations.\n5. Environmental stress: Environmental stress, such as starvation or exposure to antibiotics, can cause DNA damage and lead to mutations. This damage can be repaired by the bacteria's DNA repair mechanisms, leading to the evolution of new traits.\nOverall, adaptive mutagenesis is a complex process that involves multiple mechanisms, including mutation accumulation, DNA repair mechanisms, transposable elements, the CRISPR-Cas system, and environmental stress.",
    "vicuna-7b_fact_raw": "1. Adaptive mutagenesis in Bacillus subtilis is a response to environmental stress.\n2. DNA damage in Bacillus subtilis can lead to mutations due to environmental stressors like starvation or exposure to antibiotics.\n3. Bacillus subtilis has DNA repair mechanisms such as base excision repair, nucleotide excision repair, and mismatch repair.\n4. Transposable elements in Bacillus subtilis can move around the genome and contribute to adaptive mutagenesis.\n5. The CRISPR-Cas system in Bacillus subtilis can cut DNA and lead to mutations as part of adaptive mutagenesis.",
    "vicuna-7b_fact": [
      "Adaptive mutagenesis in Bacillus subtilis is a response to environmental stress.",
      "DNA damage in Bacillus subtilis can lead to mutations due to environmental stressors like starvation or exposure to antibiotics.",
      "Bacillus subtilis has DNA repair mechanisms such as base excision repair, nucleotide excision repair, and mismatch repair.",
      "Transposable elements in Bacillus subtilis can move around the genome and contribute to adaptive mutagenesis.",
      "The CRISPR-Cas system in Bacillus subtilis can cut DNA and lead to mutations as part of adaptive mutagenesis."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The CRISPR-Cas system in Bacillus subtilis is primarily involved in providing immunity against phages and plasmids by cutting foreign DNA. It is not typically associated with causing mutations as part of adaptive mutagenesis.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "vicuna-7b_response": "Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that causes red, itchy, and scaly patches on the skin. The exact cause of eczema is not fully understood, but it is thought to be caused by a combination of genetic and environmental factors.\nSome of the known triggers that can cause eczema flare-ups include:\n1. Environmental allergens: Pollens, dust mites, and animal dander can trigger eczema flare-ups.\n2. Irritants: Soap, detergents, and other chemicals can cause eczema to flare up.\n3. Emotional stress: Stress can cause the skin to become more sensitive and prone to eczema flare-ups.\n4. Climate: Changes in temperature and humidity can cause eczema to flare up.\n5. Diet: Some foods, such as dairy and eggs, can trigger eczema flare-ups in some people.\nIt is important to note that everyone's experience with eczema is different, and what triggers one person's eczema may not trigger another person's. If you have eczema, it is important to work with your healthcare provider to identify your individual triggers and develop a plan to manage them.",
    "vicuna-7b_fact_raw": "1. Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition.\n2. The exact cause of eczema is thought to be a combination of genetic and environmental factors.\n3. Environmental allergens such as pollens, dust mites, and animal dander can trigger eczema flare-ups.\n4. Irritants like soap, detergents, and other chemicals can cause eczema to flare up.\n5. Emotional stress can make the skin more sensitive and prone to eczema flare-ups.",
    "vicuna-7b_fact": [
      "Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition.",
      "The exact cause of eczema is thought to be a combination of genetic and environmental factors.",
      "Environmental allergens such as pollens, dust mites, and animal dander can trigger eczema flare-ups.",
      "Irritants like soap, detergents, and other chemicals can cause eczema to flare up.",
      "Emotional stress can make the skin more sensitive and prone to eczema flare-ups."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "vicuna-7b_response": "Hydrochlorothiazide is a diuretic medication that is used to reduce the amount of water and salt in the body. It is primarily used to treat high blood pressure, but it can also be used to treat other conditions such as heart failure, kidney disease, and certain types of edema (swelling).\nHydrochlorothiazide works by increasing the amount of urine that the body produces, which helps to reduce the amount of fluid and salt in the body. This can help to lower blood pressure and reduce the risk of complications associated with high blood pressure, such as heart attack and stroke.\nIt is important to note that hydrochlorothiazide is not suitable for everyone, and it may not be appropriate for use in certain individuals. It is important to consult with a healthcare professional before starting treatment with hydrochlorothiazide to determine if it is the right treatment for you.\nIn addition to its use in treating high blood pressure, hydrochlorothiazide may also be used to treat other conditions such as diabetes insipidus, a condition in which the body is unable to regulate the amount of urine that it produces. It may also be used to treat certain types of kidney disease, such as nephrotic syndrome, and to prevent kidney damage in individuals who are at risk of developing kidney disease.\nIt is important to follow the dosage instructions provided by your healthcare professional when taking hydrochlorothiazide. It is also important to inform your healthcare professional of any other medications that you are taking, as hydrochlorothiazide can interact with certain medications and may not be suitable for everyone.",
    "vicuna-7b_fact_raw": "1. Hydrochlorothiazide is used to treat high blood pressure.\n2. Hydrochlorothiazide can be used to treat heart failure.\n3. Hydrochlorothiazide is used to treat certain types of edema.\n4. Hydrochlorothiazide works by increasing the amount of urine produced by the body.\n5. Hydrochlorothiazide may be used to treat diabetes insipidus and certain types of kidney disease, such as nephrotic syndrome.",
    "vicuna-7b_fact": [
      "Hydrochlorothiazide is used to treat high blood pressure.",
      "Hydrochlorothiazide can be used to treat heart failure.",
      "Hydrochlorothiazide is used to treat certain types of edema.",
      "Hydrochlorothiazide works by increasing the amount of urine produced by the body.",
      "Hydrochlorothiazide may be used to treat diabetes insipidus and certain types of kidney disease, such as nephrotic syndrome."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "vicuna-7b_response": "Yes, silicon has been used in the treatment of incontinence. Silicon is a synthetic material that is commonly used in the production of medical devices, including devices used in the treatment of incontinence.\nOne type of silicon device used in the treatment of incontinence is a silicone urinary incontinence device. These devices are designed to be placed in the vagina and are intended to provide support to the urethra and bladder neck, reducing the risk of urinary leakage.\nSilicone urinary incontinence devices are typically made from a flexible, pliable material that is designed to conform to the shape of the vagina. They are often used in women who have stress urinary incontinence, which is a type of incontinence that occurs when the bladder is put under pressure, such as when coughing, sneezing, or laughing.\nIt is important to note that silicone urinary incontinence devices are not suitable for everyone, and they should only be used under the guidance of a healthcare professional. It is also important to follow the instructions provided by the manufacturer when using these devices.\nIn addition to silicone urinary incontinence devices, there are other types of silicon-based devices that are used in the treatment of incontinence, including silicone gel-filled implants and silicone-coated mesh devices. However, these devices are typically used in more severe cases of incontinence and are not suitable for everyone.\nOverall, silicon has been used in the treatment of incontinence, and silicone-based devices are one type of treatment option that may be recommended by a healthcare professional for certain types of incontinence.",
    "vicuna-7b_fact_raw": "1. Silicon has been used in the treatment of incontinence.\n2. Silicone urinary incontinence devices are designed to be placed in the vagina to support the urethra and bladder neck.\n3. These silicone devices are often used in women who have stress urinary incontinence.\n4. Silicone urinary incontinence devices should be used under the guidance of a healthcare professional.\n5. There are other silicon-based devices used in the treatment of incontinence, such as silicone gel-filled implants and silicone-coated mesh devices.",
    "vicuna-7b_fact": [
      "Silicon has been used in the treatment of incontinence.",
      "Silicone urinary incontinence devices are designed to be placed in the vagina to support the urethra and bladder neck.",
      "These silicone devices are often used in women who have stress urinary incontinence.",
      "Silicone urinary incontinence devices should be used under the guidance of a healthcare professional.",
      "There are other silicon-based devices used in the treatment of incontinence, such as silicone gel-filled implants and silicone-coated mesh devices."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Silicone, not silicon, has been used in the treatment of incontinence. Silicon is a chemical element, while silicone is a polymer used in medical devices.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "vicuna-7b_response": "The association between the moon cycle and rupture risk of intracranial aneurysms is a topic of ongoing research and debate. Some studies have suggested that the moon's gravitational pull may affect the pressure inside an intracranial aneurysm, leading to an increased risk of rupture during certain phases of the lunar cycle. However, other studies have found no significant association between the moon and the rupture risk of intracranial aneurysms.\nIntracranial aneurysms are abnormal balloon-like swellings in the blood vessels of the brain. They can be caused by a variety of factors, including genetics, high blood pressure, and smoking. When an intracranial aneurysm ruptures, it can cause a subarachnoid hemorrhage, which can lead to severe brain damage or death.\nThe moon's gravitational pull is thought to affect the Earth's tides and the pressure inside the body's fluids, including the blood inside an intracranial aneurysm. Some researchers have suggested that the moon's gravitational pull may cause changes in the pressure inside an aneurysm, leading to an increased risk of rupture during certain phases of the lunar cycle. However, other researchers have found no significant association between the moon and the rupture risk of intracranial aneurysms.\nOverall, the association between the moon cycle and rupture risk of intracranial aneurysms is not well understood, and more research is needed to determine the potential role of the moon's gravitational pull in this process. It is important to note that the risk of rupture of an intracranial aneurysm is influenced by many factors, including the size and location of the aneurysm, the patient's age and medical history, and the presence of other risk factors such as high blood pressure and smoking.",
    "vicuna-7b_fact_raw": "1. Some studies have suggested that the moon's gravitational pull may affect the pressure inside an intracranial aneurysm.\n2. Other studies have found no significant association between the moon's gravitational pull and the rupture risk of intracranial aneurysms.\n3. Intracranial aneurysms are abnormal balloon-like swellings in the blood vessels of the brain.\n4. A ruptured intracranial aneurysm can cause a subarachnoid hemorrhage.\n5. The risk of rupture of an intracranial aneurysm is influenced by factors such as the size and location of the aneurysm, the patient's age and medical history, and the presence of other risk factors like high blood pressure and smoking.",
    "vicuna-7b_fact": [
      "Some studies have suggested that the moon's gravitational pull may affect the pressure inside an intracranial aneurysm.",
      "Other studies have found no significant association between the moon's gravitational pull and the rupture risk of intracranial aneurysms.",
      "Intracranial aneurysms are abnormal balloon-like swellings in the blood vessels of the brain.",
      "A ruptured intracranial aneurysm can cause a subarachnoid hemorrhage.",
      "The risk of rupture of an intracranial aneurysm is influenced by factors such as the size and location of the aneurysm, the patient's age and medical history, and the presence of other risk factors like high blood pressure and smoking."
    ],
    "vicuna-7b_judge_raw": "1. TRUE: Some studies have indeed suggested that the moon's gravitational pull might have an effect on the pressure inside an intracranial aneurysm, although this is a topic of debate and research is ongoing.\n2. TRUE: Other studies have found no significant association between the moon's gravitational pull and the rupture risk of intracranial aneurysms, indicating that there is no consensus in the scientific community on this matter.\n3. TRUE: Intracranial aneurysms are indeed abnormal balloon-like swellings that occur in the blood vessels of the brain.\n4. TRUE: A ruptured intracranial aneurysm can indeed cause a subarachnoid hemorrhage, which is a type of stroke caused by bleeding into the space surrounding the brain.\n5. TRUE: The risk of rupture of an intracranial aneurysm is influenced by various factors, including the size and location of the aneurysm, the patient's age and medical history, and the presence of other risk factors such as high blood pressure and smoking.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "vicuna-7b_response": "Yes, the HU Antisense RNA (HuR) protein has been shown to regulate the splicing process. HuR is a nuclear protein that binds to messenger RNA (mRNA) and regulates the stability and translation of mRNAs, including those involved in splicing.\nHuR has been shown to interact with a variety of splicing factors, including the splicing factor SF2/ASF, which is involved in the recognition of exons and the recruitment of splicing complexes to the splice site. By binding to SF2/ASF, HuR may help to stabilize the splicing complex and promote the efficient recognition and splicing of exons.\nIn addition, HuR has been shown to interact with the splicing factor SC35, which is involved in the formation of the spliceosome, the complex that catalyzes the splicing reaction. By binding to SC35, HuR may help to recruit the spliceosome to the splice site and promote the efficient recognition and splicing of exons.\nOverall, the interaction of HuR with splicing factors suggests that HuR plays a critical role in the regulation of the splicing process.",
    "vicuna-7b_fact_raw": "1. The HuR protein regulates the splicing process.\n2. HuR is a nuclear protein that binds to messenger RNA (mRNA).\n3. HuR regulates the stability and translation of mRNAs involved in splicing.\n4. HuR interacts with the splicing factor SF2/ASF, which is involved in exon recognition and recruitment of splicing complexes.\n5. HuR also interacts with the splicing factor SC35, which is involved in the formation of the spliceosome.",
    "vicuna-7b_fact": [
      "The HuR protein regulates the splicing process.",
      "HuR is a nuclear protein that binds to messenger RNA (mRNA).",
      "HuR regulates the stability and translation of mRNAs involved in splicing.",
      "HuR interacts with the splicing factor SF2/ASF, which is involved in exon recognition and recruitment of splicing complexes.",
      "HuR also interacts with the splicing factor SC35, which is involved in the formation of the spliceosome."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The HuR protein does not regulate the splicing process; it is primarily involved in regulating the stability and translation of mRNAs.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe HuR protein is indeed known for its role in mRNA stability and translation, but its direct involvement with specific splicing factors and the splicing process is not as widely recognized or may not be the primary function of the protein. Without specific context or references, the interactions with splicing factors SF2/ASF and SC35 cannot be confirmed as true or false.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "vicuna-7b_response": "Prothymosin alpha (PTMA) is a protein that plays a crucial role in the development and function of the thymus gland. The c-terminal peptide of PTMA, which is the part of the protein that is located at the end of the protein chain, has several known functions.\nOne of the known functions of the c-terminal peptide of PTMA is its ability to bind to and regulate the activity of other proteins. This binding can affect the activity of proteins involved in the development and maturation of T cells, which are a type of immune cell that is produced in the thymus gland.\nAnother known function of the c-terminal peptide of PTMA is its ability to regulate the expression of certain genes. This regulation can affect the production of proteins involved in the development and maturation of T cells, as well as the production of other proteins involved in the immune response.\nIn addition to its role in the development and function of the immune system, the c-terminal peptide of PTMA has also been shown to have a role in the regulation of cell growth and division. This regulation can affect the growth and division of T cells and other types of cells, and may play a role in the development of certain types of cancer.\nOverall, the c-terminal peptide of PTMA is a complex and multifunctional protein that plays a critical role in the development and function of the immune system, as well as in the regulation of cell growth and division.",
    "vicuna-7b_fact_raw": "1. The c-terminal peptide of prothymosin alpha (PTMA) can bind to and regulate the activity of other proteins.\n2. This binding by the c-terminal peptide of PTMA affects the activity of proteins involved in the development and maturation of T cells.\n3. The c-terminal peptide of PTMA can regulate the expression of certain genes.\n4. The regulation by the c-terminal peptide of PTMA affects the production of proteins involved in the development and maturation of T cells and the immune response.\n5. The c-terminal peptide of PTMA has a role in the regulation of cell growth and division, which may play a role in the development of certain types of cancer.",
    "vicuna-7b_fact": [
      "The c-terminal peptide of prothymosin alpha (PTMA) can bind to and regulate the activity of other proteins.",
      "This binding by the c-terminal peptide of PTMA affects the activity of proteins involved in the development and maturation of T cells.",
      "The c-terminal peptide of PTMA can regulate the expression of certain genes.",
      "The regulation by the c-terminal peptide of PTMA affects the production of proteins involved in the development and maturation of T cells and the immune response.",
      "The c-terminal peptide of PTMA has a role in the regulation of cell growth and division, which may play a role in the development of certain types of cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE: The c-terminal peptide of prothymosin alpha (PTMA) is known to interact with various proteins and can regulate their activity.\n2. TRUE: Given that prothymosin alpha is involved in immune system function, it is reasonable to assume that its c-terminal peptide could affect proteins involved in T cell development and maturation.\n3. TRUE: The c-terminal peptide of PTMA, like many regulatory peptides, can influence gene expression.\n4. TRUE: If the c-terminal peptide of PTMA regulates the activity of proteins involved in T cell development and maturation, it would logically affect the production of these proteins and thus the immune response.\n5. TRUE: The role of PTMA in cell proliferation and its potential implications in cancer development have been studied, suggesting that its c-terminal peptide may indeed play a role in the regulation of cell growth and division.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "vicuna-7b_response": "Cystatin C is a cysteine protease inhibitor that is found in various tissues and fluids in the human body. It is a small protein that is composed of 126 amino acids and is involved in regulating the activity of proteases, which are enzymes that break down other proteins.\nThere are several peptides that have been identified as playing a role in the fibrillization of cystatin C. One of these is the C-terminal peptide, which is located at the end of the protein and is composed of 12 amino acids. This peptide has been shown to be important for the formation of fibrils, which are the aggregates of cystatin C that are responsible for its fibrillization.\nOther peptides that have been implicated in cystatin C fibrillization include the N-terminal peptide, which is located at the beginning of the protein, and the middle peptide, which is located in the middle of the protein. These peptides may also play a role in the formation of fibrils, although their exact functions are not yet fully understood.\nOverall, the C-terminal peptide is one of the peptides that plays a pivotal role in human cystatin C fibrillization.",
    "vicuna-7b_fact_raw": "1. Cystatin C is a cysteine protease inhibitor found in various tissues and fluids in the human body.\n2. Cystatin C is composed of 126 amino acids.\n3. The C-terminal peptide of cystatin C, composed of 12 amino acids, plays a role in the fibrillization of the protein.\n4. Fibrils are aggregates of cystatin C that are responsible for its fibrillization.\n5. The N-terminal and middle peptides of cystatin C may also be involved in the formation of fibrils.",
    "vicuna-7b_fact": [
      "Cystatin C is a cysteine protease inhibitor found in various tissues and fluids in the human body.",
      "Cystatin C is composed of 126 amino acids.",
      "The C-terminal peptide of cystatin C, composed of 12 amino acids, plays a role in the fibrillization of the protein.",
      "Fibrils are aggregates of cystatin C that are responsible for its fibrillization.",
      "The N-terminal and middle peptides of cystatin C may also be involved in the formation of fibrils."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Fibrils are aggregates of proteins, but they are not responsible for the process of fibrillization; rather, fibrillization is the process by which fibrils are formed.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1 increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "vicuna-7b_response": "The concentration of protein HIF-1 (hypoxia-inducible factor 1 alpha) can increase after the administration of the cytoprotective prodrug amifostine (ethyol) in certain circumstances.\nAmifostine is a cytoprotective agent that is commonly used in cancer therapy to protect healthy cells from the toxic effects of radiation and chemotherapy. It works by binding to and inactivating endogenous and exogenous toxic compounds, including free radicals and other reactive oxygen species (ROS), before they can cause damage to cells.\nOne of the mechanisms by which amifostine exerts its cytoprotective effects is by increasing the expression and activity of the transcription factor HIF-1. HIF-1 is a key regulator of the cellular response to hypoxia (low oxygen levels), and its activation leads to the expression of genes involved in the synthesis of erythropoietin, angiogenesis, and other processes that help the body adapt to low oxygen conditions.\nIn some studies, amifostine has been shown to increase the expression and activity of HIF-1 in cancer cells, leading to the upregulation of genes involved in angiogenesis and the synthesis of erythropoietin. This can help to improve the delivery of oxygen to the tumor and promote the growth of new blood vessels, which can enhance the efficacy of cancer therapy.\nHowever, it is important to note that the effects of amifostine on HIF-1 concentration can vary depending on the specific context and the type of cancer being treated. In some cases, amifostine may not increase the concentration of HIF-1, and its cytoprotective effects may be mediated through other mechanisms.\nOverall, the effect of amifostine on the concentration of HIF-1 depends on various factors, including the dose and duration of treatment, the type of cancer being treated, and the presence of other cytoprotective agents. Further research is needed to fully understand the mechanisms underlying the effects of amifostine on HIF-1 and its potential therapeutic applications.",
    "vicuna-7b_fact_raw": "1. Amifostine is a cytoprotective agent used in cancer therapy to protect healthy cells from the toxic effects of radiation and chemotherapy.\n2. Amifostine works by binding to and inactivating toxic compounds, including free radicals and reactive oxygen species (ROS).\n3. One of the mechanisms by which amifostine exerts its effects is by increasing the expression and activity of the transcription factor HIF-1.\n4. HIF-1 is a key regulator of the cellular response to hypoxia and its activation leads to the expression of genes involved in erythropoietin synthesis and angiogenesis.\n5. In some studies, amifostine has been shown to increase the expression and activity of HIF-1 in cancer cells.",
    "vicuna-7b_fact": [
      "Amifostine is a cytoprotective agent used in cancer therapy to protect healthy cells from the toxic effects of radiation and chemotherapy.",
      "Amifostine works by binding to and inactivating toxic compounds, including free radicals and reactive oxygen species (ROS).",
      "One of the mechanisms by which amifostine exerts its effects is by increasing the expression and activity of the transcription factor HIF-1.",
      "HIF-1 is a key regulator of the cellular response to hypoxia and its activation leads to the expression of genes involved in erythropoietin synthesis and angiogenesis.",
      "In some studies, amifostine has been shown to increase the expression and activity of HIF-1 in cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN\n\nThe first two statements about amifostine are correct. It is indeed a cytoprotective agent used to protect healthy cells during cancer therapy, and it works by detoxifying harmful compounds. The fourth statement about HIF-1 is also true; it is a key regulator of the cellular response to hypoxia. However, the third and fifth statements about the specific mechanism of amifostine and its effects on HIF-1 in cancer cells are not widely established facts and would require specific scientific references to confirm their accuracy. Therefore, without additional context or references, the truth of these statements remains unknown.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "vicuna-7b_response": "Set7 is a histone methyltransferase that adds a methyl group to lysine 56 of histone H3 (H3K56me1). This modification is typically associated with transcriptional repression and is often found in developmental genes and in the heterochromatin of eukaryotic cells. Set7 is also known to deposit other histone marks, including H3K9me2 and H3K27me3, but these modifications are less common than H3K56me1.\nH3K9me2 is a mono-methylation of histone H3 on lysine 9 (H3K9me2), which is typically associated with transcriptional repression. Set7 has been shown to deposit H3K9me2 at the boundary between active and inactive chromatin, where it acts as a repressor of transcription.\nH3K27me3 is a trimethylation of histone H3 on lysine 27 (H3K27me3), which is also associated with transcriptional repression. Set7 has been shown to deposit H3K27me3 at the boundary between active and inactive chromatin, where it acts as a repressor of transcription.\nIt's important to note that while Set7 is known to deposit these other histone marks, H3K56me1 is the most common and well-studied modification associated with Set7.",
    "vicuna-7b_fact_raw": "1. Set7 is a histone methyltransferase that adds a methyl group to lysine 56 of histone H3 (H3K56me1).\n2. The H3K56me1 modification is typically associated with transcriptional repression.\n3. Set7 is known to deposit the histone mark H3K9me2.\n4. Set7 is also known to deposit the histone mark H3K27me3.\n5. H3K56me1 is the most common and well-studied modification associated with Set7.",
    "vicuna-7b_fact": [
      "Set7 is a histone methyltransferase that adds a methyl group to lysine 56 of histone H3 (H3K56me1).",
      "The H3K56me1 modification is typically associated with transcriptional repression.",
      "Set7 is known to deposit the histone mark H3K9me2.",
      "Set7 is also known to deposit the histone mark H3K27me3.",
      "H3K56me1 is the most common and well-studied modification associated with Set7."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Set7 (also known as Set7/9 or SETD7) is a histone methyltransferase that specifically targets lysine 4 of histone H3 (H3K4), not lysine 56.\n2. FALSE [correction]: The H3K56me1 modification is typically associated with active transcription and DNA damage repair, not transcriptional repression.\n3. FALSE [correction]: Set7 is known to specifically deposit the histone mark H3K4me1, not H3K9me2.\n4. FALSE [correction]: Set7 does not deposit the histone mark H3K27me3; this modification is associated with other histone methyltransferases like EZH2.\n5. FALSE [correction]: H3K4me1 is the most common and well-studied modification associated with Set7, not H3K56me1.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "vicuna-7b_response": "Hepcidin is a protein that plays a crucial role in the regulation of iron metabolism in the body. The exact number of disulfide bridges in hepcidin can vary depending on the species and the specific isoform of the protein.\nIn humans, hepcidin is composed of 296 amino acids and contains 10 disulfide bridges. These disulfide bridges are important for the stability and function of the protein.\nIt's worth noting that the number of disulfide bridges in a protein can vary depending on the species and the specific isoform of the protein. However, the general consensus is that hepcidin contains 10 disulfide bridges.",
    "vicuna-7b_fact_raw": "1. Hepcidin is a protein involved in the regulation of iron metabolism in the body.\n2. The number of disulfide bridges in hepcidin can vary depending on the species and the specific isoform of the protein.\n3. In humans, hepcidin is composed of 296 amino acids.\n4. Human hepcidin contains 10 disulfide bridges.\n5. Disulfide bridges contribute to the stability and function of hepcidin.",
    "vicuna-7b_fact": [
      "Hepcidin is a protein involved in the regulation of iron metabolism in the body.",
      "The number of disulfide bridges in hepcidin can vary depending on the species and the specific isoform of the protein.",
      "In humans, hepcidin is composed of 296 amino acids.",
      "Human hepcidin contains 10 disulfide bridges.",
      "Disulfide bridges contribute to the stability and function of hepcidin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In humans, hepcidin is much shorter, typically composed of 25 amino acids.\n4. FALSE [correction]: Human hepcidin contains 4 disulfide bridges.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "vicuna-7b_response": "DNAJC11 is a protein encoded by a gene that is localized in various tissues and organisms.\nIn humans, DNAJC11 is expressed in many tissues, including the brain, heart, liver, kidney, and pancreas. It is also expressed in fetal tissues, such as the lung and intestine. DNAJC11 has been localized to the endoplasmic reticulum (ER) and the mitochondria.\nIn mice, DNAJC11 is expressed in many tissues, including the brain, heart, liver, kidney, and pancreas. It is also expressed in fetal tissues, such as the lung and intestine. DNAJC11 has been localized to the ER and the mitochondria.\nIn other organisms, such as zebrafish and fruit flies, DNAJC11 has been localized to the ER and the mitochondria.\nOverall, DNAJC11 is a protein that is localized in various tissues and organisms, including the ER and the mitochondria.",
    "vicuna-7b_fact_raw": "1. In humans, DNAJC11 is expressed in the brain, heart, liver, kidney, and pancreas.\n2. DNAJC11 is also expressed in human fetal tissues, including the lung and intestine.\n3. DNAJC11 has been localized to the endoplasmic reticulum (ER) in humans.\n4. DNAJC11 has been localized to the mitochondria in humans.\n5. In mice, DNAJC11 is expressed in the brain, heart, liver, kidney, and pancreas.",
    "vicuna-7b_fact": [
      "In humans, DNAJC11 is expressed in the brain, heart, liver, kidney, and pancreas.",
      "DNAJC11 is also expressed in human fetal tissues, including the lung and intestine.",
      "DNAJC11 has been localized to the endoplasmic reticulum (ER) in humans.",
      "DNAJC11 has been localized to the mitochondria in humans.",
      "In mice, DNAJC11 is expressed in the brain, heart, liver, kidney, and pancreas."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: DNAJC11 has been localized to the mitochondria in humans.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "vicuna-7b_response": "Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species, meaning that they are found in similar forms in different organisms. UCEs are typically found in the 3' region of genes and are thought to be important for gene regulation.\nCopy number variants (CNVs) are changes in the number of copies of a particular region of DNA in a genome. CNVs can be either gain, which means that a region of DNA is present in more copies than expected, or loss, which means that a region of DNA is present in fewer copies than expected.\nIt is possible that UCEs could be depleted among CNVs, meaning that CNVs are more likely to occur in regions of the genome that do not contain UCEs. However, the relationship between UCEs and CNVs is complex and not well understood. Some studies have suggested that UCEs may be more likely to be present in regions of the genome that are not affected by CNVs, while other studies have found that UCEs are more likely to be present in regions of the genome that are affected by CNVs.\nOverall, it is difficult to make generalizations about the relationship between UCEs and CNVs, as the relationship may vary depending on the specific context and the type of CNV that is being considered.",
    "vicuna-7b_fact_raw": "1. Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species.\n2. UCEs are typically found in the 3' region of genes.\n3. UCEs are thought to be important for gene regulation.\n4. Copy number variants (CNVs) are changes in the number of copies of a particular region of DNA in a genome.\n5. CNVs can be either a gain (more copies than expected) or a loss (fewer copies than expected) of a DNA region.",
    "vicuna-7b_fact": [
      "Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across different species.",
      "UCEs are typically found in the 3' region of genes.",
      "UCEs are thought to be important for gene regulation.",
      "Copy number variants (CNVs) are changes in the number of copies of a particular region of DNA in a genome.",
      "CNVs can be either a gain (more copies than expected) or a loss (fewer copies than expected) of a DNA region."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Ultraconserved elements (UCEs) are not typically found in the 3' region of genes; they can be found in various regions of the genome, including non-coding regions.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "vicuna-7b_response": "The Haspin kinase is a mitotic kinase that is active during the G2 phase of the cell cycle. It is not clear what the substrate of Haspin is during mitosis. However, it is known that Haspin phosphorylates several proteins, including the anaphase-promoting complex/cyclosome (APC/C), which is involved in the regulation of mitosis. Haspin also phosphorylates the protein BubR1, which is involved in the regulation of the spindle assembly checkpoint.",
    "vicuna-7b_fact_raw": "1. Haspin kinase is active during the G2 phase of the cell cycle.\n2. Haspin kinase phosphorylates several proteins.\n3. The anaphase-promoting complex/cyclosome (APC/C) is involved in the regulation of mitosis and is phosphorylated by Haspin kinase.\n4. The protein BubR1 is involved in the regulation of the spindle assembly checkpoint and is phosphorylated by Haspin kinase.",
    "vicuna-7b_fact": [
      "Haspin kinase is active during the G2 phase of the cell cycle.",
      "Haspin kinase phosphorylates several proteins.",
      "The anaphase-promoting complex/cyclosome (APC/C) is involved in the regulation of mitosis and is phosphorylated by Haspin kinase.",
      "The protein BubR1 is involved in the regulation of the spindle assembly checkpoint and is phosphorylated by Haspin kinase."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The anaphase-promoting complex/cyclosome (APC/C) is involved in the regulation of mitosis, but it is not phosphorylated by Haspin kinase. Haspin kinase specifically phosphorylates histone H3 to facilitate proper chromosome segregation.\n4. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "vicuna-7b_response": "Viroids are small infectious RNA molecules that replicate in the cytoplasm of host cells. They are not considered to be true viruses, but rather a unique class of infectious agents that are capable of replicating themselves using a single-stranded RNA as a template.\nThe mechanism of viroid replication involves the following steps:\n1. Entry: Viroids enter host cells through receptor-mediated endocytosis or by binding to specific cellular receptors.\n2. Uncoating: The viroid is released from the endosome and transported to the cytoplasm, where it is uncoated from the endosome membrane.\n3. RNA replication: The viroid RNA is replicated using the host cell's ribonucleoprotein (RNP) complex. The RNP complex is composed of ribonucleic acid (RNA), ribosomes, and proteins. The viroid RNA is incorporated into the RNP complex, which then transcribes the viroid RNA into complementary DNA (cDNA) using the host cell's enzymes.\n4. cDNA integration: The cDNA is integrated into the host cell's genome, either as a single copy or as multiple copies, depending on the viroid species.\n5. Replication: The cDNA is transcribed into RNA, which is then translated into proteins by the host cell's ribosomes. The proteins produced by the host cell are used by the viroid to replicate itself.\n6. Cycle: The replicated viroid RNA is released from the host cell and can infect other cells, starting the replication cycle again.\nIt's important to note that viroid replication is a self-replicating process, meaning that the viroid RNA can replicate itself without the need for a helper virus or other external factors. This makes viroids unique among infectious agents and makes them a significant threat to plant health.",
    "vicuna-7b_fact_raw": "1. Viroids are small infectious RNA molecules that replicate in the cytoplasm of host cells.\n2. Viroids use a single-stranded RNA as a template for replication.\n3. Viroid replication involves the host cell's ribonucleoprotein (RNP) complex, which transcribes the viroid RNA into complementary DNA (cDNA).\n4. The cDNA of a viroid can be integrated into the host cell's genome.\n5. Viroid replication is a self-replicating process that does not require a helper virus or other external factors.",
    "vicuna-7b_fact": [
      "Viroids are small infectious RNA molecules that replicate in the cytoplasm of host cells.",
      "Viroids use a single-stranded RNA as a template for replication.",
      "Viroid replication involves the host cell's ribonucleoprotein (RNP) complex, which transcribes the viroid RNA into complementary DNA (cDNA).",
      "The cDNA of a viroid can be integrated into the host cell's genome.",
      "Viroid replication is a self-replicating process that does not require a helper virus or other external factors."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Viroid replication does not involve transcription into complementary DNA (cDNA). Instead, viroids replicate within the host cell using RNA-based mechanisms.\n4. FALSE [correction]: Viroids do not integrate their RNA into the host cell's genome; they exist as independent RNA molecules.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "vicuna-7b_response": "Fibronectin is a protein that is found in the extracellular matrix and plays a role in cell adhesion and migration. It is not typically considered a serum biomarker for Duchenne muscular dystrophy (DMD).\nDMD is a genetic disorder that affects muscle strength and function. It is caused by a mutation in the dystrophin gene, which results in a lack of dystrophin protein in muscle cells. The hallmark of DMD is progressive muscle weakness and wasting, particularly in the legs.\nThere are several serum biomarkers that have been studied in DMD, including creatine kinase (CK), muscle enzymes such as aldolase and aspartate aminotransferase (AST/ALT), and muscle-specific proteins such as myoglobin and troponin. These biomarkers can be used to diagnose DMD and monitor disease progression.\nHowever, it is important to note that fibronectin is not a specific biomarker for DMD, and its levels in the serum are not typically used to diagnose or monitor the disease. Further research is needed to determine the potential role of fibronectin in DMD.",
    "vicuna-7b_fact_raw": "1. Fibronectin is a protein found in the extracellular matrix involved in cell adhesion and migration.\n2. Duchenne muscular dystrophy (DMD) is caused by a mutation in the dystrophin gene.\n3. The lack of dystrophin protein in muscle cells is a characteristic of DMD.\n4. Creatine kinase (CK), aldolase, aspartate aminotransferase (AST/ALT), myoglobin, and troponin are serum biomarkers studied in DMD.\n5. Fibronectin is not typically considered a serum biomarker for Duchenne muscular dystrophy.",
    "vicuna-7b_fact": [
      "Fibronectin is a protein found in the extracellular matrix involved in cell adhesion and migration.",
      "Duchenne muscular dystrophy (DMD) is caused by a mutation in the dystrophin gene.",
      "The lack of dystrophin protein in muscle cells is a characteristic of DMD.",
      "Creatine kinase (CK), aldolase, aspartate aminotransferase (AST/ALT), myoglobin, and troponin are serum biomarkers studied in DMD.",
      "Fibronectin is not typically considered a serum biomarker for Duchenne muscular dystrophy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "vicuna-7b_response": "The DeepBlue epigenomic data server contains data from several major epigenome projects, including:\n1. ENCODE (Encyclopedia Of DNA Elements) project: This project aims to identify all functional elements in the human genome, including regulatory elements that control gene expression. The ENCODE project has generated a large amount of data on DNA methylation, histone modifications, and other epigenetic marks in a variety of cell types.\n2. Roadmap Epigenomics Project: This project aims to map the epigenomes of several human cell types and tissues, and to identify the regulatory elements that control gene expression. The Roadmap Epigenomics Project has generated data on DNA methylation, histone modifications, and other epigenetic marks in a variety of cell types.\n3. Epigenomics Project of the Human Cell: This project aims to map the epigenomes of several human cell types and tissues, and to identify the regulatory elements that control gene expression. The Epigenomics Project of the Human Cell has generated data on DNA methylation, histone modifications, and other epigenetic marks in a variety of cell types.\n4. ENCODE Drug Response Project: This project aims to identify the regulatory elements that control gene expression in response to drugs, and to use this information to develop new drugs and personalized therapies.\n5. ENCODE Transcription Factor Binding Project: This project aims to identify the transcription factors that bind to regulatory elements in the human genome, and to use this information to understand how gene expression is regulated.\nThese are some of the major epigenome projects that are contained in the DeepBlue epigenomic data server.",
    "vicuna-7b_fact_raw": "1. The DeepBlue epigenomic data server contains data from the ENCODE (Encyclopedia Of DNA Elements) project.\n2. The ENCODE project has generated data on DNA methylation, histone modifications, and other epigenetic marks in a variety of cell types.\n3. The Roadmap Epigenomics Project, which aims to map the epigenomes of several human cell types and tissues, is included in the DeepBlue epigenomic data server.\n4. The Epigenomics Project of the Human Cell has generated data on DNA methylation, histone modifications, and other epigenetic marks in a variety of cell types, and its data is contained in the DeepBlue server.\n5. The ENCODE Drug Response Project and the ENCODE Transcription Factor Binding Project are among the projects whose data are contained in the DeepBlue epigenomic data server.",
    "vicuna-7b_fact": [
      "The DeepBlue epigenomic data server contains data from the ENCODE (Encyclopedia Of DNA Elements) project.",
      "The ENCODE project has generated data on DNA methylation, histone modifications, and other epigenetic marks in a variety of cell types.",
      "The Roadmap Epigenomics Project, which aims to map the epigenomes of several human cell types and tissues, is included in the DeepBlue epigenomic data server.",
      "The Epigenomics Project of the Human Cell has generated data on DNA methylation, histone modifications, and other epigenetic marks in a variety of cell types, and its data is contained in the DeepBlue server.",
      "The ENCODE Drug Response Project and the ENCODE Transcription Factor Binding Project are among the projects whose data are contained in the DeepBlue epigenomic data server."
    ],
    "vicuna-7b_judge_raw": "1. TRUE: The DeepBlue epigenomic data server does contain data from the ENCODE project, which is a major source of epigenomic data.\n2. TRUE: The ENCODE project has indeed generated data on DNA methylation, histone modifications, and other epigenetic marks across various cell types.\n3. TRUE: The Roadmap Epigenomics Project is also a significant source of epigenomic data, and its data is included in the DeepBlue epigenomic data server.\n4. FALSE [correction]: There is no project specifically named \"The Epigenomics Project of the Human Cell.\" It is likely that this statement is referring to the Roadmap Epigenomics Project or another similar initiative. The correct statement would be that the Roadmap Epigenomics Project has generated data on DNA methylation, histone modifications, and other epigenomic marks in a variety of cell types, and its data is contained in the DeepBlue server.\n5. UNKNOWN: Without specific information about the existence of the \"ENCODE Drug Response Project\" and the \"ENCODE Transcription Factor Binding Project\" and whether their data are included in the DeepBlue epigenomic data server, it is not possible to determine the truthfulness of this statement.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "vicuna-7b_response": "One tool that employs self-organizing maps (SOMs) for analyzing synonymous codon usage is the program CodonRun.\nCodonRun is a bioinformatics tool that uses SOMs to analyze synonymous codon usage in DNA sequences. It can identify codons that are used more frequently than others and can also predict the effect of mutations on codon usage. CodonRun can be used to analyze both prokaryotic and eukaryotic DNA sequences.\nThe tool can be useful for understanding the impact of mutations on gene expression and protein synthesis, as well as for identifying potential optimization strategies for gene expression in different organisms.\nIt's worth noting that there are other tools that can be used for analyzing synonymous codon usage, such as the program CodonWise, which also uses SOMs to identify codon usage patterns.",
    "vicuna-7b_fact_raw": "1. The program CodonRun employs self-organizing maps (SOMs) for analyzing synonymous codon usage.\n2. CodonRun can identify codons that are used more frequently than others.\n3. CodonRun can predict the effect of mutations on codon usage.\n4. CodonRun is applicable for analyzing both prokaryotic and eukaryotic DNA sequences.\n5. Another tool that uses SOMs for analyzing synonymous codon usage is CodonWise.",
    "vicuna-7b_fact": [
      "The program CodonRun employs self-organizing maps (SOMs) for analyzing synonymous codon usage.",
      "CodonRun can identify codons that are used more frequently than others.",
      "CodonRun can predict the effect of mutations on codon usage.",
      "CodonRun is applicable for analyzing both prokaryotic and eukaryotic DNA sequences.",
      "Another tool that uses SOMs for analyzing synonymous codon usage is CodonWise."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: CodonRun does not predict the effect of mutations on codon usage; it analyzes codon usage patterns.\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific information about the program CodonRun and the tool CodonWise, it is not possible to accurately determine the truth of statements 1, 4, and 5. Statement 3 is corrected based on the general understanding that analyzing codon usage does not necessarily involve predicting the effects of mutations.",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "vicuna-7b_response": "MINDY-1 is a humanoid robot developed by the Robotics and Artificial Intelligence Laboratory (RAIL) at the University of California, Berkeley. It stands for \"Mobile and Independent NDY-based Intelligent Drawer\".\nMINDY-1 is a two-legged robot that is designed to be mobile and autonomous. It is equipped with sensors and software that allow it to navigate its environment and avoid obstacles. It also has a drawer-like structure that can be used to store and retrieve objects.\nMINDY-1 was developed as a research platform for the study of legged locomotion and autonomous navigation. It has been used in a variety of research studies, including those focused on balance control, gait planning, and obstacle avoidance.\nIn addition to its research applications, MINDY-1 has also been used in educational settings to introduce students to the principles of robotics and artificial intelligence. It is a popular platform for demonstrating the capabilities of humanoid robots and the potential applications of robotics in various fields.",
    "vicuna-7b_fact_raw": "1. MINDY-1 is a humanoid robot developed by the Robotics and Artificial Intelligence Laboratory at the University of California, Berkeley.\n2. MINDY-1 stands for \"Mobile and Independent NDY-based Intelligent Drawer\".\n3. The robot is designed to be mobile and autonomous with the ability to navigate and avoid obstacles.\n4. MINDY-1 has been used as a research platform for studying legged locomotion and autonomous navigation.\n5. MINDY-1 is also utilized in educational settings to teach students about robotics and artificial intelligence.",
    "vicuna-7b_fact": [
      "MINDY-1 is a humanoid robot developed by the Robotics and Artificial Intelligence Laboratory at the University of California, Berkeley.",
      "MINDY-1 stands for \"Mobile and Independent NDY-based Intelligent Drawer\".",
      "The robot is designed to be mobile and autonomous with the ability to navigate and avoid obstacles.",
      "MINDY-1 has been used as a research platform for studying legged locomotion and autonomous navigation.",
      "MINDY-1 is also utilized in educational settings to teach students about robotics and artificial intelligence."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific information about a robot named MINDY-1, it is not possible to verify these statements. They could be true or false, but without additional context or sources, the veracity of the statements cannot be determined.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "vicuna-7b_response": "There are several software packages available for the analysis of conserved genomic loci. Some of the most popular ones include:\n1. MEME: MEME (Multiple Experiment Markup Language) is a software tool that can be used to identify motifs in DNA or protein sequences. It can be used to identify conserved regions in genomic sequences, and can output the results in various formats.\n2. ConservED: ConservED is a software tool that can be used to identify conserved regions in multiple species. It can output the results in various formats, including a graphical representation of the conserved regions.\n3. RepeatMasker: RepeatMasker is a software tool that can be used to identify repetitive elements in genomic sequences. It can also be used to identify conserved regions, and can output the results in various formats.\n4. MACS: MACS (Model-based Analysis of ChIP-seq) is a software tool that can be used to identify enriched regions in genomic sequences. It can be used to identify conserved regions, and can output the results in various formats.\n5. GENE-EST: GENE-EST is a software tool that can be used to identify conserved regions in multiple species. It can output the results in various formats, including a graphical representation of the conserved regions.\nThese are just a few examples of the software packages available for the analysis of conserved genomic loci. The choice of software package will depend on the specific requirements of the user and the type of data that is available.",
    "vicuna-7b_fact_raw": "1. MEME (Multiple Experiment Markup Language) is a software tool designed to identify motifs in DNA or protein sequences.\n2. ConservED is a software tool used for identifying conserved regions across multiple species.\n3. RepeatMasker is a software tool that identifies repetitive elements in genomic sequences and can also be used to find conserved regions.\n4. MACS (Model-based Analysis of ChIP-seq) is a software tool for identifying enriched regions in genomic sequences, including conserved regions.\n5. GENE-EST is a software tool that identifies conserved regions in multiple species and provides various output formats, including graphical representations.",
    "vicuna-7b_fact": [
      "MEME (Multiple Experiment Markup Language) is a software tool designed to identify motifs in DNA or protein sequences.",
      "ConservED is a software tool used for identifying conserved regions across multiple species.",
      "RepeatMasker is a software tool that identifies repetitive elements in genomic sequences and can also be used to find conserved regions.",
      "MACS (Model-based Analysis of ChIP-seq) is a software tool for identifying enriched regions in genomic sequences, including conserved regions.",
      "GENE-EST is a software tool that identifies conserved regions in multiple species and provides various output formats, including graphical representations."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: RepeatMasker is a software tool that identifies repetitive elements in genomic sequences, but it is not specifically used for finding conserved regions.\n4. TRUE\n5. FALSE [correction]: GENE-EST is not a recognized software tool for identifying conserved regions in multiple species. The name seems incorrect or fictional, and there is no widely known tool by that name for such a purpose.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "vicuna-7b_response": "The PIEZO2 gene is a gene that encodes for a protein called Piezo2, which is a member of the Piezo family of ion channels. Piezo2 is expressed in various tissues, including the inner ear, heart, and blood vessels, and plays a role in sensing mechanical stimuli such as pressure and touch.\nThere are several diseases that have been associated with mutations or dysfunction of the PIEZO2 gene. Here are three examples:\n1. Autosomal recessive non-syndromic hearing loss: Mutations in the PIEZO2 gene have been identified as a cause of non-syndromic hearing loss, which is a genetic condition that results in hearing impairment without any other associated symptoms.\n2. Hypertension: Dysfunction of the Piezo2 channel has been implicated in the development of hypertension, or high blood pressure. This is because Piezo2 plays a role in regulating blood pressure by sensing changes in blood volume and blood pressure.\n3. Congenital malformations, including cleft lip and palate: Mutations in the PIEZO2 gene have been associated with congenital malformations, including cleft lip and palate. This is because Piezo2 is expressed in the developing embryo, and its dysfunction can disrupt normal development and lead to malformations.",
    "vicuna-7b_fact_raw": "1. Mutations in the PIEZO2 gene have been identified as a cause of autosomal recessive non-syndromic hearing loss.\n2. Dysfunction of the Piezo2 channel has been implicated in the development of hypertension.\n3. Mutations in the PIEZO2 gene have been associated with congenital malformations, including cleft lip and palate.",
    "vicuna-7b_fact": [
      "Mutations in the PIEZO2 gene have been identified as a cause of autosomal recessive non-syndromic hearing loss.",
      "Dysfunction of the Piezo2 channel has been implicated in the development of hypertension.",
      "Mutations in the PIEZO2 gene have been associated with congenital malformations, including cleft lip and palate."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Mutations in the PIEZO2 gene have been identified as a cause of conditions related to mechanosensation, such as distal arthrogryposis and Gordon Syndrome, not specifically non-syndromic hearing loss.\n2. UNKNOWN\n3. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "vicuna-7b_response": "ERAP1 and ERAP2 are two proteins that are involved in the endoplasmic reticulum-associated degradation (ERAD) pathway, which is responsible for removing misfolded proteins from the endoplasmic reticulum (ER) in the cell.\nERAP1 and ERAP2 are the two main components of the ERAD pathway. They form a heterodimeric complex that recognizes and binds to misfolded proteins in the ER. Once bound, the ERAP1-ERAP2 complex targets the misfolded proteins for degradation by the proteasome, a protein complex that breaks down proteins into smaller peptides for recycling or disposal.\nThe ERAP1-ERAP2 dimerization is essential for the proper functioning of the ERAD pathway. It allows for the specific recognition and binding of misfolded proteins, which is necessary for their efficient degradation. Additionally, the dimerization of ERAP1 and ERAP2 also helps to stabilize the complex and ensure that it is able to function properly over time.\nIn summary, ERAP1-ERAP2 dimerization is promoted by the interaction between these two proteins, which allows them to recognize and bind to misfolded proteins in the ER, leading to their efficient degradation by the proteasome.",
    "vicuna-7b_fact_raw": "1. ERAP1 and ERAP2 are involved in the endoplasmic reticulum-associated degradation (ERAD) pathway.\n2. The ERAD pathway is responsible for removing misfolded proteins from the endoplasmic reticulum (ER) in the cell.\n3. ERAP1 and ERAP2 form a heterodimeric complex that recognizes and binds to misfolded proteins in the ER.\n4. The ERAP1-ERAP2 complex targets misfolded proteins for degradation by the proteasome.\n5. Dimerization of ERAP1 and ERAP2 is essential for the proper functioning of the ERAD pathway.",
    "vicuna-7b_fact": [
      "ERAP1 and ERAP2 are involved in the endoplasmic reticulum-associated degradation (ERAD) pathway.",
      "The ERAD pathway is responsible for removing misfolded proteins from the endoplasmic reticulum (ER) in the cell.",
      "ERAP1 and ERAP2 form a heterodimeric complex that recognizes and binds to misfolded proteins in the ER.",
      "The ERAP1-ERAP2 complex targets misfolded proteins for degradation by the proteasome.",
      "Dimerization of ERAP1 and ERAP2 is essential for the proper functioning of the ERAD pathway."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: ERAP1 and ERAP2 are involved in the antigen processing pathway, not the endoplasmic reticulum-associated degradation (ERAD) pathway. They trim peptides for presentation by MHC class I molecules.\n2. TRUE\n3. FALSE [correction]: ERAP1 and ERAP2 do not form a heterodimeric complex that recognizes and binds to misfolded proteins in the ER. They function in the trimming of peptides for MHC class I presentation, not in recognizing misfolded proteins.\n4. FALSE [correction]: The ERAP1-ERAP2 complex does not target misfolded proteins for degradation by the proteasome. Instead, they are involved in trimming peptides for MHC class I-mediated antigen presentation.\n5. FALSE [correction]: Dimerization of ERAP1 and ERAP2 is not related to the ERAD pathway. While ERAP1 and ERAP2 can form heterodimers, their role in the dimerized form is not essential for the ERAD pathway but rather for the antigen processing pathway.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "vicuna-7b_response": "R-spondin 1 and noggin are both proteins that play important roles in the development and maintenance of the gallbladder.\nR-spondin 1 is a protein that is expressed in the developing gallbladder and is involved in the formation of the gallbladder's epithelial lining. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells, which are the cells that make up the lining of the gallbladder. R-spondin 1 also promotes the formation of tight junctions between epithelial cells, which are important for maintaining the integrity of the epithelial lining.\nNoggin is a protein that is expressed in the developing embryo and is involved in the regulation of bone morphogenetic protein (BMP) signaling. BMP signaling is important for the development of many tissues, including the gallbladder. Noggin inhibits BMP signaling, which is important for the development of the gallbladder. Noggin also promotes the differentiation of epithelial cells into cuboidal cells, which are the cells that make up the lining of the gallbladder.\nIn non-damaged gallbladders, R-spondin 1 and noggin work together to promote the development and maintenance of the gallbladder's epithelial lining. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells and the formation of tight junctions between epithelial cells, while noggin inhibits BMP signaling and promotes the differentiation of epithelial cells into cuboidal cells.\nIn summary, R-spondin 1 and noggin play important roles in the development and maintenance of the gallbladder. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells and the formation of tight junctions between epithelial cells, while noggin inhibits BMP signaling and promotes the differentiation of epithelial cells into cuboidal cells.",
    "vicuna-7b_fact_raw": "1. R-spondin 1 is expressed in the developing gallbladder and is involved in the formation of the gallbladder's epithelial lining.\n2. R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells in the gallbladder.\n3. R-spondin 1 also promotes the formation of tight junctions between epithelial cells in the gallbladder.\n4. Noggin is involved in the regulation of bone morphogenetic protein (BMP) signaling, which is important for the development of the gallbladder.\n5. Noggin promotes the differentiation of epithelial cells into cuboidal cells in the gallbladder.",
    "vicuna-7b_fact": [
      "R-spondin 1 is expressed in the developing gallbladder and is involved in the formation of the gallbladder's epithelial lining.",
      "R-spondin 1 promotes the differentiation of epithelial cells into cuboidal cells in the gallbladder.",
      "R-spondin 1 also promotes the formation of tight junctions between epithelial cells in the gallbladder.",
      "Noggin is involved in the regulation of bone morphogenetic protein (BMP) signaling, which is important for the development of the gallbladder.",
      "Noggin promotes the differentiation of epithelial cells into cuboidal cells in the gallbladder."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN\n\nExplanation:\n1. R-spondin 1 is known to be involved in the development of various organs, including the gallbladder, and it plays a role in the formation of epithelial linings.\n2. The specific role of R-spondin 1 in promoting the differentiation of epithelial cells into cuboidal cells in the gallbladder is not commonly documented, and without specific context, it's difficult to confirm its accuracy.\n3. While R-spondin proteins are involved in the regulation of cell junctions, the specific promotion of tight junction formation in gallbladder epithelial cells by R-spondin 1 is not well-established in the literature.\n4. Noggin is a well-known antagonist of BMP signaling, and BMP signaling is important for the development of various organs, including the gallbladder.\n5. The specific role of Noggin in promoting the differentiation of epithelial cells into cuboidal cells in the gallbladder is not well-documented, and without specific context, it's difficult to confirm its accuracy.",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "vicuna-7b_response": "Yes, NADPH oxidase 5 (Nox5) requires multiple subunits for its function. Nox5 is a subunit of the NADPH oxidase complex, which is responsible for generating reactive oxygen species (ROS) in cells. The NADPH oxidase complex is composed of several subunits, including p22phox, p47phox, p67phox, and Nox5.\nThe p22phox, p47phox, and p67phox subunits are required for the assembly and activation of the NADPH oxidase complex. These subunits interact with Nox5 to form the functional NADPH oxidase complex, which is localized in the plasma membrane of cells.\nIn the absence of these subunits, the NADPH oxidase complex is not assembled or activated, and ROS generation is impaired. This can lead to a variety of cellular dysfunctions, including inflammation, oxidative stress, and cell death.\nTherefore, Nox5 requires the p22phox, p47phox, and p67phox subunits for its function as a subunit of the NADPH oxidase complex.",
    "vicuna-7b_fact_raw": "1. NADPH oxidase 5 (Nox5) requires multiple subunits for its function.\n2. The NADPH oxidase complex, which includes Nox5, is responsible for generating reactive oxygen species (ROS) in cells.\n3. The subunits p22phox, p47phox, and p67phox are required for the assembly and activation of the NADPH oxidase complex.\n4. The functional NADPH oxidase complex is localized in the plasma membrane of cells.\n5. In the absence of the p22phox, p47phox, and p67phox subunits, the NADPH oxidase complex is not assembled or activated, leading to impaired ROS generation.",
    "vicuna-7b_fact": [
      "NADPH oxidase 5 (Nox5) requires multiple subunits for its function.",
      "The NADPH oxidase complex, which includes Nox5, is responsible for generating reactive oxygen species (ROS) in cells.",
      "The subunits p22phox, p47phox, and p67phox are required for the assembly and activation of the NADPH oxidase complex.",
      "The functional NADPH oxidase complex is localized in the plasma membrane of cells.",
      "In the absence of the p22phox, p47phox, and p67phox subunits, the NADPH oxidase complex is not assembled or activated, leading to impaired ROS generation."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: NADPH oxidase 5 (Nox5) is a calcium-dependent enzyme that does not require the p22phox, p47phox, and p67phox subunits for its function, unlike other members of the NADPH oxidase family.\n2. TRUE\n3. FALSE [correction]: The subunits p22phox, p47phox, and p67phox are required for the assembly and activation of some NADPH oxidase complexes, but not for Nox5, which functions independently of these subunits.\n4. TRUE\n5. FALSE [correction]: While the absence of the p22phox, p47phox, and p67phox subunits would impair the assembly and activation of some NADPH oxidase complexes, Nox5 can still assemble and be activated without these subunits, as it operates independently of them.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "vicuna-7b_response": "Furin and hepcidin are two different proteins that have a connection in the regulation of iron metabolism.\nHepcidin is a hormone produced by cells in the liver that plays a key role in regulating the amount of iron available in the body. It does this by binding to iron transporters in the duodenum, preventing iron from being absorbed from the diet. Hepcidin production is regulated by the body's need for iron, with higher levels of hepcidin being produced when iron stores are low and vice versa.\nFurin is an enzyme that plays a role in the processing of proteins. It is involved in the cleavage of certain proteins, including hepcidin, to release the active form of the protein. This is important because the inactive form of hepcidin is not as effective at regulating iron metabolism.\nIn summary, furin and hepcidin are connected in the regulation of iron metabolism because furin is involved in the processing of hepcidin, allowing it to function properly and regulate the amount of iron available in the body.",
    "vicuna-7b_fact_raw": "1. Furin is an enzyme that plays a role in the processing of proteins, including hepcidin.\n2. Hepcidin is a hormone produced by cells in the liver that regulates the amount of iron available in the body.\n3. Hepcidin functions by binding to iron transporters in the duodenum, which prevents iron from being absorbed from the diet.\n4. The production of hepcidin is regulated by the body's need for iron, with higher levels produced when iron stores are full.\n5. Furin is involved in the cleavage of certain proteins to release their active forms, which includes converting inactive hepcidin to its active form.",
    "vicuna-7b_fact": [
      "Furin is an enzyme that plays a role in the processing of proteins, including hepcidin.",
      "Hepcidin is a hormone produced by cells in the liver that regulates the amount of iron available in the body.",
      "Hepcidin functions by binding to iron transporters in the duodenum, which prevents iron from being absorbed from the diet.",
      "The production of hepcidin is regulated by the body's need for iron, with higher levels produced when iron stores are full.",
      "Furin is involved in the cleavage of certain proteins to release their active forms, which includes converting inactive hepcidin to its active form."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Furin is involved in the cleavage of certain proteins to release their active forms, but it does not convert inactive hepcidin to its active form. Hepcidin is synthesized as a preprohormone and then processed by other enzymes into its mature, active form.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "vicuna-7b_response": "The largest metabolic gene cluster in yeast is the PHO5 cluster, which is located on chromosome V. The PHO5 cluster encodes enzymes involved in the biosynthesis of the aromatic amino acids phenylalanine, tyrosine, and tryptophan, which are essential for cell growth. The PHO5 cluster is composed of 18 genes, and it is the largest metabolic gene cluster in yeast in terms of the number of genes it encodes.",
    "vicuna-7b_fact_raw": "1. The PHO5 cluster is the largest metabolic gene cluster in yeast.\n2. The PHO5 cluster is located on chromosome V of yeast.\n3. The PHO5 cluster encodes enzymes for the biosynthesis of phenylalanine, tyrosine, and tryptophan.\n4. Phenylalanine, tyrosine, and tryptophan are aromatic amino acids essential for cell growth.\n5. The PHO5 cluster is composed of 18 genes.",
    "vicuna-7b_fact": [
      "The PHO5 cluster is the largest metabolic gene cluster in yeast.",
      "The PHO5 cluster is located on chromosome V of yeast.",
      "The PHO5 cluster encodes enzymes for the biosynthesis of phenylalanine, tyrosine, and tryptophan.",
      "Phenylalanine, tyrosine, and tryptophan are aromatic amino acids essential for cell growth.",
      "The PHO5 cluster is composed of 18 genes."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: The PHO5 gene in yeast encodes an acid phosphatase enzyme, not enzymes for the biosynthesis of phenylalanine, tyrosine, and tryptophan.\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "vicuna-7b_response": "LIMT (Long intergenic non-coding RNA METastasis) is a lncRNA (long non-coding RNA) that has been shown to play a role in the regulation of metastasis, which is the spread of cancer cells from one organ or tissue to another.\nResearch has shown that LIMT is upregulated in a variety of cancer types, including breast, lung, and colon cancer, and that it promotes the migration and invasion of cancer cells. Additionally, studies have shown that LIMT can interact with and regulate the expression of various genes involved in the metastatic process, including genes involved in cell adhesion, migration, and invasion.\nOverall, the role of LIMT in the regulation of metastasis is an area of active research, and further studies are needed to fully understand the mechanisms by which LIMT promotes the spread of cancer cells and to develop targeted therapies that can inhibit its function.",
    "vicuna-7b_fact_raw": "1. LIMT stands for Long intergenic non-coding RNA METastasis.\n2. LIMT is a long non-coding RNA (lncRNA).\n3. LIMT has been shown to play a role in the regulation of metastasis in cancer.\n4. LIMT is upregulated in various cancer types, including breast, lung, and colon cancer.\n5. LIMT promotes the migration and invasion of cancer cells.",
    "vicuna-7b_fact": [
      "LIMT stands for Long intergenic non-coding RNA METastasis.",
      "LIMT is a long non-coding RNA (lncRNA).",
      "LIMT has been shown to play a role in the regulation of metastasis in cancer.",
      "LIMT is upregulated in various cancer types, including breast, lung, and colon cancer.",
      "LIMT promotes the migration and invasion of cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: LIMT stands for Long Intergenic Non-protein Coding RNA, Metastasis Associated Lung Adenocarcinoma Transcript 1.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "vicuna-7b_response": "The R/Bioconductor package used for performing SNP enrichment analysis is called \"SNPEff\".",
    "vicuna-7b_fact_raw": "1. SNPEff is an R/Bioconductor package.\n2. SNPEff is used for performing SNP enrichment analysis.",
    "vicuna-7b_fact": [
      "SNPEff is an R/Bioconductor package.",
      "SNPEff is used for performing SNP enrichment analysis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: SNPEff is not an R/Bioconductor package; it is a standalone program written in Java that can be used to annotate and predict the effects of genetic variants (such as SNPs).\n2. FALSE [correction]: SNPEff is used for annotating and predicting the effects of genetic variants on genes, such as SNPs, but it is not specifically for performing SNP enrichment analysis. Enrichment analysis is typically a separate process that involves statistical methods to determine if certain functions or pathways are overrepresented in a set of genes or variants.",
    "vicuna-7b_judge": [
      "false",
      "false"
    ]
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "vicuna-7b_response": "Radial glial cells are a type of glial cell that play a crucial role in the development of the central nervous system, including the formation of the ependymal cells that line the ventricular system of the brain. The key players in radial glial specification to ependymal cells are transcription factors.\nOne of the most important transcription factors in the specification of radial glial cells to ependymal cells is the transcription factor Sox2. Sox2 is expressed in radial glial cells during embryonic development and is necessary for the differentiation of these cells into ependymal cells.\nAnother important transcription factor in the specification of radial glial cells to ependymal cells is the transcription factor Nkx2.1. Nkx2.1 is expressed in radial glial cells and is necessary for the differentiation of these cells into ependymal cells.\nAdditionally, the transcription factor Ascl1 is also important in the specification of radial glial cells to ependymal cells. Ascl1 is expressed in radial glial cells and is necessary for the differentiation of these cells into ependymal cells.\nFinally, the transcription factor Foxj1 is also important in the specification of radial glial cells to ependymal cells. Foxj1 is expressed in radial glial cells and is necessary for the differentiation of these cells into ependymal cells.\nIn summary, the key players in radial glial specification to ependymal cells are transcription factors such as Sox2, Nkx2.1, Ascl1 and Foxj1. These transcription factors are necessary for the differentiation of radial glial cells into ependymal cells, and play a crucial role in the development of the central nervous system.",
    "vicuna-7b_fact_raw": "1. Radial glial cells are crucial for the development of the central nervous system and the formation of ependymal cells.\n2. The transcription factor Sox2 is necessary for the differentiation of radial glial cells into ependymal cells.\n3. The transcription factor Nkx2.1 is necessary for the differentiation of radial glial cells into ependymal cells.\n4. The transcription factor Ascl1 is necessary for the differentiation of radial glial cells into ependymal cells.\n5. The transcription factor Foxj1 is necessary for the differentiation of radial glial cells into ependymal cells.",
    "vicuna-7b_fact": [
      "Radial glial cells are crucial for the development of the central nervous system and the formation of ependymal cells.",
      "The transcription factor Sox2 is necessary for the differentiation of radial glial cells into ependymal cells.",
      "The transcription factor Nkx2.1 is necessary for the differentiation of radial glial cells into ependymal cells.",
      "The transcription factor Ascl1 is necessary for the differentiation of radial glial cells into ependymal cells.",
      "The transcription factor Foxj1 is necessary for the differentiation of radial glial cells into ependymal cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The transcription factor Nkx2.1 is not necessary for the differentiation of radial glial cells into ependymal cells; it is involved in the development of certain neuronal subtypes and other structures in the central nervous system.\n4. FALSE [correction]: The transcription factor Ascl1 is not necessary for the differentiation of radial glial cells into ependymal cells; it is involved in the differentiation of neural progenitors into neurons.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "vicuna-7b_response": "Triple negative gliomas (TNGs) are a type of brain tumor that do not express the proteins normally found on the surface of most brain tumors, such as glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE). Instead, TNGs express other proteins, such as epithelial membrane antigen (EMA) and cytokeratin 8 and 18 (CK8/18).\nTNGs are also characterized by the absence of positive staining for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu). This is why they are called \"triple negative\" - they do not express any of the three main proteins that are typically found on the surface of brain tumors.\nIn addition to these characteristic markers, TNGs are also characterized by their aggressive behavior and poor prognosis. They tend to grow quickly and invade surrounding tissue, and they are often resistant to radiation and chemotherapy.\nOverall, the diagnosis of TNGs is based on a combination of histological and immunohistochemical features, as well as the absence of expression of the typical markers of other types of brain tumors.",
    "vicuna-7b_fact_raw": "1. Triple negative gliomas do not express glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE).\n2. Triple negative gliomas express epithelial membrane antigen (EMA) and cytokeratin 8 and 18 (CK8/18).\n3. Triple negative gliomas do not show positive staining for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu).\n4. Triple negative gliomas are characterized by aggressive behavior and poor prognosis.\n5. The diagnosis of triple negative gliomas is based on histological and immunohistochemical features, as well as the absence of typical brain tumor markers.",
    "vicuna-7b_fact": [
      "Triple negative gliomas do not express glial fibrillary acidic protein (GFAP) and neuron-specific enolase (NSE).",
      "Triple negative gliomas express epithelial membrane antigen (EMA) and cytokeratin 8 and 18 (CK8/18).",
      "Triple negative gliomas do not show positive staining for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu).",
      "Triple negative gliomas are characterized by aggressive behavior and poor prognosis.",
      "The diagnosis of triple negative gliomas is based on histological and immunohistochemical features, as well as the absence of typical brain tumor markers."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Triple negative gliomas typically do not express traditional glioma markers such as GFAP, but the statement is incorrect as it includes neuron-specific enolase (NSE), which is not a standard marker for gliomas.\n2. UNKNOWN: The expression of epithelial membrane antigen (EMA) and cytokeratin 8 and 18 (CK8/18) in triple negative gliomas is not standard knowledge and can vary; therefore, without specific context or reference, the truth of this statement cannot be determined.\n3. TRUE: Triple negative gliomas are defined by the lack of expression of ER, PR, and HER2/neu, which are markers more commonly associated with breast cancer.\n4. TRUE: Triple negative gliomas are generally recognized to have aggressive behavior and a poor prognosis.\n5. TRUE: The diagnosis of triple negative gliomas is indeed based on histological and immunohistochemical features, including the absence of certain markers that are typically found in other types of brain tumors.",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "vicuna-7b_response": "TOPAZ1 is a cryptocurrency that was created in 2017. It is a privacy-focused cryptocurrency that uses a technology called \"Zero Knowledge Proofs\" to provide users with enhanced privacy and security. TOPAZ1 is based on the Zerocoin protocol, which was developed by Dr. Matthew Green and Dr. Eli Ben-Sasson.\nTOPAZ1 aims to provide users with the ability to conduct private transactions without the need for a trusted third party, such as a bank or government. This is achieved by using a technique called \"Zero Knowledge Proofs\" to verify transactions without revealing the underlying details of the transaction.\nTOPAZ1 also uses a decentralized governance model, where the network is governed by a group of elected community members known as \"stewards\". The stewards are responsible for making decisions about the future development of the TOPAZ1 network, such as implementing new features or upgrading the network's security.\nIn summary, TOPAZ1 is a privacy-focused cryptocurrency that uses Zero Knowledge Proofs to provide users with enhanced privacy and security. It is based on the Zerocoin protocol and uses a decentralized governance model to ensure that the network is governed by the community.",
    "vicuna-7b_fact_raw": "1. TOPAZ1 is a cryptocurrency that was created in 2017.\n2. TOPAZ1 uses a technology called \"Zero Knowledge Proofs\" for enhanced privacy and security.\n3. The Zerocoin protocol, which TOPAZ1 is based on, was developed by Dr. Matthew Green and Dr. Eli Ben-Sasson.\n4. TOPAZ1 allows for private transactions without the need for a trusted third party.\n5. TOPAZ1's network is governed by a group of elected community members known as \"stewards\".",
    "vicuna-7b_fact": [
      "TOPAZ1 is a cryptocurrency that was created in 2017.",
      "TOPAZ1 uses a technology called \"Zero Knowledge Proofs\" for enhanced privacy and security.",
      "The Zerocoin protocol, which TOPAZ1 is based on, was developed by Dr. Matthew Green and Dr. Eli Ben-Sasson.",
      "TOPAZ1 allows for private transactions without the need for a trusted third party.",
      "TOPAZ1's network is governed by a group of elected community members known as \"stewards\"."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN: Without specific information about a cryptocurrency named TOPAZ1, it is not possible to verify the creation date or even its existence.\n2. UNKNOWN: Since the existence of TOPAZ1 is not confirmed, it is not possible to verify whether it uses \"Zero Knowledge Proofs\" or not.\n3. FALSE [correction]: The Zerocoin protocol was initially conceived by Johns Hopkins University professor Matthew D. Green and his graduate students, Ian Miers and Christina Garman, as part of a research project. Dr. Eli Ben-Sasson is associated with the development of Zcash, which also uses zero-knowledge proofs but is a different protocol.\n4. UNKNOWN: Without confirmation of TOPAZ1's features, it is not possible to verify the claim about private transactions without a trusted third party.\n5. UNKNOWN: The governance structure of TOPAZ1 cannot be confirmed without specific information about the cryptocurrency.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "vicuna-7b_response": "GATA-1 is a transcription factor that plays a crucial role in the development and function of various cell types, including hematopoietic cells. GATA-1 isoforms are generated by alternative splicing of the GATA-1 mRNA, which results in the production of different protein isoforms with distinct functions.\nThe gene that controls the expression of GATA-1 isoforms is the GATA-1 gene itself. The GATA-1 gene is located on chromosome X and consists of 17 exons that are spliced together to produce the GATA-1 mRNA. The alternative splicing of the GATA-1 mRNA results in the production of different isoforms of GATA-1, each with a unique combination of exons.\nThe specific splicing events that give rise to the different GATA-1 isoforms are regulated by a complex network of transcription factors and cofactors, as well as by the presence of specific regulatory elements in the GATA-1 gene promoter. Some of the transcription factors that have been shown to regulate GATA-1 splicing include the GATA-1 binding protein 1 (GATA1BP1), the GATA-1 binding protein 2 (GATA1BP2), and the GATA-1 binding protein 3 (GATA1BP3).\nIn summary, the gene that controls the expression of GATA-1 isoforms is the GATA-1 gene itself, and the specific splicing events that give rise to the different GATA-1 isoforms are regulated by a complex network of transcription factors and cofactors.",
    "vicuna-7b_fact_raw": "1. GATA-1 is a transcription factor important for the development and function of hematopoietic cells.\n2. GATA-1 isoforms are generated by alternative splicing of the GATA-1 mRNA.\n3. The GATA-1 gene is located on chromosome X.\n4. The GATA-1 gene consists of 17 exons that are spliced to produce GATA-1 mRNA.\n5. The alternative splicing of GATA-1 mRNA is regulated by transcription factors and cofactors, including GATA1BP1, GATA1BP2, and GATA1BP3.",
    "vicuna-7b_fact": [
      "GATA-1 is a transcription factor important for the development and function of hematopoietic cells.",
      "GATA-1 isoforms are generated by alternative splicing of the GATA-1 mRNA.",
      "The GATA-1 gene is located on chromosome X.",
      "The GATA-1 gene consists of 17 exons that are spliced to produce GATA-1 mRNA.",
      "The alternative splicing of GATA-1 mRNA is regulated by transcription factors and cofactors, including GATA1BP1, GATA1BP2, and GATA1BP3."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The GATA-1 gene consists of 6 exons that are spliced to produce GATA-1 mRNA.\n5. FALSE [correction]: The alternative splicing of GATA-1 mRNA is regulated by transcription factors and cofactors, including FOG-1 (also known as ZFPM1), not GATA1BP1, GATA1BP2, and GATA1BP3. The \"BP\" in the provided acronyms suggests \"binding protein,\" but these are not standard nomenclature for known cofactors of GATA-1.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "vicuna-7b_response": "MIRA-seq (Mutation Identification by Deep Sequencing) is a powerful technique used to identify somatic mutations in a genome. It is a high-throughput sequencing-based approach that involves capturing and sequencing the entire exome (all protein-coding genes) of a sample, followed by a targeted sequencing of the remaining genome.\nThe exome capture step uses a specific set of probes to enrich for the coding regions of the genome, while the remaining genome is sequenced using a targeted sequencing approach. This allows for the identification of both coding and non-coding mutations, including single nucleotide variants (SNVs), insertions and deletions (indels), and copy number variations (CNVs).\nMIRA-seq is particularly useful for studying somatic mutations, which are mutations that occur in cells other than the germline cells (sperm or egg cells). These mutations can be caused by various factors, such as environmental exposures, aging, or genetic predisposition, and can lead to the development of cancer or other diseases.\nBy using MIRA-seq, researchers can identify somatic mutations in a genome and study their impact on the development and progression of diseases. This technique has been used to study a wide range of diseases, including cancer, neurological disorders, and genetic diseases.\nIn summary, MIRA-seq is a powerful technique used to identify somatic mutations in a genome, which can provide valuable insights into the development and progression of various diseases.",
    "vicuna-7b_fact_raw": "1. MIRA-seq stands for Mutation Identification by Deep Sequencing.\n2. MIRA-seq is a technique used to identify somatic mutations in a genome.\n3. The process involves capturing and sequencing the entire exome of a sample.\n4. MIRA-seq uses a specific set of probes to enrich for the coding regions of the genome.\n5. The technique is used to study somatic mutations that can lead to the development of cancer or other diseases.",
    "vicuna-7b_fact": [
      "MIRA-seq stands for Mutation Identification by Deep Sequencing.",
      "MIRA-seq is a technique used to identify somatic mutations in a genome.",
      "The process involves capturing and sequencing the entire exome of a sample.",
      "MIRA-seq uses a specific set of probes to enrich for the coding regions of the genome.",
      "The technique is used to study somatic mutations that can lead to the development of cancer or other diseases."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: MIRA-seq stands for Methylation-based Inference of Regulatory Activity sequencing.\n2. FALSE [correction]: MIRA-seq is a technique used to identify regulatory activity in the genome based on DNA methylation patterns, not specifically to identify somatic mutations.\n3. FALSE [correction]: MIRA-seq does not involve capturing and sequencing the entire exome; it focuses on inferring regulatory activity through DNA methylation patterns.\n4. UNKNOWN: Without specific information about the MIRA-seq protocol, it is unclear whether it uses a specific set of probes to enrich for coding regions or other genomic features related to regulatory activity.\n5. TRUE: While MIRA-seq is not used to identify somatic mutations, it is used to study regulatory activities that can be related to the development of diseases, including cancer.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "vicuna-7b_response": "ARCALYST is a prescription medication used to treat adults and children with cryopyrin-associated periodic syndromes (CAPS), such as familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS). It is given as an injection under the skin (subcutaneous injection) or into a muscle (intramuscular injection).\nThe main indication of ARCALYST is to reduce the frequency and severity of flares of symptoms associated with CAPS, such as fever, fatigue, and joint pain. ARCALYST works by blocking the action of a protein called interleukin-1 beta (IL-1), which plays a role in the inflammatory response.\nIt is important to note that ARCALYST is not a cure for CAPS and may not completely eliminate all symptoms. It is also not recommended for use in people with certain medical conditions, such as a history of heart attack or stroke, or certain types of cancer.\nIt is important to consult with a healthcare provider to determine if ARCALYST is appropriate for a specific patient and to receive proper instructions on how to use the medication.",
    "vicuna-7b_fact_raw": "1. ARCALYST is used to treat cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).\n2. ARCALYST is administered as a subcutaneous injection or an intramuscular injection.\n3. The medication is designed to reduce the frequency and severity of flares of symptoms associated with CAPS.\n4. ARCALYST works by blocking the action of interleukin-1 beta (IL-1), a protein involved in the inflammatory response.\n5. ARCALYST is not recommended for use in people with a history of heart attack or stroke, or certain types of cancer.",
    "vicuna-7b_fact": [
      "ARCALYST is used to treat cryopyrin-associated periodic syndromes (CAPS), including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).",
      "ARCALYST is administered as a subcutaneous injection or an intramuscular injection.",
      "The medication is designed to reduce the frequency and severity of flares of symptoms associated with CAPS.",
      "ARCALYST works by blocking the action of interleukin-1 beta (IL-1), a protein involved in the inflammatory response.",
      "ARCALYST is not recommended for use in people with a history of heart attack or stroke, or certain types of cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: ARCALYST is administered as a subcutaneous injection, not an intramuscular injection.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "vicuna-7b_response": "Robertsonian translocation is a type of chromosomal abnormality that occurs when two acrocentric chromosomes (chromosomes that have their centromeres located at the ends of the chromosome) exchange genetic material. The human acrocentric chromosomes involved in Robertsonian translocation are chromosomes 13 and 14.\nChromosome 13 is a small acrocentric chromosome that contains 138 million base pairs (MWP) and 68 genes. It is involved in various genetic disorders such as Down syndrome, Williams syndrome, and Turner syndrome.\nChromosome 14 is also a small acrocentric chromosome that contains 145 MWP and 68 genes. It is involved in various genetic disorders such as Patau syndrome, Edwards syndrome, and Miller-Dieker syndrome.\nWhen these two chromosomes exchange genetic material, they form a Robertsonian translocation, which results in the formation of a derivative chromosome that contains part of chromosomes 13 and 14. The derivative chromosome is typically smaller than the original chromosomes and is not balanced, meaning that it contains an extra or missing portion of genetic material. This can lead to various genetic disorders and health problems.",
    "vicuna-7b_fact_raw": "1. Robertsonian translocation involves the exchange of genetic material between two acrocentric chromosomes.\n2. The human acrocentric chromosomes involved in Robertsonian translocation are chromosomes 13 and 14.\n3. Chromosome 13 contains 138 million base pairs and 68 genes.\n4. Chromosome 14 contains 145 million base pairs and 68 genes.\n5. Robertsonian translocation can result in the formation of a derivative chromosome that is typically smaller than the original chromosomes and is not balanced.",
    "vicuna-7b_fact": [
      "Robertsonian translocation involves the exchange of genetic material between two acrocentric chromosomes.",
      "The human acrocentric chromosomes involved in Robertsonian translocation are chromosomes 13 and 14.",
      "Chromosome 13 contains 138 million base pairs and 68 genes.",
      "Chromosome 14 contains 145 million base pairs and 68 genes.",
      "Robertsonian translocation can result in the formation of a derivative chromosome that is typically smaller than the original chromosomes and is not balanced."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The human acrocentric chromosomes that can be involved in Robertsonian translocations are chromosomes 13, 14, 15, 21, and 22, not just 13 and 14.\n3. FALSE [correction]: Chromosome 13 contains approximately 114 million base pairs and has around 300-400 genes, not 68 genes.\n4. FALSE [correction]: Chromosome 14 contains approximately 107 million base pairs and has around 800-900 genes, not 68 genes.\n5. FALSE [correction]: Robertsonian translocation can result in the formation of a derivative chromosome that may be larger or smaller than the original chromosomes, and it can be balanced or unbalanced depending on the specific chromosomes involved and the breakpoints.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "vicuna-7b_response": "There are several R packages that can be used for the identification of pediatric brain tumors, including:\n1. Brain-Tumor-Classifier: This package uses machine learning algorithms to classify brain tumors into different categories, including pediatric brain tumors.\n2. R-CNN: This package is a deep learning framework that can be used for object detection, including the detection of brain tumors in pediatric MRI scans.\n3. TensorFlow: This is a popular deep learning framework that can be used for a variety of tasks, including image classification and object detection.\n4. H2O.ai: This package is a machine learning platform that can be used for a variety of tasks, including the identification of pediatric brain tumors.\n5. Caret: This package is a collection of functions for planning, fitting, and assessing machine learning models, including those used for the identification of pediatric brain tumors.\nIt's important to note that the choice of package will depend on the specific task and the data that is available. It's also important to consult with a medical professional before using any package for diagnostic purposes.",
    "vicuna-7b_fact_raw": "1. The Brain-Tumor-Classifier R package uses machine learning algorithms to classify brain tumors.\n2. The R-CNN R package is a deep learning framework for object detection, which can be applied to detecting brain tumors in pediatric MRI scans.\n3. TensorFlow is a deep learning framework that can be used for image classification and object detection.\n4. H2O.ai is a machine learning platform that can be utilized for identifying pediatric brain tumors.\n5. The Caret R package includes functions for planning, fitting, and assessing machine learning models, applicable to the identification of pediatric brain tumors.",
    "vicuna-7b_fact": [
      "The Brain-Tumor-Classifier R package uses machine learning algorithms to classify brain tumors.",
      "The R-CNN R package is a deep learning framework for object detection, which can be applied to detecting brain tumors in pediatric MRI scans.",
      "TensorFlow is a deep learning framework that can be used for image classification and object detection.",
      "H2O.ai is a machine learning platform that can be utilized for identifying pediatric brain tumors.",
      "The Caret R package includes functions for planning, fitting, and assessing machine learning models, applicable to the identification of pediatric brain tumors."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN: Without specific information about a package named \"Brain-Tumor-Classifier,\" it is not possible to confirm the accuracy of this statement.\n2. FALSE [correction]: The R-CNN (Region-based Convolutional Neural Networks) is a concept in deep learning for object detection, but it is not an R package. The correct name for an R package that implements R-CNN might be different, and it is not specified whether it is used for detecting brain tumors in pediatric MRI scans.\n3. TRUE: TensorFlow is indeed a deep learning framework that can be used for image classification and object detection.\n4. TRUE: H2O.ai is a machine learning platform that provides tools for various machine learning tasks, including classification problems, which could theoretically include identifying pediatric brain tumors.\n5. TRUE: The Caret (Classification And REgression Training) R package is a set of functions that aid in the process of creating machine learning models, including model training, feature selection, and model evaluation, which can be applied to various machine learning tasks such as identifying pediatric brain tumors.",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "vicuna-7b_response": "Yes, Nemo is a zinc finger protein. Zinc finger proteins are proteins that contain a zinc ion in their structure and are involved in regulating gene expression. Nemo is a zinc finger protein that is involved in the regulation of gene expression in the nervous system.",
    "vicuna-7b_fact_raw": "1. Nemo is a zinc finger protein.\n2. Zinc finger proteins contain a zinc ion in their structure.\n3. Zinc finger proteins are involved in regulating gene expression.\n4. Nemo is involved in the regulation of gene expression in the nervous system.",
    "vicuna-7b_fact": [
      "Nemo is a zinc finger protein.",
      "Zinc finger proteins contain a zinc ion in their structure.",
      "Zinc finger proteins are involved in regulating gene expression.",
      "Nemo is involved in the regulation of gene expression in the nervous system."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n\nWithout additional context or specific scientific references, it's unclear whether \"Nemo\" refers to a specific zinc finger protein known by that name in scientific literature. Therefore, the statements regarding Nemo's function and involvement in gene regulation in the nervous system cannot be confirmed as true or false.",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "vicuna-7b_response": "TFIIS (Transcription Factor IIS) is a transcriptional elongation factor that plays a critical role in the initiation and elongation of RNA polymerase II transcription. TFIIS interacts with the RNA polymerase II holoenzyme and helps to recruit and stabilize the transcription elongation factor EF-1.\nIn terms of nucleosome positioning, TFIIS does not directly affect nucleosome positioning. Nucleosomes are composed of histone proteins that are arranged around DNA in a way that compacts the DNA and allows it to be more easily packaged into the cell's nucleus. Nucleosomes are typically found at the core of the chromatin fiber, and their positioning is determined by the interactions between the histone tails and the DNA.\nHowever, TFIIS can indirectly affect nucleosome positioning by influencing the transcriptional elongation process. For example, TFIIS can help to recruit the transcription elongation factor EF-1 to the promoter region, which can lead to the disassembly of nucleosomes and the opening up of the chromatin structure. This can allow for the transcriptional machinery to access the DNA and initiate transcription.\nIn summary, while TFIIS does not directly affect nucleosome positioning, it can indirectly influence nucleosome positioning by influencing the transcriptional elongation process.",
    "vicuna-7b_fact_raw": "1. TFIIS is a transcriptional elongation factor that plays a role in the initiation and elongation of RNA polymerase II transcription.\n2. TFIIS interacts with the RNA polymerase II holoenzyme.\n3. TFIIS helps to recruit and stabilize the transcription elongation factor EF-1.\n4. Nucleosomes are composed of histone proteins and are involved in compacting DNA for packaging into the cell's nucleus.\n5. TFIIS can indirectly affect nucleosome positioning by influencing the transcriptional elongation process.",
    "vicuna-7b_fact": [
      "TFIIS is a transcriptional elongation factor that plays a role in the initiation and elongation of RNA polymerase II transcription.",
      "TFIIS interacts with the RNA polymerase II holoenzyme.",
      "TFIIS helps to recruit and stabilize the transcription elongation factor EF-1.",
      "Nucleosomes are composed of histone proteins and are involved in compacting DNA for packaging into the cell's nucleus.",
      "TFIIS can indirectly affect nucleosome positioning by influencing the transcriptional elongation process."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: TFIIS is a transcription elongation factor that plays a role in the elongation phase of RNA polymerase II transcription, not in the initiation.\n2. TRUE\n3. FALSE [correction]: TFIIS does not recruit or stabilize the translation elongation factor EF-1, as EF-1 is involved in translation, not transcription.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "vicuna-7b_response": "The origins of replication close to yeast centromeres fire early.\nCentromeres are the regions of the chromosome where the two sister chromatids are joined during cell division, and they are also the sites where the replication originates. In yeast, the origins of replication are located close to the centromeres, and they fire early during the S phase of the cell cycle.\nThis is in contrast to origins located far from the centromeres, which fire later in the S phase. The early firing of origins close to the centromeres ensures that replication occurs before the chromosomes are separated during cell division, ensuring that each daughter cell receives an exact copy of the genetic material.\nOverall, the timing of replication origin firing is critical for maintaining genetic stability and ensuring proper cell division.",
    "vicuna-7b_fact_raw": "1. Origins of replication close to yeast centromeres fire early during the S phase of the cell cycle.\n2. Centromeres are regions where the two sister chromatids are joined during cell division.\n3. In yeast, the origins of replication are located close to the centromeres.\n4. Origins of replication located far from the centromeres fire later in the S phase.\n5. The early firing of origins close to the centromeres is important for ensuring that each daughter cell receives an exact copy of the genetic material.",
    "vicuna-7b_fact": [
      "Origins of replication close to yeast centromeres fire early during the S phase of the cell cycle.",
      "Centromeres are regions where the two sister chromatids are joined during cell division.",
      "In yeast, the origins of replication are located close to the centromeres.",
      "Origins of replication located far from the centromeres fire later in the S phase.",
      "The early firing of origins close to the centromeres is important for ensuring that each daughter cell receives an exact copy of the genetic material."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Centromeres are regions of the chromosome where the kinetochore forms and spindle fibers attach, not necessarily where the two sister chromatids are joined. Sister chromatids are joined along their lengths by cohesins; the centromere is a specific part of the chromosome that plays a crucial role during cell division.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "vicuna-7b_response": "Mammalian GA-sequences are a type of non-coding RNA that are found in the nuclei of mammalian cells. They are characterized by the presence of a specific sequence called the GA-sequence, which is composed of the nucleotides guanine, adenine, and cytosine.\nIn addition to the GA-sequence, mammalian GA-sequences also contain a specific type of modification called N6-methyladenosine (m6A). This modification is thought to play a role in regulating the expression of genes and is involved in a variety of cellular processes, including development, differentiation, and cellular metabolism.\nMammalian GA-sequences are found in a variety of tissues and cell types, and their expression is regulated by a complex network of transcription factors, epigenetic modifications, and other regulatory mechanisms.\nOverall, mammalian GA-sequences are an important class of non-coding RNA that play a critical role in regulating gene expression and cellular processes in mammalian cells.",
    "vicuna-7b_fact_raw": "1. Mammalian GA-sequences are a type of non-coding RNA found in the nuclei of mammalian cells.\n2. The GA-sequence is composed of the nucleotides guanine, adenine, and cytosine.\n3. Mammalian GA-sequences contain a modification called N6-methyladenosine (m6A).\n4. N6-methyladenosine (m6A) is involved in regulating gene expression and various cellular processes including development, differentiation, and cellular metabolism.\n5. The expression of mammalian GA-sequences is regulated by transcription factors, epigenetic modifications, and other regulatory mechanisms.",
    "vicuna-7b_fact": [
      "Mammalian GA-sequences are a type of non-coding RNA found in the nuclei of mammalian cells.",
      "The GA-sequence is composed of the nucleotides guanine, adenine, and cytosine.",
      "Mammalian GA-sequences contain a modification called N6-methyladenosine (m6A).",
      "N6-methyladenosine (m6A) is involved in regulating gene expression and various cellular processes including development, differentiation, and cellular metabolism.",
      "The expression of mammalian GA-sequences is regulated by transcription factors, epigenetic modifications, and other regulatory mechanisms."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: The GA-sequence is typically composed of the nucleotides guanine (G) and adenine (A), not cytosine (C). The name \"GA-sequence\" suggests a sequence rich in guanine and adenine, but without more context, it's not clear if cytosine is a significant component or not.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "vicuna-7b_response": "The number of Groucho-related genes (GRG) in the mouse genome is not a fixed number, as the genome is constantly evolving and new genes are being discovered. However, as of the latest mouse genome assembly (mm10), there are 10 known Groucho-related genes (GRG1-GRG10) that have been identified. These genes are also known as the Groucho family of genes, and they play a role in regulating the expression of other genes.",
    "vicuna-7b_fact_raw": "1. The mouse genome contains Groucho-related genes (GRGs).\n2. As of the latest mouse genome assembly (mm10), there are 10 known Groucho-related genes identified.\n3. These genes are referred to as GRG1 through GRG10.\n4. Groucho-related genes play a role in regulating the expression of other genes.",
    "vicuna-7b_fact": [
      "The mouse genome contains Groucho-related genes (GRGs).",
      "As of the latest mouse genome assembly (mm10), there are 10 known Groucho-related genes identified.",
      "These genes are referred to as GRG1 through GRG10.",
      "Groucho-related genes play a role in regulating the expression of other genes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "vicuna-7b_response": "RNA polymerase II is a complex enzyme that is responsible for transcribing DNA into RNA. It is composed of several subunits, including the catalytic subunit, which carries the RNA cleavage activity.\nThe catalytic subunit of RNA polymerase II is called the C-terminal domain (CTD). The CTD is responsible for the synthesis of the RNA polymerase II transcript, which is the primary template for transcription. The CTD also carries the RNA cleavage activity of the enzyme, which is necessary for the proper initiation and elongation of transcription.\nThe CTD is composed of a series of repeating units, called the C-repeat region, which are linked by a variable region. Each repeat unit contains a high-affinity site for the general transcription factor TFIIS, which is responsible for recruiting the enzyme to the promoter region of the DNA template. The CTD also contains a low-affinity site for the transcription elongation factor EF-1, which is responsible for the translocation of the enzyme along the DNA template.\nIn addition to the CTD, RNA polymerase II also contains several other subunits, including the largest subunit, which is responsible for the binding of the enzyme to the DNA template, and the sigma subunit, which is responsible for the recognition of the promoter region of the DNA template.\nOverall, the C-terminal domain of RNA polymerase II is responsible for the synthesis of the RNA polymerase II transcript and the RNA cleavage activity of the enzyme, which are necessary for the proper initiation and elongation of transcription.",
    "vicuna-7b_fact_raw": "1. RNA polymerase II is responsible for transcribing DNA into RNA.\n2. The catalytic subunit of RNA polymerase II, known as the C-terminal domain (CTD), carries the RNA cleavage activity.\n3. The CTD is responsible for the synthesis of the RNA polymerase II transcript.\n4. The CTD contains a high-affinity site for the general transcription factor TFIIS.\n5. The largest subunit of RNA polymerase II is responsible for the binding of the enzyme to the DNA template.",
    "vicuna-7b_fact": [
      "RNA polymerase II is responsible for transcribing DNA into RNA.",
      "The catalytic subunit of RNA polymerase II, known as the C-terminal domain (CTD), carries the RNA cleavage activity.",
      "The CTD is responsible for the synthesis of the RNA polymerase II transcript.",
      "The CTD contains a high-affinity site for the general transcription factor TFIIS.",
      "The largest subunit of RNA polymerase II is responsible for the binding of the enzyme to the DNA template."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The catalytic subunit of RNA polymerase II is not known as the C-terminal domain (CTD). The CTD is involved in the processing of the pre-mRNA, not the cleavage activity. The RNA cleavage activity is associated with specific RNA cleavage factors, not the CTD itself.\n3. FALSE [correction]: The CTD does not synthesize the RNA polymerase II transcript; rather, it plays a role in the processing of the pre-mRNA by serving as a platform for the binding of various factors involved in RNA splicing, polyadenylation, and other processing events.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "vicuna-7b_response": "Ohdo syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and distinctive facial features such as a broad nasal bridge and a flat nasal tip. The genetic basis of Ohdo syndrome has been identified as a mutation in the GFI1 gene.\nGFI1 is a transcription factor that plays a crucial role in the development of several organs, including the brain and the face. Mutations in the GFI1 gene can lead to reduced expression of this protein, which can result in the developmental abnormalities seen in individuals with Ohdo syndrome.\nThe GFI1 gene is located on the long (q) arm of chromosome 12 at position 12q24.13. The specific mutation that causes Ohdo syndrome is a deletion of a small piece of the GFI1 gene, which results in a frameshift and the production of a non-functional protein.\nIndividuals with Ohdo syndrome may also have other medical issues, such as seizures, heart defects, and kidney problems. The severity of the symptoms can vary among individuals, and the diagnosis is typically made through a combination of clinical examination, genetic testing, and other diagnostic procedures.\nTreatment for Ohdo syndrome is primarily supportive, and may include therapy, medication, and surgery to address specific medical issues. There is currently no cure for the disorder, but early intervention and support can help improve the quality of life for individuals with Ohdo syndrome and their families.",
    "vicuna-7b_fact_raw": "1. Ohdo syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and distinctive facial features.\n2. The genetic basis of Ohdo syndrome is a mutation in the GFI1 gene.\n3. The GFI1 gene is a transcription factor important for the development of several organs, including the brain and face.\n4. The GFI1 gene is located on the long (q) arm of chromosome 12 at position 12q24.13.\n5. The specific mutation causing Ohdo syndrome is a deletion in the GFI1 gene that results in a frameshift and the production of a non-functional protein.",
    "vicuna-7b_fact": [
      "Ohdo syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and distinctive facial features.",
      "The genetic basis of Ohdo syndrome is a mutation in the GFI1 gene.",
      "The GFI1 gene is a transcription factor important for the development of several organs, including the brain and face.",
      "The GFI1 gene is located on the long (q) arm of chromosome 12 at position 12q24.13.",
      "The specific mutation causing Ohdo syndrome is a deletion in the GFI1 gene that results in a frameshift and the production of a non-functional protein."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The genetic basis of Ohdo syndrome can be due to mutations in several genes, including MED12, KAT6B, and SALL1, but not specifically the GFI1 gene.\n3. TRUE\n4. UNKNOWN: Without specific information about the location of the GFI1 gene, this statement cannot be verified.\n5. FALSE [correction]: Since the GFI1 gene is not the established cause of Ohdo syndrome, the specific mutation causing Ohdo syndrome is not necessarily a deletion in the GFI1 gene that results in a frameshift and the production of a non-functional protein. The mutations causing Ohdo syndrome can vary and are associated with different genes.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "vicuna-7b_response": "The R/Bioconductor package that has been developed for the analysis of psychiatric disease genes is called \"affy\".\naffy is a package in the R/Bioconductor framework that provides tools for the analysis of gene expression data. It is specifically designed for the Affymetrix GeneChip platform, but it can also be used with data from other microarray platforms.\naffy provides a number of functions for the analysis of gene expression data, including:\n* Normalization of expression data to remove variation due to differences in library size and other technical factors\n* Detection of differentially expressed genes between two groups (e.g. healthy vs. diseased)\n* Clustering of genes based on their expression patterns\n* Heatmap visualization of expression data\naffy has been widely used in the analysis of gene expression data in psychiatric disease research, particularly in the analysis of data from the Affymetrix GeneChip Human Genome U133 Plus 2.0 array.\nIt's worth noting that there are other R/Bioconductor packages that can be used for the analysis of psychiatric disease genes, such as \"limma\" and \"edgeR\", but affy is specifically designed for the analysis of gene expression data from microarray platforms.",
    "vicuna-7b_fact_raw": "1. The R/Bioconductor package developed for the analysis of psychiatric disease genes is called \"affy\".\n2. The affy package provides tools for the analysis of gene expression data.\n3. It is designed for the Affymetrix GeneChip platform but can be used with other microarray platforms.\n4. The affy package includes functions for normalization, detection of differentially expressed genes, clustering of genes, and heatmap visualization.\n5. The affy package has been widely used in psychiatric disease research, particularly with the Affymetrix GeneChip Human Genome U133 Plus 2.0 array.",
    "vicuna-7b_fact": [
      "The R/Bioconductor package developed for the analysis of psychiatric disease genes is called \"affy\".",
      "The affy package provides tools for the analysis of gene expression data.",
      "It is designed for the Affymetrix GeneChip platform but can be used with other microarray platforms.",
      "The affy package includes functions for normalization, detection of differentially expressed genes, clustering of genes, and heatmap visualization.",
      "The affy package has been widely used in psychiatric disease research, particularly with the Affymetrix GeneChip Human Genome U133 Plus 2.0 array."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The R/Bioconductor package \"affy\" is not specifically developed for the analysis of psychiatric disease genes; it is a general package for the analysis of Affymetrix microarray data.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "vicuna-7b_response": "Intracerebral hemorrhage, also known as a stroke, is a medical emergency that occurs when there is bleeding within the brain. The swirl sign is a radiological finding that is seen on CT scans of the brain in patients with intracerebral hemorrhage.\nThe swirl sign is characterized by a swirling pattern of blood within the affected hemisphere of the brain. This pattern is caused by the movement of blood within the brain, which can cause the brain tissue to become distorted and twisted. The swirl sign is often seen in the early stages of intracerebral hemorrhage, and it can help doctors to diagnose the condition and determine the severity of the bleeding.\nThe swirl sign is not always present in all cases of intracerebral hemorrhage, and it is not a specific diagnostic indicator. However, it can be a useful tool for doctors to help diagnose and manage this serious medical condition.\nIn summary, the swirl sign is a radiological finding that is seen on CT scans of the brain in patients with intracerebral hemorrhage. It is characterized by a swirling pattern of blood within the affected hemisphere of the brain, and it can help doctors to diagnose and manage this serious medical condition.",
    "vicuna-7b_fact_raw": "1. Intracerebral hemorrhage is a medical emergency that occurs when there is bleeding within the brain.\n2. The swirl sign is a radiological finding seen on CT scans of the brain in patients with intracerebral hemorrhage.\n3. The swirl sign is characterized by a swirling pattern of blood within the affected hemisphere of the brain.\n4. The swirl sign is often seen in the early stages of intracerebral hemorrhage.\n5. The swirl sign can help doctors to diagnose the condition and determine the severity of the bleeding.",
    "vicuna-7b_fact": [
      "Intracerebral hemorrhage is a medical emergency that occurs when there is bleeding within the brain.",
      "The swirl sign is a radiological finding seen on CT scans of the brain in patients with intracerebral hemorrhage.",
      "The swirl sign is characterized by a swirling pattern of blood within the affected hemisphere of the brain.",
      "The swirl sign is often seen in the early stages of intracerebral hemorrhage.",
      "The swirl sign can help doctors to diagnose the condition and determine the severity of the bleeding."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The swirl sign is characterized by a heterogeneous appearance of blood on a CT scan, which may represent active bleeding within the hematoma, not necessarily a swirling pattern of blood within the affected hemisphere.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "vicuna-7b_response": "ROF1, also known as RNA polymerase II factor 1, is a transcription factor that plays a crucial role in the regulation of gene expression in Arabidopsis thaliana. ROF1 is induced in response to various stimuli, including environmental stressors such as heat, cold, drought, and salinity, as well as abiotic stressors such as UV-B and oxidative stress.\nROF1 is also induced by various hormones, including abscisic acid (ABA), ethylene, and jasmonic acid. ABA is a plant hormone that plays a key role in the response to drought stress, and ROF1 is induced by ABA in a variety of tissues, including roots, leaves, and flowers.\nIn addition to environmental and hormonal stimuli, ROF1 is also induced by various pathogens, including fungi and bacteria. ROF1 is upregulated in response to the presence of pathogens, and it has been shown to play a role in the defense response to infection.\nOverall, ROF1 is induced by a variety of stimuli, including environmental stressors, hormones, and pathogens, and it plays a crucial role in the regulation of gene expression in response to these stimuli.",
    "vicuna-7b_fact_raw": "1. ROF1, also known as RNA polymerase II factor 1, is a transcription factor in Arabidopsis thaliana.\n2. ROF1 expression is induced by environmental stressors such as heat, cold, drought, and salinity.\n3. ROF1 expression is induced by abiotic stressors such as UV-B and oxidative stress.\n4. Abscisic acid (ABA), ethylene, and jasmonic acid are hormones that induce ROF1 expression.\n5. ROF1 is upregulated in response to pathogens, including fungi and bacteria, and plays a role in the defense response to infection.",
    "vicuna-7b_fact": [
      "ROF1, also known as RNA polymerase II factor 1, is a transcription factor in Arabidopsis thaliana.",
      "ROF1 expression is induced by environmental stressors such as heat, cold, drought, and salinity.",
      "ROF1 expression is induced by abiotic stressors such as UV-B and oxidative stress.",
      "Abscisic acid (ABA), ethylene, and jasmonic acid are hormones that induce ROF1 expression.",
      "ROF1 is upregulated in response to pathogens, including fungi and bacteria, and plays a role in the defense response to infection."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements about ROF1 (presumably a gene or protein in Arabidopsis thaliana) are very specific and would require access to scientific literature or databases to verify. Without specific information on ROF1 and its inducers or functions, it is not possible to accurately determine the truthfulness of statements 1, 4, and 5. Statements 2 and 3 are generally true for many genes involved in stress responses in plants, but without specific evidence for ROF1, they cannot be confirmed for this particular gene.",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "vicuna-7b_response": "Hereditary renal amyloidosis is a rare genetic disorder characterized by the accumulation of an abnormal protein called amyloid in the kidneys. The most common cause of hereditary renal amyloidosis is a protein called transthyretin (TTR). TTR is a plasma protein that is normally found in the blood and is involved in the transport of thyroid hormones and vitamin A. In hereditary renal amyloidosis, mutations in the TTR gene cause the production of an abnormal TTR protein that accumulates in the kidneys and leads to the formation of amyloid fibrils. Other less common causes of hereditary renal amyloidosis include the presence of other abnormal proteins such as immunoglobulin light chains and the presence of wild-type transthyretin (TTR-Wt).",
    "vicuna-7b_fact_raw": "1. Hereditary renal amyloidosis is characterized by the accumulation of amyloid in the kidneys.\n2. The most common cause of hereditary renal amyloidosis is a protein called transthyretin (TTR).\n3. Transthyretin is a plasma protein involved in the transport of thyroid hormones and vitamin A.\n4. Mutations in the TTR gene can lead to the production of an abnormal TTR protein that accumulates in the kidneys.\n5. Other causes of hereditary renal amyloidosis can include abnormal proteins such as immunoglobulin light chains and wild-type transthyretin (TTR-Wt).",
    "vicuna-7b_fact": [
      "Hereditary renal amyloidosis is characterized by the accumulation of amyloid in the kidneys.",
      "The most common cause of hereditary renal amyloidosis is a protein called transthyretin (TTR).",
      "Transthyretin is a plasma protein involved in the transport of thyroid hormones and vitamin A.",
      "Mutations in the TTR gene can lead to the production of an abnormal TTR protein that accumulates in the kidneys.",
      "Other causes of hereditary renal amyloidosis can include abnormal proteins such as immunoglobulin light chains and wild-type transthyretin (TTR-Wt)."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The most common cause of hereditary renal amyloidosis is not transthyretin (TTR), but mutations in the genes encoding fibrinogen A alpha-chain, apolipoprotein A-I, apolipoprotein A-II, and lysozyme. Transthyretin-related amyloidosis is a form of amyloidosis, but not all hereditary renal amyloidosis is caused by TTR.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Wild-type transthyretin (TTR-Wt) is not a cause of hereditary renal amyloidosis. It is associated with senile systemic amyloidosis, which is not hereditary. Hereditary forms are caused by mutations in the genes mentioned above, which lead to the production of abnormal proteins that can accumulate in the kidneys. Immunoglobulin light chains are associated with a different type of amyloidosis called AL amyloidosis, which is not typically classified as hereditary.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "vicuna-7b_response": "Yes, the proteome of mouse hippocampus has been analyzed. The hippocampus is a brain structure involved in learning and memory, and its proteome, or the set of all proteins expressed in a particular cell or tissue type, has been studied extensively in mice.\nSeveral studies have used proteomic techniques, such as two-dimensional gel electrophoresis and mass spectrometry, to identify and quantify the proteins expressed in the mouse hippocampus. These studies have identified thousands of proteins, including both protein-coding genes and non-coding RNAs, as well as proteins involved in various biological processes such as neurotransmission, synaptic plasticity, and cellular metabolism.\nOne study published in the journal Molecular and Cellular Proteomics in 2012 used a combination of mass spectrometry and bioinformatics approaches to identify over 7,000 proteins in the mouse hippocampus. Another study published in the journal Neuroscience Letters in 2016 used two-dimensional gel electrophoresis to identify over 1,000 proteins in the mouse hippocampus, including proteins involved in synaptic plasticity and neuronal signaling.\nOverall, the proteome of mouse hippocampus has been extensively studied, and these studies have provided important insights into the biology of this brain structure and the mechanisms underlying learning and memory.",
    "vicuna-7b_fact_raw": "1. The proteome of the mouse hippocampus has been analyzed.\n2. The hippocampus is involved in learning and memory.\n3. Proteomic techniques such as two-dimensional gel electrophoresis and mass spectrometry have been used to study the mouse hippocampus.\n4. A study published in Molecular and Cellular Proteomics in 2012 identified over 7,000 proteins in the mouse hippocampus.\n5. A study published in Neuroscience Letters in 2016 identified over 1,000 proteins in the mouse hippocampus.",
    "vicuna-7b_fact": [
      "The proteome of the mouse hippocampus has been analyzed.",
      "The hippocampus is involved in learning and memory.",
      "Proteomic techniques such as two-dimensional gel electrophoresis and mass spectrometry have been used to study the mouse hippocampus.",
      "A study published in Molecular and Cellular Proteomics in 2012 identified over 7,000 proteins in the mouse hippocampus.",
      "A study published in Neuroscience Letters in 2016 identified over 1,000 proteins in the mouse hippocampus."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe first three statements are true based on common scientific knowledge. The proteome of the mouse hippocampus has indeed been analyzed, the hippocampus is known to be involved in learning and memory, and proteomic techniques such as two-dimensional gel electrophoresis and mass spectrometry are commonly used in such studies.\n\nHowever, without access to the specific articles from \"Molecular and Cellular Proteomics\" in 2012 and \"Neuroscience Letters\" in 2016, I cannot verify the exact number of proteins identified in those studies. Therefore, the truthfulness of statements 4 and 5 is unknown.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "vicuna-7b_response": "No, mouse chromosomes are not acrocentric. Acrocentric chromosomes are a type of chromosome that have their centromeres located at the ends of the chromosome, whereas mouse chromosomes have their centromeres located in the middle of the chromosome.",
    "vicuna-7b_fact_raw": "1. Acrocentric chromosomes have their centromeres located at the ends of the chromosome.\n2. Mouse chromosomes have their centromeres located in the middle of the chromosome.",
    "vicuna-7b_fact": [
      "Acrocentric chromosomes have their centromeres located at the ends of the chromosome.",
      "Mouse chromosomes have their centromeres located in the middle of the chromosome."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Acrocentric chromosomes have their centromeres located close to but not at the very end of the chromosome, resulting in a long arm and a very short arm.\n2. FALSE [correction]: Mouse chromosomes are acrocentric, meaning their centromeres are located close to the ends of the chromosomes, not in the middle.",
    "vicuna-7b_judge": [
      "false",
      "false"
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "vicuna-7b_response": "One example of an siRNA-based drug that is currently in clinical trials for the treatment of pancreatic cancer is GEN-1.\nGEN-1 is an siRNA drug that targets the Hedgehog signaling pathway, which is known to play a role in the development and progression of pancreatic cancer. By inhibiting the Hedgehog pathway, GEN-1 has been shown to reduce the growth and proliferation of pancreatic cancer cells in preclinical studies.\nGEN-1 is currently being studied in a phase 1b/2 clinical trial in patients with advanced pancreatic cancer. The trial is evaluating the safety and efficacy of GEN-1 in combination with chemotherapy and is expected to enroll up to 100 patients.\nIt's important to note that siRNA-based drugs are still in the early stages of development and more research is needed to fully understand their safety and efficacy.",
    "vicuna-7b_fact_raw": "1. GEN-1 is an siRNA-based drug currently in clinical trials for the treatment of pancreatic cancer.\n2. GEN-1 targets the Hedgehog signaling pathway.\n3. The Hedgehog signaling pathway is associated with the development and progression of pancreatic cancer.\n4. GEN-1 has been shown to reduce the growth and proliferation of pancreatic cancer cells in preclinical studies.\n5. GEN-1 is being studied in a phase 1b/2 clinical trial that plans to enroll up to 100 patients with advanced pancreatic cancer.",
    "vicuna-7b_fact": [
      "GEN-1 is an siRNA-based drug currently in clinical trials for the treatment of pancreatic cancer.",
      "GEN-1 targets the Hedgehog signaling pathway.",
      "The Hedgehog signaling pathway is associated with the development and progression of pancreatic cancer.",
      "GEN-1 has been shown to reduce the growth and proliferation of pancreatic cancer cells in preclinical studies.",
      "GEN-1 is being studied in a phase 1b/2 clinical trial that plans to enroll up to 100 patients with advanced pancreatic cancer."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN: Without specific and current information about GEN-1, it is not possible to confirm whether it is an siRNA-based drug in clinical trials for pancreatic cancer.\n2. UNKNOWN: Without specific information about GEN-1, it is not possible to confirm whether it targets the Hedgehog signaling pathway.\n3. TRUE: The Hedgehog signaling pathway is known to be associated with the development and progression of various cancers, including pancreatic cancer.\n4. UNKNOWN: Without specific data or results from preclinical studies, it is not possible to confirm whether GEN-1 has been shown to reduce the growth and proliferation of pancreatic cancer cells.\n5. UNKNOWN: Without current and specific information about the clinical trials of GEN-1, it is not possible to confirm the details of the phase 1b/2 clinical trial or the number of patients planned to be enrolled.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "vicuna-7b_response": "The HPG pore is a type of protein channel that is found in the plasma membrane of certain types of cells, including neurons and endocrine cells. It is also known as the high-affinity potassium channel or the tetrameric potassium channel.\nThe HPG pore is a complex structure that is composed of four identical subunits, each of which contains six transmembrane domains. These domains form a pore that is selective for potassium ions, allowing them to pass through the channel while blocking the passage of other ions.\nThe HPG pore plays an important role in regulating the flow of potassium ions across the plasma membrane, which is essential for a variety of cellular processes, including electrical signaling, muscle contraction, and hormone secretion. Dysfunction of the HPG pore has been implicated in a number of diseases, including epilepsy, migraines, and certain types of cancer.\nOverall, the HPG pore is a critical component of the cell membrane that plays a crucial role in regulating the flow of ions and other molecules across the membrane, which is essential for normal cellular function.",
    "vicuna-7b_fact_raw": "1. The HPG pore is found in the plasma membrane of certain types of cells, such as neurons and endocrine cells.\n2. It is also referred to as the high-affinity potassium channel or the tetrameric potassium channel.\n3. The HPG pore is composed of four identical subunits, each with six transmembrane domains.\n4. This pore is selective for potassium ions, allowing their passage while blocking other ions.\n5. Dysfunction of the HPG pore has been implicated in diseases like epilepsy, migraines, and certain types of cancer.",
    "vicuna-7b_fact": [
      "The HPG pore is found in the plasma membrane of certain types of cells, such as neurons and endocrine cells.",
      "It is also referred to as the high-affinity potassium channel or the tetrameric potassium channel.",
      "The HPG pore is composed of four identical subunits, each with six transmembrane domains.",
      "This pore is selective for potassium ions, allowing their passage while blocking other ions.",
      "Dysfunction of the HPG pore has been implicated in diseases like epilepsy, migraines, and certain types of cancer."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: The HPG pore is not typically referred to as the high-affinity potassium channel or the tetrameric potassium channel. These terms describe different types of potassium channels, not the HPG pore.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe term \"HPG pore\" is not a standard term in cell biology or neuroscience as of my knowledge cutoff in 2023. It is possible that \"HPG pore\" is a misnomer or a very specific term not widely recognized in scientific literature. Without additional context, it is difficult to verify the statements about its structure, function, or implications in diseases. The corrections and assessments provided are based on the assumption that the term \"HPG pore\" is incorrect or not widely used, and the statements are evaluated based on common knowledge about potassium channels, which are often tetrameric and selective for potassium ions.",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "vicuna-7b_response": "The 959 Nematode Genomes initiative is a large-scale project aimed at sequencing and analyzing the genomes of 959 species of roundworms, also known as nematodes. Nematodes are a diverse group of parasitic and free-living organisms that play important roles in many ecosystems, including as model organisms for biological research.\nThe 959 Nematode Genomes initiative is a collaborative effort between researchers from around the world, with the goal of generating a comprehensive understanding of the genetic diversity and evolutionary history of nematodes. By sequencing and analyzing the genomes of a large number of nematode species, researchers hope to gain insights into the genetic basis of nematode biology, evolution, and ecology, as well as to identify new targets for the development of drugs and other interventions to control nematode-transmitted diseases.\nThe 959 Nematode Genomes initiative is an ambitious project that will require significant resources and expertise, but it has the potential to revolutionize our understanding of nematode biology and to lead to important advances in biotechnology and medicine.",
    "vicuna-7b_fact_raw": "1. The 959 Nematode Genomes initiative aims to sequence and analyze the genomes of 959 species of roundworms.\n2. Nematodes are a diverse group of organisms that include both parasitic and free-living species.\n3. The initiative is a collaborative effort involving researchers from around the world.\n4. One of the goals of the initiative is to understand the genetic diversity and evolutionary history of nematodes.\n5. The project seeks to identify new targets for drug development and interventions to control nematode-transmitted diseases.",
    "vicuna-7b_fact": [
      "The 959 Nematode Genomes initiative aims to sequence and analyze the genomes of 959 species of roundworms.",
      "Nematodes are a diverse group of organisms that include both parasitic and free-living species.",
      "The initiative is a collaborative effort involving researchers from around the world.",
      "One of the goals of the initiative is to understand the genetic diversity and evolutionary history of nematodes.",
      "The project seeks to identify new targets for drug development and interventions to control nematode-transmitted diseases."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "vicuna-7b_response": "There are several R packages that have been developed for analyzing Non-invasive prenatal testing (NIPT) data. Some of the popular R packages for NIPT analysis include:\n1. \"nipstest\": This package provides functions for analyzing and interpreting NIPT data. It includes functions for quality control, data visualization, and statistical analysis.\n2. \"nipstools\": This package provides functions for processing, analyzing, and visualizing NIPT data. It includes functions for data preprocessing, quality control, and statistical analysis.\n3. \"nipstestR\": This package provides functions for analyzing and interpreting NIPT data. It includes functions for quality control, data visualization, and statistical analysis.\n4. \"nipstoolsR\": This package provides functions for processing, analyzing, and visualizing NIPT data. It includes functions for data preprocessing, quality control, and statistical analysis.\n5. \"nipstest.r\": This package provides functions for analyzing and interpreting NIPT data. It includes functions for quality control, data visualization, and statistical analysis.\n6. \"nipstools.r\": This package provides functions for processing, analyzing, and visualizing NIPT data. It includes functions for data preprocessing, quality control, and statistical analysis.\nIt's worth noting that these packages are not the only ones available, and new packages may be developed in the future. It's always a good idea to check the package documentation and examples before using it for your specific analysis.",
    "vicuna-7b_fact_raw": "1. The \"nipstest\" R package provides functions for analyzing and interpreting Non-invasive prenatal testing (NIPT) data.\n2. The \"nipstools\" R package provides functions for processing, analyzing, and visualizing NIPT data.\n3. The \"nipstestR\" R package provides functions for analyzing and interpreting NIPT data.\n4. The \"nipstoolsR\" R package provides functions for processing, analyzing, and visualizing NIPT data.\n5. The \"nipstest.r\" and \"nipstools.r\" are mentioned as R packages for NIPT data analysis.",
    "vicuna-7b_fact": [
      "The \"nipstest\" R package provides functions for analyzing and interpreting Non-invasive prenatal testing (NIPT) data.",
      "The \"nipstools\" R package provides functions for processing, analyzing, and visualizing NIPT data.",
      "The \"nipstestR\" R package provides functions for analyzing and interpreting NIPT data.",
      "The \"nipstoolsR\" R package provides functions for processing, analyzing, and visualizing NIPT data.",
      "The \"nipstest.r\" and \"nipstools.r\" are mentioned as R packages for NIPT data analysis."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: R package names are case sensitive and typically do not include a \".r\" at the end. The correct names would likely be \"nipstest\" and \"nipstools\" if these are indeed R packages, but without specific information about these packages, it's not possible to confirm their existence or functionality.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbachs syndrome.",
    "vicuna-7b_response": "Achenbach's syndrome, also known as \"painful heel syndrome,\" is a condition characterized by pain in the heel of the foot. The pain is typically worse when standing or walking and may be accompanied by swelling and redness in the heel. The exact cause of Achenbach's syndrome is not known, but it is thought to be related to overuse or injury to the heel.\nSymptoms of Achenbach's syndrome may include:\n* Pain in the heel of the foot, usually worse in the morning or after rest\n* Swelling and redness in the heel\n* Pain that worsens with standing or walking\n* Pain that improves with rest\nTreatment for Achenbach's syndrome typically includes rest, ice, and over-the-counter pain medications. In some cases, physical therapy or orthotics may be recommended to help alleviate symptoms. In severe cases, surgery may be necessary.\nIt is important to see a healthcare provider if you are experiencing persistent heel pain, as there may be an underlying condition that requires treatment.",
    "vicuna-7b_fact_raw": "1. Achenbach's syndrome is characterized by pain in the heel of the foot.\n2. Symptoms of Achenbach's syndrome can include swelling and redness in the heel.\n3. The pain associated with Achenbach's syndrome typically worsens with standing or walking.\n4. Treatment for Achenbach's syndrome may involve rest, ice, and over-the-counter pain medications.\n5. In some cases of Achenbach's syndrome, physical therapy or orthotics may be recommended.",
    "vicuna-7b_fact": [
      "Achenbach's syndrome is characterized by pain in the heel of the foot.",
      "Symptoms of Achenbach's syndrome can include swelling and redness in the heel.",
      "The pain associated with Achenbach's syndrome typically worsens with standing or walking.",
      "Treatment for Achenbach's syndrome may involve rest, ice, and over-the-counter pain medications.",
      "In some cases of Achenbach's syndrome, physical therapy or orthotics may be recommended."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Achenbach's syndrome is characterized by pain and bruising in the hands, not the heel of the foot.\n2. FALSE [correction]: Symptoms of Achenbach's syndrome can include swelling, redness, and bruising, but these symptoms are typically in the hands, not the heel.\n3. FALSE [correction]: Since Achenbach's syndrome affects the hands, the statement about pain worsening with standing or walking is not applicable.\n4. TRUE: Treatment for Achenbach's syndrome may indeed involve rest, ice, and over-the-counter pain medications to alleviate symptoms.\n5. UNKNOWN: While physical therapy or orthotics may be recommended for various conditions, there is no specific information provided about their use in Achenbach's syndrome, and given that the syndrome affects the hands, orthotics (which are generally for the feet) would not be relevant. Physical therapy might be recommended for hand function improvement, but without specific context, this statement's accuracy is unclear.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "vicuna-7b_response": "Long repeat expansions are a type of genetic mutation that can cause a variety of diseases, including Huntington's disease, myotonic dystrophy, and fragile X syndrome. There are several algorithms that can be used to detect long repeat expansions, including:\n1. PCR-based methods: These methods use polymerase chain reaction (PCR) to amplify specific regions of the genome and then sequence the amplified regions. PCR can be used to detect repeat expansions by amplifying a specific region of the genome and then sequencing the amplified region to identify repeat expansions.\n2. Sequencing-based methods: These methods use next-generation sequencing (NGS) to sequence the entire genome or specific regions of the genome. Sequencing can be used to detect repeat expansions by identifying repeat expansions in the sequenced regions.\n3. Microarray-based methods: These methods use microarrays to detect repeat expansions by comparing the expression of specific genes to a reference genome. Microarrays can be used to detect repeat expansions by identifying genes that are differentially expressed between individuals with and without repeat expansions.\nOverall, the choice of algorithm for detecting long repeat expansions will depend on the specific disease being studied and the available resources.",
    "vicuna-7b_fact_raw": "1. PCR-based methods can be used to detect long repeat expansions by amplifying and sequencing specific regions of the genome.\n2. Sequencing-based methods involve using next-generation sequencing to identify repeat expansions in the genome.\n3. Microarray-based methods detect repeat expansions by comparing gene expression to a reference genome.\n4. Long repeat expansions are genetic mutations that can cause diseases such as Huntington's disease, myotonic dystrophy, and fragile X syndrome.\n5. The choice of algorithm for detecting long repeat expansions depends on the specific disease being studied and the available resources.",
    "vicuna-7b_fact": [
      "PCR-based methods can be used to detect long repeat expansions by amplifying and sequencing specific regions of the genome.",
      "Sequencing-based methods involve using next-generation sequencing to identify repeat expansions in the genome.",
      "Microarray-based methods detect repeat expansions by comparing gene expression to a reference genome.",
      "Long repeat expansions are genetic mutations that can cause diseases such as Huntington's disease, myotonic dystrophy, and fragile X syndrome.",
      "The choice of algorithm for detecting long repeat expansions depends on the specific disease being studied and the available resources."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: PCR-based methods can be used to detect repeat expansions, but they are generally not suitable for detecting very long repeat expansions because the PCR process can be inhibited by such long repeats.\n2. TRUE\n3. FALSE [correction]: Microarray-based methods detect copy number variations and single nucleotide polymorphisms, not repeat expansions. Repeat expansions are typically detected using methods like PCR, Southern blotting, or next-generation sequencing.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "vicuna-7b_response": "Neuroligin-3 is a protein that is involved in the development and function of synapses, the connections between neurons. While neuroligin-3 has been shown to play a role in the development and maintenance of some types of brain tumors, it is not clear whether it promotes the growth of specific brain tumors.\nResearch has shown that neuroligin-3 is overexpressed in some types of brain tumors, including glioblastoma and ependymoma. However, the exact role that neuroligin-3 plays in the development and progression of these tumors is not well understood. Some studies have suggested that neuroligin-3 may promote the growth and survival of tumor cells, while other studies have found that it may have a more complex role in tumor development.\nIt is important to note that the role of neuroligin-3 in brain tumors is still an area of active research, and more studies are needed to fully understand its role in the development and progression of these tumors. If you have concerns about your own health or the health of a loved one, it is always best to consult with a medical professional.",
    "vicuna-7b_fact_raw": "1. Neuroligin-3 is involved in the development and function of synapses in the brain.\n2. Neuroligin-3 has been shown to play a role in the development and maintenance of some types of brain tumors.\n3. Neuroligin-3 is overexpressed in some types of brain tumors, including glioblastoma and ependymoma.\n4. Research on the role of neuroligin-3 in brain tumors is still ongoing and not fully understood.\n5. The exact role of neuroligin-3 in the development and progression of brain tumors like glioblastoma and ependymoma is not well understood.",
    "vicuna-7b_fact": [
      "Neuroligin-3 is involved in the development and function of synapses in the brain.",
      "Neuroligin-3 has been shown to play a role in the development and maintenance of some types of brain tumors.",
      "Neuroligin-3 is overexpressed in some types of brain tumors, including glioblastoma and ependymoma.",
      "Research on the role of neuroligin-3 in brain tumors is still ongoing and not fully understood.",
      "The exact role of neuroligin-3 in the development and progression of brain tumors like glioblastoma and ependymoma is not well understood."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "vicuna-7b_response": "Gas vesicles are small, gas-filled organelles found in some bacteria, such as cyanobacteria. They are typically about 100-200 nanometers in diameter, which is about the same size as a red blood cell. Gas vesicles are responsible for the buoyancy of cyanobacteria, allowing them to float on water or other liquid environments. They are also involved in photosynthesis, as they contain chlorophyll and other pigments that absorb light energy and convert it into chemical energy.",
    "vicuna-7b_fact_raw": "1. Gas vesicles are typically about 100-200 nanometers in diameter.\n2. Gas vesicles are found in some bacteria, including cyanobacteria.\n3. Gas vesicles contribute to the buoyancy of cyanobacteria.\n4. Gas vesicles are involved in photosynthesis.\n5. Gas vesicles contain chlorophyll and other pigments that absorb light energy.",
    "vicuna-7b_fact": [
      "Gas vesicles are typically about 100-200 nanometers in diameter.",
      "Gas vesicles are found in some bacteria, including cyanobacteria.",
      "Gas vesicles contribute to the buoyancy of cyanobacteria.",
      "Gas vesicles are involved in photosynthesis.",
      "Gas vesicles contain chlorophyll and other pigments that absorb light energy."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Gas vesicles are typically about 45-200 nanometers in diameter.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Gas vesicles are not directly involved in photosynthesis; they provide buoyancy to cyanobacteria, which can help position the bacteria in the water column to receive optimal light for photosynthesis.\n5. FALSE [correction]: Gas vesicles do not contain chlorophyll or other pigments; they are protein-bound structures that trap gas to regulate buoyancy.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "vicuna-7b_response": "BET (Bromodomain and Extra-terminal domain) proteins are a family of proteins that contain bromodomains and extra-terminal domains. Bromodomains are protein recognition modules that bind to acetylated lysine residues, while extra-terminal domains are involved in regulating the activity of bromodomains.\nThere are several subfamilies of BET proteins, including BET bromodomains, BET tandem bromodomains, BET-like proteins, and BET-specific proteins. BET bromodomains are the most well-known subfamily and are involved in regulating the transcription of genes involved in cell growth and differentiation.\nBET proteins play a role in a variety of cellular processes, including transcriptional regulation, chromatin remodeling, and protein-protein interactions. Dysregulation of BET proteins has been implicated in a number of diseases, including cancer, neurodegeneration, and immune disorders.\nSome examples of BET proteins include BRD4, BRDT, BAP1, BAP3, BAPL1, and BAPL2.",
    "vicuna-7b_fact_raw": "1. BET proteins contain bromodomains and extra-terminal domains.\n2. Bromodomains bind to acetylated lysine residues.\n3. Extra-terminal domains are involved in regulating the activity of bromodomains.\n4. Dysregulation of BET proteins has been implicated in diseases such as cancer, neurodegeneration, and immune disorders.\n5. Examples of BET proteins include BRD4, BRDT, BAP1, BAP3, BAPL1, and BAPL2.",
    "vicuna-7b_fact": [
      "BET proteins contain bromodomains and extra-terminal domains.",
      "Bromodomains bind to acetylated lysine residues.",
      "Extra-terminal domains are involved in regulating the activity of bromodomains.",
      "Dysregulation of BET proteins has been implicated in diseases such as cancer, neurodegeneration, and immune disorders.",
      "Examples of BET proteins include BRD4, BRDT, BAP1, BAP3, BAPL1, and BAPL2."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Extra-terminal domains do not regulate the activity of bromodomains. Instead, they are involved in protein-protein interactions and often serve as a different functional domain within BET proteins.\n4. TRUE\n5. FALSE [correction]: Examples of BET proteins include BRD2, BRD3, BRD4, and BRDT. BAP1, BAP3, BAPL1, and BAPL2 are not recognized as BET proteins.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "vicuna-7b_response": "One algorithm that has been developed for prediction of protein subcellular localization using deep learning is called DeepLoc.\nDeepLoc is a deep learning-based method that uses a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs) to predict the subcellular localization of proteins. The method was developed by researchers from the University of California, San Francisco (UCSF) and was published in the journal Nature Biotechnology in 2018.\nDeepLoc uses a large dataset of protein sequences and their corresponding subcellular localization information to train its deep learning models. The models are trained to predict the subcellular localization of proteins based on their amino acid sequences, using features such as the presence of certain amino acids, the presence of certain motifs, and the presence of certain patterns of amino acids.\nDeepLoc has been shown to be highly accurate in predicting the subcellular localization of proteins, with an accuracy of over 90%. This makes it a valuable tool for researchers who are studying the subcellular localization of proteins, and for those who are developing new drugs or other therapeutics that target specific subcellular locations.\nOverall, DeepLoc is a powerful algorithm that has the potential to revolutionize the field of protein subcellular localization prediction, and it is likely to be widely used in the future for a variety of applications.",
    "vicuna-7b_fact_raw": "1. DeepLoc is an algorithm developed for predicting protein subcellular localization using deep learning.\n2. DeepLoc employs a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs).\n3. The algorithm was developed by researchers from the University of California, San Francisco (UCSF).\n4. DeepLoc was published in the journal Nature Biotechnology in 2018.\n5. DeepLoc has demonstrated an accuracy of over 90% in predicting the subcellular localization of proteins.",
    "vicuna-7b_fact": [
      "DeepLoc is an algorithm developed for predicting protein subcellular localization using deep learning.",
      "DeepLoc employs a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs).",
      "The algorithm was developed by researchers from the University of California, San Francisco (UCSF).",
      "DeepLoc was published in the journal Nature Biotechnology in 2018.",
      "DeepLoc has demonstrated an accuracy of over 90% in predicting the subcellular localization of proteins."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: DeepLoc was developed by researchers from the Technical University of Denmark.\n4. FALSE [correction]: DeepLoc was published in the journal Bioinformatics in 2017.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "vicuna-7b_response": "MULTOVL is a cryptocurrency that is built on the MULTOS platform. MULTOS is a multi-application operating system for smart cards, which is designed to provide secure storage for a wide range of applications. MULTOVL is a cryptocurrency that runs on the MULTOS platform, allowing for the secure storage and transfer of MULTOVL tokens.\nMULTOVL is a decentralized cryptocurrency, meaning that it is not controlled by any central authority or institution. Instead, it is governed by a decentralized network of nodes that verify and record transactions on the blockchain. This makes MULTOVL resistant to censorship and manipulation, as there is no single point of control that can be seized or manipulated by a malicious actor.\nMULTOVL uses a proof-of-stake consensus algorithm, which is a type of consensus algorithm that is based on the amount of cryptocurrency that a user holds, rather than their ability to perform computational tasks. This makes MULTOVL more energy-efficient than proof-of-work algorithms, as it does not require the intense computational effort that proof-of-work algorithms do.\nMULTOVL tokens are issued on the MULTOS platform, and can be used to facilitate transactions on the MULTOVL blockchain. Users can send and receive MULTOVL tokens to one another, and can use them to purchase goods and services from merchants that accept MULTOVL.\nIn summary, MULTOVL is a cryptocurrency that is built on the MULTOS platform, allowing for the secure storage and transfer of MULTOVL tokens. It is a decentralized cryptocurrency that is governed by a decentralized network of nodes, and uses a proof-of-stake consensus algorithm to facilitate transactions on the blockchain.",
    "vicuna-7b_fact_raw": "1. MULTOVL is a cryptocurrency built on the MULTOS platform.\n2. MULTOS is a multi-application operating system for smart cards designed to provide secure storage for a wide range of applications.\n3. MULTOVL operates as a decentralized cryptocurrency without central authority control.\n4. MULTOVL uses a proof-of-stake consensus algorithm.\n5. MULTOVL tokens can be used to facilitate transactions and purchase goods and services from merchants that accept MULTOVL.",
    "vicuna-7b_fact": [
      "MULTOVL is a cryptocurrency built on the MULTOS platform.",
      "MULTOS is a multi-application operating system for smart cards designed to provide secure storage for a wide range of applications.",
      "MULTOVL operates as a decentralized cryptocurrency without central authority control.",
      "MULTOVL uses a proof-of-stake consensus algorithm.",
      "MULTOVL tokens can be used to facilitate transactions and purchase goods and services from merchants that accept MULTOVL."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nExplanation:\nWithout specific information about \"MULTOVL\" as a cryptocurrency, it's not possible to confirm or deny the statements related to it. The term \"MULTOVL\" does not correspond to any widely recognized cryptocurrency as of my knowledge cutoff date in 2023. Therefore, the statements regarding its characteristics, consensus algorithm, and usage are marked as UNKNOWN.\n\nHowever, the statement about MULTOS being a multi-application operating system for smart cards designed to provide secure storage for a wide range of applications is TRUE. MULTOS is a well-known secure operating system for smart cards and similar devices.",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "vicuna-7b_response": "GDF15, also known as growth differentiation factor 15, is a protein that has been studied as a potential biomarker for various conditions, including cancer, cardiovascular disease, and diabetes. Metformin is a medication that is commonly used to treat type 2 diabetes, and some studies have suggested that metformin may have anti-cancer effects by reducing the levels of GDF15 in the body.\nHowever, the relationship between metformin treatment and GDF15 levels is not straightforward, and more research is needed to fully understand the role of GDF15 as a biomarker for metformin treatment. Some studies have found that metformin treatment is associated with decreased levels of GDF15 in patients with type 2 diabetes, while others have found no association or have reported conflicting results.\nIt is also important to note that GDF15 is a complex and multifaceted protein with many potential functions, and its role in metformin treatment may depend on various factors, such as the individual's underlying health status, the dose and duration of metformin treatment, and other medications or lifestyle factors that may affect GDF15 levels.\nIn summary, while GDF15 has been studied as a potential biomarker for metformin treatment, the relationship between the two is not yet fully understood, and more research is needed to clarify their relationship.",
    "vicuna-7b_fact_raw": "1. GDF15 is known as growth differentiation factor 15.\n2. Metformin is commonly used to treat type 2 diabetes.\n3. Some studies suggest that metformin may reduce the levels of GDF15 in the body.\n4. Research on the relationship between metformin treatment and GDF15 levels has produced conflicting results.\n5. GDF15 is a protein that has been studied as a potential biomarker for various conditions, including cancer, cardiovascular disease, and diabetes.",
    "vicuna-7b_fact": [
      "GDF15 is known as growth differentiation factor 15.",
      "Metformin is commonly used to treat type 2 diabetes.",
      "Some studies suggest that metformin may reduce the levels of GDF15 in the body.",
      "Research on the relationship between metformin treatment and GDF15 levels has produced conflicting results.",
      "GDF15 is a protein that has been studied as a potential biomarker for various conditions, including cancer, cardiovascular disease, and diabetes."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Some studies suggest that metformin may increase the levels of GDF15 in the body.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "vicuna-7b_response": "Recursive splicing is a process in which a small RNA molecule called a microRNA (miRNA) binds to the messenger RNA (mRNA) of a target gene and then recruits other proteins to cleave the mRNA into smaller pieces, leading to the degradation of the target gene. Recursive splicing can occur in both short and long introns.\nIntrons are the non-coding regions of the genome that are present between the exons, which are the coding regions. Introns can be either short or long. Short introns are those that are less than 1 kilobase (kb) in length, while long introns are those that are greater than 1 kb in length.\nRecursive splicing can occur in both short and long introns. In the case of short introns, recursive splicing can be more common because the small size of these introns makes them more accessible to the miRNA molecule. This is because the small size of the intron means that the miRNA molecule can bind to the intron more easily, leading to a higher probability of recursive splicing occurring.\nIn contrast, long introns are less accessible to the miRNA molecule because they are larger and more difficult to bind to. This means that recursive splicing is less likely to occur in long introns. However, it is important to note that the likelihood of recursive splicing occurring in a particular intron depends on a variety of factors, including the specific miRNA molecule involved, the target gene, and the cellular context in which the process is occurring.\nIn summary, recursive splicing can occur in both short and long introns, but it is more common in short introns because the small size of these introns makes them more accessible to the miRNA molecule.",
    "vicuna-7b_fact_raw": "1. Recursive splicing is a process where a microRNA (miRNA) binds to the messenger RNA (mRNA) of a target gene and recruits proteins to cleave the mRNA.\n2. Introns are non-coding regions of the genome present between exons.\n3. Short introns are defined as being less than 1 kilobase (kb) in length.\n4. Long introns are defined as being greater than 1 kb in length.\n5. Recursive splicing is more common in short introns due to their small size making them more accessible to the miRNA molecule.",
    "vicuna-7b_fact": [
      "Recursive splicing is a process where a microRNA (miRNA) binds to the messenger RNA (mRNA) of a target gene and recruits proteins to cleave the mRNA.",
      "Introns are non-coding regions of the genome present between exons.",
      "Short introns are defined as being less than 1 kilobase (kb) in length.",
      "Long introns are defined as being greater than 1 kb in length.",
      "Recursive splicing is more common in short introns due to their small size making them more accessible to the miRNA molecule."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Recursive splicing is a process where a long intron is removed in multiple steps, with a lariat intermediate forming at a \"recursive\" splice site within the intron. It is not related to the action of microRNAs (miRNAs) binding to mRNA.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Recursive splicing is not related to the accessibility of introns to miRNA molecules. It is a mechanism that allows for the stepwise removal of long introns from pre-mRNA and is not necessarily more common in short introns.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "vicuna-7b_response": "The TALE-iD method is a technique used to identify and characterize specific regions of the genome, known as transposable elements (TEs). TE's are DNA sequences that can move and copy themselves within the genome, and they make up a significant portion of the human genome. The TALE-iD method uses a combination of computational and experimental approaches to identify and characterize specific TEs in the human genome.\nThe TALE-iD method is based on the use of transposase enzymes, which are proteins that can move TEs within the genome. By using transposase enzymes to move specific TEs in the genome, the TALE-iD method can identify the specific regions of the genome that are targeted by these enzymes. This information can then be used to identify and characterize specific TEs in the genome.\nThe TALE-iD method has a number of potential applications, including the identification of TEs that may be involved in disease, the study of the evolution of the human genome, and the development of new tools for genome engineering. Overall, the TALE-iD method is a powerful tool for understanding the role of TEs in the human genome and for studying the mechanisms that regulate their movement within the genome.",
    "vicuna-7b_fact_raw": "1. The TALE-iD method is used to identify and characterize specific regions of the genome known as transposable elements (TEs).\n2. Transposable elements are DNA sequences that can move and copy themselves within the genome.\n3. The TALE-iD method uses a combination of computational and experimental approaches.\n4. The method involves the use of transposase enzymes to move specific TEs within the genome.\n5. The TALE-iD method has potential applications in identifying TEs involved in disease, studying human genome evolution, and developing genome engineering tools.",
    "vicuna-7b_fact": [
      "The TALE-iD method is used to identify and characterize specific regions of the genome known as transposable elements (TEs).",
      "Transposable elements are DNA sequences that can move and copy themselves within the genome.",
      "The TALE-iD method uses a combination of computational and experimental approaches.",
      "The method involves the use of transposase enzymes to move specific TEs within the genome.",
      "The TALE-iD method has potential applications in identifying TEs involved in disease, studying human genome evolution, and developing genome engineering tools."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The TALE-iD method does not involve the use of transposase enzymes to move specific TEs within the genome. Instead, it is a method for identifying and characterizing TEs, which may involve other techniques such as DNA-binding proteins like TALEs (Transcription Activator-Like Effectors) to target specific DNA sequences.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "vicuna-7b_response": "There are several Lisp frameworks that have been developed for image processing, including:\n1. Common Lisp Image Processing (CLIP): CLIP is a library for image processing in Common Lisp. It provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n2. Lisp-based Image Processing System (LIPS): LIPS is a Lisp-based image processing system that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n3. Lisp-based Image Processing Library (LIP): LIP is a Lisp-based image processing library that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n4. Lisp-based Image Processing System (LIPS): LIPS is a Lisp-based image processing system that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\n5. Lisp-based Image Processing Library (LIP): LIP is a Lisp-based image processing library that provides a wide range of image processing functions, including filtering, thresholding, morphological operations, and more.\nIt's worth noting that these frameworks are not the only ones available, and there are many other libraries and frameworks that can be used for image processing in Lisp.",
    "vicuna-7b_fact_raw": "1. Common Lisp Image Processing (CLIP) is a library for image processing in Common Lisp.\n2. Lisp-based Image Processing System (LIPS) is a Lisp-based image processing system.\n3. Lisp-based Image Processing Library (LIP) is a Lisp-based image processing library.",
    "vicuna-7b_fact": [
      "Common Lisp Image Processing (CLIP) is a library for image processing in Common Lisp.",
      "Lisp-based Image Processing System (LIPS) is a Lisp-based image processing system.",
      "Lisp-based Image Processing Library (LIP) is a Lisp-based image processing library."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n\nWithout specific information about the existence or characteristics of \"Common Lisp Image Processing (CLIP),\" \"Lisp-based Image Processing System (LIPS),\" or \"Lisp-based Image Processing Library (LIP),\" it is not possible to determine the truthfulness of these statements. They could be real projects, hypothetical examples, or simply made-up names for the purpose of this task.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "vicuna-7b_response": "The genome of Saccharomyces cerevisiae, also known as baker's yeast, underwent an ancient whole genome duplication event approximately 100 million years ago, which resulted in the formation of a pair of homologous chromosomes. This event led to the duplication of approximately 90% of the yeast genes, with each duplicate gene being present on one of the two homologous chromosomes.\nThe duplication event had a profound impact on the evolution of the yeast genome, leading to the expansion of gene families, the emergence of new functions, and the adaptation of the organism to its environment. The duplicated genes have been subject to various forms of evolutionary change, including gene loss, functional divergence, and neo-functionalization, which has contributed to the complexity and diversity of the yeast genome.\nIn summary, approximately 90% of the genes in the genome of Saccharomyces cerevisiae are the result of an ancient whole genome duplication event.",
    "vicuna-7b_fact_raw": "1. The genome of Saccharomyces cerevisiae underwent an ancient whole genome duplication event approximately 100 million years ago.\n2. The whole genome duplication event resulted in the formation of a pair of homologous chromosomes in Saccharomyces cerevisiae.\n3. Approximately 90% of the genes in Saccharomyces cerevisiae are the result of the ancient whole genome duplication event.\n4. The duplication event led to the expansion of gene families in Saccharomyces cerevisiae.\n5. The duplicated genes in Saccharomyces cerevisiae have undergone evolutionary changes such as gene loss, functional divergence, and neo-functionalization.",
    "vicuna-7b_fact": [
      "The genome of Saccharomyces cerevisiae underwent an ancient whole genome duplication event approximately 100 million years ago.",
      "The whole genome duplication event resulted in the formation of a pair of homologous chromosomes in Saccharomyces cerevisiae.",
      "Approximately 90% of the genes in Saccharomyces cerevisiae are the result of the ancient whole genome duplication event.",
      "The duplication event led to the expansion of gene families in Saccharomyces cerevisiae.",
      "The duplicated genes in Saccharomyces cerevisiae have undergone evolutionary changes such as gene loss, functional divergence, and neo-functionalization."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The genome of Saccharomyces cerevisiae underwent an ancient whole genome duplication event approximately 100 to 150 million years ago, but the more precise estimates are closer to 100 million years.\n2. FALSE [correction]: The whole genome duplication event did not result in the formation of a pair of homologous chromosomes; instead, it doubled the entire genome, resulting in a temporary state of having two copies of each chromosome.\n3. FALSE [correction]: Approximately 90% of the genes in Saccharomyces cerevisiae are not the result of the ancient whole genome duplication event. While a significant number of genes have been retained from the duplication event, the majority of the genes in the yeast genome are not direct results of this event.\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor  (Esrrb)?",
    "vicuna-7b_response": "Estrogen-related receptor  (Esrrb) is a nuclear receptor that is primarily expressed in the brain and testis. It is a member of the nuclear receptor superfamily and belongs to the estrogen receptor (ER) family of transcription factors. Esrrb is known to play a role in the regulation of various biological processes, including cell proliferation, differentiation, and apoptosis.\nThere are several ligands that have been identified as binding to Esrrb, including estrogens, androgens, and various synthetic compounds. However, the specific complex that is bound by Esrrb is not well characterized.\nIt is important to note that Esrrb is a transcription factor, and its activity is regulated by the binding of its ligands to its DNA-binding domain. The binding of ligands to Esrrb can lead to the formation of a complex that includes the receptor, coactivators, and corepressors, which can then interact with DNA to regulate the expression of target genes.",
    "vicuna-7b_fact_raw": "1. Estrogen-related receptor  (Esrrb) is primarily expressed in the brain and testis.\n2. Esrrb is a member of the nuclear receptor superfamily.\n3. Esrrb belongs to the estrogen receptor (ER) family of transcription factors.\n4. Esrrb plays a role in the regulation of cell proliferation, differentiation, and apoptosis.\n5. The activity of Esrrb as a transcription factor is regulated by the binding of its ligands to its DNA-binding domain.",
    "vicuna-7b_fact": [
      "Estrogen-related receptor  (Esrrb) is primarily expressed in the brain and testis.",
      "Esrrb is a member of the nuclear receptor superfamily.",
      "Esrrb belongs to the estrogen receptor (ER) family of transcription factors.",
      "Esrrb plays a role in the regulation of cell proliferation, differentiation, and apoptosis.",
      "The activity of Esrrb as a transcription factor is regulated by the binding of its ligands to its DNA-binding domain."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Although Esrrb is named for its similarity to estrogen receptors, it is not a member of the estrogen receptor (ER) family of transcription factors. It is an orphan receptor that does not bind estrogens.\n4. TRUE\n5. FALSE [correction]: The activity of Esrrb as a transcription factor is typically not regulated by the binding of ligands to its DNA-binding domain, as it is considered an orphan receptor with no known endogenous ligands. Its activity is regulated by other means, such as post-translational modifications, protein-protein interactions, and promoter context.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "vicuna-7b_response": "ZCCHC17 is a protein that plays a role in the regulation of the cell cycle. Specifically, it is a member of the Zinc Finger CCCH Zinc Finger Proteins family, which are known to be involved in the regulation of various cellular processes, including cell cycle progression.\nThe exact function of ZCCHC17 in the cell cycle is not fully understood, but it is thought to play a role in the regulation of the G1 phase of the cell cycle. During this phase, cells undergo DNA replication and cell growth, and ZCCHC17 may be involved in the regulation of these processes.\nAdditionally, ZCCHC17 has been shown to interact with other proteins involved in the regulation of the cell cycle, such as CDK2 and CDK4, suggesting that it may play a role in the regulation of these proteins and their activity.\nOverall, while more research is needed to fully understand the role of ZCCHC17 in the cell cycle, it is clear that it plays a critical role in the regulation of this process and may be a promising target for the development of new cancer therapies.",
    "vicuna-7b_fact_raw": "1. ZCCHC17 is a protein that is involved in the regulation of the cell cycle.\n2. It is a member of the Zinc Finger CCCH Zinc Finger Proteins family.\n3. ZCCHC17 is thought to play a role in the regulation of the G1 phase of the cell cycle.\n4. ZCCHC17 has been shown to interact with other proteins involved in the regulation of the cell cycle, such as CDK2 and CDK4.\n5. ZCCHC17 may be a potential target for the development of new cancer therapies.",
    "vicuna-7b_fact": [
      "ZCCHC17 is a protein that is involved in the regulation of the cell cycle.",
      "It is a member of the Zinc Finger CCCH Zinc Finger Proteins family.",
      "ZCCHC17 is thought to play a role in the regulation of the G1 phase of the cell cycle.",
      "ZCCHC17 has been shown to interact with other proteins involved in the regulation of the cell cycle, such as CDK2 and CDK4.",
      "ZCCHC17 may be a potential target for the development of new cancer therapies."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements about ZCCHC17 are very specific and would require access to up-to-date scientific literature or databases to verify. Without the specific context or references, it is not possible to determine the accuracy of statements 1, 3, 4, and 5. However, statement 2 is true as ZCCHC17 is indeed a member of the Zinc Finger CCCH-type containing protein family.",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "vicuna-7b_response": "The nuclear pore basket is a complex structure in the nuclear envelope that regulates the movement of molecules between the nucleus and the cytoplasm. The proteins that form the nuclear pore basket in human cells include:\n1. FG-nucleoporin proteins: These proteins are the major components of the nuclear pore complex and are responsible for forming the structural framework of the pore.\n2. Transcription factors: These proteins play a role in regulating gene expression and can interact with RNA polymerase to initiate transcription.\n3. Nuclear transport receptors: These proteins are responsible for recognizing and transporting molecules across the nuclear pore.\n4. Adaptor proteins: These proteins help to coordinate the movement of molecules across the nuclear pore and can also play a role in regulating gene expression.\n5. Nuclear pore complex associated proteins: These proteins are involved in the regulation of nuclear pore complex function and can also play a role in the transport of molecules across the pore.\nIt's important to note that the composition of the nuclear pore basket can vary depending on the cell type and the stage of the cell cycle.",
    "vicuna-7b_fact_raw": "1. FG-nucleoporin proteins are major components of the nuclear pore complex in human cells.\n2. Transcription factors are proteins that can interact with RNA polymerase to initiate transcription in human cells.\n3. Nuclear transport receptors are proteins responsible for transporting molecules across the nuclear pore in human cells.\n4. Adaptor proteins coordinate the movement of molecules across the nuclear pore in human cells.\n5. Nuclear pore complex associated proteins are involved in the regulation of nuclear pore complex function in human cells.",
    "vicuna-7b_fact": [
      "FG-nucleoporin proteins are major components of the nuclear pore complex in human cells.",
      "Transcription factors are proteins that can interact with RNA polymerase to initiate transcription in human cells.",
      "Nuclear transport receptors are proteins responsible for transporting molecules across the nuclear pore in human cells.",
      "Adaptor proteins coordinate the movement of molecules across the nuclear pore in human cells.",
      "Nuclear pore complex associated proteins are involved in the regulation of nuclear pore complex function in human cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Transcription factors are proteins that bind to specific DNA sequences to control the flow (or transcription) of genetic information from DNA to mRNA.\n3. TRUE\n4. FALSE [correction]: Adaptor proteins typically facilitate interactions between different proteins, but in the context of the nuclear pore complex, it is the nuclear transport receptors (also known as karyopherins) that directly mediate the transport of molecules across the nuclear envelope.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "vicuna-7b_response": "Gepotidacin is a type of topoisomerase inhibitor called a \"topoisomerase I inhibitor.\" It works by binding to and inhibiting the activity of topoisomerase I, an enzyme that is involved in the replication of DNA. This can lead to the formation of DNA breaks and the accumulation of DNA damage, ultimately resulting in cell death. Gepotidacin is being studied as a potential treatment for various types of cancer.",
    "vicuna-7b_fact_raw": "1. Gepotidacin is a topoisomerase inhibitor.\n2. It is classified as a \"topoisomerase I inhibitor.\"\n3. Gepotidacin binds to and inhibits the activity of the enzyme topoisomerase I.\n4. The enzyme topoisomerase I is involved in the replication of DNA.\n5. Gepotidacin is being studied as a potential treatment for various types of cancer.",
    "vicuna-7b_fact": [
      "Gepotidacin is a topoisomerase inhibitor.",
      "It is classified as a \"topoisomerase I inhibitor.\"",
      "Gepotidacin binds to and inhibits the activity of the enzyme topoisomerase I.",
      "The enzyme topoisomerase I is involved in the replication of DNA.",
      "Gepotidacin is being studied as a potential treatment for various types of cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Gepotidacin is classified as a topoisomerase II inhibitor, specifically targeting bacterial type II topoisomerases, such as DNA gyrase and topoisomerase IV.\n3. FALSE [correction]: Gepotidacin binds to and inhibits the activity of bacterial type II topoisomerases, not topoisomerase I.\n4. TRUE (although the statement is true, it is important to note that topoisomerase I is involved in the replication of DNA in humans, while Gepotidacin targets bacterial topoisomerases)\n5. FALSE [correction]: Gepotidacin is being studied as a potential treatment for bacterial infections, not for various types of cancer.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "vicuna-7b_response": "SPW stands for \"Single Page Web\" and refers to a type of web application that is built using a single HTML page. This page contains all the necessary elements for the application, including the user interface, data storage, and logic.\nIn a SPW application, the user interface is typically built using a front-end framework such as React, Angular, or Vue.js. The front-end code is responsible for rendering the user interface and handling user interactions.\nThe data storage for a SPW application is typically provided by a back-end server, which can be built using a variety of technologies such as Node.js, Python, or Java. The back-end server can be hosted on a cloud platform such as AWS, Google Cloud, or Microsoft Azure.\nThe logic for a SPW application is typically implemented using a server-side programming language such as Node.js, Python, or Java. This code can be used to handle user authentication, data validation, and other business logic.\nOne of the main advantages of a SPW application is that it can provide a seamless user experience by loading all the necessary data and functionality on a single page. This can make it easier for users to navigate and interact with the application.\nHowever, a SPW application can also have some limitations. For example, it can be difficult to update or change the application's functionality without reloading the entire page. Additionally, a SPW application may not be suitable for applications that require complex user authentication or data validation.\nOverall, the choice of whether to use a SPW or a multi-page web application depends on the specific requirements of the application and the preferences of the development team.",
    "vicuna-7b_fact_raw": "1. SPW stands for \"Single Page Web.\"\n2. A Single Page Web application is built using a single HTML page that contains all necessary elements for the application.\n3. The user interface of a SPW application is typically built using front-end frameworks such as React, Angular, or Vue.js.\n4. The data storage for a SPW application is usually provided by a back-end server, which can be built using technologies like Node.js, Python, or Java.\n5. The logic of a SPW application is often implemented using server-side programming languages such as Node.js, Python, or Java.",
    "vicuna-7b_fact": [
      "SPW stands for \"Single Page Web.\"",
      "A Single Page Web application is built using a single HTML page that contains all necessary elements for the application.",
      "The user interface of a SPW application is typically built using front-end frameworks such as React, Angular, or Vue.js.",
      "The data storage for a SPW application is usually provided by a back-end server, which can be built using technologies like Node.js, Python, or Java.",
      "The logic of a SPW application is often implemented using server-side programming languages such as Node.js, Python, or Java."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: SPW stands for \"Single Page Web application\" or \"Single Page Application\" (SPA).\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The logic of a Single Page Application (SPA) is often implemented using client-side programming languages such as JavaScript, possibly in conjunction with frameworks like React, Angular, or Vue.js. Server-side programming languages like Node.js, Python, or Java are typically used for the back-end server logic.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "vicuna-7b_response": "STING (Stimulator of Interferon Genes) agonists are a class of drugs that activate the STING pathway, which plays a crucial role in the immune system's response to viral infections. STING agonists have been shown to have potent antiviral effects and have been studied for the treatment of various viral infections, including influenza, SARS-CoV-2 (the virus that causes COVID-19), and Ebola virus.\nSome examples of STING agonists include:\n1. MK-8628: This is a small molecule STING agonist that has been shown to be effective against a wide range of viruses, including influenza, SARS-CoV-2, and Ebola virus.\n2. GS-9620: This is another small molecule STING agonist that has been shown to be effective against SARS-CoV-2 in animal models.\n3. CX804: This is a STING agonist that has been shown to be effective against influenza in animal models.\n4. TLR7 agonists: TLR7 (Toll-like receptor 7) agonists, which include imiquimod and resiquimod, have been shown to activate the STING pathway and have antiviral effects.\nIt's important to note that while STING agonists show promise as antiviral drugs, they are still in the early stages of development and more research is needed to fully understand their safety and efficacy.",
    "vicuna-7b_fact_raw": "1. STING agonists are drugs that activate the STING pathway, which is involved in the immune response to viral infections.\n2. MK-8628 is a small molecule STING agonist that has been shown to be effective against influenza, SARS-CoV-2, and Ebola virus.\n3. GS-9620 is a small molecule STING agonist that has been shown to be effective against SARS-CoV-2 in animal models.\n4. CX804 is a STING agonist that has been shown to be effective against influenza in animal models.\n5. TLR7 agonists, such as imiquimod and resiquimod, can activate the STING pathway and have antiviral effects.",
    "vicuna-7b_fact": [
      "STING agonists are drugs that activate the STING pathway, which is involved in the immune response to viral infections.",
      "MK-8628 is a small molecule STING agonist that has been shown to be effective against influenza, SARS-CoV-2, and Ebola virus.",
      "GS-9620 is a small molecule STING agonist that has been shown to be effective against SARS-CoV-2 in animal models.",
      "CX804 is a STING agonist that has been shown to be effective against influenza in animal models.",
      "TLR7 agonists, such as imiquimod and resiquimod, can activate the STING pathway and have antiviral effects."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: TLR7 agonists, such as imiquimod and resiquimod, activate the TLR7 pathway, not the STING pathway, although both pathways are part of the immune response to viral infections.",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "vicuna-7b_response": "SLIC-CAGE is a method for analyzing and classifying the structure of proteins. It stands for \"Sequence Logistic Inference of Contacts and Geometry from Amino Acids and Energies\".\nThe SLIC-CAGE method uses a combination of sequence information and structural information to predict the contact and geometry information of a protein. It does this by first analyzing the amino acid sequence of the protein, and then using this information to predict the contact and geometry information.\nThe SLIC-CAGE method is based on the idea that the contact and geometry information of a protein is determined by the sequence of amino acids in the protein. This is because the sequence of amino acids in a protein determines the shape of the protein, and the shape of the protein determines the interactions between the protein and other molecules.\nThe SLIC-CAGE method is a powerful tool for analyzing and classifying the structure of proteins. It has been used to study the structure and function of a wide range of proteins, including enzymes, receptors, and transporters.\nOverall, SLIC-CAGE is a useful tool for understanding the structure and function of proteins, and it has many potential applications in fields such as biotechnology and medicine.",
    "vicuna-7b_fact_raw": "1. SLIC-CAGE is a method for analyzing and classifying the structure of proteins.\n2. SLIC-CAGE stands for \"Sequence Logistic Inference of Contacts and Geometry from Amino Acids and Energies\".\n3. The method uses a combination of sequence information and structural information to predict protein contact and geometry information.\n4. SLIC-CAGE is based on the idea that the sequence of amino acids in a protein determines its shape and interactions with other molecules.\n5. SLIC-CAGE has been used to study the structure and function of various proteins, including enzymes, receptors, and transporters.",
    "vicuna-7b_fact": [
      "SLIC-CAGE is a method for analyzing and classifying the structure of proteins.",
      "SLIC-CAGE stands for \"Sequence Logistic Inference of Contacts and Geometry from Amino Acids and Energies\".",
      "The method uses a combination of sequence information and structural information to predict protein contact and geometry information.",
      "SLIC-CAGE is based on the idea that the sequence of amino acids in a protein determines its shape and interactions with other molecules.",
      "SLIC-CAGE has been used to study the structure and function of various proteins, including enzymes, receptors, and transporters."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: SLIC-CAGE is not a known standard method for analyzing and classifying the structure of proteins. It seems to be a made-up acronym for the purpose of this task.\n2. FALSE [correction]: Since SLIC-CAGE is not a recognized method in protein analysis, the provided acronym \"Sequence Logistic Inference of Contacts and Geometry from Amino Acids and Energies\" is also not accurate.\n3. UNKNOWN: Without valid information on SLIC-CAGE, it's not possible to confirm the details of how it supposedly works.\n4. TRUE: The statement that the sequence of amino acids in a protein determines its shape and interactions with other molecules is a fundamental concept in biochemistry, known as the sequence-structure-function paradigm.\n5. UNKNOWN: Since SLIC-CAGE is not an established method, we cannot confirm its use in studying the structure and function of various proteins.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "vicuna-7b_response": "LEM-3, also known as Leucine-rich repeat-containing protein 3, is a protein that plays a role in various cellular processes. The specific roles of LEM-3 are not well understood, but it is thought to be involved in regulating cell growth and division, as well as in the development of certain diseases.\nOne of the functions of LEM-3 is to regulate the activity of the CDK2/cyclin A1 complex, which is involved in cell division. This complex is responsible for phosphorylating and activating the CDK2 kinase, which then phosphorylates and activates other proteins involved in cell division. LEM-3 has been shown to bind to the CDK2/cyclin A1 complex and to inhibit its activity, suggesting that it plays a role in regulating cell division.\nIn addition to its role in cell division, LEM-3 has also been implicated in the development of certain diseases. For example, it has been shown to be overexpressed in certain types of cancer, including breast cancer and ovarian cancer. This suggests that LEM-3 may play a role in the development and progression of these diseases.\nOverall, while the specific roles of LEM-3 are not well understood, it is clear that it plays a role in regulating cell growth and division, and may be involved in the development of certain diseases.",
    "vicuna-7b_fact_raw": "1. LEM-3 is thought to be involved in regulating cell growth and division.\n2. LEM-3 is known to regulate the activity of the CDK2/cyclin A1 complex, which is involved in cell division.\n3. The CDK2/cyclin A1 complex is responsible for phosphorylating and activating the CDK2 kinase.\n4. LEM-3 has been shown to bind to the CDK2/cyclin A1 complex and inhibit its activity.\n5. LEM-3 has been found to be overexpressed in certain types of cancer, including breast cancer and ovarian cancer.",
    "vicuna-7b_fact": [
      "LEM-3 is thought to be involved in regulating cell growth and division.",
      "LEM-3 is known to regulate the activity of the CDK2/cyclin A1 complex, which is involved in cell division.",
      "The CDK2/cyclin A1 complex is responsible for phosphorylating and activating the CDK2 kinase.",
      "LEM-3 has been shown to bind to the CDK2/cyclin A1 complex and inhibit its activity.",
      "LEM-3 has been found to be overexpressed in certain types of cancer, including breast cancer and ovarian cancer."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: The CDK2/cyclin A complex is responsible for phosphorylating and activating other proteins involved in cell cycle progression, not the CDK2 kinase itself. CDK2 is already a kinase and is activated when it forms a complex with cyclin A.\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements about LEM-3's specific interactions with the CDK2/cyclin A1 complex and its overexpression in certain types of cancer are highly specific and would require access to current scientific literature to verify. Without that information, we cannot determine the truthfulness of those statements.",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "vicuna-7b_response": "tmVar is a software package for managing and visualizing temporal data. It is developed by the Department of Genetics and Genomics at the University of Veterinary Medicine Vienna. Here is a list of the releases of tmVar:\n1. tmVar 1.0: This was the first release of tmVar, which was released in 2012. It was primarily designed for the analysis of RNA-seq data.\n2. tmVar 1.1: This release was released in 2013 and included several new features, including the ability to analyze ChIP-seq data and the ability to visualize the results of the analysis using interactive heatmaps.\n3. tmVar 1.2: This release was released in 2014 and included several new features, including the ability to analyze single-cell RNA-seq data and the ability to perform batch processing of large datasets.\n4. tmVar 1.3: This release was released in 2015 and included several new features, including the ability to perform differential expression analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n5. tmVar 1.4: This release was released in 2016 and included several new features, including the ability to perform functional enrichment analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n6. tmVar 1.5: This release was released in 2017 and included several new features, including the ability to perform clustering analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n7. tmVar 1.6: This release was released in 2018 and included several new features, including the ability to perform network analysis and the ability to visualize the results of the analysis using interactive heatmaps.\n8. tmVar 1.7: This release was released in 2019 and included several new features, including the ability to perform batch processing of large datasets and the ability to visualize the results of the analysis using interactive heatmaps.\n9. tmVar 1.8: This release was released in 2020 and included several new features, including the ability to perform batch processing of large datasets and the ability to visualize the results of the analysis using interactive heatmaps.\n10. tmVar 1.9:",
    "vicuna-7b_fact_raw": "1. tmVar is developed by the Department of Genetics and Genomics at the University of Veterinary Medicine Vienna.\n2. tmVar 1.0 was released in 2012 and was designed for the analysis of RNA-seq data.\n3. tmVar 1.1 was released in 2013 and included the ability to analyze ChIP-seq data.\n4. tmVar 1.2 was released in 2014 and introduced the ability to analyze single-cell RNA-seq data.\n5. tmVar 1.6 was released in 2018 and introduced the ability to perform network analysis.",
    "vicuna-7b_fact": [
      "tmVar is developed by the Department of Genetics and Genomics at the University of Veterinary Medicine Vienna.",
      "tmVar 1.0 was released in 2012 and was designed for the analysis of RNA-seq data.",
      "tmVar 1.1 was released in 2013 and included the ability to analyze ChIP-seq data.",
      "tmVar 1.2 was released in 2014 and introduced the ability to analyze single-cell RNA-seq data.",
      "tmVar 1.6 was released in 2018 and introduced the ability to perform network analysis."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements provided are very specific and pertain to the development and features of a tool called tmVar. Without access to specific and reliable information about tmVar and its version history, it is not possible to accurately verify these statements. Therefore, the truthfulness of these statements remains unknown.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "vicuna-7b_response": "There are several databases that contain information on somatic mutations in normal cells. Here are a few examples:\n1. The Cancer Genome Atlas (TCGA) database: This database contains comprehensive genomic data on a variety of cancer types, including information on somatic mutations.\n2. The International Cancer Genome Consortium (ICGC) database: This database contains genomic data on a variety of cancer types, including information on somatic mutations.\n3. The National Cancer Institute's (NCI) SEQUENOM database: This database contains information on somatic mutations in normal and cancer cells, including mutations in genes involved in DNA replication, repair, and cell cycle control.\n4. The European Bioinformatics Institute's (EBI) Somatic Mutation Database (SMDB): This database contains information on somatic mutations in normal and cancer cells, including mutations in genes involved in DNA replication, repair, and cell cycle control.\nThese are just a few examples of databases that contain information on somatic mutations in normal cells. There are many other databases available, and the specific database that is most relevant to a particular question will depend on the type of information being sought.",
    "vicuna-7b_fact_raw": "1. The Cancer Genome Atlas (TCGA) database contains comprehensive genomic data on a variety of cancer types, including information on somatic mutations.\n2. The International Cancer Genome Consortium (ICGC) database contains genomic data on a variety of cancer types, including information on somatic mutations.\n3. The National Cancer Institute's (NCI) SEQUENOM database contains information on somatic mutations in normal and cancer cells.\n4. The European Bioinformatics Institute's (EBI) Somatic Mutation Database (SMDB) contains information on somatic mutations in normal and cancer cells.",
    "vicuna-7b_fact": [
      "The Cancer Genome Atlas (TCGA) database contains comprehensive genomic data on a variety of cancer types, including information on somatic mutations.",
      "The International Cancer Genome Consortium (ICGC) database contains genomic data on a variety of cancer types, including information on somatic mutations.",
      "The National Cancer Institute's (NCI) SEQUENOM database contains information on somatic mutations in normal and cancer cells.",
      "The European Bioinformatics Institute's (EBI) Somatic Mutation Database (SMDB) contains information on somatic mutations in normal and cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The National Cancer Institute (NCI) does not have a database called SEQUENOM. NCI supports multiple cancer genomic data resources, but SEQUENOM is not one of them. One of the databases supported by NCI is the Genomic Data Commons (GDC).\n4. FALSE [correction]: The European Bioinformatics Institute (EBI) does not have a database specifically called the Somatic Mutation Database (SMDB). EBI provides access to a range of databases relevant to genomics, including the Catalogue of Somatic Mutations in Cancer (COSMIC), which contains information on somatic mutations in cancer.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "vicuna-7b_response": "Yes, there are several graph kernel libraries available implemented in Java. Some of the popular ones include:\n1. JUNG: JUNG is a Java library for working with graph data structures. It provides a set of classes for creating, manipulating, and analyzing graphs. JUNG is a popular choice for graph processing in Java.\n2. igraph: igraph is a C++ library for working with graphs. It provides a set of classes for creating, manipulating, and analyzing graphs. igraph also has a Java wrapper library called JAGL that allows Java developers to use igraph in their Java applications.\n3. GraphX: GraphX is a distributed graph processing library for Apache Spark. It provides a set of high-level abstractions for creating, manipulating, and analyzing graphs. GraphX is designed to work with large-scale graphs and can be used with Spark on Hadoop clusters.\n4. NetworkX: NetworkX is a Python library for working with graphs. It provides a set of classes for creating, manipulating, and analyzing graphs. NetworkX also has a Java wrapper library called JythonX that allows Java developers to use NetworkX in their Java applications.\nThese are just a few examples of the graph kernel libraries available implemented in Java. Each library has its own strengths and weaknesses, so it's important to evaluate them based on your specific requirements and use case.",
    "vicuna-7b_fact_raw": "1. JUNG is a Java library designed for working with graph data structures.\n2. igraph is a C++ library with a Java wrapper called JAGL.\n3. GraphX is a distributed graph processing library for Apache Spark.\n4. NetworkX is a Python library with a Java wrapper called JythonX.",
    "vicuna-7b_fact": [
      "JUNG is a Java library designed for working with graph data structures.",
      "igraph is a C++ library with a Java wrapper called JAGL.",
      "GraphX is a distributed graph processing library for Apache Spark.",
      "NetworkX is a Python library with a Java wrapper called JythonX."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: igraph is a C library with a C++ wrapper, and it has interfaces for R and Python, but there is no Java wrapper called JAGL.\n3. TRUE\n4. FALSE [correction]: NetworkX is a Python library for working with graphs, but there is no Java wrapper called JythonX. Jython is a Python implementation for the Java platform, but it is not a wrapper for NetworkX.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "vicuna-7b_response": "The SHERLOCKv2 platform integrates four key advances:\n1. **Deep Learning**: SHERLOCKv2 uses deep learning algorithms to analyze and interpret medical images, including CT scans, MRIs, and X-rays. These algorithms can detect and diagnose a wide range of medical conditions, including cancer, cardiovascular disease, and neurological disorders.\n2. **Computer Vision**: SHERLOCKv2 also uses computer vision techniques to analyze medical images and extract relevant information, such as the location and size of tumors or other abnormalities.\n3. **Natural Language Processing**: SHERLOCKv2 uses natural language processing (NLP) to enable physicians to interact with the platform using natural language, rather than having to navigate complex user interfaces. This makes it easier for physicians to access the platform's capabilities and get the information they need to make informed decisions.\n4. **Machine Learning**: SHERLOCKv2 uses machine learning algorithms to continually improve its accuracy and performance over time. As the platform processes more data and makes more accurate diagnoses, it can learn from its mistakes and improve its performance, leading to better outcomes for patients.\nOverall, the integration of these four advances into the SHERLOCKv2 platform enables physicians to access powerful medical imaging analysis capabilities that can help them make more accurate diagnoses and improve patient outcomes.",
    "vicuna-7b_fact_raw": "1. SHERLOCKv2 uses deep learning algorithms to analyze medical images such as CT scans, MRIs, and X-rays.\n2. The platform employs computer vision techniques to analyze medical images and extract information like the location and size of tumors.\n3. SHERLOCKv2 incorporates natural language processing to allow physicians to interact with the platform using natural language.\n4. Machine learning algorithms in SHERLOCKv2 are used to improve the platform's accuracy and performance over time.",
    "vicuna-7b_fact": [
      "SHERLOCKv2 uses deep learning algorithms to analyze medical images such as CT scans, MRIs, and X-rays.",
      "The platform employs computer vision techniques to analyze medical images and extract information like the location and size of tumors.",
      "SHERLOCKv2 incorporates natural language processing to allow physicians to interact with the platform using natural language.",
      "Machine learning algorithms in SHERLOCKv2 are used to improve the platform's accuracy and performance over time."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific information about a platform named \"SHERLOCKv2,\" it is not possible to verify the accuracy of these statements. They could be true if there is indeed a medical image analysis platform with this name that has these capabilities, but without additional context or data, the truthfulness of these statements cannot be determined.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "vicuna-7b_response": "The bartender algorithm is a simple algorithm used in artificial intelligence and machine learning to solve a variety of problems. It is called the \"bartender algorithm\" because it is often used to solve problems that involve finding the shortest path between two points in a graph.\nThe algorithm works by starting at a random point in the graph and then moving to the nearest unvisited point. It then moves to the nearest unvisited point from that point, and so on, until it reaches a goal state. The algorithm uses a priority queue to keep track of the most promising moves, and it also maintains a graph of the current state of the search.\nThe bartender algorithm is a greedy algorithm, which means that it makes the locally optimal choice at each step. This can make it very efficient for solving problems with a large number of possible solutions, as it is able to quickly converge on the optimal solution.\nThe bartender algorithm is often used in conjunction with other search algorithms, such as depth-first search and breadth-first search, to solve more complex problems. It is also used in a variety of other applications, such as scheduling and resource allocation.\nOverall, the bartender algorithm is a simple but powerful algorithm that is widely used in artificial intelligence and machine learning.",
    "vicuna-7b_fact_raw": "1. The bartender algorithm is used in artificial intelligence and machine learning.\n2. It is designed to find the shortest path between two points in a graph.\n3. The algorithm starts at a random point and moves to the nearest unvisited point until it reaches a goal state.\n4. A priority queue is used to keep track of the most promising moves in the bartender algorithm.\n5. The bartender algorithm is a greedy algorithm, making the locally optimal choice at each step.",
    "vicuna-7b_fact": [
      "The bartender algorithm is used in artificial intelligence and machine learning.",
      "It is designed to find the shortest path between two points in a graph.",
      "The algorithm starts at a random point and moves to the nearest unvisited point until it reaches a goal state.",
      "A priority queue is used to keep track of the most promising moves in the bartender algorithm.",
      "The bartender algorithm is a greedy algorithm, making the locally optimal choice at each step."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: There is no widely recognized algorithm in artificial intelligence and machine learning known as the \"bartender algorithm.\" It is possible that this is a misunderstanding or a fictional term not used in the field.\n2. UNKNOWN: Since the \"bartender algorithm\" is not a recognized term, it cannot be determined if it is designed to find the shortest path between two points in a graph.\n3. UNKNOWN: Without a clear definition of the \"bartender algorithm,\" it is not possible to confirm how it operates or if it starts at a random point.\n4. UNKNOWN: The use of a priority queue is a detail that would depend on the specific algorithm being described. Since the \"bartender algorithm\" is not recognized, the use of a priority queue cannot be confirmed.\n5. UNKNOWN: Whether the \"bartender algorithm\" is a greedy algorithm cannot be determined because the algorithm itself is not recognized or defined in the context provided.",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "vicuna-7b_response": "There are several web-based pedigree editors available, including:\n1. Geni: Geni is a popular web-based genealogy and family tree application that allows users to create and manage their family trees online. It offers a range of features, including collaboration tools, photo sharing, and integration with other genealogy websites.\n2. WeRelate: WeRelate is a free, open-source genealogy website that allows users to create and share family trees. It offers a range of features, including collaboration tools, research tools, and integration with other genealogy websites.\n3. Ancestry: Ancestry is a paid genealogy website that offers a range of tools for researching and managing family trees. It allows users to create and share family trees, collaborate with other users, and access a range of genealogy records and resources.\n4. MyHeritage: MyHeritage is a paid genealogy website that offers a range of tools for researching and managing family trees. It allows users to create and share family trees, collaborate with other users, and access a range of genealogy records and resources.\n5. FamilySearch: FamilySearch is a free genealogy website that offers a range of tools for researching and managing family trees. It allows users to create and share family trees, collaborate with other users, and access a range of genealogy records and resources.\nThese are just a few examples of the many web-based pedigree editors available. It's worth noting that some of these tools may offer different features and pricing plans, so it's important to research and compare the options to find the one that best meets your needs.",
    "vicuna-7b_fact_raw": "1. Geni is a web-based genealogy and family tree application that allows users to create and manage their family trees online.\n2. WeRelate is a free, open-source genealogy website that enables users to create and share family trees.\n3. Ancestry is a paid genealogy website that provides tools for researching and managing family trees, as well as access to genealogy records and resources.\n4. MyHeritage is a paid genealogy website that offers tools for creating and sharing family trees and accessing genealogy records and resources.\n5. FamilySearch is a free genealogy website that provides tools for creating and sharing family trees and accessing genealogy records and resources.",
    "vicuna-7b_fact": [
      "Geni is a web-based genealogy and family tree application that allows users to create and manage their family trees online.",
      "WeRelate is a free, open-source genealogy website that enables users to create and share family trees.",
      "Ancestry is a paid genealogy website that provides tools for researching and managing family trees, as well as access to genealogy records and resources.",
      "MyHeritage is a paid genealogy website that offers tools for creating and sharing family trees and accessing genealogy records and resources.",
      "FamilySearch is a free genealogy website that provides tools for creating and sharing family trees and accessing genealogy records and resources."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "vicuna-7b_response": "There are several curated databases that exist for spider venom toxins. Here are a few examples:\n1. SpiderTox: SpiderTox is a database of spider venom toxins that was developed by researchers at the University of Melbourne. It contains information on the toxins found in over 50 species of spiders, including details on their structure, function, and effects on human cells.\n2. SpiderVenomDB: SpiderVenomDB is a database of spider venom toxins that was developed by researchers at the University of California, San Diego. It contains information on the toxins found in over 20 species of spiders, including details on their structure, function, and effects on human cells.\n3. Spider Venom Database: The Spider Venom Database is a database of spider venom toxins that was developed by researchers at the University of Melbourne. It contains information on the toxins found in over 50 species of spiders, including details on their structure, function, and effects on human cells.\n4. Spider Venom Toxins Database: The Spider Venom Toxins Database is a database of spider venom toxins that was developed by researchers at the University of California, Los Angeles. It contains information on the toxins found in over 20 species of spiders, including details on their structure, function, and effects on human cells.\nThese databases are valuable resources for researchers studying spider venom toxins, as they provide detailed information on the toxins and their effects on human cells. They can also be useful for identifying potential therapeutic targets for treating spider venom-induced toxicity.",
    "vicuna-7b_fact_raw": "1. SpiderTox is a database developed by researchers at the University of Melbourne containing information on spider venom toxins from over 50 species of spiders.\n2. SpiderVenomDB is a database developed by researchers at the University of California, San Diego with information on spider venom toxins from over 20 species of spiders.\n3. The Spider Venom Database is a resource developed by researchers at the University of Melbourne with details on spider venom toxins from over 50 species of spiders.\n4. The Spider Venom Toxins Database is created by researchers at the University of California, Los Angeles and includes information on toxins from over 20 species of spiders.",
    "vicuna-7b_fact": [
      "SpiderTox is a database developed by researchers at the University of Melbourne containing information on spider venom toxins from over 50 species of spiders.",
      "SpiderVenomDB is a database developed by researchers at the University of California, San Diego with information on spider venom toxins from over 20 species of spiders.",
      "The Spider Venom Database is a resource developed by researchers at the University of Melbourne with details on spider venom toxins from over 50 species of spiders.",
      "The Spider Venom Toxins Database is created by researchers at the University of California, Los Angeles and includes information on toxins from over 20 species of spiders."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific information about the databases mentioned and their creators, it is not possible to verify the accuracy of these statements. The names of the databases and the details provided could be hypothetical or real, but without additional context or access to current databases and their origins, the truthfulness of these statements cannot be determined.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "vicuna-7b_response": "Axitinib is a targeted therapy drug that is used to treat advanced renal cell carcinoma and advanced melanoma. It is not approved for the treatment of pancreatic cancer.\nThere have been some studies that have looked at the use of axitinib in combination with other drugs in the treatment of pancreatic cancer, but the results have been mixed and more research is needed to determine its effectiveness in this setting.\nIt's important to note that the prognosis for pancreatic cancer is generally poor, and the survival rate for this disease is low. The treatment options for pancreatic cancer are limited, and the effectiveness of any given treatment can vary depending on the individual patient and the stage of the disease.\nIf you have been diagnosed with pancreatic cancer and are considering treatment with axitinib or any other drug, it is important to speak with your healthcare provider about the potential benefits and risks of the treatment, as well as any clinical trials that may be available to you.",
    "vicuna-7b_fact_raw": "1. Axitinib is used to treat advanced renal cell carcinoma and advanced melanoma.\n2. Axitinib is not approved for the treatment of pancreatic cancer.\n3. Studies have been conducted on the use of axitinib in combination with other drugs for treating pancreatic cancer, but results are mixed.\n4. The prognosis for pancreatic cancer is generally poor.\n5. The survival rate for pancreatic cancer is low.",
    "vicuna-7b_fact": [
      "Axitinib is used to treat advanced renal cell carcinoma and advanced melanoma.",
      "Axitinib is not approved for the treatment of pancreatic cancer.",
      "Studies have been conducted on the use of axitinib in combination with other drugs for treating pancreatic cancer, but results are mixed.",
      "The prognosis for pancreatic cancer is generally poor.",
      "The survival rate for pancreatic cancer is low."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Axitinib is used to treat advanced renal cell carcinoma, but it is not approved for the treatment of advanced melanoma.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "vicuna-7b_response": "MLP (Mechano Growth Factor-Induced Protein) is a protein that plays a role in regulating F-actin dynamics, which are the dynamics of the actin cytoskeleton. MLP regulates F-actin dynamics through its interaction with the Arp2/3 complex, which is a key regulator of actin polymerization.\nThe Arp2/3 complex is a complex of proteins that catalyzes the formation of branched actin filaments, which are essential for the dynamic reorganization of the actin cytoskeleton. MLP binds to the Arp2/3 complex and inhibits its activity, thereby regulating the formation of branched actin filaments and the dynamic reorganization of the actin cytoskeleton.\nIn this way, MLP regulates F-actin dynamics through its interaction with the Arp2/3 complex, which is a key regulator of actin polymerization. This interaction is an important mechanism by which MLP regulates the dynamic reorganization of the actin cytoskeleton and contributes to its role in cellular processes such as cell growth, migration, and differentiation.",
    "vicuna-7b_fact_raw": "1. MLP (Mechano Growth Factor-Induced Protein) regulates F-actin dynamics.\n2. MLP interacts with the Arp2/3 complex to regulate F-actin dynamics.\n3. The Arp2/3 complex is a key regulator of actin polymerization.\n4. MLP binds to the Arp2/3 complex and inhibits its activity.\n5. The interaction between MLP and the Arp2/3 complex contributes to the dynamic reorganization of the actin cytoskeleton.",
    "vicuna-7b_fact": [
      "MLP (Mechano Growth Factor-Induced Protein) regulates F-actin dynamics.",
      "MLP interacts with the Arp2/3 complex to regulate F-actin dynamics.",
      "The Arp2/3 complex is a key regulator of actin polymerization.",
      "MLP binds to the Arp2/3 complex and inhibits its activity.",
      "The interaction between MLP and the Arp2/3 complex contributes to the dynamic reorganization of the actin cytoskeleton."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements regarding MLP (Mechano Growth Factor-Induced Protein) and its specific interactions with the Arp2/3 complex are highly specialized and would require specific scientific knowledge or literature to confirm. Without the context of the passage or access to relevant scientific research, it is not possible to accurately determine the truthfulness of statements 1, 2, 4, and 5. However, statement 3 is a well-established fact in cell biology, as the Arp2/3 complex is indeed a key regulator of actin polymerization.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "vicuna-7b_response": "There are 51 pseudokinases in the human kinome.",
    "vicuna-7b_fact_raw": "1. There are 51 pseudokinases in the human kinome.",
    "vicuna-7b_fact": [
      "There are 51 pseudokinases in the human kinome."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n\nThe statement regarding the number of pseudokinases in the human kinome is specific and would require current and precise scientific data to verify. The number of pseudokinases identified can change as new research is published, and without access to the latest scientific literature or databases, it is not possible to confirm the accuracy of this statement as of my knowledge cutoff date in 2023.",
    "vicuna-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "vicuna-7b_response": "ApoE mimetics are molecules that mimic the structure and function of the apoE protein, which is a major protein component of low-density lipoprotein (LDL) in the blood. ApoE mimetics have been studied as potential therapeutic agents for the treatment of various diseases, including Alzheimer's disease, atherosclerosis, and other conditions related to lipid metabolism. Here are three examples of apoE mimetics:\n1. Apolipoprotein E (apoE) mimetic peptides: These are short peptides that mimic the structure of apoE protein and have been shown to have beneficial effects on lipid metabolism and brain function. For example, a study published in the journal Nature Medicine in 2012 found that a specific apoE mimetic peptide called PPMI-111 reduced the accumulation of beta-amyloid plaques in the brains of Alzheimer's disease mice.\n2. Apolipoprotein E (apoE) mimetic small molecules: These are small molecules that mimic the structure of apoE protein and have been shown to have beneficial effects on lipid metabolism and brain function. For example, a study published in the journal Nature in 2018 found that a specific apoE mimetic small molecule called CNP (cyanopeptide) improved memory and learning in mice with Alzheimer's disease.\n3. Apolipoprotein E (apoE) mimetic nanoparticles: These are nanoparticles that mimic the structure of apoE protein and have been shown to have beneficial effects on lipid metabolism and brain function. For example, a study published in the journal ACS Nano in 2019 found that a specific apoE mimetic nanoparticle called NP-205 reduced the accumulation of beta-amyloid plaques in the brains of Alzheimer's disease mice.",
    "vicuna-7b_fact_raw": "1. Apolipoprotein E (apoE) mimetic peptides are short peptides designed to mimic the structure of apoE protein.\n2. A study published in Nature Medicine in 2012 reported that an apoE mimetic peptide called PPMI-111 reduced beta-amyloid plaque accumulation in Alzheimer's disease mice.\n3. Apolipoprotein E (apoE) mimetic small molecules are designed to mimic the structure of apoE protein.\n4. A study published in Nature in 2018 found that an apoE mimetic small molecule called CNP improved memory and learning in mice with Alzheimer's disease.\n5. A study published in ACS Nano in 2019 reported that an apoE mimetic nanoparticle called NP-205 reduced beta-amyloid plaque accumulation in the brains of Alzheimer's disease mice.",
    "vicuna-7b_fact": [
      "Apolipoprotein E (apoE) mimetic peptides are short peptides designed to mimic the structure of apoE protein.",
      "A study published in Nature Medicine in 2012 reported that an apoE mimetic peptide called PPMI-111 reduced beta-amyloid plaque accumulation in Alzheimer's disease mice.",
      "Apolipoprotein E (apoE) mimetic small molecules are designed to mimic the structure of apoE protein.",
      "A study published in Nature in 2018 found that an apoE mimetic small molecule called CNP improved memory and learning in mice with Alzheimer's disease.",
      "A study published in ACS Nano in 2019 reported that an apoE mimetic nanoparticle called NP-205 reduced beta-amyloid plaque accumulation in the brains of Alzheimer's disease mice."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements about specific studies and their findings (statements 2, 4, and 5) cannot be verified without access to the actual publications or additional context. Therefore, the truthfulness of these statements remains unknown.",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "vicuna-7b_response": "SAMHD1 is an enzyme that plays a critical role in controlling the replication of HIV-1 in human cells. There are sex differences in SAMHD1 activity that have been observed in various studies.\nIn general, SAMHD1 activity is higher in males than in females. This is due to the fact that males have a higher expression of SAMHD1 in their cells, particularly in the testes and prostate gland. In contrast, SAMHD1 expression is lower in female reproductive tissues and in the brain.\nStudies have also shown that SAMHD1 activity is lower in immune cells of females compared to males. This is thought to be due to the fact that females have a higher proportion of immune cells that are resistant to HIV-1 infection, such as CD4+ T cells and macrophages.\nIt is important to note that the sex differences in SAMHD1 activity are not absolute and can vary depending on the cell type and the context in which SAMHD1 is being studied. Additionally, the role of SAMHD1 in HIV-1 replication is complex and influenced by a variety of factors, including the viral strain, the presence of other antiviral drugs, and the host genetics.\nOverall, the sex differences in SAMHD1 activity are an area of active research, and further studies are needed to fully understand the role of SAMHD1 in HIV-1 replication and the mechanisms underlying the sex differences in SAMHD1 activity.",
    "vicuna-7b_fact_raw": "1. SAMHD1 is an enzyme that plays a critical role in controlling the replication of HIV-1 in human cells.\n2. SAMHD1 activity is generally higher in males than in females.\n3. Males have a higher expression of SAMHD1 in their cells, particularly in the testes and prostate gland.\n4. SAMHD1 expression is lower in female reproductive tissues and in the brain.\n5. SAMHD1 activity is lower in immune cells of females compared to males.",
    "vicuna-7b_fact": [
      "SAMHD1 is an enzyme that plays a critical role in controlling the replication of HIV-1 in human cells.",
      "SAMHD1 activity is generally higher in males than in females.",
      "Males have a higher expression of SAMHD1 in their cells, particularly in the testes and prostate gland.",
      "SAMHD1 expression is lower in female reproductive tissues and in the brain.",
      "SAMHD1 activity is lower in immune cells of females compared to males."
    ],
    "vicuna-7b_judge_raw": "1. TRUE: SAMHD1 is indeed an enzyme that plays a critical role in controlling the replication of HIV-1 in human cells by hydrolyzing deoxynucleoside triphosphates (dNTPs), thus limiting the building blocks needed for the synthesis of viral DNA.\n2. FALSE [correction]: There is no consistent evidence to suggest that SAMHD1 activity is generally higher in males than in females. SAMHD1 activity can vary among individuals, but this variation is not typically characterized by gender.\n3. UNKNOWN: The expression of SAMHD1 can vary in different tissues, but there is no widely accepted evidence that specifically indicates higher expression of SAMHD1 in male reproductive tissues such as the testes and prostate gland.\n4. UNKNOWN: There is limited information regarding the comparative levels of SAMHD1 expression in female reproductive tissues and the brain, and such differences would not typically be generalized without specific studies to support the claim.\n5. UNKNOWN: There is no general consensus or clear evidence to suggest that SAMHD1 activity is lower in immune cells of females compared to males. SAMHD1 activity can be influenced by various factors, but gender-based differences in immune cells are not well-established in this context.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "vicuna-7b_response": "RUNX2 is a transcription factor that plays a crucial role in the development and differentiation of many cell types, including astrocytes. While there is some evidence to suggest that RUNX2 may have a role in regulating astrocyte differentiation, the exact nature of this relationship is still not fully understood.\nStudies have shown that RUNX2 is expressed in astrocytes during development and in adult brains, and that it may be involved in the regulation of genes that are important for astrocyte function. For example, one study found that RUNX2 was required for the differentiation of astrocytes from neural stem cells in the mouse brain, and that it may play a role in the regulation of genes involved in the production of neurotransmitters and the maintenance of synaptic connections.\nHowever, other studies have suggested that RUNX2 may have a more complex role in astrocyte differentiation. For example, one study found that overexpression of RUNX2 in astrocytes in culture led to an increase in cell proliferation and a decrease in differentiation, suggesting that high levels of RUNX2 may inhibit astrocyte differentiation.\nOverall, while there is some evidence to suggest that RUNX2 may play a role in regulating astrocyte differentiation, the exact nature of this relationship is still not fully understood. Further research is needed to fully understand the role of RUNX2 in astrocyte development and differentiation.",
    "vicuna-7b_fact_raw": "1. RUNX2 is a transcription factor involved in the development and differentiation of many cell types, including astrocytes.\n2. RUNX2 is expressed in astrocytes during development and in adult brains.\n3. A study indicated that RUNX2 is required for the differentiation of astrocytes from neural stem cells in the mouse brain.\n4. The same study suggested that RUNX2 may be involved in the regulation of genes important for astrocyte function, such as those involved in neurotransmitter production and synaptic maintenance.\n5. Another study found that overexpression of RUNX2 in astrocytes led to increased cell proliferation and decreased differentiation.",
    "vicuna-7b_fact": [
      "RUNX2 is a transcription factor involved in the development and differentiation of many cell types, including astrocytes.",
      "RUNX2 is expressed in astrocytes during development and in adult brains.",
      "A study indicated that RUNX2 is required for the differentiation of astrocytes from neural stem cells in the mouse brain.",
      "The same study suggested that RUNX2 may be involved in the regulation of genes important for astrocyte function, such as those involved in neurotransmitter production and synaptic maintenance.",
      "Another study found that overexpression of RUNX2 in astrocytes led to increased cell proliferation and decreased differentiation."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: RUNX2 is a transcription factor involved in the development and differentiation of osteoblasts, which are bone-forming cells, not astrocytes.\n2. FALSE [correction]: Since RUNX2 is primarily involved with osteoblasts, it is not typically expressed in astrocytes during development or in adult brains.\n3. FALSE [correction]: RUNX2 is not required for the differentiation of astrocytes from neural stem cells in the mouse brain; it is involved in bone development and osteoblast differentiation.\n4. UNKNOWN: Without specific details from the study, it is unclear whether RUNX2 is involved in the regulation of genes important for astrocyte function. This statement would generally be considered false given the primary role of RUNX2 in osteoblasts, but without the context of the study, a definitive correction cannot be provided.\n5. UNKNOWN: Similarly, without specific details from the study, it is unclear whether overexpression of RUNX2 in astrocytes would lead to increased cell proliferation and decreased differentiation. This statement is also generally inconsistent with the known function of RUNX2 in osteoblasts, but without the context of the study, a definitive correction cannot be provided.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "vicuna-7b_response": "The Cobb-Stainsby excision arthroplasty is a surgical procedure that is typically performed on the knee joint. It is used to treat osteochondritis dissecans, a condition in which a piece of cartilage and bone in the joint becomes detached.\nThe Cobb-Stainsby excision arthroplasty involves making an incision over the affected joint and removing the damaged cartilage and bone. The joint is then stabilized using a graft of healthy cartilage and bone, or a metal or plastic implant.\nThe procedure is typically performed on an outpatient basis, which means that the patient can go home on the same day as the surgery. The recovery time for the Cobb-Stainsby excision arthroplasty can vary depending on the specifics of the procedure and the patient's overall health, but most people are able to resume normal activities within a few weeks to a few months.",
    "vicuna-7b_fact_raw": "1. The Cobb-Stainsby excision arthroplasty is a surgical procedure performed on the knee joint.\n2. It is used to treat osteochondritis dissecans, a condition where a piece of cartilage and bone becomes detached in the joint.\n3. The procedure involves removing the damaged cartilage and bone from the joint.\n4. The joint may be stabilized using a graft of healthy cartilage and bone, or a metal or plastic implant after the removal of damaged parts.\n5. The Cobb-Stainsby excision arthroplasty is typically performed on an outpatient basis.",
    "vicuna-7b_fact": [
      "The Cobb-Stainsby excision arthroplasty is a surgical procedure performed on the knee joint.",
      "It is used to treat osteochondritis dissecans, a condition where a piece of cartilage and bone becomes detached in the joint.",
      "The procedure involves removing the damaged cartilage and bone from the joint.",
      "The joint may be stabilized using a graft of healthy cartilage and bone, or a metal or plastic implant after the removal of damaged parts.",
      "The Cobb-Stainsby excision arthroplasty is typically performed on an outpatient basis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Cobb-Stainsby excision arthroplasty is a surgical procedure performed on the hip joint, not the knee joint.\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "vicuna-7b_response": "Yes, GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).\nEMT is a crucial process in embryonic development, tissue repair, and cancer progression. It involves the loss of epithelial cell polarity and the acquisition of a mesenchymal phenotype, characterized by the expression of mesenchymal markers and the ability to migrate and proliferate in a three-dimensional environment.\nGRHL2 is a transcription factor that plays a crucial role in regulating the expression of genes involved in cell-cell adhesion, cell polarity, and the epithelial-to-mesenchymal transition (EMT). Over-expression of GRHL2 has been shown to disrupt cell-cell adhesion and promote EMT in various cell types, including epithelial cells.\nIn addition, GRHL2 has been shown to regulate the expression of genes involved in the mesenchymal phenotype, such as N-cadherin and vimentin, and to promote the migration and invasion of cancer cells.\nTherefore, it is likely that over-expression of GRHL2 would lead to EMT in epithelial cells.",
    "vicuna-7b_fact_raw": "1. GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).\n2. EMT is involved in embryonic development, tissue repair, and cancer progression.\n3. GRHL2 is a transcription factor that regulates the expression of genes involved in cell-cell adhesion, cell polarity, and EMT.\n4. Over-expression of GRHL2 disrupts cell-cell adhesion and promotes EMT in various cell types.\n5. GRHL2 regulates the expression of mesenchymal markers such as N-cadherin and vimentin and promotes the migration and invasion of cancer cells.",
    "vicuna-7b_fact": [
      "GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).",
      "EMT is involved in embryonic development, tissue repair, and cancer progression.",
      "GRHL2 is a transcription factor that regulates the expression of genes involved in cell-cell adhesion, cell polarity, and EMT.",
      "Over-expression of GRHL2 disrupts cell-cell adhesion and promotes EMT in various cell types.",
      "GRHL2 regulates the expression of mesenchymal markers such as N-cadherin and vimentin and promotes the migration and invasion of cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: GRHL2 over-expression has been shown to suppress epithelial-to-mesenchymal transition (EMT).\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Over-expression of GRHL2 typically enhances cell-cell adhesion and suppresses EMT in various cell types.\n5. FALSE [correction]: GRHL2 is generally associated with the suppression of mesenchymal markers such as N-cadherin and vimentin and inhibits the migration and invasion of cancer cells.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "vicuna-7b_response": "T-UCRs, or Tumor-Associated Antigens, are proteins or carbohydrates that are expressed on the surface of cancer cells and can be recognized by the immune system. Some T-UCRs that have been implicated in lung cancer include:\n* TAG-72: A protein that is expressed in many types of cancer, including lung cancer.\n* MUC1: A mucin protein that is expressed in many epithelial tissues, including the lungs, and has been found to be overexpressed in some lung cancer cells.\n* CEA: A carcinoembryonic antigen that is expressed in many types of cancer, including lung cancer.\n* RNASEL: An RNA-editing enzyme that has been found to be overexpressed in some lung cancer cells and may play a role in the development of the disease.\nIt's important to note that these are just a few examples of T-UCRs that have been implicated in lung cancer, and there are many other T-UCRs that have been studied in this context. Additionally, the role of T-UCRs in lung cancer is an active area of research, and new T-UCRs may be identified in the future.",
    "vicuna-7b_fact_raw": "1. TAG-72 is a protein expressed in many types of cancer, including lung cancer.\n2. MUC1 is a mucin protein expressed in epithelial tissues and overexpressed in some lung cancer cells.\n3. CEA, or carcinoembryonic antigen, is expressed in many types of cancer, including lung cancer.\n4. RNASEL is an RNA-editing enzyme overexpressed in some lung cancer cells.\n5. The role of T-UCRs in lung cancer is an active area of research.",
    "vicuna-7b_fact": [
      "TAG-72 is a protein expressed in many types of cancer, including lung cancer.",
      "MUC1 is a mucin protein expressed in epithelial tissues and overexpressed in some lung cancer cells.",
      "CEA, or carcinoembryonic antigen, is expressed in many types of cancer, including lung cancer.",
      "RNASEL is an RNA-editing enzyme overexpressed in some lung cancer cells.",
      "The role of T-UCRs in lung cancer is an active area of research."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: RNASEL is an enzyme involved in RNA degradation and is not typically known for being overexpressed in lung cancer cells. It is more commonly associated with antiviral defense and has been studied in the context of prostate cancer.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "vicuna-7b_response": "GPR151 is a G protein-coupled receptor that has been identified as an orphan receptor, meaning that it has not been shown to bind to any known ligands. However, recent studies have suggested that GPR151 may play a role in the regulation of metabolic processes, including glucose and lipid metabolism.\nOne study published in the journal Molecular Endocrinology in 2012 found that GPR151 is expressed in various tissues, including the liver, adipose tissue, and skeletal muscle, and that it is involved in the regulation of glucose and lipid metabolism. The study also found that GPR151 is activated by a variety of compounds, including fatty acids and bile acids, which suggests that it may play a role in the regulation of lipid metabolism.\nAnother study published in the journal Diabetes in 2014 found that GPR151 is expressed in pancreatic beta cells and that it is involved in the regulation of insulin secretion. The study found that activation of GPR151 by fatty acids increased insulin secretion in pancreatic beta cells, suggesting that it may play a role in the regulation of glucose metabolism.\nOverall, while more research is needed to fully understand the function of GPR151, recent studies have suggested that it may play a role in the regulation of metabolic processes, including glucose and lipid metabolism.",
    "vicuna-7b_fact_raw": "1. GPR151 is a G protein-coupled receptor identified as an orphan receptor.\n2. GPR151 has been suggested to play a role in the regulation of metabolic processes, including glucose and lipid metabolism.\n3. A study published in Molecular Endocrinology in 2012 reported that GPR151 is expressed in the liver, adipose tissue, and skeletal muscle.\n4. The same study indicated that GPR151 is activated by compounds such as fatty acids and bile acids.\n5. Research published in the journal Diabetes in 2014 found that GPR151 is expressed in pancreatic beta cells and involved in the regulation of insulin secretion.",
    "vicuna-7b_fact": [
      "GPR151 is a G protein-coupled receptor identified as an orphan receptor.",
      "GPR151 has been suggested to play a role in the regulation of metabolic processes, including glucose and lipid metabolism.",
      "A study published in Molecular Endocrinology in 2012 reported that GPR151 is expressed in the liver, adipose tissue, and skeletal muscle.",
      "The same study indicated that GPR151 is activated by compounds such as fatty acids and bile acids.",
      "Research published in the journal Diabetes in 2014 found that GPR151 is expressed in pancreatic beta cells and involved in the regulation of insulin secretion."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: The study published in Molecular Endocrinology in 2012 did not report that GPR151 is activated by compounds such as fatty acids and bile acids. This statement cannot be verified without specific reference to the study, and typically, the activation of orphan receptors by specific ligands is a significant discovery that would be explicitly stated.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "vicuna-7b_response": "Fluzone intradermal quadrivalent vaccine contains attenuated live viruses of four strains: influenza virus type A (H1N1), influenza virus type A (H3N2), influenza virus type B (Yamagata), and influenza virus type B (Victoria).",
    "vicuna-7b_fact_raw": "NO FACTS",
    "vicuna-7b_fact": [],
    "vicuna-7b_judge": []
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "vicuna-7b_response": "The TNFR2 gene, also known as the tumor necrosis factor receptor 2 gene, is a gene that encodes for a protein called TNF receptor 2. This protein is a receptor for the TNF-alpha cytokine, which plays a role in the immune system.\nThere are several variations in the TNFR2 gene that have been associated with Systemic Lupus Erythematosus (SLE), which is an autoimmune disease characterized by the production of autoantibodies and the formation of immune complexes that can cause damage to various organs and tissues in the body.\nOne of the most well-known variations in the TNFR2 gene that has been associated with SLE is a single nucleotide polymorphism (SNP) called rs1143679. This SNP results in the substitution of the amino acid arginine for glutamine at position 69 (R69Q) in the TNFR2 protein.\nStudies have shown that individuals with the R69Q variant of the TNFR2 gene are at increased risk for developing SLE compared to individuals without the variant. Additionally, the R69Q variant has been shown to reduce the ability of the TNFR2 protein to bind to TNF-alpha, which may contribute to the development of SLE by increasing the levels of TNF-alpha in the body.\nOverall, the TNFR2 gene and its variants, particularly the R69Q variant, are important genetic factors that contribute to the development of SLE.",
    "vicuna-7b_fact_raw": "1. The TNFR2 gene encodes for a protein called TNF receptor 2.\n2. TNF receptor 2 is a receptor for the TNF-alpha cytokine.\n3. Systemic Lupus Erythematosus (SLE) is associated with variations in the TNFR2 gene.\n4. The single nucleotide polymorphism (SNP) rs1143679 in the TNFR2 gene results in an arginine to glutamine substitution at position 69 (R69Q).\n5. Individuals with the R69Q variant of the TNFR2 gene have an increased risk for developing SLE.",
    "vicuna-7b_fact": [
      "The TNFR2 gene encodes for a protein called TNF receptor 2.",
      "TNF receptor 2 is a receptor for the TNF-alpha cytokine.",
      "Systemic Lupus Erythematosus (SLE) is associated with variations in the TNFR2 gene.",
      "The single nucleotide polymorphism (SNP) rs1143679 in the TNFR2 gene results in an arginine to glutamine substitution at position 69 (R69Q).",
      "Individuals with the R69Q variant of the TNFR2 gene have an increased risk for developing SLE."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The single nucleotide polymorphism (SNP) rs1143679 is associated with the ITGAM gene, not the TNFR2 gene, and it results in an arginine to histidine substitution at position 77 (R77H).\n5. FALSE [correction]: The R77H variant in the ITGAM gene, not the TNFR2 gene, has been associated with an increased risk for developing Systemic Lupus Erythematosus (SLE).",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "vicuna-7b_response": "Yes, there is a vaccine for peanut allergy. It is called the AR101 vaccine and it is the first and only FDA-approved vaccine for the prevention of peanut allergy in children.\nThe AR101 vaccine is administered in two doses, with the first dose given at 4-6 years of age and the second dose given 6-12 months later. The vaccine is designed to gradually increase the body's tolerance to peanut protein, which can help prevent the development of peanut allergy.\nIt is important to note that the vaccine is not a cure for peanut allergy and it does not eliminate the risk of an allergic reaction to peanuts. However, it can significantly reduce the risk of developing a peanut allergy and can provide long-term protection against the allergy.\nIt is also important to note that the vaccine is not recommended for individuals who have a severe allergy to peanuts or any other ingredients in the vaccine.\nIt is important to consult with a healthcare provider to determine if the vaccine is appropriate for you or your child.",
    "vicuna-7b_fact_raw": "1. The AR101 vaccine is FDA-approved for the prevention of peanut allergy in children.\n2. The AR101 vaccine is administered in two doses.\n3. The first dose of the AR101 vaccine is given at 4-6 years of age.\n4. The second dose of the AR101 vaccine is given 6-12 months after the first dose.\n5. The AR101 vaccine is not recommended for individuals with a severe allergy to peanuts or any other ingredients in the vaccine.",
    "vicuna-7b_fact": [
      "The AR101 vaccine is FDA-approved for the prevention of peanut allergy in children.",
      "The AR101 vaccine is administered in two doses.",
      "The first dose of the AR101 vaccine is given at 4-6 years of age.",
      "The second dose of the AR101 vaccine is given 6-12 months after the first dose.",
      "The AR101 vaccine is not recommended for individuals with a severe allergy to peanuts or any other ingredients in the vaccine."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: As of my knowledge cutoff in 2023, there is no FDA-approved vaccine for the prevention of peanut allergies. AR101, also known as Palforzia, is an oral immunotherapy treatment, not a vaccine, and it has been FDA-approved for mitigating allergic reactions to peanuts.\n2. FALSE [correction]: Palforzia (AR101) is not administered in two doses. It is an oral immunotherapy treatment that involves several phases, including initial dose escalation, up-dosing, and maintenance phases.\n3. TRUE: Palforzia is approved for use in children aged 4 to 17 with a confirmed diagnosis of peanut allergy.\n4. FALSE [correction]: Since AR101 is not a vaccine and does not have a two-dose regimen, this statement is incorrect. Palforzia's dosing schedule involves multiple doses over an extended period, not just a first and second dose.\n5. TRUE: Palforzia (AR101) is not recommended for individuals with uncontrolled asthma or those with a history of severe allergic reactions to peanuts, as it may pose a risk of anaphylaxis or other serious reactions.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "vicuna-7b_response": "The mouse Fxy gene is located on chromosome 10 at position 10.10. The gene is composed of 10 exons and spans approximately 100 kilobases. The Fxy gene encodes for a protein that is involved in the regulation of cell growth and differentiation. The Fxy protein is a transcription factor that binds to specific DNA sequences and regulates the expression of target genes involved in cell proliferation and apoptosis. The Fxy gene has been shown to be important in the development of various tissues, including the brain, heart, and skeletal muscle.",
    "vicuna-7b_fact_raw": "1. The mouse Fxy gene is located on chromosome 10 at position 10.10.\n2. The Fxy gene is composed of 10 exons.\n3. The Fxy gene spans approximately 100 kilobases.\n4. The Fxy protein is a transcription factor that regulates the expression of target genes.\n5. The Fxy gene plays a role in the development of the brain, heart, and skeletal muscle.",
    "vicuna-7b_fact": [
      "The mouse Fxy gene is located on chromosome 10 at position 10.10.",
      "The Fxy gene is composed of 10 exons.",
      "The Fxy gene spans approximately 100 kilobases.",
      "The Fxy protein is a transcription factor that regulates the expression of target genes.",
      "The Fxy gene plays a role in the development of the brain, heart, and skeletal muscle."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific scientific literature or a database reference to verify the details of the mouse Fxy gene, such as its chromosomal location, exon count, size, protein function, and role in development, it is not possible to determine the truthfulness of these statements. These are highly specific scientific claims that require access to up-to-date genetic databases or research articles for verification.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "vicuna-7b_response": "Methidiumpropyl-EDTA (MPE) sequencing is a method used to sequence DNA molecules by using MPE as a primer for DNA amplification. MPE is a modified nucleotide analog that contains a methidium group, which is a derivative of psoralen, and a propyl group. The methidium group allows MPE to bind to DNA through its intercalating properties, while the propyl group enhances the stability of the MPE-DNA complex.\nThe MPE-seq method involves the following steps:\n1. MPE is added to the DNA sample to make the MPE-DNA complex.\n2. The complex is denatured to separate the DNA strands.\n3. The denatured DNA is then amplified using PCR, with MPE as the primer.\n4. The amplified product is then sequenced using standard DNA sequencing techniques, such as capillary electrophoresis or Sanger sequencing.\nThe MPE-seq method has several advantages over other sequencing methods, such as its ability to sequence long DNA molecules, its high sensitivity and specificity, and its ability to sequence both DNA and RNA. However, it also has some limitations, such as the potential for cross-linking to other nucleic acids and the need for specialized equipment and expertise.",
    "vicuna-7b_fact_raw": "1. Methidiumpropyl-EDTA (MPE) sequencing uses MPE as a primer for DNA amplification.\n2. MPE contains a methidium group, which is a derivative of psoralen, and a propyl group.\n3. The methidium group allows MPE to bind to DNA through intercalating properties.\n4. The MPE-seq method includes steps such as adding MPE to DNA, denaturing the complex, amplifying the DNA using PCR with MPE as the primer, and sequencing the amplified product.\n5. The MPE-seq method can sequence both DNA and RNA.",
    "vicuna-7b_fact": [
      "Methidiumpropyl-EDTA (MPE) sequencing uses MPE as a primer for DNA amplification.",
      "MPE contains a methidium group, which is a derivative of psoralen, and a propyl group.",
      "The methidium group allows MPE to bind to DNA through intercalating properties.",
      "The MPE-seq method includes steps such as adding MPE to DNA, denaturing the complex, amplifying the DNA using PCR with MPE as the primer, and sequencing the amplified product.",
      "The MPE-seq method can sequence both DNA and RNA."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Methidiumpropyl-EDTA (MPE) sequencing does not use MPE as a primer for DNA amplification. Instead, MPE is a DNA-cleaving agent that is used in footprinting studies to investigate DNA-protein interactions.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The MPE-seq method does not involve amplifying DNA using MPE as the primer. Instead, it typically involves treating DNA with MPE under controlled conditions to cleave the DNA at specific sites, followed by other steps such as end-labeling the DNA, denaturing, and then separating the fragments by size using gel electrophoresis to analyze the cleavage pattern.\n5. FALSE [correction]: The MPE-seq method is designed for sequencing DNA, not RNA. RNA sequencing typically involves converting RNA to cDNA before sequencing, and MPE-seq is not a method used for this process.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "vicuna-7b_response": "GWAR is a web-based game development platform that allows users to create and share their own games. It is built using a combination of technologies, including HTML, CSS, JavaScript, and a few other web technologies.\nHTML (Hypertext Markup Language) is used to define the structure and content of a web page. It provides a way to define the different elements of a web page, such as headings, paragraphs, images, and links.\nCSS (Cascading Style Sheets) is used to define the visual style of a web page, such as colors, fonts, and layout. It allows developers to create a consistent look and feel for their web pages.\nJavaScript is used to add interactive elements to a web page. It allows developers to add animations, interactions, and other dynamic effects to their web pages.\nGWAR also uses a few other web technologies, such as WebGL (Web Graphics Library) for 3D graphics, and WebRTC (Web Real-Time Communication) for real-time communication between users.\nOverall, GWAR is built using a combination of web technologies that allow developers to create and share their own games on the web.",
    "vicuna-7b_fact_raw": "1. GWAR is a web-based game development platform.\n2. GWAR is built using HTML, CSS, and JavaScript among other web technologies.\n3. HTML is used in GWAR to define the structure and content of web pages.\n4. CSS is used in GWAR to define the visual style of web pages.\n5. JavaScript is used in GWAR to add interactive elements to web pages.",
    "vicuna-7b_fact": [
      "GWAR is a web-based game development platform.",
      "GWAR is built using HTML, CSS, and JavaScript among other web technologies.",
      "HTML is used in GWAR to define the structure and content of web pages.",
      "CSS is used in GWAR to define the visual style of web pages.",
      "JavaScript is used in GWAR to add interactive elements to web pages."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: GWAR is not a web-based game development platform; it is actually a rock band known for its elaborate science fiction-themed costumes and performances.\n2. FALSE [correction]: Since GWAR is not a web development platform, it is not built using HTML, CSS, and JavaScript. These technologies are used for web development in general.\n3. UNKNOWN: Without context on what \"GWAR\" refers to in this statement, it is unclear whether HTML is used or not. However, if GWAR were a web development platform, this statement would be true for web development in general.\n4. UNKNOWN: Similar to the previous statement, without proper context, it is unclear whether CSS is used in GWAR. If GWAR were a web development platform, this statement would be true for web development in general.\n5. UNKNOWN: As with the previous statements, without context, it is unclear whether JavaScript is used in GWAR. If GWAR were a web development platform, this statement would be true for web development in general.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "vicuna-7b_response": "Xaliproden is a drug that has been studied for its potential to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. However, the evidence regarding the effectiveness of xaliproden in improving the prognosis of ALS is limited and inconclusive.\nXaliproden is a selective agonist of the melanocortin-4 receptor (MC4R), which is a receptor that is involved in the regulation of appetite, metabolism, and inflammation. Some studies have suggested that xaliproden may have neuroprotective effects and may slow the progression of ALS in animal models of the disease. However, these studies have not been replicated in clinical trials in humans.\nThere have been two clinical trials of xaliproden in patients with ALS, but both of these trials were small and had limited power to detect a difference in the progression of the disease. The first trial found that xaliproden was well-tolerated and had no significant effect on the progression of the disease, while the second trial found that xaliproden was associated with a slight delay in the decline of respiratory function, but again, the study was not large enough to determine whether this was statistically significant.\nOverall, while xaliproden may have some potential as a treatment for ALS, the evidence regarding its effectiveness in improving the prognosis of the disease is limited and inconclusive. Further research is needed to determine the safety and efficacy of xaliproden in treating ALS.",
    "vicuna-7b_fact_raw": "1. Xaliproden has been studied for its potential to treat amyotrophic lateral sclerosis (ALS).\n2. Xaliproden is a selective agonist of the melanocortin-4 receptor (MC4R).\n3. Some studies have suggested that xaliproden may have neuroprotective effects in animal models of ALS.\n4. There have been two clinical trials of xaliproden in patients with ALS.\n5. The first clinical trial found that xaliproden had no significant effect on the progression of ALS.",
    "vicuna-7b_fact": [
      "Xaliproden has been studied for its potential to treat amyotrophic lateral sclerosis (ALS).",
      "Xaliproden is a selective agonist of the melanocortin-4 receptor (MC4R).",
      "Some studies have suggested that xaliproden may have neuroprotective effects in animal models of ALS.",
      "There have been two clinical trials of xaliproden in patients with ALS.",
      "The first clinical trial found that xaliproden had no significant effect on the progression of ALS."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Xaliproden is not a selective agonist of the melanocortin-4 receptor (MC4R); it is a serotonergic compound that has been studied for its potential neuroprotective effects.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "vicuna-7b_response": "The LiPS-A3S line is a transgenic line that was created by inserting the A3S promoter upstream of the luciferase gene. The A3S promoter is a constitutive promoter that is active in all tissues and cell types, and it is commonly used to drive the expression of genes in transgenic animals.\nIn the case of the LiPS-A3S line, the A3S promoter was used to drive the expression of the luciferase gene, which is a reporter gene that encodes an enzyme that catalyzes the conversion of a substrate (luciferin) to light. The luciferase gene was inserted into the genome of the mouse embryonic stem cells that were used to create the LiPS-A3S line, and the A3S promoter was used to drive the expression of the luciferase gene in these cells.\nThe luciferase gene was inserted into the genome of the LiPS-A3S line using a technique called gene targeting. In this technique, a small piece of DNA that contains the luciferase gene is inserted into the genome of the mouse embryonic stem cells at a specific location, using a special enzyme called a recombinase. The recombinase is used to cut the DNA at a specific site, and then the luciferase gene is inserted into the resulting gap in the DNA. The A3S promoter is then used to drive the expression of the luciferase gene in the cells that contain the transgene.\nIn summary, the LiPS-A3S line was created by inserting the A3S promoter upstream of the luciferase gene, and the A3S promoter was used to drive the expression of the luciferase gene in the mouse embryonic stem cells that were used to create the line. The luciferase gene was inserted into the genome of the LiPS-A3S line using a technique called gene targeting, and the A3S promoter was used to drive the expression of the luciferase gene in these cells.",
    "vicuna-7b_fact_raw": "1. The LiPS-A3S line is a transgenic line where the A3S promoter is used to drive the expression of the luciferase gene.\n2. The A3S promoter is a constitutive promoter active in all tissues and cell types.\n3. The luciferase gene encodes an enzyme that catalyzes the conversion of luciferin to light.\n4. The luciferase gene was inserted into the genome of mouse embryonic stem cells to create the LiPS-A3S line.\n5. Gene targeting, which involves using a recombinase enzyme, was the technique used to insert the luciferase gene into the genome of the LiPS-A3S line.",
    "vicuna-7b_fact": [
      "The LiPS-A3S line is a transgenic line where the A3S promoter is used to drive the expression of the luciferase gene.",
      "The A3S promoter is a constitutive promoter active in all tissues and cell types.",
      "The luciferase gene encodes an enzyme that catalyzes the conversion of luciferin to light.",
      "The luciferase gene was inserted into the genome of mouse embryonic stem cells to create the LiPS-A3S line.",
      "Gene targeting, which involves using a recombinase enzyme, was the technique used to insert the luciferase gene into the genome of the LiPS-A3S line."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN (The statement does not provide enough context to determine whether the A3S promoter is indeed constitutive and active in all tissues and cell types. This would require specific knowledge about the A3S promoter.)\n3. TRUE (The luciferase gene does indeed encode an enzyme that catalyzes the emission of light through the oxidation of luciferin.)\n4. UNKNOWN (While the statement is plausible, there is not enough context to confirm that the luciferase gene was specifically inserted into mouse embryonic stem cells to create the LiPS-A3S line without additional information.)\n5. FALSE [correction]: Gene targeting typically involves the use of homologous recombination, not a recombinase enzyme, to insert genes into specific locations within the genome. Recombinase enzymes are used in other genetic engineering techniques, such as site-specific recombination systems like Cre-loxP.",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "vicuna-7b_response": "There are several tools and frameworks that use deep learning to predict drug synergy. One example is the DeepDrug framework, which uses a deep neural network to predict the synergy between two drugs based on their chemical structure and pharmacological properties. Another example is the Drug Combination Analysis tool, which uses a combination of machine learning and bioinformatics techniques to predict the synergy between drugs. Additionally, there are also pre-trained models like DrugBank and Chemical Space that can be used for drug synergy prediction.",
    "vicuna-7b_fact_raw": "1. The DeepDrug framework uses a deep neural network to predict drug synergy.\n2. The DeepDrug framework considers chemical structure and pharmacological properties to predict drug synergy.\n3. The Drug Combination Analysis tool uses machine learning and bioinformatics to predict drug synergy.\n4. DrugBank is a pre-trained model that can be used for drug synergy prediction.\n5. Chemical Space is a pre-trained model used for predicting drug synergy.",
    "vicuna-7b_fact": [
      "The DeepDrug framework uses a deep neural network to predict drug synergy.",
      "The DeepDrug framework considers chemical structure and pharmacological properties to predict drug synergy.",
      "The Drug Combination Analysis tool uses machine learning and bioinformatics to predict drug synergy.",
      "DrugBank is a pre-trained model that can be used for drug synergy prediction.",
      "Chemical Space is a pre-trained model used for predicting drug synergy."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: DrugBank is not a pre-trained model; it is a comprehensive database that provides detailed drug data, including chemical, pharmacological, and pharmaceutical information, which can be used in drug synergy research but is not a model itself.\n5. FALSE [correction]: Chemical Space refers to the multi-dimensional space where all possible chemical compounds can be represented based on their properties. It is not a pre-trained model but a concept used in cheminformatics to explore and characterize the diversity of chemical compounds.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "vicuna-7b_response": "There are several cloud-based platforms that have been developed for comparing genome-wide association studies (GWAS). Some examples include:\n1. GWAS Central: This is a cloud-based platform that provides a centralized repository for storing and analyzing GWAS data. It allows researchers to upload their data and perform analyses using a variety of statistical methods.\n2. The Global Alliance for Genomics and Health (GA4GH): This is a cloud-based platform that provides tools and resources for sharing and analyzing genomic data. It includes a variety of tools for comparing GWAS data, such as the GWAS Catalog and the Variation Effects Catalogue.\n3. The National Center for Biotechnology Information (NCBI): This is a cloud-based platform that provides a variety of tools for analyzing GWAS data, including the dbGaP database.\n4. The European Bioinformatics Institute (EBI): This is a cloud-based platform that provides a variety of tools for analyzing GWAS data, including the European Genome-Phenome Archive (EGA).\nThese are just a few examples of cloud-based platforms that have been developed for comparing GWAS data. There are many other platforms available, and the best one for a particular researcher will depend on their specific needs and goals.",
    "vicuna-7b_fact_raw": "1. GWAS Central is a cloud-based platform designed for storing and analyzing GWAS data.\n2. The Global Alliance for Genomics and Health (GA4GH) provides tools for sharing and analyzing genomic data, including tools for comparing GWAS data.\n3. The National Center for Biotechnology Information (NCBI) offers tools for analyzing GWAS data, including the dbGaP database.\n4. The European Bioinformatics Institute (EBI) provides tools for analyzing GWAS data, including the European Genome-Phenome Archive (EGA).\n5. The GWAS Catalog and the Variation Effects Catalogue are tools included in the GA4GH platform for comparing GWAS data.",
    "vicuna-7b_fact": [
      "GWAS Central is a cloud-based platform designed for storing and analyzing GWAS data.",
      "The Global Alliance for Genomics and Health (GA4GH) provides tools for sharing and analyzing genomic data, including tools for comparing GWAS data.",
      "The National Center for Biotechnology Information (NCBI) offers tools for analyzing GWAS data, including the dbGaP database.",
      "The European Bioinformatics Institute (EBI) provides tools for analyzing GWAS data, including the European Genome-Phenome Archive (EGA).",
      "The GWAS Catalog and the Variation Effects Catalogue are tools included in the GA4GH platform for comparing GWAS data."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: GWAS Central is a web-based resource for storing and accessing summary-level genetic association findings, not specifically a cloud-based platform.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The GWAS Catalog is provided by EMBL-EBI and is not a tool included in the GA4GH platform. The Variation Effects Catalogue is not a recognized tool associated with GA4GH; instead, there is a tool called the Variant Effect Predictor (VEP) provided by EMBL-EBI.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "vicuna-7b_response": "CMB305 is a monoclonal antibody that targets the CD33 protein, which is expressed on the surface of certain cancer cells, including acute myeloid leukemia (AML) cells. CMB305 has been shown to have potential in the treatment of AML, and it is currently being studied in clinical trials for the treatment of other types of cancer as well, including sarcomas.\nSarcomas are a type of cancer that develops from the soft tissues of the body, such as muscle, fat, bone, and connective tissue. They are relatively rare cancers, and they can occur in both adults and children. There are many different subtypes of sarcomas, and the treatment options for each subtype can vary.\nCMB305 has been shown to have potential in the treatment of sarcomas in preclinical studies, but it has not yet been studied in clinical trials specifically for the treatment of sarcomas. However, given its potential activity against CD33-expressing cancer cells, it is possible that CMB305 could be a promising treatment option for some patients with sarcomas.\nIt is important to note that clinical trials are the best way to determine the safety and effectiveness of a treatment for a specific type of cancer. If you are interested in participating in a clinical trial for CMB305 or any other treatment for sarcomas, it is best to speak with your oncologist or a cancer specialist. They can provide you with more information about available clinical trials and help you determine whether participating in a trial is right for you.",
    "vicuna-7b_fact_raw": "1. CMB305 is a monoclonal antibody that targets the CD33 protein.\n2. CMB305 has been shown to have potential in the treatment of acute myeloid leukemia (AML).\n3. CMB305 is currently being studied in clinical trials for the treatment of other types of cancer, including sarcomas.\n4. Sarcomas are cancers that develop from soft tissues of the body such as muscle, fat, bone, and connective tissue.\n5. CMB305 has not yet been studied in clinical trials specifically for the treatment of sarcomas.",
    "vicuna-7b_fact": [
      "CMB305 is a monoclonal antibody that targets the CD33 protein.",
      "CMB305 has been shown to have potential in the treatment of acute myeloid leukemia (AML).",
      "CMB305 is currently being studied in clinical trials for the treatment of other types of cancer, including sarcomas.",
      "Sarcomas are cancers that develop from soft tissues of the body such as muscle, fat, bone, and connective tissue.",
      "CMB305 has not yet been studied in clinical trials specifically for the treatment of sarcomas."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: CMB305 is currently being studied in clinical trials for the treatment of other types of cancer, including sarcomas, which implies that it has been studied in clinical trials specifically for the treatment of sarcomas.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "vicuna-7b_response": "The Saint's Triad is a concept in Christian theology that refers to the three persons of the Trinity: the Father, the Son, and the Holy Spirit. The manifestations of the Saint's Triad are the ways in which these three persons are revealed and experienced in the world.\nThe Father is often revealed through creation, as the creator of the universe and all that exists within it. The Son is revealed through the person of Jesus Christ, who is believed to be the Son of God and the savior of humanity. The Holy Spirit is revealed through the work of the Holy Spirit, which includes the guidance of believers, the empowerment of the church, and the conviction of sinners.\nIn addition to these primary manifestations, the Saint's Triad is also revealed in the sacraments, such as baptism and communion, and in the lives of believers who are filled with the Holy Spirit and live in accordance with God's will.\nOverall, the manifestations of the Saint's Triad are diverse and multifaceted, reflecting the complexity and richness of the Christian faith.",
    "vicuna-7b_fact_raw": "1. The Saint's Triad in Christian theology refers to the Father, the Son, and the Holy Spirit.\n2. The Father is revealed through creation as the creator of the universe.\n3. The Son is revealed through the person of Jesus Christ, who is considered the Son of God.\n4. The Holy Spirit is believed to guide believers and empower the church.\n5. The Saint's Triad is also revealed in the sacraments, such as baptism and communion.",
    "vicuna-7b_fact": [
      "The Saint's Triad in Christian theology refers to the Father, the Son, and the Holy Spirit.",
      "The Father is revealed through creation as the creator of the universe.",
      "The Son is revealed through the person of Jesus Christ, who is considered the Son of God.",
      "The Holy Spirit is believed to guide believers and empower the church.",
      "The Saint's Triad is also revealed in the sacraments, such as baptism and communion."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The term commonly used in Christian theology is the Holy Trinity, not the Saint's Triad.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The Holy Trinity is revealed in the sacraments, such as baptism and communion, not the Saint's Triad.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "vicuna-7b_response": "LY6K, also known as Ly6K or CD272, is a protein that is expressed on the surface of immune cells, including T cells, B cells, and natural killer cells. It is also expressed on some cancer cells, including non-small cell lung cancer (NSCLC) cells.\nThere is limited research on the relationship between LY6K expression and prognosis in NSCLC patients. However, some studies have suggested that overexpression of LY6K in cancer cells may be associated with better prognosis.\nFor example, one study published in the journal Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC. The study suggested that LY6K may play a role in regulating the immune response to cancer and may be a potential target for immunotherapy in NSCLC.\nAnother study published in the journal Clinical Cancer Research in 2018 found that high levels of LY6K expression were associated with improved survival in patients with advanced NSCLC who had undergone surgery. The study suggested that LY6K may be a potential biomarker for identifying patients who are likely to benefit from immunotherapy.\nHowever, it is important to note that these studies are limited and more research is needed to fully understand the role of LY6K in NSCLC and its potential as a prognostic biomarker. Additionally, the prognosis of NSCLC patients can be influenced by many factors, including the stage and grade of the cancer, the presence of certain genetic mutations, and the response to treatment. Therefore, it is important for patients to discuss their individual prognosis with their healthcare provider.",
    "vicuna-7b_fact_raw": "1. LY6K is a protein expressed on the surface of immune cells such as T cells, B cells, and natural killer cells.\n2. LY6K is also expressed on some cancer cells, including non-small cell lung cancer (NSCLC) cells.\n3. A study published in the journal Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.\n4. A study published in the journal Clinical Cancer Research in 2018 found that high levels of LY6K expression were associated with improved survival in patients with advanced NSCLC who had undergone surgery.\n5. The studies suggest that LY6K may be a potential target for immunotherapy in NSCLC and a potential biomarker for identifying patients who may benefit from immunotherapy.",
    "vicuna-7b_fact": [
      "LY6K is a protein expressed on the surface of immune cells such as T cells, B cells, and natural killer cells.",
      "LY6K is also expressed on some cancer cells, including non-small cell lung cancer (NSCLC) cells.",
      "A study published in the journal Cancer Research in 2015 found that high levels of LY6K expression were associated with improved overall survival in patients with NSCLC.",
      "A study published in the journal Clinical Cancer Research in 2018 found that high levels of LY6K expression were associated with improved survival in patients with advanced NSCLC who had undergone surgery.",
      "The studies suggest that LY6K may be a potential target for immunotherapy in NSCLC and a potential biomarker for identifying patients who may benefit from immunotherapy."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. FALSE [correction]: A study published in the journal Cancer Research in 2015 found that high levels of LY6K expression were associated with poor overall survival in patients with NSCLC.\n4. UNKNOWN\n5. TRUE\n\nThe corrections and responses are based on typical scientific findings where high expression of certain proteins in cancer cells is often associated with poorer outcomes, not improved survival. However, without access to the specific studies mentioned, the truthfulness of statements 1, 2, and 4 cannot be determined. Statement 5 is generally true as proteins expressed on cancer cells can be targets for immunotherapy and biomarkers for treatment response.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "vicuna-7b_response": "During cytokinesis, the CDK (Cyclin-dependent kinase) targets specific phosphorylation sites on proteins to regulate their activity. The dephosphorylation of these targets is important for the completion of cytokinesis. Here are some examples of Cdk targets that are dephosphorylated during cytokinesis:\n1. Plk1 (Polo-like kinase 1) - Plk1 is a key regulator of centromeric cohesion and the formation of the mitotic spindle. It is dephosphorylated by Cdk1 during cytokinesis, allowing it to activate the separation of sister chromatids.\n2. Aurora B - Aurora B is a kinase that is involved in the regulation of chromosome segregation and the maintenance of the spindle assembly checkpoint. It is dephosphorylated by Cdk1 during cytokinesis, allowing it to activate the separation of sister chromatids.\n3. BubR1 - BubR1 is a kinase that is involved in the regulation of chromosome segregation and the maintenance of the spindle assembly checkpoint. It is dephosphorylated by Cdk1 during cytokinesis, allowing it to activate the separation of sister chromatids.\n4. Cdc14 - Cdc14 is a phosphatase that is involved in the dephosphorylation of proteins involved in the G2/M transition, including Cdc2/Cyclin B and Cdc25. It is dephosphorylated by Cdc28 during cytokinesis, allowing it to activate the transition from G2 to mitosis.\n5. Cdc28 - Cdc28 is a kinase that is involved in the regulation of the G2/M transition. It is dephosphorylated by Cdc14 during cytokinesis, allowing it to activate the transition from G2 to mitosis.\nThese are just a few examples of Cdk targets that are dephosphorylated during cytokinesis. The specific targets that are dephosphorylated can vary depending on the species and cell type.",
    "vicuna-7b_fact_raw": "1. Plk1 is dephosphorylated by Cdk1 during cytokinesis.\n2. Aurora B is dephosphorylated by Cdk1 during cytokinesis.\n3. BubR1 is dephosphorylated by Cdk1 during cytokinesis.\n4. Cdc14 is dephosphorylated by Cdc28 during cytokinesis.\n5. Cdc28 is dephosphorylated by Cdc14 during cytokinesis.",
    "vicuna-7b_fact": [
      "Plk1 is dephosphorylated by Cdk1 during cytokinesis.",
      "Aurora B is dephosphorylated by Cdk1 during cytokinesis.",
      "BubR1 is dephosphorylated by Cdk1 during cytokinesis.",
      "Cdc14 is dephosphorylated by Cdc28 during cytokinesis.",
      "Cdc28 is dephosphorylated by Cdc14 during cytokinesis."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Plk1 is not dephosphorylated by Cdk1 during cytokinesis. Plk1 (Polo-like kinase 1) is actually activated by phosphorylation during mitosis and is involved in the regulation of cytokinesis.\n2. FALSE [correction]: Aurora B is not dephosphorylated by Cdk1 during cytokinesis. Aurora B is a kinase that is part of the chromosomal passenger complex and plays a role in cytokinesis, but it is not dephosphorylated by Cdk1.\n3. UNKNOWN: The phosphorylation status of BubR1 (BUB1-related kinase) by Cdk1 during cytokinesis is not well-defined in the literature, and it may vary depending on the context of the cell cycle and specific experimental conditions.\n4. FALSE [correction]: Cdc14 is not dephosphorylated by Cdc28 during cytokinesis. Cdc14 is a phosphatase that is known to dephosphorylate various substrates during the exit from mitosis, but it is not a substrate of Cdc28 (also known as Cdk1 in yeast).\n5. TRUE: Cdc28 (Cdk1 in yeast) is dephosphorylated by Cdc14 during cytokinesis, which is part of the regulatory mechanism that controls the exit from mitosis in yeast.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "vicuna-7b_response": "Xanamem is a drug that is used to treat the symptoms of mild to moderate Alzheimer's disease. It is a type of drug called a cholinesterase inhibitor, which works by increasing the levels of a chemical in the brain called acetylcholine. Acetylcholine is important for memory and cognitive function.\nXanamem is typically taken as a pill, usually once daily. It is not a cure for Alzheimer's disease, but it can help improve symptoms such as memory loss, confusion, and disorientation.\nIt is important to note that Xanamem should only be used under the guidance of a healthcare professional, as it can have side effects and may not be suitable for everyone. It is also important to continue taking the medication as directed even if symptoms improve, as the drug works best when taken consistently.",
    "vicuna-7b_fact_raw": "1. Xanamem is used to treat symptoms of mild to moderate Alzheimer's disease.\n2. Xanamem is a cholinesterase inhibitor.\n3. Xanamem works by increasing levels of acetylcholine in the brain.\n4. Xanamem is typically taken as a pill once daily.\n5. Xanamem is not a cure for Alzheimer's disease but can help improve symptoms.",
    "vicuna-7b_fact": [
      "Xanamem is used to treat symptoms of mild to moderate Alzheimer's disease.",
      "Xanamem is a cholinesterase inhibitor.",
      "Xanamem works by increasing levels of acetylcholine in the brain.",
      "Xanamem is typically taken as a pill once daily.",
      "Xanamem is not a cure for Alzheimer's disease but can help improve symptoms."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Xanamem is not a cholinesterase inhibitor; it is designed to block the production of excess cortisol by inhibiting the activity of the enzyme 11-HSD1.\n3. FALSE [correction]: Xanamem does not work by increasing levels of acetylcholine in the brain; it works by targeting the cortisol production in the brain.\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "vicuna-7b_response": "The Hof1-Cyk3 interaction plays a crucial role in the regulation of the cytochrome c oxidase (COX) complex in yeast. The COX complex is responsible for generating ATP from the oxidation of molecular oxygen in the mitochondria of the cell.\nHof1 is a component of the COX complex and is responsible for the transfer of electrons from the cytochrome c protein to the copper centers of the complex. Cyk3 is a protein that interacts with Hof1 and is involved in the regulation of the COX complex.\nThe Hof1-Cyk3 interaction is important for the proper functioning of the COX complex, as it helps to maintain the proper conformation of Hof1 and ensures that it is in close proximity to the copper centers of the complex. This interaction is also important for the proper assembly of the COX complex and for the regulation of its activity.\nIn summary, the Hof1-Cyk3 interaction plays a critical role in the regulation of the cytochrome c oxidase complex in yeast, ensuring that it is properly assembled and functioning properly.",
    "vicuna-7b_fact_raw": "1. The Hof1-Cyk3 interaction is involved in the regulation of the cytochrome c oxidase (COX) complex in yeast.\n2. The COX complex is responsible for generating ATP from the oxidation of molecular oxygen in the mitochondria.\n3. Hof1 is a component of the COX complex that transfers electrons from the cytochrome c protein to the copper centers of the complex.\n4. Cyk3 is a protein that interacts with Hof1 and is involved in the regulation of the COX complex.\n5. The Hof1-Cyk3 interaction helps maintain the proper conformation of Hof1 and ensures its proximity to the copper centers of the COX complex.",
    "vicuna-7b_fact": [
      "The Hof1-Cyk3 interaction is involved in the regulation of the cytochrome c oxidase (COX) complex in yeast.",
      "The COX complex is responsible for generating ATP from the oxidation of molecular oxygen in the mitochondria.",
      "Hof1 is a component of the COX complex that transfers electrons from the cytochrome c protein to the copper centers of the complex.",
      "Cyk3 is a protein that interacts with Hof1 and is involved in the regulation of the COX complex.",
      "The Hof1-Cyk3 interaction helps maintain the proper conformation of Hof1 and ensures its proximity to the copper centers of the COX complex."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Hof1-Cyk3 interaction is not involved in the regulation of the cytochrome c oxidase (COX) complex in yeast. Hof1 and Cyk3 are involved in cytokinesis in yeast, not in the regulation of the COX complex.\n2. TRUE\n3. FALSE [correction]: Hof1 is not a component of the COX complex. Hof1 is involved in cytokinesis in yeast. Cytochrome c oxidase (COX) is a component of the electron transport chain in mitochondria and does not include Hof1.\n4. TRUE, but the statement is vague because it does not specify that Cyk3's role in the regulation of the COX complex is incorrect. Cyk3 is indeed a protein that interacts with Hof1, but they are involved in cytokinesis, not in the regulation of the COX complex.\n5. FALSE [correction]: The Hof1-Cyk3 interaction does not help maintain the proper conformation of Hof1 for its proximity to the copper centers of the COX complex. Hof1 and Cyk3 are involved in cytokinesis, and this interaction has no known role in the COX complex's function.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "vicuna-7b_response": "T-UCRs, or Tumor-Associated Urokinase-Type Plasminogen Activator Receptor, have been implicated in gastric cancer.\nGastric cancer is a type of cancer that develops in the stomach. T-UCRs are a type of protein that plays a role in the development and progression of cancer. Research has shown that high levels of T-UCRs can promote the growth and spread of gastric cancer cells.\nSeveral studies have identified specific T-UCRs that have been implicated in gastric cancer. For example, a study published in the journal Cancer Research in 2015 found that high levels of T-UCR-1, a specific type of T-UCR, were associated with poor outcomes in patients with gastric cancer. Another study published in the journal Cancer Research in 2017 found that high levels of T-UCR-2, another type of T-UCR, were associated with poor survival in patients with gastric cancer.\nOverall, while more research is needed to fully understand the role of T-UCRs in gastric cancer, there is evidence to suggest that high levels of certain T-UCRs can promote the growth and spread of gastric cancer cells.",
    "vicuna-7b_fact_raw": "1. T-UCRs, or Tumor-Associated Urokinase-Type Plasminogen Activator Receptor, have been implicated in gastric cancer.\n2. High levels of T-UCRs can promote the growth and spread of gastric cancer cells.\n3. A study published in the journal Cancer Research in 2015 found that high levels of T-UCR-1 were associated with poor outcomes in patients with gastric cancer.\n4. Another study published in the journal Cancer Research in 2017 found that high levels of T-UCR-2 were associated with poor survival in patients with gastric cancer.\n5. Gastric cancer is a type of cancer that develops in the stomach.",
    "vicuna-7b_fact": [
      "T-UCRs, or Tumor-Associated Urokinase-Type Plasminogen Activator Receptor, have been implicated in gastric cancer.",
      "High levels of T-UCRs can promote the growth and spread of gastric cancer cells.",
      "A study published in the journal Cancer Research in 2015 found that high levels of T-UCR-1 were associated with poor outcomes in patients with gastric cancer.",
      "Another study published in the journal Cancer Research in 2017 found that high levels of T-UCR-2 were associated with poor survival in patients with gastric cancer.",
      "Gastric cancer is a type of cancer that develops in the stomach."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN (The statement may be true, but without access to the specific article from Cancer Research in 2015, the veracity of the statement cannot be confirmed.)\n4. UNKNOWN (Similar to statement 3, without access to the specific article from Cancer Research in 2017, the veracity of the statement cannot be confirmed.)\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "vicuna-7b_response": "The Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE), an autoimmune disease that can affect various parts of the body. The LSI is a simple, easy-to-use tool that helps healthcare providers to assess the overall health status of patients with SLE.\nThe LSI is a composite score that is based on the presence and severity of 11 different organ systems that can be affected by SLE, such as the skin, joints, kidneys, and heart. Each organ system is assigned a score based on the degree of involvement, ranging from 0 to 3. The scores for each organ system are then added together to obtain the total LSI score, which ranges from 0 to 33.\nThe LSI score can be used to monitor the disease activity and response to treatment in patients with SLE. A higher LSI score indicates more severe disease activity, while a lower score indicates less severe disease activity. The LSI can also be used to identify patients who are at high risk of disease complications, such as kidney disease or lupus nephritis.\nIt is important to note that the LSI is just one tool that can be used to assess the severity of SLE. Other tools, such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) or the British Isles Lupus Assessment Group (BILAG) index, may also be used to assess disease activity and response to treatment.\nIn summary, the Lupus Severity Index (LSI) is a tool used to assess the severity of systemic lupus erythematosus (SLE), an autoimmune disease that can affect various parts of the body. The LSI is a simple, easy-to-use tool that helps healthcare providers to assess the overall health status of patients with SLE. The LSI score can be used to monitor the disease activity and response to treatment in patients with SLE, and it can also be used to identify patients who are at high risk of disease complications.",
    "vicuna-7b_fact_raw": "1. The Lupus Severity Index (LSI) is used to assess the severity of systemic lupus erythematosus (SLE).\n2. The LSI evaluates the presence and severity of symptoms in 11 different organ systems affected by SLE.\n3. Each organ system in the LSI is assigned a score from 0 to 3 based on the degree of involvement.\n4. The total LSI score ranges from 0 to 33, with higher scores indicating more severe disease activity.\n5. The LSI can be used to monitor disease activity, response to treatment, and identify patients at high risk of complications like kidney disease.",
    "vicuna-7b_fact": [
      "The Lupus Severity Index (LSI) is used to assess the severity of systemic lupus erythematosus (SLE).",
      "The LSI evaluates the presence and severity of symptoms in 11 different organ systems affected by SLE.",
      "Each organ system in the LSI is assigned a score from 0 to 3 based on the degree of involvement.",
      "The total LSI score ranges from 0 to 33, with higher scores indicating more severe disease activity.",
      "The LSI can be used to monitor disease activity, response to treatment, and identify patients at high risk of complications like kidney disease."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "vicuna-7b_response": "ZSWIM6 is a gene that has been associated with several disorders caused by de novo mutations. Here are some of the disorders that have been linked to ZSWIM6 mutations:\n1. Schinzel-Giedion syndrome (SGS): SGS is a rare genetic disorder that is caused by mutations in the ZWS6 gene. It is characterized by intellectual disability, distinctive facial features, and abnormalities of the skull and limbs.\n2. Cerebral palsy: Cerebral palsy is a group of disorders that affect movement and posture. Some studies have suggested that ZWS6 mutations may be associated with cerebral palsy, but more research is needed to confirm this link.\n3. Autism spectrum disorder (ASD): ASD is a neurodevelopmental disorder that affects communication and social interaction. Some studies have suggested that ZWS6 mutations may be associated with ASD, but more research is needed to confirm this link.\n4. Microcephaly: Microcephaly is a condition in which a child's head is smaller than expected for their age. Some studies have suggested that ZWS6 mutations may be associated with microcephaly, but more research is needed to confirm this link.\nIt's important to note that these associations are still being studied and more research is needed to fully understand the role of ZSWIM6 mutations in these disorders.",
    "vicuna-7b_fact_raw": "1. Schinzel-Giedion syndrome (SGS) is caused by mutations in the ZSWIM6 gene.\n2. ZSWIM6 mutations have been linked to cerebral palsy, but more research is needed to confirm this association.\n3. ZSWIM6 mutations have been suggested to be associated with autism spectrum disorder (ASD), but more research is needed to confirm this link.\n4. ZSWIM6 mutations may be associated with microcephaly, but more research is needed to confirm this link.\n5. The role of ZSWIM6 mutations in the mentioned disorders is still being studied and not yet fully understood.",
    "vicuna-7b_fact": [
      "Schinzel-Giedion syndrome (SGS) is caused by mutations in the ZSWIM6 gene.",
      "ZSWIM6 mutations have been linked to cerebral palsy, but more research is needed to confirm this association.",
      "ZSWIM6 mutations have been suggested to be associated with autism spectrum disorder (ASD), but more research is needed to confirm this link.",
      "ZSWIM6 mutations may be associated with microcephaly, but more research is needed to confirm this link.",
      "The role of ZSWIM6 mutations in the mentioned disorders is still being studied and not yet fully understood."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Schinzel-Giedion syndrome (SGS) is caused by mutations in the SETBP1 gene, not the ZSWIM6 gene.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "vicuna-7b_response": "The Koos Classification is a system used to classify diseases of the musculoskeletal system, including the joints, muscles, bones, and tendons. Some examples of diseases that can be classified using the Koos Classification include:\n* Osteoarthritis: a degenerative joint disease that affects the cartilage that cushions the ends of bones and allows them to move smoothly.\n* Rheumatoid arthritis: an autoimmune disease that causes inflammation in the joints and can lead to joint damage and loss of function.\n* Osteoporosis: a condition in which the bones become weak and brittle, leading to an increased risk of fractures.\n* Tendinitis: inflammation of a tendon, which can cause pain and stiffness in the affected area.\n* Bursitis: inflammation of a bursa, which is a small, fluid-filled sac that acts as a cushion between bones, muscles, and tendons.\nThese are just a few examples of the many diseases that can be classified using the Koos Classification.",
    "vicuna-7b_fact_raw": "1. The Koos Classification is used to classify diseases of the musculoskeletal system.\n2. Osteoarthritis is a degenerative joint disease that can be classified using the Koos Classification.\n3. Rheumatoid arthritis, an autoimmune disease that causes joint inflammation, can be classified using the Koos Classification.\n4. Osteoporosis, a condition where bones become weak and brittle, can be classified using the Koos Classification.\n5. Tendinitis and bursitis, both inflammatory conditions, can be classified using the Koos Classification.",
    "vicuna-7b_fact": [
      "The Koos Classification is used to classify diseases of the musculoskeletal system.",
      "Osteoarthritis is a degenerative joint disease that can be classified using the Koos Classification.",
      "Rheumatoid arthritis, an autoimmune disease that causes joint inflammation, can be classified using the Koos Classification.",
      "Osteoporosis, a condition where bones become weak and brittle, can be classified using the Koos Classification.",
      "Tendinitis and bursitis, both inflammatory conditions, can be classified using the Koos Classification."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The Kellgren-Lawrence Classification is used to classify the severity of osteoarthritis. The Koos Classification is not a recognized system for classifying diseases of the musculoskeletal system.\n2. FALSE [correction]: While osteoarthritis is a degenerative joint disease, it is typically classified using the Kellgren-Lawrence grading scale, not the Koos Classification.\n3. FALSE [correction]: Rheumatoid arthritis can be classified by various criteria, but the Koos Classification is not one of them. The American College of Rheumatology criteria is commonly used for classification.\n4. FALSE [correction]: Osteoporosis is typically assessed using bone mineral density measurements, such as the T-score from a DEXA scan, not the Koos Classification.\n5. FALSE [correction]: Tendinitis and bursitis are inflammatory conditions that are not classified using the Koos Classification. They are typically diagnosed based on clinical examination and imaging if necessary.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "vicuna-7b_response": "AZD8601 is a small molecule inhibitor of the enzyme phosphoinositide-3-kinase (PI3K) delta. PI3K delta is a subunit of the PI3K enzyme complex, which plays a key role in regulating cell growth, survival, and metabolism.\nIn vivo studies have shown that AZD8601 can effectively inhibit the PI3K delta pathway in various types of cancer cells, leading to decreased cell proliferation, migration, and invasion. Additionally, AZD8601 has been shown to induce apoptosis (programmed cell death) in cancer cells, which can lead to a reduction in tumor size and growth.\nAZD8601 has also been shown to have anti-angiogenic effects, which means it can inhibit the formation of new blood vessels that tumors need to grow. This can lead to a reduction in the supply of oxygen and nutrients to the tumor, further reducing its growth and progression.\nOverall, AZD8601 has shown promising in vivo effects in preclinical studies and is currently being evaluated in clinical trials for the treatment of various types of cancer.",
    "vicuna-7b_fact_raw": "1. AZD8601 is a small molecule inhibitor of the enzyme phosphoinositide-3-kinase (PI3K) delta.\n2. In vivo studies have indicated that AZD8601 can inhibit the PI3K delta pathway in various types of cancer cells.\n3. AZD8601 has been observed to decrease cell proliferation, migration, and invasion in cancer cells.\n4. AZD8601 can induce apoptosis in cancer cells.\n5. AZD8601 has anti-angiogenic effects, which can inhibit the formation of new blood vessels in tumors.",
    "vicuna-7b_fact": [
      "AZD8601 is a small molecule inhibitor of the enzyme phosphoinositide-3-kinase (PI3K) delta.",
      "In vivo studies have indicated that AZD8601 can inhibit the PI3K delta pathway in various types of cancer cells.",
      "AZD8601 has been observed to decrease cell proliferation, migration, and invasion in cancer cells.",
      "AZD8601 can induce apoptosis in cancer cells.",
      "AZD8601 has anti-angiogenic effects, which can inhibit the formation of new blood vessels in tumors."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: AZD8601 is not a small molecule inhibitor of PI3K delta; it is an mRNA-based therapy designed to encode for vascular endothelial growth factor A (VEGF-A) as a novel therapeutic strategy for heart disease.\n2. UNKNOWN: Without specific in vivo study references, it is difficult to confirm the effects of AZD8601 on the PI3K delta pathway in various types of cancer cells, especially since AZD8601 is primarily associated with heart disease therapy.\n3. UNKNOWN: Given that AZD8601 is designed for heart disease and not as a cancer treatment, the statement regarding its effects on cancer cell proliferation, migration, and invasion is difficult to verify without specific study references.\n4. UNKNOWN: Similar to the previous statements, without specific references, it is difficult to confirm whether AZD8601 can induce apoptosis in cancer cells.\n5. UNKNOWN: While anti-angiogenic effects are relevant to cancer treatment, AZD8601 is designed to promote angiogenesis in the context of heart disease by encoding VEGF-A. Therefore, without specific references, it is unclear whether AZD8601 has anti-angiogenic effects in the context of tumor blood vessel formation.",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "vicuna-7b_response": "SAHFS, or Secure Access to Healthcare Facilities and Systems, are created through a process called \"decentralization.\" Decentralization is the process of moving data and services from a centralized location to a distributed network of computers.\nIn the case of SAHFS, the decentralization process involves creating a network of computers that are connected to each other and to the internet. These computers are typically located in healthcare facilities, such as hospitals and clinics, and are used to store and process patient data.\nOnce the network is set up, the next step is to create a secure and reliable way for patients to access their data. This is typically done through the use of blockchain technology, which allows for secure and transparent data storage and sharing.\nIn addition to blockchain, other technologies such as encryption, access control, and auditing are used to ensure the security and privacy of patient data.\nIt's important to note that the process of creating SAHFS is complex and requires a significant amount of planning, implementation and maintenance. It's also important to note that the process of creating SAHFS is not only limited to healthcare facilities, but it can also be applied to other industries as well.",
    "vicuna-7b_fact_raw": "1. SAHFS stands for Secure Access to Healthcare Facilities and Systems.\n2. The creation of SAHFS involves a process called \"decentralization.\"\n3. Decentralization in the context of SAHFS involves moving data and services to a distributed network of computers.\n4. Blockchain technology is used in SAHFS to allow for secure and transparent data storage and sharing.\n5. Technologies such as encryption, access control, and auditing are also used to ensure the security and privacy of patient data in SAHFS.",
    "vicuna-7b_fact": [
      "SAHFS stands for Secure Access to Healthcare Facilities and Systems.",
      "The creation of SAHFS involves a process called \"decentralization.\"",
      "Decentralization in the context of SAHFS involves moving data and services to a distributed network of computers.",
      "Blockchain technology is used in SAHFS to allow for secure and transparent data storage and sharing.",
      "Technologies such as encryption, access control, and auditing are also used to ensure the security and privacy of patient data in SAHFS."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: SAHFS is not a recognized acronym for Secure Access to Healthcare Facilities and Systems. Without additional context, the true meaning of SAHFS cannot be determined.\n2. UNKNOWN: Without specific context about what SAHFS stands for, it is not possible to confirm whether its creation involves a process called \"decentralization.\"\n3. UNKNOWN: Similarly, without knowing what SAHFS refers to, it cannot be determined if decentralization in this context involves moving data and services to a distributed network of computers.\n4. UNKNOWN: Without clear context, it cannot be confirmed that blockchain technology is used in SAHFS for secure and transparent data storage and sharing.\n5. UNKNOWN: Without additional information, it cannot be verified that technologies such as encryption, access control, and auditing are used within SAHFS to ensure the security and privacy of patient data.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "vicuna-7b_response": "The PDZ domain is a protein interaction domain that plays a role in regulating the localization and stability of proteins. The SATB1 protein, also known as special AT-rich sequence binding protein 1, is a nuclear protein that is involved in the regulation of chromatin structure and transcription. The PDZ domain in SATB1 is thought to interact with other proteins and play a role in the regulation of SATB1's function. For example, the PDZ domain in SATB1 has been shown to interact with the protein hDlg, which is involved in the regulation of chromatin structure and transcription. Additionally, the PDZ domain in SATB1 has been shown to interact with the protein CASZ1, which is involved in the regulation of chromatin structure and transcription.",
    "vicuna-7b_fact_raw": "1. The PDZ domain is a protein interaction domain involved in regulating the localization and stability of proteins.\n2. SATB1, or special AT-rich sequence binding protein 1, is a nuclear protein.\n3. SATB1 is involved in the regulation of chromatin structure and transcription.\n4. The PDZ domain in SATB1 has been shown to interact with the protein hDlg.\n5. The PDZ domain in SATB1 has been shown to interact with the protein CASZ1.",
    "vicuna-7b_fact": [
      "The PDZ domain is a protein interaction domain involved in regulating the localization and stability of proteins.",
      "SATB1, or special AT-rich sequence binding protein 1, is a nuclear protein.",
      "SATB1 is involved in the regulation of chromatin structure and transcription.",
      "The PDZ domain in SATB1 has been shown to interact with the protein hDlg.",
      "The PDZ domain in SATB1 has been shown to interact with the protein CASZ1."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: SATB1 does not contain a PDZ domain; therefore, it does not interact with hDlg through a PDZ domain. hDlg is known to interact with proteins through its PDZ domain, but SATB1 is not reported to be one of its interacting partners via this domain.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "vicuna-7b_response": "The BLISS technique is based on the principles of behaviorism, specifically on the idea that behavior is acquired through learning and can be shaped and changed through reinforcement and punishment. The BLISS technique is a type of behavioral therapy that aims to help individuals with substance use disorders by teaching them new behaviors and skills that can replace their substance-using behaviors.\nThe BLISS technique stands for Brief Life-Space Intervention Supporting Sobriety, and it was developed by Dr. Mark Willenbring, a psychiatrist and addiction specialist. The technique is based on the idea that addiction is a chronic disease that requires ongoing management and support.\nThe BLISS technique involves a brief intervention that is delivered in a single session, usually in a primary care setting. The intervention is designed to help individuals identify and change their substance-using behaviors by teaching them new coping skills and strategies.\nThe BLISS technique is based on the principles of motivational interviewing, which is a counseling style that focuses on helping individuals identify their own motivation for change and developing a plan for achieving their goals. The technique also incorporates elements of cognitive-behavioral therapy, which aims to help individuals identify and change negative thoughts and beliefs that may be contributing to their substance use.\nOverall, the BLISS technique is a brief, evidence-based intervention that can be effective in helping individuals with substance use disorders achieve and maintain sobriety.",
    "vicuna-7b_fact_raw": "1. The BLISS technique is based on the principles of behaviorism.\n2. The BLISS technique was developed by Dr. Mark Willenbring, a psychiatrist and addiction specialist.\n3. The BLISS technique is designed as a brief intervention delivered in a single session.\n4. The BLISS technique incorporates elements of motivational interviewing.\n5. The BLISS technique also includes aspects of cognitive-behavioral therapy.",
    "vicuna-7b_fact": [
      "The BLISS technique is based on the principles of behaviorism.",
      "The BLISS technique was developed by Dr. Mark Willenbring, a psychiatrist and addiction specialist.",
      "The BLISS technique is designed as a brief intervention delivered in a single session.",
      "The BLISS technique incorporates elements of motivational interviewing.",
      "The BLISS technique also includes aspects of cognitive-behavioral therapy."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific context or additional information about the BLISS technique, it is not possible to determine the accuracy of these statements. The BLISS technique is not a widely recognized term in the field of psychology or psychiatry as of my knowledge cutoff date, and without further details, I cannot verify these claims or provide corrections.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "vicuna-7b_response": "NK3R antagonists are drugs that block the action of the NK3 receptor, which is a type of receptor found on cells in the nervous system. Here are three examples of NK3R antagonists:\n1. APD334: APD334 is a selective NK3R antagonist that is being developed for the treatment of pain. It has been shown to be effective in reducing pain in animal models and has been tested in clinical trials for the treatment of chronic pain.\n2. Tegoprazan: Tegoprazan is another selective NK3R antagonist that is used to treat acute and chronic pain. It has been shown to be effective in reducing pain in animal models and has been approved for use in several countries for the treatment of acute pain.\n3. SB-277011: SB-277011 is a selective NK3R antagonist that is being developed for the treatment of chronic pain. It has been shown to be effective in reducing pain in animal models and has been tested in clinical trials for the treatment of chronic pain.",
    "vicuna-7b_fact_raw": "1. APD334 is a selective NK3R antagonist being developed for the treatment of pain.\n2. Tegoprazan is a selective NK3R antagonist used to treat acute and chronic pain.\n3. SB-277011 is a selective NK3R antagonist being developed for the treatment of chronic pain.",
    "vicuna-7b_fact": [
      "APD334 is a selective NK3R antagonist being developed for the treatment of pain.",
      "Tegoprazan is a selective NK3R antagonist used to treat acute and chronic pain.",
      "SB-277011 is a selective NK3R antagonist being developed for the treatment of chronic pain."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Tegoprazan is not a selective NK3R antagonist; it is a potassium-competitive acid blocker (P-CAB) used for the treatment of gastroesophageal reflux disease (GERD) and peptic ulcers.\n3. UNKNOWN",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "vicuna-7b_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is known as Liraglutide. Liraglutide is a GLP-1 receptor agonist that also acts as a ghrelin receptor inverse agonist. It is used in the treatment of type 2 diabetes and obesity. Liraglutide is marketed under the brand name Victoza by Novo Nordisk.",
    "vicuna-7b_fact_raw": "1. Liraglutide is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.\n2. Liraglutide is a GLP-1 receptor agonist.\n3. Liraglutide is used in the treatment of type 2 diabetes and obesity.\n4. Liraglutide is marketed under the brand name Victoza.\n5. Novo Nordisk is the company that markets Liraglutide under the brand name Victoza.",
    "vicuna-7b_fact": [
      "Liraglutide is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "Liraglutide is a GLP-1 receptor agonist.",
      "Liraglutide is used in the treatment of type 2 diabetes and obesity.",
      "Liraglutide is marketed under the brand name Victoza.",
      "Novo Nordisk is the company that markets Liraglutide under the brand name Victoza."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Liraglutide is not an oral ghrelin receptor inverse agonist; it is an injectable GLP-1 receptor agonist.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "vicuna-7b_response": "Vaxchora is a vaccine that is approved for the prevention of cholera caused by the serogroup Ogawa in individuals aged 18 years or older. The vaccine is administered as a single dose and is estimated to provide protection against cholera for up to 5 years.\nStudies have shown that Vaxchora is effective in preventing cholera caused by the serogroup Ogawa. In a clinical trial, the vaccine was found to be 77% effective in preventing symptomatic cholera and 87% effective in preventing severe cholera.\nIt is important to note that Vaxchora is not approved for use in individuals under the age of 18, and its effectiveness may vary in individuals with underlying health conditions. It is also important to follow the recommended dosing schedule and to consult with a healthcare provider before receiving the vaccine.",
    "vicuna-7b_fact_raw": "1. Vaxchora is approved for the prevention of cholera caused by the serogroup Ogawa in individuals aged 18 years or older.\n2. The vaccine is administered as a single dose.\n3. Vaxchora is estimated to provide protection against cholera for up to 5 years.\n4. In a clinical trial, Vaxchora was found to be 77% effective in preventing symptomatic cholera.\n5. The same clinical trial found Vaxchora to be 87% effective in preventing severe cholera.",
    "vicuna-7b_fact": [
      "Vaxchora is approved for the prevention of cholera caused by the serogroup Ogawa in individuals aged 18 years or older.",
      "The vaccine is administered as a single dose.",
      "Vaxchora is estimated to provide protection against cholera for up to 5 years.",
      "In a clinical trial, Vaxchora was found to be 77% effective in preventing symptomatic cholera.",
      "The same clinical trial found Vaxchora to be 87% effective in preventing severe cholera."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Vaxchora is estimated to provide protection against cholera for up to 3 years in adults.\n4. UNKNOWN\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "vicuna-7b_response": "The first cholera vaccine approved in the US was the killed whole-cell cholera vaccine, also known as the Dukor-Smith vaccine. It was licensed for use in 1914 and was the first cholera vaccine to be widely used in the United States. The vaccine was developed by Dr. Paul Dukor and Dr. Charles Smith and was made from a killed preparation of the bacteria that causes cholera. It was administered orally and was effective against both classical and El Tor strains of cholera. The vaccine was later replaced by more effective vaccines, but it played an important role in the control of cholera in the United States.",
    "vicuna-7b_fact_raw": "1. The first cholera vaccine approved in the US was known as the killed whole-cell cholera vaccine or the Dukor-Smith vaccine.\n2. The Dukor-Smith vaccine was licensed for use in 1914.\n3. Dr. Paul Dukor and Dr. Charles Smith developed the first cholera vaccine approved in the US.\n4. The vaccine was made from a killed preparation of the bacteria that causes cholera.\n5. The Dukor-Smith vaccine was effective against both classical and El Tor strains of cholera.",
    "vicuna-7b_fact": [
      "The first cholera vaccine approved in the US was known as the killed whole-cell cholera vaccine or the Dukor-Smith vaccine.",
      "The Dukor-Smith vaccine was licensed for use in 1914.",
      "Dr. Paul Dukor and Dr. Charles Smith developed the first cholera vaccine approved in the US.",
      "The vaccine was made from a killed preparation of the bacteria that causes cholera.",
      "The Dukor-Smith vaccine was effective against both classical and El Tor strains of cholera."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE - The first cholera vaccines were indeed made from a killed preparation of the Vibrio cholerae bacteria.\n5. UNKNOWN\n\nNote: The first cholera vaccine was developed long before 1914, and the names \"Dukor-Smith\" do not correspond with historical records of cholera vaccine development. The actual development of cholera vaccines involved several researchers over time, with early work dating back to the 19th century. However, without specific historical context or additional information, the veracity of the names \"Dukor\" and \"Smith\" and the year 1914 cannot be confirmed.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "vicuna-7b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is the Fc receptor 3B (FcR3B) gene.\nCVID is a primary immunodeficiency disorder characterized by reduced levels of immunoglobulins (IgG, IgA, and IgM) and an increased susceptibility to infections. CVID can be caused by both genetic and environmental factors. Monogenic causes of CVID are rare, but they account for about 10-15% of all cases.\nThe FcR3B gene provides instructions for making a protein called Fc receptor 3B, which is involved in the clearance of immune complexes from the blood. Mutations in the FcR3B gene can lead to reduced levels of Fc receptor 3B protein, which can result in the accumulation of immune complexes in the blood and a reduced ability to clear them. This can lead to the symptoms of CVID, including recurrent infections, low levels of immunoglobulins, and autoimmune disorders.\nThe FcR3B gene is located on chromosome 11q23.3 and is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated gene (one from each parent) to develop CVID caused by FcR3B mutations.\nIt is important to note that there are other genetic and environmental factors that can cause CVID, and the diagnosis of CVID should be made by a qualified healthcare professional based on a thorough clinical evaluation and laboratory testing.",
    "vicuna-7b_fact_raw": "1. The Fc receptor 3B (FcR3B) gene is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.\n2. CVID is characterized by reduced levels of immunoglobulins (IgG, IgA, and IgM) and an increased susceptibility to infections.\n3. Monogenic causes account for about 10-15% of all CVID cases.\n4. The FcR3B gene is located on chromosome 11q23.3.\n5. The FcR3B gene is inherited in an autosomal recessive manner, requiring two copies of the mutated gene for the development of CVID caused by FcR3B mutations.",
    "vicuna-7b_fact": [
      "The Fc receptor 3B (FcR3B) gene is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.",
      "CVID is characterized by reduced levels of immunoglobulins (IgG, IgA, and IgM) and an increased susceptibility to infections.",
      "Monogenic causes account for about 10-15% of all CVID cases.",
      "The FcR3B gene is located on chromosome 11q23.3.",
      "The FcR3B gene is inherited in an autosomal recessive manner, requiring two copies of the mutated gene for the development of CVID caused by FcR3B mutations."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is not well-established, and while mutations in various genes including TNFRSF13B (TACI), ICOS, and others have been implicated in CVID, FcR3B is not recognized as the most common monogenic cause.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The FcR3B gene, also known as FCGR3B, is located on chromosome 1q23.3, not chromosome 11q23.3.\n5. UNKNOWN",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "vicuna-7b_response": "The IFIT1 gene, also known as interferon, alpha-2, is a gene that encodes for a protein called interferon-alpha-2. Interferon-alpha-2 is a type of interferon, which is a group of signaling proteins that are produced by cells in response to viral infections or other harmful stimuli.\nIn the context of Systemic Lupus Erythematosus (SLE), the role of IFIT1 gene is not well understood. However, some studies have suggested that IFIT1 gene may play a role in the development of SLE.\nOne study published in the journal Arthritis Research & Therapy in 2018 found that individuals with SLE had lower levels of IFIT1 gene expression in their peripheral blood mononuclear cells compared to healthy controls. Additionally, another study published in the journal Rheumatology in 2019 found that IFIT1 gene may be associated with the development of lupus nephritis, a complication of SLE that affects the kidneys.\nHowever, more research is needed to fully understand the role of IFIT1 gene in the development and progression of SLE.",
    "vicuna-7b_fact_raw": "1. The IFIT1 gene encodes for a protein called interferon-alpha-2.\n2. Interferon-alpha-2 is a type of interferon produced by cells in response to viral infections or other harmful stimuli.\n3. Some studies suggest that the IFIT1 gene may play a role in the development of Systemic Lupus Erythematosus (SLE).\n4. A study published in Arthritis Research & Therapy in 2018 found that individuals with SLE had lower levels of IFIT1 gene expression in their peripheral blood mononuclear cells compared to healthy controls.\n5. Research published in the journal Rheumatology in 2019 suggested that the IFIT1 gene may be associated with the development of lupus nephritis, a kidney complication of SLE.",
    "vicuna-7b_fact": [
      "The IFIT1 gene encodes for a protein called interferon-alpha-2.",
      "Interferon-alpha-2 is a type of interferon produced by cells in response to viral infections or other harmful stimuli.",
      "Some studies suggest that the IFIT1 gene may play a role in the development of Systemic Lupus Erythematosus (SLE).",
      "A study published in Arthritis Research & Therapy in 2018 found that individuals with SLE had lower levels of IFIT1 gene expression in their peripheral blood mononuclear cells compared to healthy controls.",
      "Research published in the journal Rheumatology in 2019 suggested that the IFIT1 gene may be associated with the development of lupus nephritis, a kidney complication of SLE."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: The IFIT1 gene encodes for a protein called Interferon-Induced Protein with Tetratricopeptide Repeats 1, not interferon-alpha-2.\n2. TRUE\n3. TRUE\n4. UNKNOWN (without access to the specific study, the statement's accuracy cannot be verified)\n5. UNKNOWN (without access to the specific research article, the statement's accuracy cannot be verified)",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "vicuna-7b_response": "The Liverpool Elbow Score (LES) is a clinical scoring system used to assess the severity of elbow pain in patients with elbow osteoarthritis. It is a simple, reliable, and valid tool that can be used in clinical practice to assess the functional status of patients with elbow osteoarthritis.\nThe LES is based on the patient's ability to perform five tasks with their affected elbow:\n1. Flexion: The patient is asked to bend their elbow to 90 degrees.\n2. Extension: The patient is asked to straighten their elbow.\n3. Internal rotation: The patient is asked to rotate their forearm so that their little finger faces forward.\n4. External rotation: The patient is asked to rotate their forearm so that their little finger faces backward.\n5. Pronation: The patient is asked to bend and straighten their wrist.\nEach task is scored on a scale of 0 to 3, with 0 indicating complete loss of function and 3 indicating normal function. The scores for each task are then added together to give a total LES score, which ranges from 0 to 15.\nThe LES has been shown to be a reliable and valid tool for assessing the functional status of patients with elbow osteoarthritis. It can be used to monitor the progress of patients over time and to guide treatment decisions, such as the need for surgical intervention.\nIn summary, the Liverpool Elbow Score is a clinical scoring system used to assess the severity of elbow pain in patients with elbow osteoarthritis. It is based on the patient's ability to perform five tasks with their affected elbow and provides a simple, reliable, and valid tool for assessing the functional status of patients with elbow osteoarthritis.",
    "vicuna-7b_fact_raw": "1. The Liverpool Elbow Score (LES) is used to assess the severity of elbow pain in patients with elbow osteoarthritis.\n2. The LES is a clinical scoring system that assesses the functional status of patients with elbow osteoarthritis.\n3. The LES involves the patient's ability to perform five tasks with their affected elbow, including flexion, extension, internal rotation, external rotation, and pronation.\n4. Each task in the LES is scored on a scale of 0 to 3, with 0 indicating complete loss of function and 3 indicating normal function.\n5. The total LES score ranges from 0 to 15, with higher scores indicating better elbow function.",
    "vicuna-7b_fact": [
      "The Liverpool Elbow Score (LES) is used to assess the severity of elbow pain in patients with elbow osteoarthritis.",
      "The LES is a clinical scoring system that assesses the functional status of patients with elbow osteoarthritis.",
      "The LES involves the patient's ability to perform five tasks with their affected elbow, including flexion, extension, internal rotation, external rotation, and pronation.",
      "Each task in the LES is scored on a scale of 0 to 3, with 0 indicating complete loss of function and 3 indicating normal function.",
      "The total LES score ranges from 0 to 15, with higher scores indicating better elbow function."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Liverpool Elbow Score (LES) involves the patient's ability to perform tasks with their affected elbow, but the specific tasks are not limited to or necessarily include flexion, extension, internal rotation, external rotation, and pronation. The LES typically assesses pain, function, and movement, but the exact tasks may vary.\n4. UNKNOWN: Without specific reference to the LES scoring criteria, it is not possible to confirm the scoring scale.\n5. UNKNOWN: Without specific reference to the LES scoring criteria, it is not possible to confirm the total score range.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "vicuna-7b_response": "The 100,000 Genomes Project is a UK-based initiative that aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases. The project was launched in 2012 and is expected to be completed by 2021.\nIn terms of sarcoma, the 100,000 Genomes Project has made significant efforts to sequence sarcoma patients' genomes. The project has identified several genetic mutations that are specific to sarcoma, including those that are associated with poor prognosis.\nOne of the key findings from the 100,000 Genomes Project is that sarcoma is a highly genetically diverse disease, with many different genetic mutations present in different patients. This diversity makes it difficult to develop targeted therapies for sarcoma, but it also presents an opportunity to identify new therapeutic targets.\nThe 100,000 Genomes Project has also identified several genetic subtypes of sarcoma, each with its own unique set of genetic mutations. This has allowed researchers to develop more personalized treatment plans for patients based on their specific genetic profile.\nOverall, the 100,000 Genomes Project has made significant progress in understanding the genetic basis of sarcoma and has paved the way for the development of new and more effective treatments for this disease.",
    "vicuna-7b_fact_raw": "1. The 100,000 Genomes Project is a UK-based initiative that aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases.\n2. The project was launched in 2012 and was expected to be completed by 2021.\n3. The 100,000 Genomes Project has identified several genetic mutations specific to sarcoma.\n4. The project has revealed that sarcoma is a highly genetically diverse disease.\n5. Genetic subtypes of sarcoma have been identified by the 100,000 Genomes Project, enabling more personalized treatment plans.",
    "vicuna-7b_fact": [
      "The 100,000 Genomes Project is a UK-based initiative that aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases.",
      "The project was launched in 2012 and was expected to be completed by 2021.",
      "The 100,000 Genomes Project has identified several genetic mutations specific to sarcoma.",
      "The project has revealed that sarcoma is a highly genetically diverse disease.",
      "Genetic subtypes of sarcoma have been identified by the 100,000 Genomes Project, enabling more personalized treatment plans."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The 100,000 Genomes Project was launched in 2013 and was expected to be completed by the end of 2018.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "vicuna-7b_response": "Protein ALEX1 is a protein that is involved in various cellular processes, including DNA repair, transcriptional regulation, and cell cycle progression. However, I do not have information on whether protein ALEX1 contains armadillo repeats.\nArmadillo repeats are a type of protein domain that is composed of a series of repeating units of approximately 60 amino acids. They are named after the armadillo, which has a similar structure. Armadillo repeats are found in a variety of proteins, including some that are involved in cellular processes such as DNA repair and transcriptional regulation. However, I do not have information on whether protein ALEX1 contains armadillo repeats.\nIf you have any additional information about protein ALEX1, such as its amino acid sequence or the experimental techniques used to study it, I may be able to provide more information.",
    "vicuna-7b_fact_raw": "1. Protein ALEX1 is involved in various cellular processes including DNA repair, transcriptional regulation, and cell cycle progression.\n2. Armadillo repeats are composed of a series of repeating units of approximately 60 amino acids.\n3. Armadillo repeats are named after the armadillo due to a similar structure.\n4. Proteins with armadillo repeats are involved in cellular processes such as DNA repair and transcriptional regulation.",
    "vicuna-7b_fact": [
      "Protein ALEX1 is involved in various cellular processes including DNA repair, transcriptional regulation, and cell cycle progression.",
      "Armadillo repeats are composed of a series of repeating units of approximately 60 amino acids.",
      "Armadillo repeats are named after the armadillo due to a similar structure.",
      "Proteins with armadillo repeats are involved in cellular processes such as DNA repair and transcriptional regulation."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: Armadillo repeats are named after the armadillo protein in fruit flies (Drosophila), not due to a similar structure to the animal.\n4. TRUE",
    "vicuna-7b_judge": [
      "unknown",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "vicuna-7b_response": "There are several enzymes that remove histone modifications from chromatin. Here are some examples:\n1. Histone deacetylases (HDACs): HDACs remove acetyl groups from histone tails, leading to a more compact chromatin structure. Some examples of HDACs include HDAC1, HDAC2, HDAC3, HDAC8, and HDAC9.\n2. Histone demethylases: Histone demethylases remove methyl groups from histone tails, leading to a more open chromatin structure. Some examples of histone demethylases include JMJD3, JMJD6, and KDM6A.\n3. Histone methyltransferases: Histone methyltransferases add methyl groups to histone tails, leading to a more compact chromatin structure. Some examples of histone methyltransferases include SETDB1, SET7, and KMT2A (also known as MLL).\n4. Chromatin remodeling complexes: Chromatin remodeling complexes, such as the SWI/SNF complex and the ISWI complex, can remove histone modifications by altering the structure of chromatin.\nOverall, the removal of histone modifications by enzymes is an important process in regulating chromatin structure and gene expression.",
    "vicuna-7b_fact_raw": "1. Histone deacetylases (HDACs) remove acetyl groups from histone tails.\n2. Examples of HDACs include HDAC1, HDAC2, HDAC3, HDAC8, and HDAC9.\n3. Histone demethylases remove methyl groups from histone tails.\n4. Examples of histone demethylases include JMJD3, JMJD6, and KDM6A.\n5. Chromatin remodeling complexes, such as the SWI/SNF complex and the ISWI complex, can remove histone modifications.",
    "vicuna-7b_fact": [
      "Histone deacetylases (HDACs) remove acetyl groups from histone tails.",
      "Examples of HDACs include HDAC1, HDAC2, HDAC3, HDAC8, and HDAC9.",
      "Histone demethylases remove methyl groups from histone tails.",
      "Examples of histone demethylases include JMJD3, JMJD6, and KDM6A.",
      "Chromatin remodeling complexes, such as the SWI/SNF complex and the ISWI complex, can remove histone modifications."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Chromatin remodeling complexes, such as the SWI/SNF complex and the ISWI complex, do not remove histone modifications. Instead, they reposition nucleosomes on DNA to regulate access to chromosomal DNA, thereby affecting gene expression.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "vicuna-7b_response": "Head CT scans are a type of medical imaging test that uses X-rays to create detailed images of the brain and surrounding structures. While head CT scans are generally considered safe, they do have some risks associated with them.\nOne potential risk of head CT scans is the possibility of developing a brain tumor as a result of exposure to radiation. However, the risk of developing a brain tumor from a head CT scan is relatively low, and the benefits of the test typically outweigh the risks in most cases.\nThe risk of developing a brain tumor from a head CT scan is generally considered to be low, especially when compared to the risks associated with other medical procedures. However, the risk increases with the number of CT scans a person has undergone, and with the use of other radiation-based medical procedures.\nIt is important to note that head CT scans are typically only recommended when medically necessary, and that other diagnostic tests may be used in some cases to diagnose and treat brain conditions. If you are concerned about the risks associated with head CT scans, it is important to discuss your concerns with your healthcare provider. They can help you determine the best course of action for your individual situation.",
    "vicuna-7b_fact_raw": "1. Head CT scans use X-rays to create detailed images of the brain and surrounding structures.\n2. There is a potential risk of developing a brain tumor from exposure to radiation during a head CT scan.\n3. The risk of developing a brain tumor from a head CT scan is considered to be relatively low.\n4. The risk of developing a brain tumor increases with the number of CT scans a person has undergone.\n5. Head CT scans are typically recommended only when medically necessary.",
    "vicuna-7b_fact": [
      "Head CT scans use X-rays to create detailed images of the brain and surrounding structures.",
      "There is a potential risk of developing a brain tumor from exposure to radiation during a head CT scan.",
      "The risk of developing a brain tumor from a head CT scan is considered to be relatively low.",
      "The risk of developing a brain tumor increases with the number of CT scans a person has undergone.",
      "Head CT scans are typically recommended only when medically necessary."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "vicuna-7b_response": "Otx2 is associated with the pluripotent state of embryonic stem cells. Otx2 is a transcription factor that plays a crucial role in the regulation of embryonic stem cell self-renewal and differentiation. It has been shown to be essential for the maintenance of pluripotency in embryonic stem cells and for the generation of differentiated cell types. Otx2 is also involved in the regulation of gene expression in the developing nervous system, and it has been shown to be expressed in a variety of cell types, including neural stem cells, germ cells, and cancer cells.",
    "vicuna-7b_fact_raw": "1. Otx2 is associated with the pluripotent state of embryonic stem cells.\n2. Otx2 is a transcription factor that regulates embryonic stem cell self-renewal and differentiation.\n3. Otx2 is essential for the maintenance of pluripotency in embryonic stem cells.\n4. Otx2 is involved in the regulation of gene expression in the developing nervous system.\n5. Otx2 is expressed in neural stem cells, germ cells, and cancer cells.",
    "vicuna-7b_fact": [
      "Otx2 is associated with the pluripotent state of embryonic stem cells.",
      "Otx2 is a transcription factor that regulates embryonic stem cell self-renewal and differentiation.",
      "Otx2 is essential for the maintenance of pluripotency in embryonic stem cells.",
      "Otx2 is involved in the regulation of gene expression in the developing nervous system.",
      "Otx2 is expressed in neural stem cells, germ cells, and cancer cells."
    ],
    "vicuna-7b_judge_raw": "1. TRUE: Otx2 is indeed associated with the pluripotent state of embryonic stem cells.\n2. TRUE: Otx2 is a transcription factor that has been shown to regulate embryonic stem cell self-renewal and differentiation.\n3. FALSE [correction]: While Otx2 plays a role in the pluripotent state of embryonic stem cells, it is not considered essential for the maintenance of pluripotency. Factors like Oct4, Sox2, and Nanog are more closely associated with the essential maintenance of pluripotency.\n4. TRUE: Otx2 is involved in the regulation of gene expression in the developing nervous system, playing a critical role in brain and eye development.\n5. TRUE: Otx2 is expressed in various cell types, including neural stem cells and certain cancer cells. Its expression in germ cells is not as widely recognized or may be context-dependent, so without specific context, this statement is generally considered true.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "vicuna-7b_response": "The murine beta globin locus region contains a large number of DNaseI hypersensitive sites (DHS). The exact number of DHS in the murine beta globin locus region can vary depending on the study and the method used to identify DHS.\nOne study using chromatin immunoprecipitation (ChIP) and DNaseI sequencing to identify DHS in the murine beta globin locus region reported the presence of over 100 DHS in this region [1]. Another study using a similar approach reported the presence of over 50 DHS in the murine beta globin locus region [2].\nIt is worth noting that the number of DHS in the murine beta globin locus region may be different in other studies, as different methods and conditions can lead to different results.\nReferences:\n1. Liu JS, et al. Genome-wide analysis of DNase I hypersensitivity in the mouse beta-globin locus. Genome Res. 2005;15(1):10-18.\n2. Zhang Y, et al. Genome-wide analysis of DNase I hypersensitivity in the mouse beta-globin locus. Genome Res. 2005;15(1):10-18.",
    "vicuna-7b_fact_raw": "1. The murine beta globin locus region contains a large number of DNaseI hypersensitive sites (DHS).\n2. One study reported the presence of over 100 DHS in the murine beta globin locus region.\n3. Another study reported the presence of over 50 DHS in the murine beta globin locus region.\n4. The exact number of DHS can vary depending on the study and the method used to identify them.\n5. Chromatin immunoprecipitation (ChIP) and DNaseI sequencing are methods used to identify DHS in the murine beta globin locus region.",
    "vicuna-7b_fact": [
      "The murine beta globin locus region contains a large number of DNaseI hypersensitive sites (DHS).",
      "One study reported the presence of over 100 DHS in the murine beta globin locus region.",
      "Another study reported the presence of over 50 DHS in the murine beta globin locus region.",
      "The exact number of DHS can vary depending on the study and the method used to identify them.",
      "Chromatin immunoprecipitation (ChIP) and DNaseI sequencing are methods used to identify DHS in the murine beta globin locus region."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: Chromatin immunoprecipitation (ChIP) is a method used to study protein-DNA interactions and would not typically be used to identify DNaseI hypersensitive sites. DNaseI sequencing (DNase-seq) is a method used to identify DHS.",
    "vicuna-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "vicuna-7b_response": "Sure, here are some European influenza vaccines:\n1. Fluarix: This is a trivalent influenza vaccine that protects against three strains of influenza virus: an A strain (usually an A/H1N1 strain), an A strain (usually an A/H3N2 strain), and a B strain (usually a B/Yamagata or B/Victoria strain). Fluarix is manufactured by GlaxoSmithKline.\n2. Fluzone: This is a trivalent influenza vaccine that protects against the same three strains of influenza virus as Fluarix. Fluzone is also manufactured by GlaxoSmithKline.\n3. Fluvirin: This is a trivalent influenza vaccine that protects against the same three strains of influenza virus as Fluarix and Fluzone. Fluvirin is manufactured by Seqirus.\n4. Fluad: This is a quadrivalent influenza vaccine that protects against four strains of influenza virus: two A strains (an A/H3N2 strain and an A/H1N1 strain) and two B strains (a B/Victoria strain and a B/Yamagata strain). Fluad is manufactured by Novartis.\n5. FluLaval: This is a trivalent influenza vaccine that protects against three strains of influenza virus: an A strain (usually an A/H1N1 strain), an A strain (usually an A/H3N2 strain), and a B strain (usually a B/Yamagata or B/Victoria strain). FluLaval is manufactured by Sanofi Pasteur.\n6. FluMist: This is a live attenuated influenza vaccine that protects against three strains of influenza virus: an A strain (usually an A/H1N1 strain), an A strain (usually an A/H3N2 strain), and a B strain (usually a B/Victoria strain). FluMist is manufactured by MedImm",
    "vicuna-7b_fact_raw": "1. Fluarix is a trivalent influenza vaccine manufactured by GlaxoSmithKline.\n2. Fluzone is a trivalent influenza vaccine also manufactured by GlaxoSmithKline.\n3. Fluvirin is a trivalent influenza vaccine manufactured by Seqirus.\n4. Fluad is a quadrivalent influenza vaccine manufactured by Novartis.\n5. FluLaval is a trivalent influenza vaccine manufactured by Sanofi Pasteur.",
    "vicuna-7b_fact": [
      "Fluarix is a trivalent influenza vaccine manufactured by GlaxoSmithKline.",
      "Fluzone is a trivalent influenza vaccine also manufactured by GlaxoSmithKline.",
      "Fluvirin is a trivalent influenza vaccine manufactured by Seqirus.",
      "Fluad is a quadrivalent influenza vaccine manufactured by Novartis.",
      "FluLaval is a trivalent influenza vaccine manufactured by Sanofi Pasteur."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Fluzone is a trivalent (and also available in quadrivalent formulations) influenza vaccine manufactured by Sanofi Pasteur.\n3. TRUE\n4. FALSE [correction]: Fluad is a trivalent or quadrivalent influenza vaccine, depending on the formulation, manufactured by Seqirus.\n5. FALSE [correction]: FluLaval is available in both trivalent and quadrivalent formulations and is manufactured by GlaxoSmithKline.",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "vicuna-7b_response": "Yes, the Paramyxovirus geneome is segmented and negative-sense RNA.\nParamyxoviruses are a type of virus that infects mammals and birds. They have a single-stranded, negative-sense RNA genome, which means that the nucleotide sequence of the RNA is complementary to that of the virus's mRNA. The negative-sense RNA is synthesized in the nucleus of the infected cell and is then transported to the cytoplasm, where it is translated into proteins by the ribosomes.\nParamyxoviruses are further classified into two genera: Pneumovirinae and Rubulavirinae. Pneumovirinae includes the respiratory syncytial virus (RSV), which is a major cause of respiratory illness in children, and the metapneumovirus, which causes respiratory disease in pigs. Rubulavirinae includes the measles virus, which is a highly contagious disease that causes fever, cough, and rash.\nThe Paramyxovirus genome is segmented, meaning that it is composed of several smaller RNA segments that are produced by the viral RNA-dependent RNA polymerase. These segments are then assembled into a single genome during the replication process. The segmented nature of the Paramyxovirus genome allows the virus to evolve and adapt to new hosts and environments more quickly than a single, continuous genome would.",
    "vicuna-7b_fact_raw": "1. Paramyxoviruses have a single-stranded, negative-sense RNA genome.\n2. The nucleotide sequence of the Paramyxovirus RNA is complementary to that of the virus's mRNA.\n3. Paramyxoviruses infect mammals and birds.\n4. The respiratory syncytial virus (RSV), which causes respiratory illness in children, is classified under the Pneumovirinae genus of Paramyxoviruses.\n5. The measles virus, which causes fever, cough, and rash, is classified under the Rubulavirinae genus of Paramyxoviruses.",
    "vicuna-7b_fact": [
      "Paramyxoviruses have a single-stranded, negative-sense RNA genome.",
      "The nucleotide sequence of the Paramyxovirus RNA is complementary to that of the virus's mRNA.",
      "Paramyxoviruses infect mammals and birds.",
      "The respiratory syncytial virus (RSV), which causes respiratory illness in children, is classified under the Pneumovirinae genus of Paramyxoviruses.",
      "The measles virus, which causes fever, cough, and rash, is classified under the Rubulavirinae genus of Paramyxoviruses."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The respiratory syncytial virus (RSV), which causes respiratory illness in children, is classified under the Pneumoviridae family, but not under the Pneumovirinae genus of Paramyxoviruses. It is classified under the Orthopneumovirus genus.\n5. FALSE [correction]: The measles virus, which causes fever, cough, and rash, is classified under the Morbillivirus genus of Paramyxoviruses, not the Rubulavirinae genus.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "vicuna-7b_response": "Roflumilast cream is a topical medication that is used to treat atopic dermatitis, a chronic inflammatory skin condition. It works by reducing inflammation and improving the skin barrier function. Roflumilast cream is applied to the affected areas of skin twice daily, usually in the morning and evening. It is important to use the cream as directed by your healthcare provider to achieve the best results.",
    "vicuna-7b_fact_raw": "1. Roflumilast cream is used to treat atopic dermatitis.\n2. Atopic dermatitis is a chronic inflammatory skin condition.\n3. Roflumilast cream works by reducing inflammation and improving skin barrier function.\n4. Roflumilast cream is typically applied to the affected areas of skin twice daily.\n5. It is recommended to use Roflumilast cream as directed by a healthcare provider.",
    "vicuna-7b_fact": [
      "Roflumilast cream is used to treat atopic dermatitis.",
      "Atopic dermatitis is a chronic inflammatory skin condition.",
      "Roflumilast cream works by reducing inflammation and improving skin barrier function.",
      "Roflumilast cream is typically applied to the affected areas of skin twice daily.",
      "It is recommended to use Roflumilast cream as directed by a healthcare provider."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Roflumilast cream is typically applied to the affected areas of skin once daily.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "vicuna-7b_response": "There are several tools that have been developed for identifying and visualizing ncRNA promoters. Here are some of the most popular ones:\n1. RNAPIII-DB: RNAPIII-DB is a database that provides information about the promoters of RNA polymerase III-transcribed genes, including non-coding RNAs. It provides a comprehensive list of RNA polymerase III promoters, along with their genomic locations and transcription start sites.\n2. ENCODE: ENCODE (Encyclopedia of DNA Elements) is a large-scale project that aims to identify all the functional elements in the human genome. It provides a comprehensive list of non-coding RNA promoters, along with their genomic locations and transcription start sites.\n3. ChIP-seq peaks: ChIP-seq (Chromatin Immunoprecipation Sequencing) is a technique that is used to identify the binding sites of transcription factors and other proteins in the genome. Many tools have been developed to analyze ChIP-seq data, and some of these tools can be used to identify non-coding RNA promoters.\n4. DNase-seq peaks: DNase-seq (DNA Sequencing of Digested Genomic DNA) is a technique that is used to identify the regions of the genome that are accessible to the cell's enzymes. Many tools have been developed to analyze DNase-seq data, and some of these tools can be used to identify non-coding RNA promoters.\n5. Motif-finding tools: Motif-finding tools are software programs that can be used to identify the DNA sequences that are associated with specific transcription factor binding sites. Some of these tools can be used to identify non-coding RNA promoters by identifying the DNA sequences that are associated with RNA polymerase III or other transcription factors that are known to be involved in non-coding RNA transcription.\nOverall, there are many tools available for identifying and visualizing ncRNA promoters. The choice of tool will depend on the specific research question and the type of data that is available.",
    "vicuna-7b_fact_raw": "1. RNAPIII-DB is a database that provides information about the promoters of RNA polymerase III-transcribed genes, including non-coding RNAs.\n2. ENCODE (Encyclopedia of DNA Elements) is a project that aims to identify all functional elements in the human genome and provides information on non-coding RNA promoters.\n3. ChIP-seq is a technique used to identify the binding sites of transcription factors and other proteins in the genome, and tools developed for ChIP-seq data analysis can identify non-coding RNA promoters.\n4. DNase-seq is a technique used to identify regions of the genome that are accessible to enzymes, and tools developed for DNase-seq data analysis can identify non-coding RNA promoters.\n5. Motif-finding tools are software programs that can identify DNA sequences associated with specific transcription factor binding sites and can be used to identify non-coding RNA promoters.",
    "vicuna-7b_fact": [
      "RNAPIII-DB is a database that provides information about the promoters of RNA polymerase III-transcribed genes, including non-coding RNAs.",
      "ENCODE (Encyclopedia of DNA Elements) is a project that aims to identify all functional elements in the human genome and provides information on non-coding RNA promoters.",
      "ChIP-seq is a technique used to identify the binding sites of transcription factors and other proteins in the genome, and tools developed for ChIP-seq data analysis can identify non-coding RNA promoters.",
      "DNase-seq is a technique used to identify regions of the genome that are accessible to enzymes, and tools developed for DNase-seq data analysis can identify non-coding RNA promoters.",
      "Motif-finding tools are software programs that can identify DNA sequences associated with specific transcription factor binding sites and can be used to identify non-coding RNA promoters."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll statements are generally true given the context provided:\n\n1. RNAPIII-DB is indeed a database that focuses on RNA polymerase III-transcribed genes, which include non-coding RNAs.\n2. ENCODE is a project that aims to catalog all functional elements in the human genome, which would include information on non-coding RNA promoters.\n3. ChIP-seq is a technique used to map protein-DNA interactions, which can be used to identify the binding sites of transcription factors at non-coding RNA promoters.\n4. DNase-seq identifies regions of open chromatin which can be indicative of regulatory elements, including non-coding RNA promoters.\n5. Motif-finding tools search for DNA sequence patterns that are likely to be transcription factor binding sites, which can be used to infer locations of non-coding RNA promoters.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "vicuna-7b_response": "The SWIM tool is a computational tool that uses a machine learning algorithm to identify genes that are differentially expressed between glioblastoma (GBM) and normal brain tissue. Here are some examples of genes that the SWIM tool has identified as being down-regulated in GBM:\n1. TP53: This gene is a tumor suppressor gene that is frequently inactivated in GBM. The SWIM tool has identified TP53 as being down-regulated in GBM.\n2. PTEN: This gene is a phosphatase and tensin homolog deleted on chromosome 10 that is involved in regulating cell growth and survival. The SWIM tool has identified PTEN as being down-regulated in GBM.\n3. CDKN2A: This gene is a tumor suppressor gene that encodes a protein that regulates the G1 phase of the cell cycle. The SWIM tool has identified CDKN2A as being down-regulated in GBM.\n4. SMAD4: This gene encodes a protein that is involved in the TGF-beta signaling pathway, which plays a role in cell growth and differentiation. The SWIM tool has identified SMAD4 as being down-regulated in GBM.\n5. PTCH1: This gene encodes a protein that is involved in the Wnt signaling pathway, which plays a role in cell growth and differentiation. The SWIM tool has identified PTCH1 as being down-regulated in GBM.\n6. CDK4: This gene encodes a protein that is involved in the G1 phase of the cell cycle and is a target of the CDK4/6 inhibitor palbociclib, which is used to treat GBM. The SWIM tool has identified CDK4 as being down-regulated in GBM.\n7. ESR1: This gene encodes the estrogen receptor alpha, which is a transcription factor that plays a role in regulating cell growth and differentiation. The SWIM tool has identified ESR1 as being down-regulated in GBM.\nThese are just a few examples of the genes that the SWIM tool has identified as being down-regulated in GBM. The tool has identified a large number of genes that",
    "vicuna-7b_fact_raw": "1. The SWIM tool identified TP53 as being down-regulated in glioblastoma (GBM).\n2. The SWIM tool identified PTEN as being down-regulated in glioblastoma (GBM).\n3. The SWIM tool identified CDKN2A as being down-regulated in glioblastoma (GBM).\n4. The SWIM tool identified SMAD4 as being down-regulated in glioblastoma (GBM).\n5. The SWIM tool identified PTCH1 as being down-regulated in glioblastoma (GBM).",
    "vicuna-7b_fact": [
      "The SWIM tool identified TP53 as being down-regulated in glioblastoma (GBM).",
      "The SWIM tool identified PTEN as being down-regulated in glioblastoma (GBM).",
      "The SWIM tool identified CDKN2A as being down-regulated in glioblastoma (GBM).",
      "The SWIM tool identified SMAD4 as being down-regulated in glioblastoma (GBM).",
      "The SWIM tool identified PTCH1 as being down-regulated in glioblastoma (GBM)."
    ],
    "vicuna-7b_judge_raw": "UNKNOWN\n\nThe provided statements refer to the SWIM tool's identification of certain genes as being down-regulated in glioblastoma (GBM). Without specific data or results from the SWIM tool, it is not possible to verify the accuracy of these statements. The SWIM (Survival Weighted by the Impact of Mutations) tool is a bioinformatics tool that can be used to analyze gene expression and mutation data, but the outcomes of such analyses are specific to the datasets used and the parameters set during the analysis. Therefore, without access to the specific study or results that these statements are based on, their truthfulness cannot be determined.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "vicuna-7b_response": "There are several R packages that have been developed for studying TADs (transcriptional activity domains). Some of these packages include:\n1. TADs: This package provides a set of functions for analyzing TADs in genomic data. It includes functions for identifying TADs, calculating TAD size, and visualizing TAD patterns.\n2. TADmap: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n3. TADtools: This package provides a set of functions for analyzing TADs in genomic data. It includes functions for identifying TADs, calculating TAD size, and visualizing TAD patterns.\n4. TADview: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n5. TADplot: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n6. TADplotR: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n7. TADplotter: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n8. TADplotterR: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n9. TADviewR: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\n10. TADview: This package provides a set of functions for visualizing TADs in genomic data. It includes functions for creating heatmaps, track plots, and other visualizations of TAD patterns.\nThese packages are widely used in the field of genomics and are known for their accuracy and ease of use",
    "vicuna-7b_fact_raw": "1. The R package \"TADs\" provides functions for analyzing transcriptional activity domains in genomic data.\n2. \"TADmap\" is an R package designed for visualizing transcriptional activity domains.\n3. \"TADtools\" is an R package that includes functions for identifying and calculating the size of transcriptional activity domains.\n4. \"TADview\" is an R package that offers functions for creating various visualizations of transcriptional activity domains.\n5. \"TADplot\" is an R package that provides functions for creating heatmaps and track plots to visualize transcriptional activity domains.",
    "vicuna-7b_fact": [
      "The R package \"TADs\" provides functions for analyzing transcriptional activity domains in genomic data.",
      "\"TADmap\" is an R package designed for visualizing transcriptional activity domains.",
      "\"TADtools\" is an R package that includes functions for identifying and calculating the size of transcriptional activity domains.",
      "\"TADview\" is an R package that offers functions for creating various visualizations of transcriptional activity domains.",
      "\"TADplot\" is an R package that provides functions for creating heatmaps and track plots to visualize transcriptional activity domains."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN: Without specific information about the R package \"TADs,\" it is not possible to confirm whether it provides functions for analyzing transcriptional activity domains in genomic data.\n2. UNKNOWN: The existence and purpose of an R package named \"TADmap\" cannot be confirmed without additional information.\n3. UNKNOWN: Without further context, it is not possible to verify the functions included in the \"TADtools\" R package.\n4. UNKNOWN: The description of \"TADview\" as an R package cannot be confirmed without more information.\n5. UNKNOWN: There is not enough information to determine the accuracy of the statement regarding the \"TADplot\" R package.\n\nNote: The statements provided are very specific to certain R packages and their functionalities. Without access to a current database of R packages and their documentation, it is not possible to verify these statements. Users interested in these packages should consult the official R package repositories or documentation for accurate information.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "vicuna-7b_response": "One bioconductor tool that has been developed for accessing bacterial regulatory networks is the \"BioNetGen\" package. This package allows users to build and analyze regulatory networks for bacteria using a variety of data types, including gene expression data, DNA sequence data, and protein-protein interaction data. The package provides a range of tools for building and analyzing regulatory networks, including tools for identifying regulatory relationships between genes, predicting the effects of mutations on gene expression, and simulating the behavior of regulatory networks under different conditions. Overall, BioNetGen is a powerful tool for studying bacterial regulatory networks and understanding how they contribute to the behavior and function of bacteria.",
    "vicuna-7b_fact_raw": "1. The \"BioNetGen\" package is a bioconductor tool developed for accessing bacterial regulatory networks.\n2. BioNetGen allows users to build and analyze regulatory networks for bacteria.\n3. The package can utilize gene expression data, DNA sequence data, and protein-protein interaction data.\n4. BioNetGen includes tools for identifying regulatory relationships between genes.\n5. The package can predict the effects of mutations on gene expression and simulate the behavior of regulatory networks under different conditions.",
    "vicuna-7b_fact": [
      "The \"BioNetGen\" package is a bioconductor tool developed for accessing bacterial regulatory networks.",
      "BioNetGen allows users to build and analyze regulatory networks for bacteria.",
      "The package can utilize gene expression data, DNA sequence data, and protein-protein interaction data.",
      "BioNetGen includes tools for identifying regulatory relationships between genes.",
      "The package can predict the effects of mutations on gene expression and simulate the behavior of regulatory networks under different conditions."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: BioNetGen is not a bioconductor tool for accessing bacterial regulatory networks; it is a software for rule-based modeling of biochemical systems.\n2. FALSE [correction]: BioNetGen is not specifically designed for building and analyzing regulatory networks for bacteria; it is used for modeling biochemical systems more generally.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE (assuming the context is about BioNetGen's capabilities in modeling biochemical systems, which can include simulating the behavior of regulatory networks under different conditions).",
    "vicuna-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "vicuna-7b_response": "The shikimate pathway is a metabolic pathway that produces aromatic amino acids, which are the building blocks of proteins. The end products of the shikimate pathway are the aromatic amino acids: phenylalanine, tyrosine, and tryptophan. These amino acids are essential for the growth and survival of all living organisms, including bacteria, archaea, and eukaryotes.\nPhenylalanine is used to produce tyrosine, which is then used to produce the catecholamine neurotransmitters, such as dopamine, norepinephrine, and epinephrine. These neurotransmitters play important roles in the regulation of mood, appetite, and the body's response to stress. Tyrosine is also used to produce L-DOPA, which is used to treat Parkinson's disease.\nTryptophan is used to produce the neurotransmitter serotonin, which is involved in regulating mood, appetite, and sleep. Tryptophan is also used to produce melatonin, which regulates the body's sleep-wake cycle.\nIn summary, the end products of the shikimate pathway are the aromatic amino acids phenylalanine, tyrosine, and tryptophan, which are essential for the growth and survival of all living organisms. These amino acids are used to produce the catecholamine neurotransmitters and the neurotransmitter serotonin, which play important roles in regulating mood, appetite, and sleep.",
    "vicuna-7b_fact_raw": "1. The shikimate pathway produces aromatic amino acids: phenylalanine, tyrosine, and tryptophan.\n2. Phenylalanine is used to produce tyrosine.\n3. Tyrosine is used to produce catecholamine neurotransmitters such as dopamine, norepinephrine, and epinephrine.\n4. Tyrosine is also used to produce L-DOPA, which is used to treat Parkinson's disease.\n5. Tryptophan is used to produce the neurotransmitter serotonin and the hormone melatonin.",
    "vicuna-7b_fact": [
      "The shikimate pathway produces aromatic amino acids: phenylalanine, tyrosine, and tryptophan.",
      "Phenylalanine is used to produce tyrosine.",
      "Tyrosine is used to produce catecholamine neurotransmitters such as dopamine, norepinephrine, and epinephrine.",
      "Tyrosine is also used to produce L-DOPA, which is used to treat Parkinson's disease.",
      "Tryptophan is used to produce the neurotransmitter serotonin and the hormone melatonin."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "vicuna-7b_response": "Yes, cabergoline is used for the treatment of Nelson's syndrome.\nNelson's syndrome is a rare condition that occurs in patients with a history of prostate cancer and the excessive production of prolactin, a hormone that is responsible for the growth and development of the prostate gland. Cabergoline is a dopamine agonist that is used to reduce the production of prolactin in the body. By reducing the levels of prolactin, cabergoline can help to control the growth of the prostate gland and relieve symptoms associated with Nelson's syndrome, such as high blood pressure, impotence, and urinary retention.\nCabergoline is typically administered as an oral medication, and the dosage and duration of treatment will depend on the individual patient and the severity of their symptoms. It is important to note that cabergoline is not a cure for Nelson's syndrome, and it may take several months to see the full benefits of the medication.\nIn addition to cabergoline, other treatments for Nelson's syndrome may include surgery, radiation therapy, or hormone therapy. It is important to work closely with your healthcare provider to determine the most appropriate treatment plan for your individual needs.",
    "vicuna-7b_fact_raw": "1. Cabergoline is used for the treatment of Nelson's syndrome.\n2. Nelson's syndrome is a rare condition that occurs in patients with a history of prostate cancer.\n3. Cabergoline is a dopamine agonist that reduces the production of prolactin in the body.\n4. Cabergoline is administered as an oral medication.\n5. Treatments for Nelson's syndrome may include surgery, radiation therapy, or hormone therapy.",
    "vicuna-7b_fact": [
      "Cabergoline is used for the treatment of Nelson's syndrome.",
      "Nelson's syndrome is a rare condition that occurs in patients with a history of prostate cancer.",
      "Cabergoline is a dopamine agonist that reduces the production of prolactin in the body.",
      "Cabergoline is administered as an oral medication.",
      "Treatments for Nelson's syndrome may include surgery, radiation therapy, or hormone therapy."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Cabergoline is not typically used for the treatment of Nelson's syndrome; it is used for conditions associated with hyperprolactinemia, such as prolactinomas.\n2. FALSE [correction]: Nelson's syndrome is a rare condition that occurs in some patients who have had their adrenal glands removed due to Cushing's disease, not prostate cancer.\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "vicuna-7b_response": "Liebenberg syndrome is a rare genetic disorder characterized by a combination of physical and developmental abnormalities. The main manifestation of Liebenberg syndrome is a set of distinct physical features that are present in most individuals with the condition. These features include:\n1. Short stature: People with Liebenberg syndrome are typically shorter than average, with a height that is below the 3rd percentile for their age.\n2. Craniofacial abnormalities: Liebenberg syndrome is characterized by a distinctive facial appearance, including a broad and flat face, a prominent forehead, and a small jaw.\n3. Brachycephaly: Liebenberg syndrome is also associated with a broad and flat skull, which is characterized by a short and broad forehead, a prominent supraorbital ridge, and a short and broad occiput.\n4. Low-set and malformed ears: People with Liebenberg syndrome often have low-set and malformed ears that are positioned closer to the head than normal.\n5. Narrow chest and abnormal ribs: Liebenberg syndrome is associated with a narrow chest and abnormalities of the ribs, which can lead to difficulty breathing and feeding.\n6. Gastrointestinal abnormalities: Liebenberg syndrome is also associated with gastrointestinal abnormalities, including an atretic or imperforate anus, and a small or absent colon.\n7. Genital and urinary abnormalities: Liebenberg syndrome can also be associated with genital and urinary abnormalities, including hypospadias (a congenital abnormality of the penis), and a small or absent urethra.\nIt's important to note that the severity of these symptoms can vary from person to person, and some individuals with Liebenberg syndrome may have only a few of these physical features. Additionally, some individuals with Liebenberg syndrome may have other medical conditions or developmental delays, which can further impact their health and well-being.",
    "vicuna-7b_fact_raw": "1. Liebenberg syndrome is a rare genetic disorder characterized by a combination of physical and developmental abnormalities.\n2. Individuals with Liebenberg syndrome typically have a height that is below the 3rd percentile for their age.\n3. Liebenberg syndrome is characterized by craniofacial abnormalities, including a broad and flat face, a prominent forehead, and a small jaw.\n4. People with Liebenberg syndrome often have low-set and malformed ears.\n5. Liebenberg syndrome can be associated with gastrointestinal abnormalities, including an atretic or imperforate anus, and a small or absent colon.",
    "vicuna-7b_fact": [
      "Liebenberg syndrome is a rare genetic disorder characterized by a combination of physical and developmental abnormalities.",
      "Individuals with Liebenberg syndrome typically have a height that is below the 3rd percentile for their age.",
      "Liebenberg syndrome is characterized by craniofacial abnormalities, including a broad and flat face, a prominent forehead, and a small jaw.",
      "People with Liebenberg syndrome often have low-set and malformed ears.",
      "Liebenberg syndrome can be associated with gastrointestinal abnormalities, including an atretic or imperforate anus, and a small or absent colon."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe provided statements pertain to a condition called \"Liebenberg syndrome,\" which is not a widely recognized or established medical condition as of my knowledge cutoff date in 2023. Without a reliable source or context to confirm the existence and characteristics of such a syndrome, it is not possible to determine the truthfulness of these statements. If \"Liebenberg syndrome\" is a fictional or hypothetical condition, or if it is a very recent discovery not yet widely documented, then the information provided cannot be verified.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "vicuna-7b_response": "Sure, here are some oral bioavailable MPS1 kinase inhibitors:\n1. BAY 53-5538 (Nexavar)\n2. TAS-102 (Xeloda)\n3. MK-8628 (Merck)\n4. GSK2879582 (GlaxoSmithKline)\n5. BAY 1439022 (Bayer)\n6. GSK1070885 (GlaxoSmithKline)\n7. MK-8629 (Merck)\n8. BAY 1841285 (Bayer)\n9. GSK2879571 (GlaxoSmithKline)\n10. MK-8627 (Merck)\nNote: This list is not exhaustive and there may be other oral bioavailable MPS1 kinase inhibitors not listed here.",
    "vicuna-7b_fact_raw": "1. BAY 53-5538 is an orally bioavailable MPS1 kinase inhibitor.\n2. TAS-102 is an orally bioavailable MPS1 kinase inhibitor.\n3. MK-8628 is an orally bioavailable MPS1 kinase inhibitor.\n4. GSK2879582 is an orally bioavailable MPS1 kinase inhibitor.\n5. BAY 1439022 is an orally bioavailable MPS1 kinase inhibitor.",
    "vicuna-7b_fact": [
      "BAY 53-5538 is an orally bioavailable MPS1 kinase inhibitor.",
      "TAS-102 is an orally bioavailable MPS1 kinase inhibitor.",
      "MK-8628 is an orally bioavailable MPS1 kinase inhibitor.",
      "GSK2879582 is an orally bioavailable MPS1 kinase inhibitor.",
      "BAY 1439022 is an orally bioavailable MPS1 kinase inhibitor."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: TAS-102 is not an MPS1 kinase inhibitor; it is a combination of trifluridine and tipiracil that targets thymidine phosphorylase and is used as an antineoplastic agent.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe correctness of statements 1, 3, 4, and 5 regarding the specificity of BAY 53-5538, MK-8628, GSK2879582, and BAY 1439022 as MPS1 kinase inhibitors cannot be determined without additional context or specific scientific references.",
    "vicuna-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "vicuna-7b_response": "Yes, golimumab, also known as Simponi, has been tested for its potential to cause or worsen diabetes.\nGolimumab is a biologic drug that is used to treat various autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking the action of a protein called tumor necrosis factor (TNF), which is involved in the immune system's response to inflammation.\nThere have been several studies that have investigated the potential for golimumab to cause or worsen diabetes. One study, published in the journal Diabetes Care in 2012, found that golimumab was associated with an increased risk of developing diabetes compared to placebo. The study followed over 1,000 patients with rheumatoid arthritis for one year and found that 1.5% of patients treated with golimumab developed diabetes, compared to 0.7% of patients who received placebo.\nAnother study, published in the journal Arthritis Care & Research in 2015, found that golimumab was associated with an increased risk of developing diabetes in patients with psoriatic arthritis. The study followed over 300 patients with psoriatic arthritis for one year and found that 4.3% of patients treated with golimumab developed diabetes, compared to 1.5% of patients who received placebo.\nIt is important to note that the risk of developing diabetes with golimumab is generally low, and the drug is still considered a useful treatment option for many patients with autoimmune diseases. However, patients should be monitored for signs of diabetes while taking golimumab and may need to have their blood sugar levels checked regularly.",
    "vicuna-7b_fact_raw": "1. Golimumab has been tested for its potential to cause or worsen diabetes.\n2. Golimumab is used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.\n3. A study published in the journal Diabetes Care in 2012 found that golimumab was associated with an increased risk of developing diabetes compared to placebo.\n4. In the 2012 study, 1.5% of patients treated with golimumab developed diabetes, compared to 0.7% of patients who received placebo.\n5. A study published in the journal Arthritis Care & Research in 2015 found that 4.3% of patients with psoriatic arthritis treated with golimumab developed diabetes, compared to 1.5% of patients who received placebo.",
    "vicuna-7b_fact": [
      "Golimumab has been tested for its potential to cause or worsen diabetes.",
      "Golimumab is used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.",
      "A study published in the journal Diabetes Care in 2012 found that golimumab was associated with an increased risk of developing diabetes compared to placebo.",
      "In the 2012 study, 1.5% of patients treated with golimumab developed diabetes, compared to 0.7% of patients who received placebo.",
      "A study published in the journal Arthritis Care & Research in 2015 found that 4.3% of patients with psoriatic arthritis treated with golimumab developed diabetes, compared to 1.5% of patients who received placebo."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: There is no evidence provided that such a study exists or that it found golimumab was associated with an increased risk of developing diabetes. Without specific evidence or a reference to this study, the statement cannot be verified.\n4. FALSE [correction]: As the previous statement about the 2012 study is incorrect or unverified, this specific statistic cannot be confirmed and is therefore considered false.\n5. FALSE [correction]: Without specific evidence or a reference to this study, the statement about the 2015 study and the percentages of patients who developed diabetes cannot be verified and is therefore considered false.",
    "vicuna-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "vicuna-7b_response": "Progeria is a rare genetic disorder that affects children and causes them to age rapidly. It is caused by a mutation in the LMNA gene, which is located on chromosome 18. This mutation results in the production of a defective protein called lamin A, which is responsible for maintaining the structure of the cell's nucleus.\nThe LMNA gene is inherited in an autosomal recessive pattern, which means that a child must inherit two copies of the mutated gene, one from each parent, to develop progeria. If a child only inherits one copy of the mutated gene from one parent, they will not develop progeria but will be a carrier of the condition.\nProgeria is a very rare disorder, affecting only about 1 in every 4-8 million children born worldwide. Despite its rarity, progeria has gained significant attention due to the efforts of the Progeria Research Foundation, which was founded in 1999 to support research into the condition and find a cure.",
    "vicuna-7b_fact_raw": "1. Progeria is caused by a mutation in the LMNA gene.\n2. The LMNA gene is located on chromosome 18.\n3. The mutation in the LMNA gene results in the production of a defective protein called lamin A.\n4. The LMNA gene is inherited in an autosomal recessive pattern.\n5. Progeria affects about 1 in every 4-8 million children born worldwide.",
    "vicuna-7b_fact": [
      "Progeria is caused by a mutation in the LMNA gene.",
      "The LMNA gene is located on chromosome 18.",
      "The mutation in the LMNA gene results in the production of a defective protein called lamin A.",
      "The LMNA gene is inherited in an autosomal recessive pattern.",
      "Progeria affects about 1 in every 4-8 million children born worldwide."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The LMNA gene is located on chromosome 1.\n3. TRUE\n4. FALSE [correction]: The LMNA gene mutation that causes progeria is typically not inherited but occurs as a new (sporadic) mutation. Progeria follows an autosomal dominant pattern when it is inherited, which is extremely rare.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "vicuna-7b_response": "Common variants at 12q14 and 12q24 have been associated with various traits and diseases.\nAt 12q14, a region known as 12q14.11 has been associated with several traits and diseases. One of the most well-known associations is with schizophrenia, where variants in this region have been found to be associated with an increased risk of developing the disorder. Other associations include with bipolar disorder, autism, and attention deficit hyperactivity disorder (ADHD).\nAt 12q24, a region known as 12q24.31 has been associated with several traits and diseases. One of the most well-known associations is with Alzheimer's disease, where variants in this region have been found to be associated with an increased risk of developing the disorder. Other associations include with type 2 diabetes, obesity, and cardiovascular disease.\nIt's important to note that these associations are complex and not all variants in these regions are associated with the same trait or disease. Further research is needed to fully understand the role of these variants in disease development and progression.",
    "vicuna-7b_fact_raw": "1. Variants at 12q14 have been associated with an increased risk of developing schizophrenia.\n2. Variants at 12q14 have also been linked to bipolar disorder, autism, and ADHD.\n3. Variants at 12q24 have been associated with an increased risk of developing Alzheimer's disease.\n4. Variants at 12q24 have also been linked to type 2 diabetes, obesity, and cardiovascular disease.\n5. Not all variants in the regions 12q14 and 12q24 are associated with the same trait or disease.",
    "vicuna-7b_fact": [
      "Variants at 12q14 have been associated with an increased risk of developing schizophrenia.",
      "Variants at 12q14 have also been linked to bipolar disorder, autism, and ADHD.",
      "Variants at 12q24 have been associated with an increased risk of developing Alzheimer's disease.",
      "Variants at 12q24 have also been linked to type 2 diabetes, obesity, and cardiovascular disease.",
      "Not all variants in the regions 12q14 and 12q24 are associated with the same trait or disease."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nThe statements about the associations between genetic variants at specific chromosomal locations (12q14 and 12q24) and various diseases are highly specific and would require access to current and reliable scientific research to verify. Without the specific research studies or data, it is not possible to confirm the accuracy of statements 1-4. However, statement 5 is generally true as not all genetic variants in a given chromosomal region are associated with the same trait or disease due to the complexity of genetics and the influence of multiple genes and environmental factors on most traits and diseases.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "vicuna-7b_response": "The Roundabout (Robo) receptors are G protein-coupled receptors that play a role in the guidance of axon growth and guidance during development. The ligands of the Roundabout receptors are a group of proteins called the Slit family.\nThe Slit family of proteins are secreted proteins that are expressed in the developing nervous system and are known to inhibit axon growth and guidance. The Slit proteins bind to the Roundabout receptors and activate them, leading to the inhibition of axon growth and guidance.\nIn addition to Slit, there are other ligands that have been identified to bind to Roundabout receptors, such as the Netrin family of proteins, which also play a role in axon guidance.\nIt is important to note that the function of Roundabout receptors and their ligands is not limited to developmental processes, and they are also involved in the regulation of axon guidance in the adult nervous system.\nIn summary, the ligands of the Roundabout (Robo) receptors are the Slit family of proteins, which are secreted proteins that inhibit axon growth and guidance. In addition to Slit, other ligands such as Netrin have also been identified to bind to Roundabout receptors.",
    "vicuna-7b_fact_raw": "1. The ligands of the Roundabout (Robo) receptors include the Slit family of proteins.\n2. The Slit family of proteins are secreted and expressed in the developing nervous system.\n3. Slit proteins bind to Roundabout receptors and activate them.\n4. The Netrin family of proteins has been identified as additional ligands that bind to Roundabout receptors.\n5. Roundabout receptors and their ligands are involved in the regulation of axon guidance in both the developing and adult nervous system.",
    "vicuna-7b_fact": [
      "The ligands of the Roundabout (Robo) receptors include the Slit family of proteins.",
      "The Slit family of proteins are secreted and expressed in the developing nervous system.",
      "Slit proteins bind to Roundabout receptors and activate them.",
      "The Netrin family of proteins has been identified as additional ligands that bind to Roundabout receptors.",
      "Roundabout receptors and their ligands are involved in the regulation of axon guidance in both the developing and adult nervous system."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The Netrin family of proteins binds to DCC (Deleted in Colorectal Cancer) and UNC5 receptors, not Roundabout receptors.\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "vicuna-7b_response": "Yes, TFII-I plays a role in megakaryopoiesis. TFII-I is a transcription factor that is involved in the regulation of gene expression. In the process of megakaryopoiesis, TFII-I is recruited to the promoter region of the genes that are involved in the differentiation of megakaryocytes. TFII-I helps to activate the transcription of these genes, which is necessary for the proper development of megakaryocytes.\nMegakaryocytes are a type of blood cell that are responsible for producing platelets. Platelets are important for blood clotting and for preventing bleeding. In order for megakaryocytes to differentiate and become fully functional platelets, they must undergo a process called maturation. This process is regulated by a number of different genes, and TFII-I plays a role in the regulation of these genes.\nOverall, TFII-I is an important factor in the development and maturation of megakaryocytes, and is therefore involved in the process of megakaryopoiesis.",
    "vicuna-7b_fact_raw": "1. TFII-I is a transcription factor involved in the regulation of gene expression.\n2. TFII-I is recruited to the promoter region of genes involved in the differentiation of megakaryocytes during megakaryopoiesis.\n3. TFII-I activates the transcription of genes necessary for the proper development of megakaryocytes.\n4. Megakaryocytes are responsible for producing platelets.\n5. Platelets are important for blood clotting and preventing bleeding.",
    "vicuna-7b_fact": [
      "TFII-I is a transcription factor involved in the regulation of gene expression.",
      "TFII-I is recruited to the promoter region of genes involved in the differentiation of megakaryocytes during megakaryopoiesis.",
      "TFII-I activates the transcription of genes necessary for the proper development of megakaryocytes.",
      "Megakaryocytes are responsible for producing platelets.",
      "Platelets are important for blood clotting and preventing bleeding."
    ],
    "vicuna-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "vicuna-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "vicuna-7b_response": "Yes, atenolol is metabolized by CYP2D6. Atenolol is a beta-blocker medication that is used to treat hypertension, angina, and heart failure. It is a substrate of CYP2D6, which is an enzyme that is responsible for the metabolism of a number of drugs, including beta-blockers.\nCYP2D6 is a polymorphic enzyme, which means that it can vary in its activity among individuals. Some people have two copies of the active form of the enzyme (extensive metabolizers), while others have one copy of the active form and one copy of a less active form (intermediate metabolizers), and still others have two copies of the less active form (poor metabolizers). This can affect the rate at which atenolol is metabolized and can lead to variations in the efficacy and side effects of the medication.\nIn summary, atenolol is metabolized by CYP2D6, which is an enzyme that is responsible for the metabolism of a number of drugs, including beta-blockers. The metabolism of atenolol can be affected by the activity of CYP2D6, which can vary among individuals.",
    "vicuna-7b_fact_raw": "1. Atenolol is metabolized by the enzyme CYP2D6.\n2. Atenolol is used to treat hypertension, angina, and heart failure.\n3. CYP2D6 is responsible for the metabolism of various drugs, including beta-blockers.\n4. CYP2D6 is a polymorphic enzyme, meaning its activity can vary among individuals.\n5. Variations in CYP2D6 activity can affect the rate at which atenolol is metabolized, influencing the drug's efficacy and side effects.",
    "vicuna-7b_fact": [
      "Atenolol is metabolized by the enzyme CYP2D6.",
      "Atenolol is used to treat hypertension, angina, and heart failure.",
      "CYP2D6 is responsible for the metabolism of various drugs, including beta-blockers.",
      "CYP2D6 is a polymorphic enzyme, meaning its activity can vary among individuals.",
      "Variations in CYP2D6 activity can affect the rate at which atenolol is metabolized, influencing the drug's efficacy and side effects."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Atenolol is not significantly metabolized by the liver and is excreted primarily unchanged in the urine. It is not metabolized by the enzyme CYP2D6.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Since atenolol is not significantly metabolized by CYP2D6, variations in CYP2D6 activity would not typically affect the rate at which atenolol is metabolized. However, variations in renal function can influence the drug's efficacy and side effects, as atenolol is excreted primarily by the kidneys.",
    "vicuna-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "vicuna-7b_response": "ExpansionHunter is a tool that allows users to monitor and analyze the performance of their Expansion Tanks. It provides real-time data on the temperature, pressure, and volume of the water in the tank, as well as alerts for any potential issues.\nThere are several versions of ExpansionHunter available, including:\n1. ExpansionHunter Pro: This version is designed for commercial and industrial applications, and provides advanced features such as remote monitoring and alerts, customizable alert thresholds, and data export options.\n2. ExpansionHunter Lite: This version is a simplified version of ExpansionHunter Pro, and is designed for residential use. It provides basic features such as temperature and pressure monitoring, and alerts for low water levels.\n3. ExpansionHunter Cloud: This version allows users to access their ExpansionHunter data and alerts from anywhere, using a web browser or mobile device. It also provides real-time data and alerts, and allows users to customize alert thresholds and data export options.\n4. ExpansionHunter API: This version allows developers to integrate ExpansionHunter data and alerts into their own applications, using the ExpansionHunter API. It provides real-time data and alerts, and allows developers to customize alert thresholds and data export options.\nOverall, ExpansionHunter is a powerful tool for monitoring and analyzing the performance of Expansion Tanks, and there are several versions available to meet the needs of different users and applications.",
    "vicuna-7b_fact_raw": "1. ExpansionHunter Pro is designed for commercial and industrial applications.\n2. ExpansionHunter Lite is designed for residential use.\n3. ExpansionHunter Cloud allows users to access data and alerts from anywhere using a web browser or mobile device.\n4. ExpansionHunter API allows developers to integrate ExpansionHunter data into their own applications.",
    "vicuna-7b_fact": [
      "ExpansionHunter Pro is designed for commercial and industrial applications.",
      "ExpansionHunter Lite is designed for residential use.",
      "ExpansionHunter Cloud allows users to access data and alerts from anywhere using a web browser or mobile device.",
      "ExpansionHunter API allows developers to integrate ExpansionHunter data into their own applications."
    ],
    "vicuna-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout additional context or information about \"ExpansionHunter\" and its various versions (Pro, Lite, Cloud, API), it is not possible to determine the accuracy of these statements. They could be referring to a hypothetical or real software suite with different editions for different uses, but without specific details, the truthfulness of these statements cannot be assessed.",
    "vicuna-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "vicuna-7b_response": "Adamts18, also known as adamalysin-like protein 18, is a protein that has been shown to play a role in hormone receptor signaling. Specifically, Adamts18 has been shown to regulate the activity of estrogen receptors, which are a type of hormone receptor that plays a key role in the development and progression of breast cancer.\nResearch has shown that Adamts18 can interact with estrogen receptors and affect their ability to bind to estrogen. This interaction can either enhance or inhibit the activity of the estrogen receptor, depending on the specific context in which it occurs.\nIn addition to its role in regulating estrogen receptor activity, Adamts18 has also been shown to play a role in the regulation of other hormone receptors, such as androgen receptors and progesterone receptors.\nOverall, the role of Adamts18 in hormone receptor signaling is complex and multifaceted, and further research is needed to fully understand its functions and mechanisms.",
    "vicuna-7b_fact_raw": "1. Adamts18 is a protein that plays a role in hormone receptor signaling.\n2. Adamts18 has been shown to regulate the activity of estrogen receptors.\n3. Estrogen receptors are involved in the development and progression of breast cancer.\n4. Adamts18 can interact with estrogen receptors and affect their ability to bind to estrogen.\n5. Adamts18 is also involved in the regulation of other hormone receptors, such as androgen receptors and progesterone receptors.",
    "vicuna-7b_fact": [
      "Adamts18 is a protein that plays a role in hormone receptor signaling.",
      "Adamts18 has been shown to regulate the activity of estrogen receptors.",
      "Estrogen receptors are involved in the development and progression of breast cancer.",
      "Adamts18 can interact with estrogen receptors and affect their ability to bind to estrogen.",
      "Adamts18 is also involved in the regulation of other hormone receptors, such as androgen receptors and progesterone receptors."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: ADAMTS18 is a protein that is part of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family, which is known for roles in extracellular matrix organization and possibly angiogenesis, not specifically hormone receptor signaling.\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements regarding ADAMTS18's specific interactions with hormone receptors such as estrogen, androgen, and progesterone receptors are not well-established in the scientific literature as of my last update. ADAMTS proteins are generally known for their roles in the structural organization of the extracellular matrix, not directly in hormone receptor signaling. However, without specific references to research studies or reviews that confirm these interactions, the statements about ADAMTS18's role in hormone receptor regulation cannot be verified.",
    "vicuna-7b_judge": [
      "false",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "vicuna-7b_response": "Thiazovivin is a chemical compound that is used as an insecticide. It works by disrupting the central nervous system of insects, leading to paralysis and death. Thiazovivin is particularly effective against certain types of insects, such as thrips, whitefly, and spider mites, which can be damaging to crops. It is often used in greenhouses and indoor growing environments to control pest infestations.",
    "vicuna-7b_fact_raw": "1. Thiazovivin is used as an insecticide.\n2. Thiazovivin disrupts the central nervous system of insects.\n3. The disruption of the central nervous system by Thiazovivin leads to paralysis and death in insects.\n4. Thiazovivin is particularly effective against thrips, whitefly, and spider mites.\n5. Thiazovivin is often used in greenhouses and indoor growing environments for pest control.",
    "vicuna-7b_fact": [
      "Thiazovivin is used as an insecticide.",
      "Thiazovivin disrupts the central nervous system of insects.",
      "The disruption of the central nervous system by Thiazovivin leads to paralysis and death in insects.",
      "Thiazovivin is particularly effective against thrips, whitefly, and spider mites.",
      "Thiazovivin is often used in greenhouses and indoor growing environments for pest control."
    ],
    "vicuna-7b_judge_raw": "1. FALSE [correction]: Thiazovivin is not used as an insecticide; it is a small molecule inhibitor used to improve the survival of human embryonic stem cells following cryopreservation.\n2. FALSE [correction]: Thiazovivin does not disrupt the central nervous system of insects; it acts on the Rho-associated kinase (ROCK) pathway in human cells.\n3. FALSE [correction]: Thiazovivin does not lead to paralysis and death in insects as it is not an insecticide.\n4. FALSE [correction]: Thiazovivin is not effective against thrips, whitefly, and spider mites because it is not an insecticide.\n5. FALSE [correction]: Thiazovivin is not used in greenhouses and indoor growing environments for pest control; it is used in stem cell research.",
    "vicuna-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  }
]